parent_name,parent_smiles,parent_inchi,metabolite_name,metabolite_smiles,metabolite_inchi,enzymes,fingerprint_similarity,reaction_type
Ademetionine,C[S+](CCC(N)C(=O)[O-])CC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1O,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27?/m0/s1",S-Adenosylhomocysteine,NC1=C2N=CN(C3OC(CSCCC(N)C(=O)O)C(O)C3O)C2=NC=N1,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,,0.98,
Ascorbic acid,O=C1OC(C(O)CO)C(O)=C1O,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,ascorbic acid-2-sulfate,O=C1OC(C(O)CO)C(O)=C1OS(=O)(=O)O,XDBMXUKHMOFBPJ-VVJJHMBFSA-N,,0.65,
Ornithine,NCCCC(N)C(=O)O,AHLPHDHHMVZTML-BYPYZUCNSA-N,L-Arginine,N=C(N)NCCCC(N)C(=O)O,ODKSFYDXXFIFQN-BYPYZUCNSA-N,,0.62,
Ornithine,NCCCC(N)C(=O)O,AHLPHDHHMVZTML-BYPYZUCNSA-N,Proline,O=C(O)C1CCCN1,ONIBWKKTOPOVIA-BYPYZUCNSA-N,,0.57,
Folic acid,NC1=NC(=O)C2=NC(CNC3=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C3)=CN=C2N1,OVBPIULPVIDEAO-LBPRGKRZSA-N,Tetrahydrofolic acid,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C3)N2)N1,"InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11?,12-/m0/s1",Dihydrofolate reductase,0.54,
Cholecalciferol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,QYSXJUFSXHHAJI-YRZJJWOYSA-N,"(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)",C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CC(OC1OC(C(=O)O)C(O)C(O)C1O)C(=O)C(C)(C)O,USYNZBLVOOXNSN-ARRWHRBTSA-N,,0.44,
Cholecalciferol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,QYSXJUFSXHHAJI-YRZJJWOYSA-N,Calcifediol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)(C)O,JWUBBDSIWDLEOM-DTOXIADCSA-N,Vitamin D 25-hydroxylase,0.97,
Calcifediol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)(C)O,JWUBBDSIWDLEOM-DTOXIADCSA-N,Calcitriol,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O,GMRQFYUYWCNGIN-NKMMMXOESA-N,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",0.87,
Fluvoxamine,COCCCCC(=NOCCN)C1=CC=C(C(F)(F)F)C=C1,CJOFXWAVKWHTFT-XSFVSMFZSA-N,fluvoxamino acid,NCCON=C(CCCC(=O)O)C1=CC=C(C(F)(F)F)C=C1,KUIZEDQDELAFQK-XDHOZWIPSA-N,Cytochrome P450 1A2,0.91,
Valsartan,CCCCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1)C(C(=O)O)C(C)C,ACWBQPMHZXGDFX-QFIPXVFZSA-N,Valeryl-4-hydroxyvalsartan,CC(O)CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1)C(C(=O)O)C(C)C,ICSQZMPILLPFKC-XLDIYJRPSA-N,Cytochrome P450 2C9,0.98,
Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,HDACQVRGBOVJII-JBDAPHQKSA-N,Ramiprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1C(C(=O)O)CC2CCCC21,KEDYTOTWMPBSLG-HILJTLORSA-N,Liver esterases,0.92,
Amphetamine,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,Cytochrome P450 2D6,0.73,
Amphetamine,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,Cytochrome P450 2D6,0.61,
Nicotine,CN1CCCC1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,N-Methylnicotinium,CN1CCCC1C1=CC=C[N+](C)=C1,HIOROZIUERMMRQ-UHFFFAOYSA-N,,0.82,
Nicotine,CN1CCCC1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,"Cytochrome P450 2A6, Cytochrome P450 2B6",0.56,
Nicotine,CN1CCCC1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,,0.79,
Nicotine,CN1CCCC1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,Nornicotine,C1=CN=CC(C2CCCN2)=C1,MYKUKUCHPMASKF-UHFFFAOYSA-N,,0.86,
Nicotine,CN1CCCC1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,Nicotine glucuronide,CN1CCCC1C1=C[N+](C2OC(C(=O)[O-])C(O)C(O)C2O)=CC=C1,SAWAIULJDYFLPD-SOAFEQHCSA-N,"UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 1-9",0.38,
Nicotine,CN1CCCC1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,Norcotinine,O=C1CCC(C2=CN=CC=C2)N1,FXFANIORDKRCCA-UHFFFAOYSA-N,,0.73,
Nicotine,CN1CCCC1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,Nicotine-1'-N-oxide,C[N+]1([O-])CCCC1C1=CN=CC=C1,RWFBQHICRCUQJJ-UHFFFAOYSA-N,Dimethylaniline monooxygenase [N-oxide-forming] 3,0.75,
Nicotine,CN1CCCC1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone,CN(CCCC(=O)C1=CC=CN=C1)N=O,FLAQQSHRLBFIEZ-UHFFFAOYSA-N,,0.39,
Nicotine,CN1CCCC1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol,CN(CCCC(O)C1=CN=CC=C1)N=O,OGRXKBUCZFFSTL-UHFFFAOYSA-N,,0.38,
Nicotine,CN1CCCC1C1=CN=CC=C1,SNICXCGAKADSCV-JTQLQIEISA-N,2'-Hydroxynicotine,CN1CCCC1(O)C1=CC=CN=C1,,Cytochrome P450 2A6,0.66,
Lorazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2Cl)=NC1O,DIWRORZWFLOCLC-UHFFFAOYSA-N,Lorazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,IWOJSSFCRQKNKN-IFBJMGMISA-N,,0.52,
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2D6, Cytochrome P450 3A4",0.77,
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,Bortezomib metabolite M34,CC(C)CC(=O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,WREPYMVPDVCLPX-HNNXBMFYSA-N,,0.8,
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,Bortezomib metabolite M23 or M24 (1),CC(C)C=CNC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,ISSYHCZWYPLNBR-FDMDGMSGSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 2D6",0.72,
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,GXJABQQUPOEUTA-RDJZCZTQSA-N,Bortezomib metabolite M23 or M24 (2),CC(C)=CCNC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,HRTUPFKOFWTBTM-INIZCTEOSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 2D6",0.76,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,TZFNLOMSOLWIDK-JTQLQIEISA-N,"3,4-Dihydroxyphenylacetone",CC(=O)CC1=CC(O)=C(O)C=C1,JQXBETDGCMQLMK-UHFFFAOYSA-N,,0.45,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,TZFNLOMSOLWIDK-JTQLQIEISA-N,3-(3-hydroxyphenyl)-2-methyllactic acid,CC(O)(CC1=CC(O)=CC=C1)C(=O)O,DQCFPKHWBJEWFV-UHFFFAOYSA-N,,0.48,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,TZFNLOMSOLWIDK-JTQLQIEISA-N,3-(3-hydroxyphenyl)-2-methylpropionic acid,CC(CC1=CC(O)=CC=C1)C(=O)O,ZTHRBJCNTAYZRE-UHFFFAOYSA-N,,0.57,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,TZFNLOMSOLWIDK-JTQLQIEISA-N,"3-(3,4-dihydroxyphenyl)-2-methylpropionic acid",CC(CC1=CC(O)=C(O)C=C1)C(=O)O,GIIOASILGOFVPI-UHFFFAOYSA-N,,0.67,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,TZFNLOMSOLWIDK-JTQLQIEISA-N,3-(4-hydroxy-3-methoxyphenyl)-2-methyllactic acid,COC1=C(O)C=CC(CC(C)(O)C(=O)O)=C1,YNNLUYGFVUZDAD-UHFFFAOYSA-N,,0.5,
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,TZFNLOMSOLWIDK-JTQLQIEISA-N,3-(4-hydroxy-3-methoxyphenyl)-2-methylpropionic acid,COC1=C(O)C=CC(CC(C)C(=O)O)=C1,XUQXZROVMZNKPO-UHFFFAOYSA-N,,0.59,
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,TVYLLZQTGLZFBW-UHFFFAOYSA-N,O-Desmethyltramadol,CN(C)CC1CCCCC1(O)C1=CC(O)=CC=C1,UWJUQVWARXYRCG-UHFFFAOYSA-N,Cytochrome P450 2D6,0.93,
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,TVYLLZQTGLZFBW-UHFFFAOYSA-N,N-Desmethyltramadol,CNCC1CCCCC1(O)C1=CC(OC)=CC=C1,VUMQHLSPUAFKKK-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6",0.97,
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,RYYVLZVUVIJVGH-UHFFFAOYSA-N,Theobromine,CN1C=NC2=C1C(=O)NC(=O)N2C,"InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)","Cytochrome P450 1A2, Cytochrome P450 2E1",0.9,
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,RYYVLZVUVIJVGH-UHFFFAOYSA-N,Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2E1, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 3A4",0.91,
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,RYYVLZVUVIJVGH-UHFFFAOYSA-N,"1,3,7-Trimethyluric acid",CN1C(=O)C2=C(NC(=O)N2C)N(C)C1=O,BYXCFUMGEBZDDI-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 1A2, Cytochrome P450 2E1",0.95,
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,RYYVLZVUVIJVGH-UHFFFAOYSA-N,"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,Cytochrome P450 1A2,0.85,
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,1-Methylxanthine,CN1C(=O)NC2=C(NC=N2)C1=O,MVOYJPOZRLFTCP-UHFFFAOYSA-N,Cytochrome P450 1A2,0.82,
Sildenafil,CCCC1=NN(C)C2=C1N=C(C1=CC(S(=O)(=O)N3CCN(C)CC3)=CC=C1OCC)NC2=O,BNRNXUUZRGQAQC-UHFFFAOYSA-N,"N-Desmethyl sildenafil (UK-103,320)",CCCC1=NN(C)C2=C1NC(C1=C(OCC)C=CC(S(=O)(=O)N3CCNCC3)=C1)=NC2=O,UZTKBZXHEOVDRL-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2D6, Cytochrome P450 2C9",0.99,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,PHWBOXQYWZNQIN-UHFFFAOYSA-N,2-Chloroticlopidine,ClC1=CC2=C(CCN(CC3=CC=CC=C3Cl)C2)S1,INYHLAYOOFHUNE-UHFFFAOYSA-N,Myeloperoxidase,0.85,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,PHWBOXQYWZNQIN-UHFFFAOYSA-N,2-Oxoticlopidine,O=C1C=C2CN(CC3=CC=CC=C3Cl)CCC2S1,DJZQIXWGIZIETJ-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19",0.32,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,PHWBOXQYWZNQIN-UHFFFAOYSA-N,Thienodihydropyridinium,ClC1=CC=CC=C1CN1C=C2C=C[S+]=C2CC1,RLTCLQFOWWSHJX-UHFFFAOYSA-N,"Myeloperoxidase, Cytochrome P450 3A4",0.32,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,PHWBOXQYWZNQIN-UHFFFAOYSA-N,Ticlopidine S-oxide,O=S1C=CC2=C1CCN(CC1=CC=CC=C1Cl)C2,SSVDYGNPKZJQKO-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2D6",0.33,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,PHWBOXQYWZNQIN-UHFFFAOYSA-N,Dehydrogenated ticlopidine,ClC1=CC=CC=C1CN1C=CC2=C(C=CS2)C1,BNJVHGHQYHAEDJ-UHFFFAOYSA-N,Myeloperoxidase,0.56,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,PHWBOXQYWZNQIN-UHFFFAOYSA-N,Ticlopidine N-oxide,[O-][N+]1(CC2=CC=CC=C2Cl)CCC2=C(C=CS2)C1,YEICEJCPALKCAT-UHFFFAOYSA-N,Myeloperoxidase,0.78,
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,PHWBOXQYWZNQIN-UHFFFAOYSA-N,7-Hydroxyticlopidine,OC1CN(CC2=CC=CC=C2Cl)CC2=C1SC=C2,GWHGEZHHJDSDMI-UHFFFAOYSA-N,,0.8,
Midodrine,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,PTKSEFOSCHHMPD-UHFFFAOYSA-N,desglymidodrine,COC1=CC(C(O)CN)=C(OC)C=C1,VFRCNXKYZVQYLX-UHFFFAOYSA-N,,0.81,
Torasemide,CC1=CC(NC2=C(S(=O)(=O)NC(=O)NC(C)C)C=NC=C2)=CC=C1,NGBFQHCMQULJNZ-UHFFFAOYSA-N,Torasemide M1 (hydroxytorsemide),CC(C)NC(=O)NS(=O)(=O)C1=CNC=CC1=NC1=CC=CC(CO)=C1,WCYVLAMJCQZUCR-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.57,
Eletriptan,CN1CCCC1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,PWVXXGRKLHYWKM-LJQANCHMSA-N,N-Desmethyleletriptan,O=S(=O)(CCC1=CC2=C(C=C1)NC=C2CC1CCCN1)C1=CC=CC=C1,HHTDENYTSCXDFO-GOSISDBHSA-N,"Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19",0.96,
Eletriptan,CN1CCCC1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,PWVXXGRKLHYWKM-LJQANCHMSA-N,Eletriptan N-oxide,C[N+]1([O-])CCCC1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,QXXCIRSBRHOOJE-PHSANKKPSA-N,Prostaglandin G/H synthase 1,0.91,
Glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C)CC3)C=C2)C1=O,WIGIZIANZCJQQY-RUCARUNLSA-N,Cyclohexyl hydroxymethyl glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(CO)CC3)C=C2)C1=O,YUNQMQLWOOVHKI-UHFFFAOYSA-N,Cytochrome P450 2C9,0.97,
Indinavir,CC(C)(C)NC(=O)C1CN(CC2=CN=CC=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(=O)NC1C2=CC=CC=C2CC1O,CBVCZFGXHXORBI-PXQQMZJSSA-N,Metabolite M6,CC(C)(C)N=C(O)C1CNCCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,MKMGKCALCCOODL-GVPWJHIJSA-N,Cytochrome P450 3A4,0.53,
Temazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,SEQDDYPDSLOBDC-UHFFFAOYSA-N,Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19",0.87,
Temazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,SEQDDYPDSLOBDC-UHFFFAOYSA-N,Oxazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,FIKQKGFUBZQEBL-IFBJMGMISA-N,,0.49,
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,12-Hydroxynevirapine,OCC1=C2N=C(O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,SEBABOMFNCVZGF-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 3A5",0.65,
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,2-Hydroxynevirapine,CC1=CC(O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,LFZSOJABLBVGRJ-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.64,
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,8-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC(O)=C3)N(C3CC3)C2=NC=C1,DZPVEPLRIKDBFC-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 2B6, Cytochrome P450 3A4",0.64,
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,NQDJXKOVJZTUJA-UHFFFAOYSA-N,3-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,DANIONWINZEYME-UHFFFAOYSA-N,Cytochrome P450 2B6,0.64,
Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,N-acetyl-5-ASA (Ac-5-ASA),CC(=O)NC1=CC(C(=O)O)=C(O)C=C1,GEFDRROBUCULOD-UHFFFAOYSA-N,Arylamine N-acetyltransferase 1,0.72,
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,MQJKPEGWNLWLTK-UHFFFAOYSA-N,dapsone hydroxylamine,NC1=CC=C(S(=O)(=O)C2=CC=C(NO)C=C2)C=C1,IYDSJDWESCGRKW-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2E1, Cytochrome P450 3A4, Myeloperoxidase, Prostaglandin G/H synthase 2",0.87,
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,MQJKPEGWNLWLTK-UHFFFAOYSA-N,Monoacetyldapsone,CC(=O)NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,WDOCBIHNYYQINH-UHFFFAOYSA-N,Arylamine N-acetyltransferase 2,0.74,
Phenytoin,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC=CC=C2)N1,CXOFVDLJLONNDW-UHFFFAOYSA-N,Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.39,
Anagrelide,O=C1CN2CC3=C(Cl)C(Cl)=CC=C3N=C2N1,OTBXOEAOVRKTNQ-UHFFFAOYSA-N,"6,7-dichloro-3-hydroxy-1,5 dihydro-imidazo[2,1-b]quinazolin-2-one",O=C1NC2=NC3=CC=C(Cl)C(Cl)=C3CN2C1O,KAXTUTDKZVOONF-UHFFFAOYSA-N,Cytochrome P450 1A2,0.85,
"6,7-dichloro-3-hydroxy-1,5 dihydro-imidazo[2,1-b]quinazolin-2-one",O=C1NC2=NC3=CC=C(Cl)C(Cl)=C3CN2C1O,KAXTUTDKZVOONF-UHFFFAOYSA-N,"2-amino-5,6-dichloro-3,4,-dihydroquinazoline",NC1=NCC2=C(C=CC(Cl)=C2Cl)N1,VBKOTIVQMCTTAQ-UHFFFAOYSA-N,Cytochrome P450 1A2,0.4,
Metoprolol,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,IUBSYMUCCVWXPE-UHFFFAOYSA-N,alpha-Hydroxymetoprolol,COCC(O)C1=CC=C(OCC(O)CNC(C)C)C=C1,OFRYBPCSEMMZHR-UHFFFAOYSA-N,Cytochrome P450 2D6,0.83,
Ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,UHSKFQJFRQCDBE-UHFFFAOYSA-N,N-despropyl ropinirole,CCCNCCC1=CC=CC2=C1CC(=O)N2,VKDWFHAQOZYATG-UHFFFAOYSA-N,Cytochrome P450 1A2,0.96,
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,3-methylxanthine,CN1C(=O)NC(=O)C2=C1N=CN2,GMSNIKWWOQHZGF-UHFFFAOYSA-N,Cytochrome P450 1A2,0.86,
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,0.91,
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,"1,3-dimethyluric acid",CN1C(=O)C2=C(NC(=O)N2)N(C)C1=O,OTSBKHHWSQYEHK-UHFFFAOYSA-N,Cytochrome P450 2E1,0.94,
Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,AUYYCJSJGJYCDS-LBPRGKRZSA-N,Monoiodothyronine,NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C=C1)C(=O)O,,,0.88,
Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,AUYYCJSJGJYCDS-LBPRGKRZSA-N,Tiratricol,O=C(O)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1,"InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20)",,0.69,
Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,AUYYCJSJGJYCDS-LBPRGKRZSA-N,Triiodothyronine sulfate,NC(CC1=CC(I)=C(OC2=CC(I)=C(OS(=O)(=O)O)C=C2)C(I)=C1)C(=O)O,XBQYQXVJBNDCGY-LBPRGKRZSA-N,,0.79,
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,UVTNFZQICZKOEM-UHFFFAOYSA-N,mono-isopropyl-disopyramide,CC(C)NCCC(C(=N)O)(C1=CC=CC=C1)C1=CC=CC=N1,UWNSWIXIVDMCHZ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.57,
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,NNJVILVZKWQKPM-UHFFFAOYSA-N,3-hydroxylidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC(O)=C1C,PMGUCIDDSCRAMY-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 3A7",0.72,
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,NNJVILVZKWQKPM-UHFFFAOYSA-N,monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 3A7",0.92,
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,NNJVILVZKWQKPM-UHFFFAOYSA-N,"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,,0.34,
Venlafaxine,COC1=CC=C(C(CN(C)C)C2(O)CCCCC2)C=C1,PNVNVHUZROJLTJ-UHFFFAOYSA-N,Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,KYYIDSXMWOZKMP-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 2C19",0.96,
Venlafaxine,COC1=CC=C(C(CN(C)C)C2(O)CCCCC2)C=C1,PNVNVHUZROJLTJ-UHFFFAOYSA-N,N-Desmethylvenlafaxine,CNCC(C1=CC=C(OC)C=C1)C1(O)CCCCC1,MKAFOJAJJMUXLW-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2C9",0.95,
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,KYYIDSXMWOZKMP-UHFFFAOYSA-N,"N,O-Didesmethylvenlafaxine",CNCC(C1=CC=C(O)C=C1)C1(O)CCCCC1,MMSWXJSQCAEDLK-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2C9",0.95,
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,KYYIDSXMWOZKMP-UHFFFAOYSA-N,O-Desmethylvenlafaxine glucuronide,NCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,VNRFTNKWISCOMJ-KUIQUDTGSA-N,,0.49,
Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N)N=CN=C21)OCOC(=O)OC(C)C,JFVZFKDSXNQEJW-CQSZACIVSA-N,Tenofovir Monophosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)O,BQDRSOMUPPCKPB-ZCFIWIBFSA-N,"Adenylate kinase 2, mitochondrial, Adenylate kinase 4, mitochondrial",0.76,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,RPLCPCMSCLEKRS-BPIQYHPVSA-N,6-alpha-hydroxydesogestrel,C#CC1(O)CCC2C3CC(O)C4=CCCCC4C3C(=C)CC21CC,GHFIULBLMLVLDK-GDLCRWSOSA-N,,0.87,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,RPLCPCMSCLEKRS-BPIQYHPVSA-N,16-hydroxy-desogestrel,C#CC1(O)C(O)CC2C3CCC4=CCCCC4C3C(=C)CC21CC,QGTKZJGOIVJHGG-DVUPJZBUSA-N,,0.85,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,RPLCPCMSCLEKRS-BPIQYHPVSA-N,Desogestrel-17-sulfate,C#CC1(OS(=O)(=O)[O-])CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,XLVAWWOSRWJYBK-BPIQYHPVSA-M,,0.72,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,RPLCPCMSCLEKRS-BPIQYHPVSA-N,15-alpha-hydroxydesogestrel,C#CC1(O)CC(O)C2C3CCC4=CCCCC4C3C(=C)CC21CC,RWVQLLLACWCLQR-YBAWMFKNSA-N,,0.87,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,RPLCPCMSCLEKRS-BPIQYHPVSA-N,2-hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CCC(O)CC4C3C(=C)C(CC)C21,OAJXJBAOKDVIQW-KSVDVDHBSA-N,,0.81,
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,RPLCPCMSCLEKRS-BPIQYHPVSA-N,3alpha-Hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,ZMLDTNLDYRJTAZ-JASYKLOUSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.9,
Valproic acid,CCCC(CCC)C(=O)O,NIJJYAXOARWZEE-UHFFFAOYSA-N,4-ene-Valproic acid,C=CCC(CCC)C(=O)O,UMYDNZXEHYSVFY-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2A6, Cytochrome P450 2B6",0.67,
Valproic acid,CCCC(CCC)C(=O)O,NIJJYAXOARWZEE-UHFFFAOYSA-N,5-Hydroxyvalproic acid,CCCC(CCCO)C(=O)O,ZIWBCJXKYKOLJK-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 2A6, Cytochrome P450 2C9, Cytochrome P450 2B6",0.82,
Valproic acid,CCCC(CCC)C(=O)O,NIJJYAXOARWZEE-UHFFFAOYSA-N,3-Hydroxyvalproic acid,CCCC(C(=O)O)C(O)CC,LLPFTSMZBSRZDV-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 2A6",0.56,
Valproic acid,CCCC(CCC)C(=O)O,NIJJYAXOARWZEE-UHFFFAOYSA-N,4-Hydroxyvalproic acid,CCCC(CC(C)O)C(=O)O,OASKNPCLIHUTTL-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 2A6, Cytochrome P450 2C9, Cytochrome P450 2B6",0.63,
Valproic acid,CCCC(CCC)C(=O)O,NIJJYAXOARWZEE-UHFFFAOYSA-N,2-ene-Valproic acid,CCC=C(CCC)C(=O)O,ZKNJEOBYOLUGKJ-FNORWQNLSA-N,,0.24,
Valproic acid,CCCC(CCC)C(=O)O,NIJJYAXOARWZEE-UHFFFAOYSA-N,(3Z)-2-Propylpent-3-enoic acid (3Z-Ene-VPA),CC=CC(CCC)C(=O)O,WTMAHJABDOHPDJ-HYXAFXHYSA-N,,0.43,
Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,RZVAJINKPMORJF-UHFFFAOYSA-N,Acetaminophen glucuronide,CC(=O)NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,IPROLSVTVHAQLE-BYNIDDHOSA-N,"UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-6, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 1-10",0.22,
Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,RZVAJINKPMORJF-UHFFFAOYSA-N,Acetaminophen sulfate,CC(=O)NC1=CC=C(OS(=O)(=O)O)C=C1,IGTYILLPRJOVFY-UHFFFAOYSA-N,"Sulfotransferase 1A1, Sulfotransferase 1A3/1A4, Bile salt sulfotransferase",0.62,
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,OROGSEYTTFOCAN-DNJOTXNNSA-N,norcodeine,COC1=CC=C2CC3NCCC45C2=C1OC4C(O)C=CC35,HKOIXWVRNLGFOR-KUYPYUECSA-N,Cytochrome P450 3A4,0.98,
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,OROGSEYTTFOCAN-DNJOTXNNSA-N,Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,BQJCRHHNABKAKU-KBQPJGBKSA-N,Cytochrome P450 2D6,0.99,
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,OROGSEYTTFOCAN-DNJOTXNNSA-N,Codeine-6-glucuronide,COC1=CC=C2CC3C4C=CC(OC5OC(C(=O)O)C(O)C(O)C5O)C5OC1=C2C45CCN3C,CRWVOYRJXPDBPM-HSCJLHHPSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B4",0.9,
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2B6, Cytochrome P450 2C8",0.99,
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,KRMDCWKBEZIMAB-UHFFFAOYSA-N,E-10-Hydroxyamitriptyline,CN(C)CCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,GHWBJXOKAFHZAI-SFQUDFHCSA-N,"Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 2B6",0.73,
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,E-10-Hydroxynortriptyline,CNCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,VAGXZGJKNUNLHK-LFIBNONCSA-N,Cytochrome P450 2D6,0.73,
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,Desmethylnortriptyline,NCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PTQFRALDEONNOA-UHFFFAOYSA-N,Cytochrome P450 2C19,0.98,
Floxuridine,O=C1NC(=O)N(C2CC(O)C(CO)O2)C=C1F,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,5-fluorouracil,O=C1NC=C(F)C(=O)N1,GHASVSINZRGABV-UHFFFAOYSA-N,"Thymidine phosphorylase, Cytochrome P450 2A6",0.22,
Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,WVLOADHCBXTIJK-YNHQPCIGSA-N,Hydromorphone-3-glucuronide,CN1CCC23C4=C5C=CC(OC6OC(C(=O)O)C(O)C(O)C6O)=C4OC2C(=O)CCC3C1C5,VLSHIBYUEOPPRX-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 2B7",0.87,
Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,WVLOADHCBXTIJK-YNHQPCIGSA-N,Norhydromorphone,O=C1CCC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3,SWIRXSKBBSJXGY-UIHHKEIPSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.98,
Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,CGIGDMFJXJATDK-UHFFFAOYSA-N,5-Hydroxyindomethacin,CC1=C(CC(=O)O)C2=C(C=CC(O)=C2)N1C(=O)C1=CC=C(Cl)C=C1,KMLNWQPYFBIALN-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.97,
Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,CGIGDMFJXJATDK-UHFFFAOYSA-N,Indomethacin acyl glucuronide,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QCBWEVBGELGABM-CZLVRFMKSA-N,UDP-glucuronosyltransferase 1-1,0.8,
Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,CGIGDMFJXJATDK-UHFFFAOYSA-N,Deacyl indomethacin,COC1=CC2=C(C=C1)NC(C)=C2CC(=O)O,TXWGINUZLBAKDF-UHFFFAOYSA-N,Liver carboxylesterase 1,0.6,
Ipratropium,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)C1=CC=CC=C1)C2,OEXHQOGQTVQTAT-BHIXFJMTSA-N,N-isopropylnortropium methobromide,C=C(C(=O)OC1CC2CCC(C1)[N+]2(C)C(C)C)C1=CC=CC=C1,APBFGXKTZSOWLK-JRJNBHHRSA-N,,0.72,
Ipratropium,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)C1=CC=CC=C1)C2,OEXHQOGQTVQTAT-BHIXFJMTSA-N,Phenylacetic acid,O=C(O)CC1=CC=CC=C1,WLJVXDMOQOGPHL-UHFFFAOYSA-N,,0.2,
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,USSIQXCVUWKGNF-UHFFFAOYSA-N,"2-Ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium (EDDP)",CC=C1N(C)C(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,AJRJPORIQGYFMT-RMOCHZDMSA-N,"Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C19, Cytochrome P450 2C9",0.45,
Olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN(C)CC2)S1,KVWDHTXUZHCGIO-UHFFFAOYSA-N,7-hydroxyolanzapine,CC1=CC2=C(NC3=C(C=C(O)C=C3)N=C2N2CCN(C)CC2)S1,SMNUCABXNXAPBY-UHFFFAOYSA-N,Cytochrome P450 1A2,0.96,
Olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN(C)CC2)S1,KVWDHTXUZHCGIO-UHFFFAOYSA-N,2-hydroxymethylolanzapine,CN1CCN(C2=NC3=CC=CC=C3NC3=C2C=C(CO)S3)CC1,FPDIERBPQFAFSI-UHFFFAOYSA-N,Cytochrome P450 2D6,0.95,
Pyrazinamide,NC(=O)C1=NC=CN=C1,IPEHBUMCGVEMRF-UHFFFAOYSA-N,5-hydroxypyrazinamide,NC(=O)C1=CNC(=O)C=N1,XENWQEOTDAQROM-UHFFFAOYSA-N,Aldehyde oxidase,0.69,
Terfenadine,CC(C)(C)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,GUGOEEXESWIERI-UHFFFAOYSA-N,fexofenadine,CC(C)(C(=O)O)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,RWTNPBWLLIMQHL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.85,
Trimethadione,CN1C(=O)OC(C)(C)C1=O,IRYJRGCIQBGHIV-UHFFFAOYSA-N,dimethadione,CC1(C)OC(=O)N=C1O,JYJFNDQBESEHJQ-UHFFFAOYSA-N,"Cytochrome P450 2E1, Cytochrome P450 3A4, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19",0.17,
Clobazam,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,CXOXHMZGEKVPMT-UHFFFAOYSA-N,N-desmethylclobazam,O=C1CC(=O)N(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)N1,RRTVVRIFVKKTJK-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 3A5, Cytochrome P450 3A7, Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 2C18",0.85,
Clobazam,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,CXOXHMZGEKVPMT-UHFFFAOYSA-N,4'-hydroxyclobazam,CN1C(=O)CC(=O)N(C2=CC=C(O)C=C2)C2=C1C=CC(Cl)=C2,NKSXJAYACJZMBM-UHFFFAOYSA-N,"Cytochrome P450 2C18, Cytochrome P450 2C19",0.95,
Tioguanine,NC1=NC(=S)C2=C(N=CN2)N1,WYWHKKSPHMUBEB-UHFFFAOYSA-N,Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Hypoxanthine-guanine phosphoribosyltransferase,0.34,
Chlorzoxazone,O=C1NC2=C(C=CC(Cl)=C2)O1,TZFWDZFKRBELIQ-UHFFFAOYSA-N,6-hydroxychlorzoxazone,OC1=NC2=C(C=C(O)C(Cl)=C2)O1,AGLXDWOTVQZHIQ-UHFFFAOYSA-N,Cytochrome P450 2E1,0.52,
Mefloquine,OC(C1=CC(C(F)(F)F)=NC2=C1C=CC=C2C(F)(F)F)C1CCCCN1,XEEQGYMUWCZPDN-UHFFFAOYSA-N,"2,8-bis-trifluoromethyl-4-quinoline carboxylic acid",O=C(O)C1=CC(C(F)(F)F)=NC2=C1C=CC=C2C(F)(F)F,QJTJIQBSZLFWFS-UHFFFAOYSA-N,Cytochrome P450 3A4,0.65,
Clozapine,CN1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,QZUDBNBUXVUHMW-UHFFFAOYSA-N,Clozapine N-oxide,C[N+]1([O-])CCN(C2=NC3=C(C=CC(Cl)=C3)NC3=CC=CC=C23)CC1,OGUCZBIQSYYWEF-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A2, Dimethylaniline monooxygenase [N-oxide-forming] 3, Cytochrome P450 2C19, Cytochrome P450 3A5, Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2E1",0.95,
Clozapine,CN1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,QZUDBNBUXVUHMW-UHFFFAOYSA-N,Clozapine 5-N-glucuronide,CN1CCN(C2=NC3=C(C=CC(Cl)=C3)N(C3OC(C(=O)O)C(O)C(O)C3O)C3=CC=CC=C23)CC1,YWWIDMPXCSUNRD-VZWAGXQNSA-N,"UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 2B10",0.6,
Norepinephrine,NCC(O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Norepinephrine sulfate,NCC(O)C1=CC(O)=C(OS(=O)(=O)O)C=C1,CVJMZWLHUCMEKO-ZETCQYMHSA-N,,0.63,
Norepinephrine,NCC(O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,3-Methoxy-4-Hydroxyphenylglycol sulfate,COC1=C(O)C=CC(C(CO)OS(=O)(=O)O)=C1,SBKADJXSGGTEPN-UHFFFAOYSA-N,,0.46,
Mirtazapine,CN1CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,RONZAEMNMFQXRA-UHFFFAOYSA-N,mirtazapine-N-oxide,C[N+]1([O-])CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,GAFCUVMEBFTFQJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.93,
Mirtazapine,CN1CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,RONZAEMNMFQXRA-UHFFFAOYSA-N,N-desmethylmirtazapine,C1=CC=C2C(=C1)CC1=C(N=CC=C1)N1CCNCC21,FGLAMNFOHWVQOH-UHFFFAOYSA-N,Cytochrome P450 3A4,0.97,
Mirtazapine,CN1CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,RONZAEMNMFQXRA-UHFFFAOYSA-N,8-hydroxymirtazapine,CN1CCN2C3=NC=C(O)C=C3CC3=CC=CC=C3C2C1,DAWYIZBOUQIVNX-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6",0.94,
Dydrogesterone,CC(=O)C1CCC2C3C=CC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C21H28O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4-5,12,16-19H,6-11H2,1-3H3/t16-,17+,18-,19+,20+,21+/m0/s1",20-dihydrodydrogesterone,C=C1C=C2C=CC3C(CCC4(C)C(C(C)C)CCC34)C2(C)CC1,YUDUQGLCBDGGNA-UHFFFAOYSA-N,,0.65,
Mexiletine,CC1=C(OCC(C)N)C(C)=CC=C1,VLPIATFUUWWMKC-UHFFFAOYSA-N,2-hydroxymexiletine,CC1=C(OCC(C)N)C(CO)=CC=C1,XMJYSMLLWRQQAE-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6",0.77,
Mexiletine,CC1=C(OCC(C)N)C(C)=CC=C1,VLPIATFUUWWMKC-UHFFFAOYSA-N,p-hydroxymexiletine,CC1=C(OCC(C)N)C(C)=CC(O)=C1,YWOSWRCXWBDSRQ-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6",0.85,
Tacrine,NC1=C2CCCCC2=NC2=CC=CC=C12,YLJREFDVOIBQDA-UHFFFAOYSA-N,1-hydroxytacrine,N=C1C2=C(CCCC2O)NC2=CC=CC=C12,HLVVITIHAZBPKB-UHFFFAOYSA-N,Cytochrome P450 1A2,0.58,
Valrubicin,CCCCC(=O)OCC(=O)C1(O)CC2=C(O)C3=C(C(=O)C4=C(OC)C=CC=C4C3=O)C(O)=C2C(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)C1,ZOCKGBMQLCSHFP-KQRAQHLDSA-N,N-trifluoroacetyladriamycinol,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(O)CO)CC(OC3CC(N=C(O)C(F)(F)F)C(O)C(C)O3)C2=C1O,TWMWXCYMYAQOTO-UHFFFAOYSA-N,,0.88,
Valrubicin,CCCCC(=O)OCC(=O)C1(O)CC2=C(O)C3=C(C(=O)C4=C(OC)C=CC=C4C3=O)C(O)=C2C(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)C1,ZOCKGBMQLCSHFP-KQRAQHLDSA-N,N-trifluoroacetyladriamycin,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(=O)CO)CC(OC3CC(NC(=O)C(F)(F)F)C(O)C(C)O3)C2=C1O,RQIOYWADAKTIJC-XUKKXQNXSA-N,,0.99,
Digoxin,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,LTMHDMANZUZIPE-PUGKRICDSA-N,Dihydrodigoxin,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7COC(=O)C7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,,,0.71,
Carisoprodol,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,OFZCIYFFPZCNJE-UHFFFAOYSA-N,Meprobamate,CCCC(C)(COC(N)=O)COC(N)=O,NPPQSCRMBWNHMW-UHFFFAOYSA-N,Cytochrome P450 2C19,0.72,
Progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,RJKFOVLPORLFTN-LEKSSAKUSA-N,6β-Hydroxyprogesterone,CC(=O)C1CCC2C3CC(O)C4=CC(=O)CCC4(C)C3CCC12C,PWCLWZOSAFOXFL-UHPWKVKZSA-N,Cytochrome P450 3A4,0.73,
Progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,RJKFOVLPORLFTN-LEKSSAKUSA-N,Pregnanolone,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,,,0.42,
Sorafenib,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(C(F)(F)F)=C(Cl)C=C3)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Sorafenib N-oxide,CNC(=O)C1=[N+]([O-])C=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)C=C2)=C1,,Cytochrome P450 3A4,0.88,
Sorafenib,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(C(F)(F)F)=C(Cl)C=C3)C=C2)=C1,MLDQJTXFUGDVEO-UHFFFAOYSA-N,Sorafenib beta-D-Glucuronide,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)N(C3=CC(C(F)(F)F)=C(Cl)C=C3)C3OC(C(=O)O)C(O)C(O)C3O)C=C2)=C1,HALZWBPBJOJUOZ-UHFFFAOYSA-N,UDP-glucuronosyltransferase 1-9,0.53,
Griseofulvin,COC1=CC(=O)CC(C)C12OC1=C(C2=O)C(OC)=CC(OC)=C1Cl,DDUHZTYCFQRHIY-RBHXEPJQSA-N,6-methyl-griseofulvin,COC1=CC(=O)CC(C)C12OC1=C(C2=O)C(OC)=CC(C)=C1Cl,QNPINWFXONNRKM-XLFHBGCDSA-N,,0.97,
Eszopiclone,CN1CCN(C(=O)OC2C3=NC=CN=C3C(=O)N2C2=NC=C(Cl)C=C2)CC1,GBBSUAFBMRNDJC-INIZCTEOSA-N,Zopiclone N-oxide,C[N+]1([O-])CCN(C(=O)OC2C3=C(N=CC=N3)C(=O)N2C2=NC=C(Cl)C=C2)CC1,IPTIKKTXLHVRKN-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2E1",0.98,
Alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,VREFGVBLTWBCJP-UHFFFAOYSA-N,4-hydroxyalprazolam,CC1=NN=C2C(O)N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,CEYGCFLPQFNPST-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2C9",0.87,
Alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,VREFGVBLTWBCJP-UHFFFAOYSA-N,alpha-Hydroxyalprazolam,OCC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,ZURUZYHEEMDQBU-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A5, Cytochrome P450 3A4",0.93,
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,YASAKCUCGLMORW-UHFFFAOYSA-N,Phenoxyacetic acid derivative of rosiglitazone,O=C(O)COC1=CC=C(CC2SC(=O)NC2=O)C=C1,SXAASESEPRXRTR-UHFFFAOYSA-N,,0.71,
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,YASAKCUCGLMORW-UHFFFAOYSA-N,N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.56,
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,YASAKCUCGLMORW-UHFFFAOYSA-N,para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.6,
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,YASAKCUCGLMORW-UHFFFAOYSA-N,N-Despyridinyl rosiglitazone,CNCCOC1=CC=C(CC2SC(=O)NC2=O)C=C1,BPSKNLFJDYBECE-UHFFFAOYSA-N,,0.76,
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,YASAKCUCGLMORW-UHFFFAOYSA-N,ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.58,
Acetohexamide,CC(=O)C1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1,VGZSUPCWNCWDAN-UHFFFAOYSA-N,Hydroxyhexamide,CC(O)C1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1,VQDAEOYLIBGCHE-UHFFFAOYSA-N,,0.85,
Phenoxymethylpenicillin,CC1(C)SC2C(NC(=O)COC3=CC=CC=C3)C(=O)N2C1C(=O)O,BPLBGHOLXOTWMN-MBNYWOFBSA-N,6-aminopenicillanic acid,CC1(C)SC2C(N)C(=O)N2C1C(=O)O,NGHVIOIJCVXTGV-ALEPSDHESA-N,,0.85,
Phenoxymethylpenicillin,CC1(C)SC2C(NC(=O)COC3=CC=CC=C3)C(=O)N2C1C(=O)O,BPLBGHOLXOTWMN-MBNYWOFBSA-N,Penicilloic acid,CC1(C)SC(C(NC(=O)CC2=CC=CC=C2)C(=O)O)NC1C(=O)O,HCYWNSXLUZRKJX-UHFFFAOYSA-N,,0.62,
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C21,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,3-Hydroxypromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC(O)=CC=C21,FCWHSDRYYOAXGG-UHFFFAOYSA-N,,0.86,
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C21,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,Promazine 5-sulfoxide,CN(C)CCCN1C2=CC=CC=C2S(=O)C2=CC=CC=C21,KSHDHDWHIWBNHA-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4",0.81,
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C21,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,N-Desmethylpromazine,CNCCCN1C2=CC=CC=C2SC2=CC=CC=C21,WOCOVPRTRIBGFZ-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2C9",0.98,
Zolpidem,CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C)C=CC3=N2)C=C1,ZAFYATHCZYHLPB-UHFFFAOYSA-N,Methoxyzolpidem derivative (M3),CC1=CN2C(CC(=O)N(C)C)=C(C3=CC=C(CO)C=C3)N=C2C=C1,MKLBTYQCCMFWQI-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 1A2, Cytochrome P450 2D6",0.98,
Zolpidem,CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C)C=CC3=N2)C=C1,ZAFYATHCZYHLPB-UHFFFAOYSA-N,Methoxyzolpidem derivative (M4),CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(CO)C=CC3=N2)C=C1,OIIJRMHQIDOMPL-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A2, Cytochrome P450 2D6",0.96,
Famciclovir,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C21)COC(C)=O,GGXKWVWZWMLJEH-UHFFFAOYSA-N,6-oxo-famciclovir,CC(=O)OCC(CCN1C=NC2=C1NC(=N)N=C2O)COC(C)=O,KQURMIWGELPUHQ-UHFFFAOYSA-N,Aldehyde oxidase,0.65,
Trifluridine,O=C1NC(=O)N(C2CC(O)C(CO)O2)C=C1C(F)(F)F,VSQQQLOSPVPRAZ-RRKCRQDMSA-N,5-carboxy-2'-deoxyuridine,O=C(O)C1=CN(C2CC(O)C(CO)O2)C(=O)N=C1O,GAGYTXTVUMXAOC-XVMARJQXSA-N,,0.69,
Gemcitabine,NC1=NC(=O)N(C2OC(CO)C(O)C2(F)F)C=C1,SDUQYLNIPVEERB-QPPQHZFASA-N,"2',2'-Difluorodeoxyuridine",O=C1N=C(O)C=CN1C1OC(CO)C(O)C1(F)F,,Cytidine deaminase,0.87,
Gemcitabine,NC1=NC(=O)N(C2OC(CO)C(O)C2(F)F)C=C1,SDUQYLNIPVEERB-QPPQHZFASA-N,Gemcitabine Monophosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)O)C(O)C2(F)F)C=C1,KNTREFQOVSMROS-QPPQHZFASA-N,"Deoxycytidine kinase, Thymidine kinase 2, mitochondrial",0.92,
Lansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,MJIHNNLFOKEZEW-UHFFFAOYSA-N,Hydroxylansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O)=CC=C2N1,,"Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 2C8",0.94,
Lansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,MJIHNNLFOKEZEW-UHFFFAOYSA-N,Lansoprazole sulfone,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)(=O)C1=NC2=CC=CC=C2N1,TVMJMCGRSSSSDJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Levothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,XUIIKFGFIJCVMT-LBPRGKRZSA-N,Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,AUYYCJSJGJYCDS-LBPRGKRZSA-N,Thyroxine 5-deiodinase,0.99,
Loratadine,CCOC(=O)N1CCC(=C2C3=C(C=C(Cl)C=C3)CCC3=C2N=CC=C3)CC1,JCCNYMKQOSZNPW-UHFFFAOYSA-N,Descarboethoxyloratadine,ClC1=CC2=C(C=C1)C(=C1CCNCC1)C1=C(C=CC=N1)CC2,JAUOIFJMECXRGI-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2C19, Cytochrome P450 1A1",0.91,
Prazosin,COC1=C(OC)C=C2C(N)=NC(N3CCN(C(=O)C4=CC=CO4)CC3)=NC2=C1,IENZQIKPVFGBNW-UHFFFAOYSA-N,"2,4-diamino-6,7-dimethoxyquinazoline",COC1=C(OC)C=C2C(N)=NC(N)=NC2=C1,ZCIPYVXKMWNKLZ-UHFFFAOYSA-N,,0.63,
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,BCGWQEUPMDMJNV-UHFFFAOYSA-N,Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C21,HCYAFALTSJYZDH-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 3A4",0.99,
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,BCGWQEUPMDMJNV-UHFFFAOYSA-N,2-hydroxyimipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,ROTCPJFWLNDKHU-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2D6, Cytochrome P450 3A4",0.86,
Ketorolac,O=C(C1=CC=CC=C1)C1=CC=C2C(C(=O)O)CCN12,OZWKMVRBQXNZKK-UHFFFAOYSA-N,4-hydroxy ketorolac,O=C(C1=CC=C(O)C=C1)C1=CC=C2C(C(=O)O)CCN12,PIQMOWBWPFGZMW-UHFFFAOYSA-N,,0.97,
Quinine,C=CC1CN2CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,LOUPRKONTZGTKE-WZBLMQSHSA-N,3-hydroxyquinine,C=CC1(O)CN2CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,BSRUJCFCZKMFMB-YGHPHNMRSA-N,Cytochrome P450 3A4,0.89,
Tenoxicam,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O,LZNWYQJJBLGYLT-UHFFFAOYSA-N,5'-Hydroxytenoxicam,CN1C(=C(O)NC2=NC=C(O)C=C2)C(=O)C2=C(C=CS2)S1(=O)=O,INPPRTDYEGRTIU-RAXLEYEMSA-N,Cytochrome P450 2C9,0.63,
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,CYQFCXCEBYINGO-IAGOWNOFSA-N,11-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,YCBKSSAWEUDACY-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2C9",0.97,
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,CYQFCXCEBYINGO-IAGOWNOFSA-N,7-beta-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1C(O)CC(C)=CC21,DJCKLUPKZRLTPE-CMVHYPBASA-N,Cytochrome P450 3A4,0.92,
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,CYQFCXCEBYINGO-IAGOWNOFSA-N,8-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(C)=CC21,INKUWBOHCFHXTJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.91,
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,CYQFCXCEBYINGO-IAGOWNOFSA-N,"9-alpha,10-alpha-epoxyhexahydrocannabinol",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC3(C)OC3C21,VSQGBNUBIDZRPJ-UHFFFAOYSA-N,"Prostaglandin G/H synthase 1, Cytochrome P450 3A4",0.68,
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Montelukast metabolite M1,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,SXJRVQZUUOADNS-FCHGAEMMSA-N,,0.75,
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Montelukast metabolite M2a,CC(C)(O)C1=CC=CC=C1CCC(C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1)S(=O)CC1(CC(=O)O)CC1,QFTNWCBEAVHLQA-XNHCCDLUSA-N,"Cytochrome P450 3A4, Cytochrome P450 2A6",0.91,
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Montelukast metabolite M5a,CC(C)(O)C1=CC=CC=C1C(O)CC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,CHRNGXJVKOMERP-SIOAQITRSA-N,Cytochrome P450 3A4,0.94,
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,UCHDWCPVSPXUMX-TZIWLTJVSA-N,Montelukast metabolite M6a,CC(O)(CO)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,UFQIEVSCRCMNLW-SHISVWIYSA-N,Cytochrome P450 2C9,0.95,
Fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,Fluoxetine glucuronide,CN(CCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1)C1OC(C(=O)O)C(O)C(O)C1O,ROQAUFRWFXOLOE-GDBUUVARSA-N,UDP-glucuronosyltransferases (UGTs),0.45,
Fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 3A5, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 2B6",0.95,
Fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4-Trifluoromethylphenol,OC1=CC=C(C(F)(F)F)C=C1,BAYGVMXZJBFEMB-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4",0.32,
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,hydroxychlorpromazine,CN(C)CCCN1C2=C(C=C(O)C=C2)SC2=C1C=C(Cl)C=C2,HICFFJZGXWEIHN-UHFFFAOYSA-N,Cytochrome P450 2D6,0.89,
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,chlorpromazine-N-oxide,C[N+](C)([O-])CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,LFDFWIIFGRXCFR-UHFFFAOYSA-N,,0.98,
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,dedimethylchlorpromazine,NCCCN1C2=C(C=CC=C2)SC2=C1C=C(Cl)C=C2,ZTQZBABFEUDZFE-UHFFFAOYSA-N,,0.98,
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,demonomethylchlorpromazine,CNCCCN1C2=C(C=CC=C2)SC2=C1C=C(Cl)C=C2,YHFXGBOUSIKGMZ-UHFFFAOYSA-N,,0.99,
Celecoxib,CC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(N)(=O)=O)C=C2)C=C1,RZEKVGVHFLEQIL-UHFFFAOYSA-N,Hydroxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1,ICRSYPPLGADZKA-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2C8",0.98,
Brimonidine,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,XYLJNLCSTIOKRM-UHFFFAOYSA-N,2-oxobrimonidine,O=C1C=NC2=C(C=CC(NC3=NCCN3)=C2Br)N1,BUVCZMAMYHMOPB-UHFFFAOYSA-N,Aldehyde oxidase,0.9,
Brimonidine,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,XYLJNLCSTIOKRM-UHFFFAOYSA-N,3-oxobrimonidine ,OC1=NC2=C(C=CC(NC3=NCCN3)=C2Br)NC1,VYULKJXHCILWPG-UHFFFAOYSA-N,Aldehyde oxidase,0.42,
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,QWCRAEMEVRGPNT-UHFFFAOYSA-N,1-Pyrimidinylpiperazine,C1=CN=C(N2CCNCC2)N=C1,MRBFGEHILMYPTF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.42,
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,QWCRAEMEVRGPNT-UHFFFAOYSA-N,Buspirone N-oxide,O=C1CC2(CCCC2)CC(=O)N1CCCC[N+]1([O-])CCN(C2=NC=CC=N2)CC1,PXFOIYSPRVISSG-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2D6",0.86,
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,QWCRAEMEVRGPNT-UHFFFAOYSA-N,3′-Hydroxybuspirone,O=C1CC2(CCC(O)C2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,RQGHABOPJRYOEZ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.89,
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,QWCRAEMEVRGPNT-UHFFFAOYSA-N,5-Hydroxybuspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=C(O)C=N2)CC1,WKAUDMPUKWYRBF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.92,
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,QWCRAEMEVRGPNT-UHFFFAOYSA-N,6'-Hydroxybuspirone,O=C1CC2(CCCC2)C(O)C(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,KOZNAHJIJGCFJJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.74,
Fosinopril,CCC(=O)OC(OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,BIDNLKIUORFRQP-FLODCBCLSA-N,Fosinoprilat,O=C(O)C1CC(C2CCCCC2)CN1C(=O)CP(=O)(O)CCCCC1=CC=CC=C1,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,,0.76,
Cefotaxime,CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(COC(C)=O)CSC12)C1=CSC(N)=N1,GPRBEKHLDVQUJE-QSWIMTSFSA-N,Desacetyl-cefotaxime,CON=C(C(O)=NC1C(=O)N2C(C(=O)O)=C(CO)CSC12)C1=CSC(=N)N1,FHYWAOQGXIZAAF-GHXIOONMSA-N,,0.76,
Zidovudine,CC1=CN(C2CC(N=[N+]=[N-])C(CO)O2)C(=O)NC1=O,HBOMLICNUCNMMY-XLPZGREQSA-N,3'-azido-3'-deoxy-5'- O-beta-D-glucopyranuronosylthymidine,CC1=CN(C2CC(N=[N+]=[N-])C(COC3OC(C(=O)O)C(O)C(O)C3O)O2)C(=O)N=C1O,NFXAJWJJNLWLOV-OTQDERTISA-N,,0.69,
Zidovudine,CC1=CN(C2CC(N=[N+]=[N-])C(CO)O2)C(=O)NC1=O,HBOMLICNUCNMMY-XLPZGREQSA-N,3'-Aminothymidine,CC1=CN(C2CC(N)C(CO)O2)C(=O)NC1=O,ADVCGXWUUOVPPB-XLPZGREQSA-N,,0.93,
Oxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,BRUQQQPBMZOVGD-XFKAJCMBSA-N,noroxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5)C=C1,RIKMCJUNPCRFMW-ISWURRPUSA-N,Cytochrome P450 3A4,0.98,
Oxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,BRUQQQPBMZOVGD-XFKAJCMBSA-N,alpha-oxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,LHTAJTFGGUDLRH-FHHXKLHRSA-N,,0.93,
Flutamide,CC(C)C(=O)NC1=CC(C(F)(F)F)=C([N+](=O)[O-])C=C1,MKXKFYHWDHIYRV-UHFFFAOYSA-N,2-hydroxyflutamide,CC(C)(O)C(O)=NC1=CC(C(F)(F)F)=C([N+](=O)[O-])C=C1,YPQLFJODEKMJEF-UHFFFAOYSA-N,Cytochrome P450 1A2,0.57,
Tolmetin,CC1=CC=C(C(=O)C2=CC=C(CC(=O)O)N2C)C=C1,UPSPUYADGBWSHF-UHFFFAOYSA-N,Tolmetin glucuronide,CC1=CC=C(C(=O)C2=CC=C(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)N2C)C=C1,MEFIGCPEYJZFFC-ZFORQUDYSA-N,,0.64,
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-pyridinium (HPP+),O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)C1=CC=C(F)C=C1,KAPIKUHBALFONG-UHFFFAOYSA-N,Cytochrome P450 3A4,0.42,
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4-(4-chlorophenyl)-4-hydroxypiperidine,OC1(C2=CC=C(Cl)C=C2)CCNCC1,LZAYOZUFUAMFLD-UHFFFAOYSA-N,Cytochrome P450 3A4,0.66,
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,"Carbonyl reductase [NADPH] 1, Cytochrome P450 3A4",0.84,
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,Haloperidol glucuronide,O=C(CCCN1CCC(OC2OC(C(=O)O)C(O)C(O)C2O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,ZFNLYKVTHNLKNZ-BFZHNPFYSA-N,UDP-glucuronosyltransferase 1-9,0.49,
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,"Haloperidol 1,2,3,6-tetrahydropyridine",O=C(CCCN1CC=C(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,ZNOLNAPJKOYTHY-UHFFFAOYSA-N,Cytochrome P450 3A4,0.51,
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,LNEPOXFFQSENCJ-UHFFFAOYSA-N,fluorobenzoylpropionic acid,O=C(O)CCC(=O)C1=CC(F)=C(F)C=C1,GYDFFFKCUNUZEL-UHFFFAOYSA-N,Cytochrome P450 1A2,0.37,
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,Ritonavir metabolite M1,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(N)CC2=CC=CC=C2)C(C)C)=CS1,IQKWCORIMSRQGZ-AMEOFWRWSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.86,
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,Ritonavir metabolite M11,CNC(=O)NC(C(=O)NC(CC1=CC=CC=C1)CC(O)C(CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)C(C)C,UVQJGJZZUNOHCX-MNUOIFNESA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.8,
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,N-Desmethylritonavir,CC(C)C1=NC(CN=C(O)NC(C(O)=NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)N=C(O)OCC2=CN=CS2)C(C)C)=CS1,SQANVQYLDPEULW-QJANCWQKSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4, Cytochrome P450 2D6",0.51,
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,NCDNCNXCDXHOMX-XGKFQTDJSA-N,Hydroxy Ritonavir,CC(C)C(NC(=O)N(C)CC1=CSC(C(C)(C)O)=N1)C(=O)NC(CC1=CC=CC=C1)CC(O)C(CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1,CLEDZMPJHBBTNZ-QJANCWQKSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.95,
Dextrothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,XUIIKFGFIJCVMT-GFCCVEGCSA-N,Thyroxine sulfate,NC(CC1=CC(I)=C(OC2=CC(I)=C(OS(=O)(=O)O)C(I)=C2)C(I)=C1)C(=O)O,QYXIJUZWSSQICT-LBPRGKRZSA-N,,0.79,
Dextrothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,XUIIKFGFIJCVMT-GFCCVEGCSA-N,Thyroxine glucuronide,NC(CC1=CC(I)=C(OC2=CC(I)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(I)=C2)C(I)=C1)C(=O)O,RGHRJBIKIYUHEV-SGPDEFQSSA-N,,0.48,
Aminocaproic acid,NCCCCCC(=O)O,SLXKOJJOQWFEFD-UHFFFAOYSA-N,Adipic acid,O=C(O)CCCCC(=O)O,WNLRTRBMVRJNCN-UHFFFAOYSA-N,,0.69,
Dextromethorphan,COC1=CC2=C(C=C1)CC1C3CCCCC23CCN1C,MKXZASYAUGDDCJ-NJAFHUGGSA-N,Dextrorphan,CN1CCC23CCCCC2C1CC1=C3C=C(O)C=C1,"InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m1/s1","Cytochrome P450 2D6, Cytochrome P450 2C9",0.96,
Dextromethorphan,COC1=CC2=C(C=C1)CC1C3CCCCC23CCN1C,MKXZASYAUGDDCJ-NJAFHUGGSA-N,(+)-3-Methoxymorphinan,COC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,ILNSWVUXAPSPEH-PVAVHDDUSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2D6, Cytochrome P450 2C9",0.94,
Dextrorphan,CN1CCC23CCCCC2C1CC1=C3C=C(O)C=C1,"InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m1/s1",Dextrorphan O-glucuronide,CN1CCC23CCCCC2C1CC1=C3C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,YQAUTKINOXBFCA-DCWOAAMISA-N,"UDP-glucuronosyltransferases (UGTs), UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 2B17",0.67,
Dextrorphan,CN1CCC23CCCCC2C1CC1=C3C=C(O)C=C1,"InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m1/s1",Dextrorphan sulfate,CN1CCC23CCCCC2C1CC1=C3C=C(OS(=O)(=O)O)C=C1,WVXRTBLFQVXOLU-PVAVHDDUSA-N,,0.89,
Dextrorphan,CN1CCC23CCCCC2C1CC1=C3C=C(O)C=C1,"InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m1/s1",3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6",0.94,
Albendazole,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,HXHWSAZORRCQMX-UHFFFAOYSA-N,albendazole sulfone,CCCS(=O)(=O)C1=CC2=C(C=C1)N=C(N=C(O)OC)N2,CLSJYOLYMZNKJB-UHFFFAOYSA-N,,0.57,
Albendazole,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,HXHWSAZORRCQMX-UHFFFAOYSA-N,albendazole sulfoxide,CCCS(=O)C1=CC=C2NC(NC(=O)OC)=NC2=C1,VXTGHWHFYNYFFV-UHFFFAOYSA-N,,0.86,
Trandolapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,VXFJYXUZANRPDJ-WTNASJBWSA-N,Trandolaprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1C(C(=O)O)CC2CCCCC21,AHYHTSYNOHNUSH-HXFGRODQSA-N,,0.92,
Trandolapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,VXFJYXUZANRPDJ-WTNASJBWSA-N,Diketopiperazine,O=C1NC(CC2=CN=CN2)C(=O)N2CCCCC12,LCXWQHWWTPOAFI-UWVGGRQHSA-N,,0.4,
Carteolol,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2,LWAFSWPYPHEXKX-UHFFFAOYSA-N,8-Hydroxycarteolol,CC(C)(C)NCC(O)COC1=C2CCC(O)=NC2=C(O)C=C1,TVZJLAKRXHGVOK-UHFFFAOYSA-N,Cytochrome P450 2D6,0.55,
Cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2C19, Cytochrome P450 3A7",0.76,
Cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,CMSMOCZEIVJLDB-UHFFFAOYSA-N,Dechloroethyl cyclophosphamide,O=P1(NCCCl)NCCCO1,DZKGMGPLDJOVCX-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A7",0.66,
Mephenytoin,CCC1(C2=CC=CC=C2)NC(=O)N(C)C1=O,GMHKMTDVRCWUDX-UHFFFAOYSA-N,S-Nirvanol,CCC1(C2=CC=CC=C2)N=C(O)N=C1O,UDTWZFJEMMUFLC-NSHDSACASA-N,Cytochrome P450 2B6,0.34,
Mephenytoin,CCC1(C2=CC=CC=C2)NC(=O)N(C)C1=O,GMHKMTDVRCWUDX-UHFFFAOYSA-N,Nirvanol,CCC1(C2=CC=CC=C2)NC(=O)NC1=O,UDTWZFJEMMUFLC-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2B6",0.86,
Mephenytoin,CCC1(C2=CC=CC=C2)NC(=O)N(C)C1=O,GMHKMTDVRCWUDX-UHFFFAOYSA-N,S-4-Hydroxymephenytoin,CCC1(C2=CC=C(O)C=C2)N=C(O)N(C)C1=O,OQPLORUDZLXXPD-LBPRGKRZSA-N,Cytochrome P450 2C19,0.48,
Toremifene,CN(C)CCOC1=CC=C(C(=C(CCCl)C2=CC=CC=C2)C2=CC=CC=C2)C=C1,XFCLJVABOIYOMF-QPLCGJKRSA-N,N-desmethyltoremifene,CNCCOC1=CC=C(C(=C(CCCl)C2=CC=CC=C2)C2=CC=CC=C2)C=C1,WKJKBQYEFAFHCY-IZHYLOQSSA-N,Cytochrome P450 3A4,0.98,
Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC1CCC2=CC=CC=C2N(CC(=O)O)C1=O,XPCFTKFZXHTYIP-PMACEKPBSA-N,Benazeprilat,O=C(O)CN1C(=O)C(NC(CCC2=CC=CC=C2)C(=O)O)CCC2=CC=CC=C21,"InChI=1S/C22H24N2O5/c25-20(26)14-24-19-9-5-4-8-16(19)11-13-17(21(24)27)23-18(22(28)29)12-10-15-6-2-1-3-7-15/h1-9,17-18,23H,10-14H2,(H,25,26)(H,28,29)/t17-,18-/m0/s1",,0.94,
Amoxapine,ClC1=CC2=C(C=C1)OC1=CC=CC=C1N=C2N1CCNCC1,QWGDMFLQWFTERH-UHFFFAOYSA-N,7-hydroxyamoxapine,OC1=CC2=C(C=C1)N=C(N1CCNCC1)C1=C(C=CC(Cl)=C1)O2,MEUGUMOVYNSGEW-UHFFFAOYSA-N,,0.96,
Amoxapine,ClC1=CC2=C(C=C1)OC1=CC=CC=C1N=C2N1CCNCC1,QWGDMFLQWFTERH-UHFFFAOYSA-N,8-hydroxyamoxapine,OC1=CC2=C(C=C1)OC1=C(C=C(Cl)C=C1)C(N1CCNCC1)=N2,QDWNOKXUZTYVGO-UHFFFAOYSA-N,,0.97,
Adinazolam,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N21,"InChI=1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3",desmethyladinazolam,NCC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,IITNCTOGXYNNRY-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4",0.95,
Adinazolam,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N21,"InChI=1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3",alpha-Hydroxyalprazolam,OCC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,ZURUZYHEEMDQBU-UHFFFAOYSA-N,,0.89,
Adinazolam,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N21,"InChI=1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3",Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,CDCHDCWJMGXXRH-UHFFFAOYSA-N,,0.9,
Zafirlukast,COC1=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Zafirlukast metabolite M5,COC1=C(CC2=CN(CO)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HZAQOSFFIGVMDH-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.98,
Zafirlukast,COC1=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2,YEEZWCHGZNKEEK-UHFFFAOYSA-N,Zafirlukast metabolite M1,COC1=C(CC2=CN(C)C3=C2C=C(N)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HNBZIIQASMYNPG-UHFFFAOYSA-N,,0.91,
Piroxicam,CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O,QYSPLQLAKJAUJT-UHFFFAOYSA-N,5'-Hydroxypiroxicam,CN1C(C(O)=NC2=NC=C(O)C=C2)=C(O)C2=CC=CC=C2S1(=O)=O,CCKOORANQAQKKV-UHFFFAOYSA-N,Cytochrome P450 2C9,0.69,
Lamotrigine,NC1=NC(N)=C(C2=C(Cl)C(Cl)=CC=C2)N=N1,PYZRQGJRPPTADH-UHFFFAOYSA-N,lamotrigine-2-N-glucuronide,NC1=C(C2=C(Cl)C(Cl)=CC=C2)N=[N+](C2OC(C(=O)O)C(O)C(O)C2O)C(N)=N1,IEVMENHZPOWVGO-XPORZQOISA-O,UDP-glucuronosyltransferases (UGTs),0.48,
Hydroxyzine,OCCOCCN1CCN(C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)CC1,ZQDWXGKKHFNSQK-UHFFFAOYSA-N,Cetirizine,O=C(O)COCCN1CCN(C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)CC1,ZKLPARSLTMPFCP-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.95,
Bosentan,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1,GJPICJJJRGTNOD-UHFFFAOYSA-N,Bosentan metabolite Ro 48-5033,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)CO)C=C1,FAJQMBCLPZWTQJ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.98,
Bosentan,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1,GJPICJJJRGTNOD-UHFFFAOYSA-N,Bosentan metabolite Ro 47-8634,CC(C)(C)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,STTLKJGYAWXIPP-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.99,
Methotrexate,CN(CC1=NC2=C(N)NC(=N)N=C2N=C1)C1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1,FBOZXECLQNJBKD-ZDUSSCGKSA-N,7-hydroxymethotrexate,CN(CC1=NC2=C(N)NC(=N)NC2=NC1=O)C1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1,HODZDDDNGRLGSI-NSHDSACASA-N,Aldehyde oxidase,0.63,
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,FFGPTBGBLSHEPO-UHFFFAOYSA-N,"10,11-Epoxycarbamazepine",NC(=O)N1C2=CC=CC=C2C2OC2C2=CC=CC=C21,ZRWWEEVEIOGMMT-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4, Cytochrome P450 2C8",0.49,
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,FFGPTBGBLSHEPO-UHFFFAOYSA-N,"Carbamazepine 2,3-epoxide",NC(=O)N1C2=CC3OC3C=C2C=CC2=CC=CC=C21,AUCXBTOAZTYKIN-UHFFFAOYSA-N,,0.31,
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,FFGPTBGBLSHEPO-UHFFFAOYSA-N,3-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=C(O)C=C21,QQCFBZCATDIWTH-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6",0.84,
Cisatracurium,COC1=C(OC)C=C(CC2C3=C(C=C(OC)C(OC)=C3)CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=C(C=C(OC)C(OC)=C3)C2CC2=CC(OC)=C(OC)C=C2)C=C1,YXSLJKQTIDHPOT-LJCJQEJUSA-N,laudanosine,COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CCN2C)C=C1,KGPAYJZAMGEDIQ-UHFFFAOYSA-N,,0.82,
Cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,"InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+",Cinnarizine metabolite M1,C1=CC=C(C(C2=CC=CC=C2)N2CCNCC2)C=C1,NWVNXDKZIQLBNM-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2A6",0.76,
Cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,"InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+",Cinnarizine metabolite M2,OC1=CC=C(C=CCN2CCN(C(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,QFWMZESBHJUDQQ-UHFFFAOYSA-N,Cytochrome P450 2D6,0.9,
Cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,"InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+",Benzophenone,O=C(C1=CC=CC=C1)C1=CC=CC=C1,RWCCWEUUXYIKHB-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2A6",0.21,
Cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,"InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+",Cinnarizine metabolite M4,OC1=CC=C(C(C2=CC=CC=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,UQMAKWWGLMGUQQ-UHFFFAOYSA-N,Cytochrome P450 2B6,0.89,
Cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,"InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+",Cinnamaldehyde,O=CC=CC1=CC=CC=C1,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A2, Cytochrome P450 2A6",0.22,
Vinblastine,CCC1(O)CC2CN(CCC3=C(NC4=C3C=CC=C4)C(C(=O)OC)(C3=C(OC)C=C4C(=C3)C35CCN6CC=CC(CC)(C(OC(C)=O)C(O)(C(=O)OC)C3N4C)C65)C2)C1,JXLYSJRDGCGARV-CFWMRBGOSA-N,Desacetylvinblastine,CCC1(O)CC2CN(CCC3=C(NC4=CC=CC=C34)C(C(=O)OC)(C3=C(OC)C=C4C(=C3)C35CCN6CC=CC(CC)(C(O)C(O)(C(=O)OC)C3N4C)C65)C2)C1,NDMPLJNOPCLANR-CYJJREDESA-N,Cytochrome P450 3A4,0.99,
Fenoprofen,CC(C(=O)O)C1=CC(OC2=CC=CC=C2)=CC=C1,RDJGLLICXDHJDY-UHFFFAOYSA-N,Fenoprofen glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC(OC2=CC=CC=C2)=C1,KXAAUVHIGIFUSM-RVLIQFCMSA-N,,0.38,
Fenoprofen,CC(C(=O)O)C1=CC(OC2=CC=CC=C2)=CC=C1,RDJGLLICXDHJDY-UHFFFAOYSA-N,4'-hydroxyfenoprofen glucuronide,CC(C(=O)O)C1=CC(OC2=CC=C(OC3C(O)C(O)OC(C(=O)O)C3O)C=C2)=CC=C1,FPPVBAMKHUAIOP-OYQCQVHHSA-N,,0.4,
Fenfluramine,CCNC(C)CC1=CC=CC(C(F)(F)F)=C1,DBGIVFWFUFKIQN-UHFFFAOYSA-N,norfenfluramine,CC(N)CC1=CC(C(F)(F)F)=CC=C1,MLBHFBKZUPLWBD-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A2",0.88,
Clonidine,ClC1=CC=CC(Cl)=C1NC1=NCCN1,GJSURZIOUXUGAL-UHFFFAOYSA-N,4-Hydroxyclonidine,OC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,NTWBRPXHGAXREI-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1A1, Cytochrome P450 3A5",0.84,
Valaciclovir,CC(C)C(N)C(=O)OCCOCN1C=NC2=C1NC(N)=NC2=O,HDOVUKNUBWVHOX-QMMMGPOBSA-N,Acyclovir,NC1=NC(=O)C2=C(N1)N(COCCO)C=N2,MKUXAQIIEYXACX-UHFFFAOYSA-N,Valacyclovir hydrolase,0.87,
Voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,Voriconazole N-Oxide,CC(C1=C(F)C=[N+]([O-])C=N1)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,KPLFPLUCFPRUHU-MGPLVRAMSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7",0.96,
Voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,BCEHBSKCWLPMDN-MGPLVRAMSA-N,4-Hydroxyvoriconazole,OCC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,BGPPSFHHAYWTMX-LRDDRELGSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7",0.96,
Levocarnitine,C[N+](C)(C)CC(O)CC(=O)[O-],PHIQHXFUZVPYII-ZCFIWIBFSA-N,[3H]-gamma-Butyrobetaine,C[N+](C)(C)CCCC(=O)O,JHPNVNIEXXLNTR-UHFFFAOYSA-O,,0.63,
Enalapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CCCC1C(=O)O,GBXSMTUPTTWBMN-XIRDDKMYSA-N,Enalaprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1CCCC1C(=O)O,LZFZMUMEGBBDTC-QEJZJMRPSA-N,,0.9,
Nizatidine,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(CN(C)C)=N1,SGXXNSQHWDMGGP-UHFFFAOYSA-N,N2-monodes-methylnizatidine,CNCC1=NC(CSCCNC(=C[N+](=O)[O-])NC)=CS1,QDLSRAPBCBFIQC-UXBLZVDNSA-N,,0.95,
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,DCOPUUMXTXDBNB-UHFFFAOYSA-N,4'-Hydroxydiclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,KGVXVPRLBMWZLG-UHFFFAOYSA-N,Cytochrome P450 2C9,0.87,
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,DCOPUUMXTXDBNB-UHFFFAOYSA-N,Diclofenac acyl glucuronide,O=C(CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl)OC1OC(C(=O)O)C(O)C(O)C1O,JXIKYYSIYCILNG-HBWRTXEVSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B4",0.48,
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,DCOPUUMXTXDBNB-UHFFFAOYSA-N,3'-Hydroxydiclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(O)=C1Cl,HYPJZSYXUWYJDG-UHFFFAOYSA-N,Cytochrome P450 2C9,0.8,
Fluticasone propionate,CCC(=O)OC1(C(=O)SCF)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,WMWTYOKRWGGJOA-CENSZEJFSA-N,fluticasone 17beta-carboxylic acid,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)O,QSVBUQTYFQFEHC-FULJYSEXSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7",0.74,
Thiopental,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,IUJDSEJGGMCXSG-UHFFFAOYSA-N,Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,WEXRUCMBJFQVBZ-UHFFFAOYSA-N,,0.74,
Cisapride,COC1=CC(N)=C(Cl)C=C1C(=O)NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,DCSUBABJRXZOMT-IRLDBZIGSA-N,norcisapride,COC1=CC(N)=C(Cl)C=C1C(=O)NC1CCNCC1OC,OMLDMGPCWMBPAN-YPMHNXCESA-N,Cytochrome P450 3A4,0.9,
Sulindac,CC1=C(CC(=O)O)C2=CC(F)=CC=C2C1=CC1=CC=C(S(C)=O)C=C1,MLKXDPUZXIRXEP-MFOYZWKCSA-N,Sulindac sulfide,CSC1=CC=C(C=C2C(C)=C(CC(=O)O)C3=C2C=CC(F)=C3)C=C1,LFWHFZJPXXOYNR-MFOYZWKCSA-N,,0.97,
Sulindac,CC1=C(CC(=O)O)C2=CC(F)=CC=C2C1=CC1=CC=C(S(C)=O)C=C1,MLKXDPUZXIRXEP-MFOYZWKCSA-N,Sulindac sulfone,CC1=C(CC(=O)O)C2=C(C=CC(F)=C2)C1=CC1=CC=C(S(C)(=O)=O)C=C1,MVGSNCBCUWPVDA-UHFFFAOYSA-N,,0.98,
Ethionamide,CCC1=NC=CC(C(N)=S)=C1,AEOCXXJPGCBFJA-UHFFFAOYSA-N,Ethionamide sulphoxide,CCC1=NC=CC(C(N)=S=O)=C1,QDQQNGZRIJPDGA-UHFFFAOYSA-N,,0.87,
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=C1,"InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)",desethylamodiaquine,CCNCC1=C(O)C=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=C1,VRXFDHAGFYWGHT-UHFFFAOYSA-N,Cytochrome P450 2C8,0.96,
Rifabutin,COC1C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C(O)=C3C,ATEBXHFBFRCZMA-VXTBVIBXSA-N,27-O-demethylrifabutin,CC(=O)OC1C(C)C(O)C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)N=C(O)C(C)=CC=CC(C)C(O)C(C)C(O)C1C)C(O)=C3C,BZRNSFHHZZYSST-VBSJQSPRSA-N,Cytochrome P450 3A4,0.95,
Rifabutin,COC1C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C(O)=C3C,ATEBXHFBFRCZMA-VXTBVIBXSA-N,25-O-deacetylrifabutin,COC1C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(O)C1C)C(O)=C3C,SCGFWNINBXENQT-FMPFFZOVSA-N,,0.99,
Paramethadione,CCC1(C)OC(=O)N(C)C1=O,"InChI=1S/C7H11NO3/c1-4-7(2)5(9)8(3)6(10)11-7/h4H2,1-3H3","5-ethyl-5-methyl-2,4-oxazolidinedione",CCC1(C)OC(=O)N=C1O,MGHNWMRNFGYJKE-UHFFFAOYSA-N,Cytochrome P450 2C9,0.2,
Imatinib,CC1=C(NC2=NC=CC(C3=CN=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,AFN911,CN1CCN(CC2=CC=C(C(=O)NC3=CC(NC4=NC=CC(C5=CN=CC=C5)=N4)C(CO)C=C3)C=C2)CC1,JBSTUPHUZMAVFU-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A1, Cytochrome P450 1B1, Cytochrome P450 4F3",0.55,
Imatinib,CC1=C(NC2=NC=CC(C3=CN=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Piperidine N-oxide imatinib,CC1=C(NC2=[NH+]C=CC(C3=C[N-][CH]C=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CC[N+](C)([O-])CC3)C=C2)C=C1,XCNZJTPSXKIWMO-UHFFFAOYSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 3, Cytochrome P450 3A4",0.58,
Imatinib,CC1=C(NC2=NC=CC(C3=CN=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,KTUFNOKKBVMGRW-UHFFFAOYSA-N,Pyridine N-oxide imatinib,CC1=C(NC2=NC=CC(C3=C[N+]([O-])=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,QEQWNPDNPZKKNH-UHFFFAOYSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 3, Cytochrome P450 3A4",0.94,
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1","Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 3A4",0.7,
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Testosterone sulfate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,WAQBISPOEAOCOG-DYKIIFRCSA-N,,0.75,
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,3-oxo-5-alpha-steroid 4-dehydrogenase 2,0.51,
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Testosterone glucuronide,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,NIKZPECGCSUSBV-HMAFJQTKSA-N,UDP-glucuronosyltransferase 2B17,0.49,
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,5-alpha-Dihydrotestosterone glucuronide,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,CLQMBSSRTBUNDV-CPKOJWPQSA-N,,0.32,
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,6-beta-hydroxytestosterone,CC12CCC(=O)C=C1C(O)CC1C2CCC2(C)C(O)CCC12,XSEGWEUVSZRCBC-ZVBLRVHNSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19",0.81,
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Cytochrome P450 19A1,0.31,
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Cytochrome P450 19A1,0.31,
Niacin,O=C(O)C1=CN=CC=C1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,Niacinamide,NC(=O)C1=CC=CN=C1,,,0.47,
Niacin,O=C(O)C1=CN=CC=C1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,Trigonelline,C[N+]1=CC=CC(C(=O)[O-])=C1,,,0.7,
Clorazepic acid,O=C(O)C1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)NC1=O,XDDJGVMJFWAHJX-UHFFFAOYSA-N,Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",Cytochrome P450 3A4,0.8,
Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,,0.87,
Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",p-Hydroxynordiazepam,O=C1CN=C(C2=CC=C(O)C=C2)C2=CC(Cl)=CC=C2N1,WVHIBVZUJQMFON-UHFFFAOYSA-N,,0.95,
Guanabenz,NC(N)=NN=CC1=C(Cl)C=CC=C1Cl,WDZVGELJXXEGPV-UHFFFAOYSA-N,Guanoxabenz,N=C(NO)NN=CC1=C(Cl)C=CC=C1Cl,"InChI=1S/C8H8Cl2N4O/c9-6-2-1-3-7(10)5(6)4-12-13-8(11)14-15/h1-4,15H,(H3,11,13,14)/b12-4+",Cytochrome P450 1A2,0.66,
Clofarabine,NC1=C2N=CN(C3OC(CO)C(O)C3F)C2=NC(Cl)=N1,WDDPHFBMKLOVOX-AYQXTPAHSA-N,clofarabind-5'-monophosphate,NC1=C2N=CN(C3OC(COP(=O)(O)O)C(O)C3F)C2=NC(Cl)=N1,JEJRVFQHFJDNJN-CQOARYKOSA-N,Deoxycytidine kinase,0.94,
Prednisone,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,Prednisolone,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,OIGNJSKKLXVSLS-VWUMJDOOSA-N,Cytochrome P450 3A4,0.83,
Astemizole,COC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,GXDALQBWZGODGZ-UHFFFAOYSA-N,Tecastemizole,FC1=CC=C(CN2C(NC3CCNCC3)=NC3=CC=CC=C32)C=C1,"InChI=1S/C19H21FN4/c20-15-7-5-14(6-8-15)13-24-18-4-2-1-3-17(18)23-19(24)22-16-9-11-21-12-10-16/h1-8,16,21H,9-13H2,(H,22,23)",Cytochrome P450 3A4,0.85,
Astemizole,COC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,GXDALQBWZGODGZ-UHFFFAOYSA-N,desmethylastemizole,OC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,LAGYWHSFHIMTPE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.98,
Adenosine,NC1=C2N=CN(C3OC(CO)C(O)C3O)C2=NC=N1,OIRDTQYFTABQOQ-KQYNXXCUSA-N,Adenosine monophosphate,NC1=C2N=CN(C3OC(COP(=O)(O)O)C(O)C3O)C2=NC=N1,UDMBCSSLTHHNCD-KQYNXXCUSA-N,Adenosine kinase,0.93,
Adenosine,NC1=C2N=CN(C3OC(CO)C(O)C3O)C2=NC=N1,OIRDTQYFTABQOQ-KQYNXXCUSA-N,Inosine,O=C1N=CNC2=C1N=CN2C1OC(CO)C(O)C1O,UGQMRVRMYYASKQ-KQYNXXCUSA-N,Adenosine deaminase,0.82,
Simvastatin,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,RYMZZMVNJRMUDD-HGQWONQESA-N,simvastatin hydroxy acid,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21,XWLXKKNPFMNSFA-HGQWONQESA-N,Cytochrome P450 3A4,0.93,
Mebendazole,COC(=O)NC1=NC2=C(C=C(C(=O)C3=CC=CC=C3)C=C2)N1,OPXLLQIJSORQAM-UHFFFAOYSA-N,2-amino-5-benzoylbenzimidazole,N=C1NC2=C(C=C(C(=O)C3=CC=CC=C3)C=C2)N1,GPMHHSJZGVOEFS-UHFFFAOYSA-N,,0.66,
Leucovorin,NC1=NC2=C(C(=O)N1)N(C=O)C(CNC1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1)CN2,VVIAGPKUTFNRDU-ABLWVSNPSA-N,5-Methyltetrahydrofolate,CN1C2=C(N=C(N)NC2=O)NCC1CNC1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1,ZNOVTXRBGFNYRX-ZGTCLIOFSA-N,,0.95,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.83,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.55,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,Cytochrome P450 3A4,0.85,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.76,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.69,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4",0.96,
Trazodone,O=C1N(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)N=C2C=CC=CN12,PHLBKPHSAVXXEF-UHFFFAOYSA-N,m-chlorophenylpiperazine (m-CPP) ,ClC1=CC=CC(N2CCNCC2)=C1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,Cytochrome P450 3A4,0.28,
Trazodone,O=C1N(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)N=C2C=CC=CN12,PHLBKPHSAVXXEF-UHFFFAOYSA-N,triazolopyridinone epoxide,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C3OC3C=CN21,QFERKVDPWYTEPE-UHFFFAOYSA-N,,0.47,
Trazodone,O=C1N(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)N=C2C=CC=CN12,PHLBKPHSAVXXEF-UHFFFAOYSA-N,4'-hydroxytrazodone ,O=C1N(CCCN2CCN(C3=CC(Cl)=C(O)C=C3)CC2)N=C2C=CC=CN12,FNUZSRSXQFIOPL-UHFFFAOYSA-N,,0.95,
Verapamil,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,SGTNSNPWRIOYBX-UHFFFAOYSA-N,Verapamil metabolite D-617,CNCCCC(C#N)(C1=CC(OC)=C(OC)C=C1)C(C)C,WLOBUUJURNEQCL-UHFFFAOYSA-N,Cytochrome P450 2C8,0.88,
Verapamil,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,SGTNSNPWRIOYBX-UHFFFAOYSA-N,Norverapamil,COC1=C(OC)C=C(CCNCCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,UPKQNCPKPOLASS-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 1A2",0.95,
Epinephrine,CNCC(O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Epinephrine sulfate,CNCC(O)C1=CC(O)=C(OS(=O)(=O)O)C=C1,AELFRHHZGTVYGJ-QMMMGPOBSA-N,,0.66,
Epinephrine,CNCC(O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Metanephrine,CNCC(O)C1=CC(OC)=C(O)C=C1,,Catechol O-methyltransferase,0.82,
Epinephrine,CNCC(O)C1=CC(O)=C(O)C=C1,UCTWMZQNUQWSLP-VIFPVBQESA-N,Epinephrine glucuronide,CNCC(O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1,BLTFFSZSAZRUSC-FYRJOLOESA-N,UDP-glucuronosyltransferase 1-3,0.33,
Chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,RKWGIWYCVPQPMF-UHFFFAOYSA-N,2-Hydroxychlorpropamide,CCCN=C(O)NS(=O)(=O)C1=C(O)C=C(Cl)C=C1,QRXRPQPWKRLTQX-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.4,
Chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,RKWGIWYCVPQPMF-UHFFFAOYSA-N,3-Hydroxychlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC(O)=C(Cl)C=C1,RXFPYNAVFFDUJE-UHFFFAOYSA-N,,0.41,
Chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,RKWGIWYCVPQPMF-UHFFFAOYSA-N,4-Chlorobenzenesulfonylurea,NC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,AZEPYUPSYWCRBG-UHFFFAOYSA-N,,0.8,
Aprepitant,CC(OC1OCCN(CC2=NNC(=O)N2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,ATALOFNDEOCMKK-OITMNORJSA-N,"(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine",CC(OC1OCCNC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,AFBDSAJOMZYQAI-CNOZUTPLSA-N,Cytochrome P450 3A4,0.74,
Tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,NKANXQFJJICGDU-QPLCGJKRSA-N,N-Desmethyltamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,NYDCDZSEEAUOHN-IZHYLOQSSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1B1, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A5",0.98,
Tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,NKANXQFJJICGDU-QPLCGJKRSA-N,Tamoxifen N-oxide,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[O-])C=C1)C1=CC=CC=C1,YAASNACECBQAFW-QPLCGJKRSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 1, Dimethylaniline monooxygenase [N-oxide-forming] 3",0.95,
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,Losartan carboxaldehyde,CCCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,FQZSMTSTFMNWQF-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.86,
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,Losartan N2-glucuronide,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN(C3OC(C(=O)O)C(O)C(O)C3O)N=N2)C=C1,NGFMQMUIOUSHGR-RTCYWULBSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-10, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B17",0.68,
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,Losartan carboxylic acid,CCCCC1=NC(Cl)=C(C(=O)O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,ZEUXAIYYDDCIRX-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 3A5",0.9,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,PJVWKTKQMONHTI-UHFFFAOYSA-N,S-7-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O,BQSUFDMOXLLKQK-HNNXBMFYSA-N,Cytochrome P450 2C9,0.66,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,PJVWKTKQMONHTI-UHFFFAOYSA-N,S-6-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC(O)=C2)OC1=O,IQWPEJBUOJQPDE-AWEZNQCLSA-N,Cytochrome P450 2C9,0.96,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,PJVWKTKQMONHTI-UHFFFAOYSA-N,S-4'-Hydroxywarfarin,CC(=O)CC(C1=CC=C(O)C=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,RRZWAMPDGRWRPF-OAHLLOKOSA-N,"Cytochrome P450 2C18, Cytochrome P450 2C19",0.98,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,PJVWKTKQMONHTI-UHFFFAOYSA-N,R-10(S)-Hydroxywarfarin,CC(=O)C(O)C(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,BPZSPAZBZFZZBN-NVXWUHKLSA-N,Cytochrome P450 3A4,0.89,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,PJVWKTKQMONHTI-UHFFFAOYSA-N,R-8-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C(O)=CC=C2,BHBOXPNWDGYJNB-CQSZACIVSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19",0.93,
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,PJVWKTKQMONHTI-UHFFFAOYSA-N,R-7-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=C(O)C=C2)OC1=O,SKFYEJMLNMTTJA-OAHLLOKOSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C8",0.99,
Midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,DDLIGBOFAVUZHB-UHFFFAOYSA-N,1-hydroxymidazolam,OCC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,QHSMEGADRFZVNE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.95,
Midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,DDLIGBOFAVUZHB-UHFFFAOYSA-N,4-hydroxymidazolam,CC1=NC=C2C(O)N=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,ZYISITHKPKHPKG-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.91,
Mycophenolate mofetil,COC1=C(CC=C(C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,RTGDFNSFWBGLEC-SYZQJQIISA-N,Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,HPNSFSBZBAHARI-RUDMXATFSA-N,"Liver carboxylesterase 1, Carboxylic ester hydrolase",0.93,
Mycophenolate mofetil,COC1=C(CC=C(C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,RTGDFNSFWBGLEC-SYZQJQIISA-N,Mycophenolic acid glucuronide,COC1=C(CC=C(C)CCC(=O)O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)OCC2=C1C,BYFGTSAYQQIUCN-WTKPLQERSA-N,"UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-10",0.66,
Flurazepam,CCN(CC)CCN1C(=O)CN=C(C2=CC=CC=C2F)C2=C1C=CC(Cl)=C2,SAADBVWGJQAEFS-UHFFFAOYSA-N,Hydroxyethylflurazepam,CCN(CCO)CCN1C(=O)CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C21,IRYBKIZHCXMFFO-UHFFFAOYSA-N,,0.98,
Flurazepam,CCN(CC)CCN1C(=O)CN=C(C2=CC=CC=C2F)C2=C1C=CC(Cl)=C2,SAADBVWGJQAEFS-UHFFFAOYSA-N,Norflurazepam,O=C1CN=C(C2=C(F)C=CC=C2)C2=C(C=CC(Cl)=C2)N1,UVCOILFBWYKHHB-UHFFFAOYSA-N,,0.83,
Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CC2=CC(OC)=C(OC)C=C2CC1C(=O)O,UWWDHYUMIORJTA-HSQYWUDLSA-N,Moexiprilat,COC1=C(OC)C=C2CN(C(=O)C(C)NC(CCC3=CC=CC=C3)C(=O)O)C(C(=O)O)CC2=C1,CMPAGYDKASJORH-YSSFQJQWSA-N,,0.95,
Furosemide,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(C(=O)O)=C1,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,4-chloro-5-sulfamoylanthranilic acid,NC1=CC(Cl)=C(S(N)(=O)=O)C=C1C(=O)O,QQLJBZFXGDHSRU-UHFFFAOYSA-N,,0.75,
Nitrofurantoin,O=C1CN(N=CC2=CC=C([N+](=O)[O-])O2)C(=O)N1,NXFQHRVNIOXGAQ-YCRREMRBSA-N,Aminofurantoin,NC1=CC=C(C=NN2CC(O)=NC2=O)O1,KLJOOBXQOIHZQM-UHFFFAOYSA-N,,0.48,
Nicergoline,COC12CC(COC(=O)C3=CN=CC(Br)=C3)CN(C)C1CC1=CN(C)C3=CC=CC2=C13,"InChI=1S/C24H26BrN3O3/c1-27-13-17-8-21-24(30-3,19-5-4-6-20(27)22(17)19)9-15(12-28(21)2)14-31-23(29)16-7-18(25)11-26-10-16/h4-7,10-11,13,15,21H,8-9,12,14H2,1-3H3/t15-,21-,24+/m1/s1","10-alpha-methoxy-9,10-dihydrolysergol",COC12CC(CO)CN(C)C1CC1=CNC3=CC=CC2=C13,JGQZSBLQHCTAJF-NFXPUDJFSA-N,Cytochrome P450 2D6,0.88,
Naltrexone,O=C1CCC2(O)C3CC4=C5C(=C(O)C=C4)OC1C52CCN3CC1CC1,DQCKKXVULJGBQN-XFWGSAIBSA-N,6-beta-naltrexol,OC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5CC2CC2)C=C1,JLVNEHKORQFVQJ-UHFFFAOYSA-N,,0.93,
Delavirdine,CC(C)NC1=C(N2CCN(C(=O)C3=CC4=C(C=CC(NS(C)(=O)=O)=C4)N3)CC2)N=CC=C1,WHBIGIKBNXZKFE-UHFFFAOYSA-N,N-desalkyl delavirdine,CS(=O)(=O)NC1=CC=C2NC(C(=O)N3CCN(C4=C(N)C=CC=N4)CC3)=CC2=C1,MTEFFPTUUPAKOV-UHFFFAOYSA-N,Cytochrome P450 3A4,0.93,
Lamivudine,NC1=NC(=O)N(C2CSC(CO)O2)C=C1,JTEGQNOMFQHVDC-NKWVEPMBSA-N,Lamivudine sulfoxide,NC1=NC(=O)N(C2CS(=O)C(CO)O2)C=C1,LJMQAXFNQNADRZ-FYZWQCAOSA-N,Sulfotransferase 1A1,0.87,
Lamivudine,NC1=NC(=O)N(C2CSC(CO)O2)C=C1,JTEGQNOMFQHVDC-NKWVEPMBSA-N,Lamivudine-monophosphate,NC1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1,WUMZLKDCOINBEA-UHFFFAOYSA-N,,0.9,
Lamivudine,NC1=NC(=O)N(C2CSC(CO)O2)C=C1,JTEGQNOMFQHVDC-NKWVEPMBSA-N,Lamivudine-triphosphate,NC1=NC(=O)N(C2CSC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)C=C1,YLEQMGZZMCJKCN-UHFFFAOYSA-N,,0.78,
Diethylcarbamazine,CCN(CC)C(=O)N1CCN(C)CC1,RCKMWOKWVGPNJF-UHFFFAOYSA-N,diethylcarbamazine N-oxide,CCN(CC)C(=O)N1CC[N+](C)([O-])CC1,KAJAFGMERLXELG-UHFFFAOYSA-N,,0.72,
Flurbiprofen,CC(C(=O)O)C1=CC(F)=C(C2=CC=CC=C2)C=C1,SYTBZMRGLBWNTM-UHFFFAOYSA-N,4'-Hydroxyflurbiprofen,CC(C(=O)O)C1=CC(F)=C(C2=CC=C(O)C=C2)C=C1,GTSMMBJBNJDFRA-UHFFFAOYSA-N,Cytochrome P450 2C9,0.92,
Flurbiprofen,CC(C(=O)O)C1=CC(F)=C(C2=CC=CC=C2)C=C1,SYTBZMRGLBWNTM-UHFFFAOYSA-N,Flurbiprofen glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC(F)=C(C2=CC=CC=C2)C=C1,PLPQBSOCUVSKTP-QGCNQZRGSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B4",0.46,
Adefovir dipivoxil,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C21)OCOC(=O)C(C)(C)C,WOZSCQDILHKSGG-UHFFFAOYSA-N,Adefovir,NC1=C2N=CN(CCOCP(=O)(O)O)C2=NC=N1,SUPKOOSCJHTBAH-UHFFFAOYSA-N,,0.81,
Procaine,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,MFDFERRIHVXMIY-UHFFFAOYSA-N,para-aminobenzoic acid,NC1=CC=C(C(=O)O)C=C1,ALYNCZNDIQEVRV-UHFFFAOYSA-N,Cholinesterase,0.57,
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,OELFLUMRDSZNSF-BRWVUGGUSA-N,Nateglinide metabolite M2/M3,CC(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,GMHTWYIGIMINLF-OKEQZYBDSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.96,
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,OELFLUMRDSZNSF-BRWVUGGUSA-N,Nateglinide metabolite M1,CC(C)(O)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IUMHIIXPABZGRF-YTPLPTRZSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.91,
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,OELFLUMRDSZNSF-BRWVUGGUSA-N,Nateglinide metabolite M7,C=C(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,QKNIFXOGUWQRIF-YJEKIOLLSA-N,,0.92,
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,OELFLUMRDSZNSF-BRWVUGGUSA-N,Nateglinide glucuronide and isomers (M4/M5/M6),CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)CC1,YTIRWNSTJVSCRW-VJQMJTOBSA-N,UDP-glucuronosyltransferases (UGTs),0.48,
Risperidone,CC1=C(CCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)C(=O)N2CCCCC2=N1,RAPZEAPATHNIPO-UHFFFAOYSA-N,9-hydroxyrisperidone,CC1=C(CCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)C(=O)N2CCCC(O)C2=N1,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Cytochrome P450 2D6,0.94,
Esomeprazole,COC1=CC2=C(C=C1)NC(S(=O)CC1=NC=C(C)C(OC)=C1C)=N2,SUBDBMMJDZJVOS-DEOSSOPVSA-N,Active Metabolite of Esomeprazole,COC1=CC2=C(C=C1)N=C1N2SCC2=C(C)C(OC)=C(C)C=[N+]12,NNKKOITVFGCNKQ-UHFFFAOYSA-N,,0.52,
Esomeprazole,COC1=CC2=C(C=C1)NC(S(=O)CC1=NC=C(C)C(OC)=C1C)=N2,SUBDBMMJDZJVOS-DEOSSOPVSA-N,Omeprazole sulfone,COC1=CC2=C(C=C1)N=C(S(=O)(=O)CC1=C(C)C(OC)=C(C)C=N1)N2,IXEQEYRTSRFZEO-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Esomeprazole,COC1=CC2=C(C=C1)NC(S(=O)CC1=NC=C(C)C(OC)=C1C)=N2,SUBDBMMJDZJVOS-DEOSSOPVSA-N,5-hydroxyesomeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(CO)C(OC)=C1C)N2,CMZHQFXXAAIBKE-UHFFFAOYSA-N,Cytochrome P450 2C19,0.94,
Hydrocortisone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,JYGXADMDTFJGBT-VWUMJDOOSA-N,6-beta-hydrocortisol,CC12CCC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,GNFTWPCIRXSCQF-ZWJNAVLBSA-N,Cytochrome P450 3A Subfamily,0.89,
Hydrocortisone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,JYGXADMDTFJGBT-VWUMJDOOSA-N,Cortisone,CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1","Corticosteroid 11-beta-dehydrogenase isozyme 1, Corticosteroid 11-beta-dehydrogenase isozyme 2",0.83,
Cortisone,CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",Tetrahydrocortisone,CC12CCC(O)CC1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,,,0.66,
Cortisone,CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",Dihydrocortisol,CC12CCC(=O)CC1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,,,0.6,
Mannitol,OCC(O)C(O)C(O)C(O)CO,FBPFZTCFMRRESA-KVTDHHQDSA-N,Glycogen,OCC1OC(OCC2OC(OC3C(CO)OC(O)C(O)C3O)C(O)C(O)C2OC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,BYSGBSNPRWKUQH-UJDJLXLFSA-N,,0.23,
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,MWLSOWXNZPKENC-UHFFFAOYSA-N,Hydroxyzileuton,CC(C1=CC2=C(C=C(O)C=C2)S1)N(O)C(=N)O,ZQQVPNNYZLDMMO-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A2",0.63,
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,MWLSOWXNZPKENC-UHFFFAOYSA-N,Zileuton sulfoxide,CC(C1=CC2=CC=CC=C2S1=O)N(O)C(=N)O,KWEAXQJUQDQMNY-UHFFFAOYSA-N,Cytochrome P450 3A4,0.23,
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,MWLSOWXNZPKENC-UHFFFAOYSA-N,Dehydroxyzyleuton,CC(NC(=N)O)C1=CC2=CC=CC=C2S1,CKVDCQYUEYONIA-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.62,
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,MWLSOWXNZPKENC-UHFFFAOYSA-N,Zileuton O-glucuronide,CC(C1=CC2=CC=CC=C2S1)N(OC1OC(C(=O)O)C(O)C(O)C1O)C(=N)O,CYYKQHWQVGZJRJ-UPZRFPAJSA-N,UDP-glucuronosyltransferase 1-9,0.43,
Modafinil,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,YFGHCGITMMYXAQ-UHFFFAOYSA-N,modafinil acid,O=C(O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,QARQPIWTMBRJFX-UHFFFAOYSA-N,Cytochrome P450 3A4,0.79,
Ethotoin,CCN1C(=O)NC(C2=CC=CC=C2)C1=O,SZQIFWWUIBRPBZ-UHFFFAOYSA-N,p-Hydroxyl-ethotoin,CCN1C(=O)NC(C2=CC=C(O)C=C2)C1=O,UUBDNHDPPHJUHB-UHFFFAOYSA-N,,0.93,
Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,4-Hydroxyretinoic acid,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,KGUMXGDKXYTTEY-FRCNGJHJSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7, Cytochrome P450 2C18, Cytochrome P450 4A11, Cytochrome P450 1A1, Cytochrome P450 2B6",0.75,
Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,18-Hydroxyretinoic acid,CC(C=CC1=C(CO)CCCC1(C)C)=CC=CC(C)=CC(=O)O,XSJOIRFEYHJNAW-FCKHSPHMSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A7, Cytochrome P450 4A11, Cytochrome P450 2B6, Cytochrome P450 2A6, Cytochrome P450 2C9, Cytochrome P450 2C18, Cytochrome P450 3A4, Cytochrome P450 3A5",0.86,
Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,"5,6-Epoxyretinoic acid",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)O,KEEHJLBAOLGBJZ-WEDZBJJJSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 1A1, Cytochrome P450 2A6, Cytochrome P450 2B6, Cytochrome P450 3A4, Cytochrome P450 3A5",0.35,
Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,SHGAZHPCJJPHSC-YCNIQYBTSA-N,Retinoyl beta-glucuronide,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,MTGFYEHKPMOVNE-NEFMKCFNSA-N,UDP-glucuronosyltransferase 2B7,0.37,
Irinotecan,CCC1=C2CN3C(=CC4=C(COC(=O)C4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(N4CCCCC4)CC3)C=C12,UWKQSNNFCGGAFS-XIFFEERXSA-N,SN-38,CCC1=C2C=C(O)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)C2(O)CC)C1=O,FJHBVJOVLFPMQE-QFIPXVFZSA-N,"Cholinesterase, Liver carboxylesterase 1, Cocaine esterase",0.96,
Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CCl,"InChI=1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",6-beta-hydroxy-mometasone furoate,CC1CC2C3C(O)CC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,NVZADOUZVHKHSK-PWHXNIGKSA-N,,0.72,
Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,JBIMVDZLSHOPLA-LSCVHKIXSA-N,N-desmethyl olopatadine,CNCCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,VQMJUHOJPCPUAM-IDUWFGFVSA-N,Cytochrome P450 3A4,0.99,
Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,JBIMVDZLSHOPLA-LSCVHKIXSA-N,Olopatadine N-oxide,C[N+](C)([O-])CCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,TXKZPVWYFNGMCP-LSCVHKIXSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 1, Dimethylaniline monooxygenase [N-oxide-forming] 3",0.98,
Malathion,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,JXSJBGJIGXNWCI-UHFFFAOYSA-N,Malaoxon,CCOC(=O)CC(SP(=O)(OC)OC)C(=O)OCC,WSORODGWGUUOBO-UHFFFAOYSA-N,,0.65,
Malathion,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,JXSJBGJIGXNWCI-UHFFFAOYSA-N,Malathion dicarboxylic acid,COP(=S)(OC)SC(CC(=O)O)C(=O)O,NIUNKPWHNGMQRE-UHFFFAOYSA-N,,0.75,
Malathion,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,JXSJBGJIGXNWCI-UHFFFAOYSA-N,Malathion monocarboxylic acid,CCOC(=O)C(CC(=O)O)SP(=S)(OC)OC,FARGSBYVTRDSKX-UHFFFAOYSA-N,,0.95,
Etoposide,COC1=C(O)C(OC)=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)=C1,VJJPUSNTGOMMGY-MRVIYFEKSA-N,Etoposide glucuronide,COC1=CC(C2C3=C(C=C4OCOC4=C3)C(OC3OC4COC(C)OC4C(O)C3O)C3COC(=O)C23)=CC(OC)=C1OC1OC(C(=O)O)C(O)C(O)C1O,URCVASXWNJQAEH-UHFFFAOYSA-N,UDP-glucuronosyltransferase 1-1,0.91,
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,(R)-MHD,NC(=O)N1C2=C(C=CC=C2)CC(O)C2=CC=CC=C21,BMPDWHIDQYTSHX-AWEZNQCLSA-N,"Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3, Aldo-keto reductase family 1 member C4",0.64,
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,(S)-MHD,NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,,"Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3, Aldo-keto reductase family 1 member C4, Carbonyl reductase [NADPH] 1, Carbonyl reductase [NADPH] 3",0.64,
Nalidixic acid,CCN1C=C(C(=O)O)C(=O)C2=C1N=C(C)C=C2,MHWLWQUZZRMNGJ-UHFFFAOYSA-N,Hydroxynalidixic acid,CCN1C=C(C(=O)O)C(=O)C2=CC=C(CO)N=C21,FRJDYPGZHOEEKU-UHFFFAOYSA-N,,0.96,
Phenelzine,NNCCC1=CC=CC=C1,RMUCZJUITONUFY-UHFFFAOYSA-N,Phenylacetic acid,O=C(O)CC1=CC=CC=C1,WLJVXDMOQOGPHL-UHFFFAOYSA-N,,0.4,
Phenelzine,NNCCC1=CC=CC=C1,RMUCZJUITONUFY-UHFFFAOYSA-N,Phenethylamine,NCCC1=CC=CC=C1,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2",,0.82,
Phenethylamine,NCCC1=CC=CC=C1,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2",Phenylacetic acid,O=C(O)CC1=CC=CC=C1,WLJVXDMOQOGPHL-UHFFFAOYSA-N,,0.46,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,UDP-glucuronosyltransferases (UGTs),0.83,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,UDP-glucuronosyltransferases (UGTs),0.51,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,"Cytochrome P450 1B1, Cytochrome P450 3A5",0.68,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,UDP-glucuronosyltransferases (UGTs),0.55,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.52,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.61,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,UDP-glucuronosyltransferases (UGTs),0.56,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1A1",0.75,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,Cytochrome P450 1B1,0.85,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.73,
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Estradiol 17-beta-dehydrogenase 1,0.78,
Acyclovir,NC1=NC(=O)C2=C(N1)N(COCCO)C=N2,MKUXAQIIEYXACX-UHFFFAOYSA-N,9-carboxymethoxymethylguanine,N=C1N=C(O)C2=C(N1)N(COCC(=O)O)C=N2,MICNQLKUSOVNNG-UHFFFAOYSA-N,,0.53,
Naproxen,COC1=CC2=C(C=C1)C=C(C(C)C(=O)O)C=C2,CMWTZPSULFXXJA-VIFPVBQESA-N,O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8, Cytochrome P450 1A2",0.91,
Naproxen,COC1=CC2=C(C=C1)C=C(C(C)C(=O)O)C=C2,CMWTZPSULFXXJA-VIFPVBQESA-N,Naproxen O-glucuronide,COC1=CC=C2C=C(C(C)C(=O)OC3OC(C(=O)O)C(C)C(C)C3C)C=CC2=C1,JPEWXHCASWOSRA-LQLJUYLHSA-N,,0.41,
Primidone,CCC1(C2=CC=CC=C2)C(=O)NCNC1=O,DQMZLTXERSFNPB-UHFFFAOYSA-N,Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,DDBREPKUVSBGFI-UHFFFAOYSA-N,Cytochrome P450 2C19,0.88,
Sulfasalazine,O=C(O)C1=CC(N=NC2=CC=C(S(=O)(=O)NC3=NC=CC=C3)C=C2)=CC=C1O,NCEXYHBECQHGNR-QZQOTICOSA-N,Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,,0.4,
Sulfasalazine,O=C(O)C1=CC(N=NC2=CC=C(S(=O)(=O)NC3=NC=CC=C3)C=C2)=CC=C1O,NCEXYHBECQHGNR-QZQOTICOSA-N,Sulfapyridine,NC1=CC=C(S(=O)(=O)NC2=CC=CC=N2)C=C1,GECHUMIMRBOMGK-UHFFFAOYSA-N,,0.61,
Candesartan,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,"InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)",O-Deethylated candesartan,O=C(O)C1=C2C(=CC=C1)N=C(O)N2CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,KLCPKPIDOPBIQW-UHFFFAOYSA-N,Cytochrome P450 2C9,0.94,
Candesartan,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,"InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)",Candesartan N2-glucuronide,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2C2OC(C(=O)O)C(O)C(O)C2O)C=C1,RGWIRVSYWBHDIC-XOEMIVIESA-N,UDP-glucuronosyltransferase 1-3,0.72,
Candesartan,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,"InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)",Candesartan O-glucuronide,CCOC1=NC2=CC=CC(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,IQMPSFXZXNRDMY-GPKAUORGSA-N,Prostaglandin G/H synthase 1,0.79,
Tazarotene,CCOC(=O)C1=CN=C(C#CC2=CC3=C(C=C2)SCCC3(C)C)C=C1,OGQICQVSFDPSEI-UHFFFAOYSA-N,Tazarotenic acid,CC1(C)CCSC2=C1C=C(C#CC1=NC=C(C(=O)O)C=C1)C=C2,IQIBKLWBVJPOQO-UHFFFAOYSA-N,,0.93,
Alfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCN2N=NN(CC)C2=O)CC1,IDBPHNDTYPBSNI-UHFFFAOYSA-N,AMX,CC1=NN(C2=CC(S(=O)(=O)O)=CC=C2)C(=O)C1N=NC1=C(S(=O)(=O)O)C=C(Cl)C(Cl)=C1,UOJXCGAWGJWRNV-FMQUCBEESA-N,Cytochrome P450 3A4,0.36,
Alfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCN2N=NN(CC)C2=O)CC1,IDBPHNDTYPBSNI-UHFFFAOYSA-N,noralfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCNCC1,ULOZGJWEIWAWML-UHFFFAOYSA-N,Cytochrome P450 3A4,0.73,
Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,Lisofylline,CC(O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m1/s1",,0.97,
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,NDDAHWYSQHTHNT-UHFFFAOYSA-N,Indapamide metabolite M5,CC1=CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,LWCDXWWLUHMMJI-UHFFFAOYSA-N,Cytochrome P450 3A4,0.49,
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,NDDAHWYSQHTHNT-UHFFFAOYSA-N,Indapamide metabolite M1,CC1CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ARPVNNMMMDXBBF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,NDDAHWYSQHTHNT-UHFFFAOYSA-N,Indapamide epoxide intermediate,CC1CC2=C(C=CC3OC23)N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ZDRCVKKLZHUQLV-UHFFFAOYSA-N,Cytochrome P450 3A4,0.5,
Fentanyl,CCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1,PJMPHNIQZUBGLI-UHFFFAOYSA-N,norfentanyl,CCC(=O)N(C1=CC=CC=C1)C1CCNCC1,PMCBDBWCQQBSRJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.78,
Meloxicam,CC1=CN=C(NC(=O)C2=C(O)C3=C(C=CC=C3)S(=O)(=O)N2C)S1,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,5'-hydroxymethyl meloxicam,CN1C(C(O)=NC2=NC=C(CO)S2)=C(O)C2=CC=CC=C2S1(=O)=O,LOOSAJMIEADILV-UHFFFAOYSA-N,,0.69,
Orciprenaline,CC(C)NCC(O)C1=CC(O)=CC(O)=C1,LMOINURANNBYCM-UHFFFAOYSA-N,Orciprenaline-3-O-sulfate,CC(C)NCC(O)C1=CC(O)=CC(OS(=O)(=O)O)=C1,IJWHPUWEGCYHMQ-UHFFFAOYSA-N,,0.65,
Propofol,CC(C)C1=CC=CC(C(C)C)=C1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,4-Hydroxypropofol,CC(C)C1=CC(O)=CC(C(C)C)=C1O,UFWIJKBKROBWTG-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2B6",0.83,
Propofol,CC(C)C1=CC=CC(C(C)C)=C1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,Propofol glucuronide,CC(C)C1=CC=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,JZSJIASBMOIIKI-RUKPJNHUSA-N,"UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 1-9",0.25,
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,AAOVKJBEBIDNHE-UHFFFAOYSA-N,desmethyldiazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,AKPLHCDWDRPJGD-UHFFFAOYSA-N,,0.87,
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,AAOVKJBEBIDNHE-UHFFFAOYSA-N,Temazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,SEQDDYPDSLOBDC-UHFFFAOYSA-N,"Prostaglandin G/H synthase 1, Cytochrome P450 2C19",0.87,
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,AAOVKJBEBIDNHE-UHFFFAOYSA-N,Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,Cytochrome P450 1A2,0.78,
Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",Nordiazepam O-glucuronide,O=C(O)C1OC(OC2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N2)C(O)C(O)C1O,HIENWGUIYHGOPI-QHKDLCCSSA-N,,0.54,
Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,Oxazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,FIKQKGFUBZQEBL-IFBJMGMISA-N,"UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-9",0.47,
Methylphenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)N(C)C1=O,ALARQZQTBTVLJV-UHFFFAOYSA-N,Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,DDBREPKUVSBGFI-UHFFFAOYSA-N,,0.84,
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,Terbinafine dihydrodiol derivative (1),CN(CC=CC#CC(C)(C)C)CC1=CC(O)=C(O)C2=CC=CC=C12,BSCJZDRHKPMNFX-WEVVVXLNSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2B6",0.66,
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,Hydroxyterbinafine,CN(CC=CC#CC(C)(C)CO)CC1=CC=CC2=CC=CC=C12,GPEJUKJZTGFNKY-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19",0.93,
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,Terbinafine dihydrodiol derivative (2),CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=C(O)C(O)=CC=C12,OZUIZHMLRLTKOH-FNORWQNLSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2B6",0.71,
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8, Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C19, Cytochrome P450 3A4",0.88,
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,1-Naphthaldehyde,O=CC1=CC=CC2=CC=CC=C12,SQAINHDHICKHLX-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.32,
Benzphetamine,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,YXKTVDFXDRQTKV-HNNXBMFYSA-N,Amphetamine,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,,0.47,
Benzphetamine,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,YXKTVDFXDRQTKV-HNNXBMFYSA-N,Methamphetamine,CNC(C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,,0.56,
Alprenolol,C=CCC1=CC=CC=C1OCC(O)CNC(C)C,"InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3",4-hydroxy-alprenolol,C=CCC1=CC(O)=CC=C1OCC(O)CNC(C)C,HNXRWPIZRBNFDD-UHFFFAOYSA-N,,0.9,
Suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,MDKGKXOCJGEUJW-UHFFFAOYSA-N,Suprofen S-oxide,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2=O)C=C1,BBVYLLCHKPXDCK-UHFFFAOYSA-N,Cytochrome P450 2C9,0.35,
Suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,MDKGKXOCJGEUJW-UHFFFAOYSA-N,"Thiophene-4,5-epoxide",CC(C(=O)O)C1=CC=C(C(=O)C2=CC3OC3S2)C=C1,SDGBIPHZPNRUFG-UHFFFAOYSA-N,Cytochrome P450 2C9,0.32,
Suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,MDKGKXOCJGEUJW-UHFFFAOYSA-N,Suprofen glucuronide,CC(C(=O)OC(=O)C1OC(O)C(O)C(O)C1O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,JSDNVZNTHLHVBN-MMWQRLKXSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 2B7",0.5,
Guaifenesin,COC1=CC=CC=C1OCC(O)CO,HSRJKNPTNIJEKV-UHFFFAOYSA-N,beta-(2-methoxyphenoxy)-lactic acid,COC1=CC=CC=C1OCC(O)C(=O)O,MXVBBOLVTSAHEX-UHFFFAOYSA-N,,0.83,
Quinapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CC2=CC=CC=C2CC1C(=O)O,JSDRRTOADPPCHY-HSQYWUDLSA-N,Quinaprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1CC2=C(C=CC=C2)CC1C(=O)O,FLSLEGPOVLMJMN-YSSFQJQWSA-N,Liver carboxylesterase 1,0.94,
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,JOFWLTCLBGQGBO-UHFFFAOYSA-N,4-hydroxytriazolam,CC1=NN=C2C(O)N=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,YUQRFPYHTPARRM-UHFFFAOYSA-N,Cytochrome P450 3A4,0.89,
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,JOFWLTCLBGQGBO-UHFFFAOYSA-N,1'-hydroxytriazolam,OCC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,BHUYWUDMVCLHND-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Didanosine,O=C1N=CNC2=C1N=CN2C1CCC(CO)O1,BXZVVICBKDXVGW-NKWVEPMBSA-N,Uric acid,O=C1NC(=O)C2=C(N1)NC(=O)N2,LEHOTFFKMJEONL-UHFFFAOYSA-N,,0.35,
Didanosine,O=C1N=CNC2=C1N=CN2C1CCC(CO)O1,BXZVVICBKDXVGW-NKWVEPMBSA-N,Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,,0.35,
Didanosine,O=C1N=CNC2=C1N=CN2C1CCC(CO)O1,BXZVVICBKDXVGW-NKWVEPMBSA-N,Hypoxanthine,O=C1N=CNC2=C1NC=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,,0.33,
Cocaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,ZPUCINDJVBIVPJ-LJISPDSOSA-N,norcocaine,COC(=O)C1C2CCC(CC1C(=O)OC1=CC=CC=C1)N2,RERBBBLSJAMJFJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.47,
Cocaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,ZPUCINDJVBIVPJ-LJISPDSOSA-N,Benzoylecgonine,CN1C2CCC1C(C(=O)O)C(OC(=O)C1=CC=CC=C1)C2,"InChI=1S/C16H19NO4/c1-17-11-7-8-12(17)14(15(18)19)13(9-11)21-16(20)10-5-3-2-4-6-10/h2-6,11-14H,7-9H2,1H3,(H,18,19)/t11-,12+,13-,14+/m0/s1",,0.96,
Cocaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,ZPUCINDJVBIVPJ-LJISPDSOSA-N,Cocaethylene,CCOC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,NMPOSNRHZIWLLL-UHFFFAOYSA-N,,0.97,
Zonisamide,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,2-sulfamoylacetylphenol,CCC1(O)CC2CN(CCC3=C(NC4=CC=CC=C34)C(C(=O)OC)(C3=C(OC)C=C4C(=C3)C35CCN6CC=CC(CC)(C(O)C(O)(C(=O)OC)C3N4C)C65)C2)C1,NDMPLJNOPCLANR-CYJJREDESA-N,Cytochrome P450 3A4,0.25,
Zonisamide,NS(=O)(=O)CC1=NOC2=CC=CC=C12,UBQNRHZMVUUOMG-UHFFFAOYSA-N,N-acetyl zonisamide,CC(=O)NS(=O)(=O)CC1=NOC2=C1C=CC=C2,HXFUTAFSEXINIW-UHFFFAOYSA-N,,0.82,
Repaglinide,CCOC1=C(C(=O)O)C=CC(CC(=O)NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1,FAEKWTJYAYMJKF-QHCPKHFHSA-N,hydroxyrepaglinide,CCOC1=C(C(=O)O)C=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)=C1,OBMAZJVHPAVADF-UHFFFAOYSA-N,Cytochrome P450 2C8,0.69,
Repaglinide,CCOC1=C(C(=O)O)C=CC(CC(=O)NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1,FAEKWTJYAYMJKF-QHCPKHFHSA-N,repaglinide aromatic amine,CCOC1=C(C(=O)O)C=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N)=C1,OSCVKZCOJUTUFD-UHFFFAOYSA-N,Cytochrome P450 3A4,0.57,
Almotriptan,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,WKEMJKQOLOHJLZ-UHFFFAOYSA-N,N-desmethylalmotriptan,CNCCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,IREINZNGILEJRP-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2E1, Cytochrome P450 2C8",0.99,
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,Ketotifen-N-glucuronide,C[N+]1(C2OC(C(=O)[O-])C(O)C(O)C2O)CCC(=C2C3=C(C=CC=C3)CC(=O)C3=C2C=CS3)CC1,WLTPAELNPGRIGG-AQTBWJFISA-N,"UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 2B10",0.73,
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,10-alpha-hydroxyl Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(O)C3=C2C=CS3)CC1,TZHJFZBFWVCFAA-UHFFFAOYSA-N,,0.76,
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,Nor-ketotifen,O=C1CC2=CC=CC=C2C(=C2CCNCC2)C2=C1SC=C2,IYSYPCSSDZBWHN-UHFFFAOYSA-N,,0.99,
Buprenorphine,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1CC4=CC=C(O)C5=C4C3(CCN1CC1CC1)C2O5,RMRJXGBAOAMLHD-IHFGGWKQSA-N,Norbuprenorphine,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1CC4=C5C(=C(O)C=C4)OC2C53CCN1,YOYLLRBMGQRFTN-IOMBULRVSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A5, Cytochrome P450 2C8, Cytochrome P450 3A4",0.98,
Buprenorphine,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1CC4=CC=C(O)C5=C4C3(CCN1CC1CC1)C2O5,RMRJXGBAOAMLHD-IHFGGWKQSA-N,Buprenorphine glucuronide,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1CC4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C5=C4C3(CCN1CC1CC1)C2O5,CZULHKGIAJASAA-RONBUCGTSA-N,UDP-glucuronosyltransferase 1-9,0.91,
Levosimendan,CC1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,"InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1",OR-1855,CC1CC(=O)NN=C1C1=CC=C(N)C=C1,GDMRFHZLKNYRRO-SSDOTTSWSA-N,,0.86,
Levosimendan,CC1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,"InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1",OR-1896,CC(=O)NC1=CC=C(C2=NNC(=O)CC2C)C=C1,GDZXNMWZXLDEKG-MRVPVSSYSA-N,,0.78,
Cyclobenzaprine,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,JURKNVYFZMSNLP-UHFFFAOYSA-N,desmethylcyclobenzaprine,CNCCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,XECQQDXTQRYYBH-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6, Cytochrome P450 3A4",0.98,
Maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C1=CC=CC=C12,QSLMDECMDJKHMQ-UHFFFAOYSA-N,demethylmaprotiline,NCCCC12CCC(C3=CC=CC=C31)C1=CC=CC=C12,IFHUOEQJTQWFGJ-UHFFFAOYSA-N,Cytochrome P450 2D6,0.97,
Salmeterol,OCC1=C(O)C=CC(C(O)CNCCCCCCOCCCCC2=CC=CC=C2)=C1,GIIZNNXWQWCKIB-UHFFFAOYSA-N,alpha-hydroxysalmeterol,OCC1=C(O)C=CC(C(O)CNCCCCCCOCCCC(O)C2=CC=CC=C2)=C1,PGRMEHUQIPZHKM-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Acetylsalicylic acid,CC(=O)OC1=CC=CC=C1C(=O)O,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,Gentisic acid,O=C(O)C1=C(O)C=CC(O)=C1,,Cytochrome P450 2C9,0.5,
Acetylsalicylic acid,CC(=O)OC1=CC=CC=C1C(=O)O,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,Salicyluric acid,O=C(O)CNC(=O)C1=C(O)C=CC=C1,,Medium-chain fatty-acid--CoA ligase,0.3,
Phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3",4'-Hydroxy-R-phenprocoumon,CCC(C1=CC=C(O)C=C1)C1=C(O)C2=CC=CC=C2OC1=O,ZPNYHQZRGWFLST-CYBMUJFWSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8",0.98,
Phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3",8-Hydroxy-R-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C(O)=CC=C2,DKNXIPNBVAVYAP-GFCCVEGCSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.92,
Phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3",7-Hydroxy-R-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=C(O)C=C2)OC1=O,HBAPGROFUGJSGR-CYBMUJFWSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.98,
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,WKGXYQFOCVYPAC-UHFFFAOYSA-N,"2-Phenyl-1,3-propanediol monocarbamate",N=C(O)OCC(CO)C1=CC=CC=C1,JQVQIZWJBLGVRW-UHFFFAOYSA-N,Cytochrome P450 2C19,0.55,
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,WKGXYQFOCVYPAC-UHFFFAOYSA-N,p-Hydroxyfelbamate,NC(=O)OCC(COC(N)=O)C1=CC=C(O)C=C1,PXBZEVLDFAKFLV-UHFFFAOYSA-N,"Cytochrome P450 3A7, Cytochrome P450 2E1",0.84,
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,WKGXYQFOCVYPAC-UHFFFAOYSA-N,2-Hydroxyfelbamate,NC(=O)OCC(O)(COC(N)=O)C1=CC=CC=C1,VTXNIAJKDLEHGX-UHFFFAOYSA-N,"Cytochrome P450 3A7, Cytochrome P450 2E1",0.66,
Rizatriptan,CN(C)CCC1=CNC2=C1C=C(CN1C=NC=N1)C=C2,ULFRLSNUDGIQQP-UHFFFAOYSA-N,N-Monodesmethyl Rizatriptan,CN(C)CCC1=CNC2=CC(O)=C(CN3C=NC=N3)C=C12,YQPPJBHQJWSUTE-UHFFFAOYSA-N,,0.81,
Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,LLPOLZWFYMWNKH-CMKMFDCUSA-N,Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,WVLOADHCBXTIJK-YNHQPCIGSA-N,"Cytochrome P450 2D6, Cytochrome P450 2B6, Cytochrome P450 2C19",0.99,
Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,LLPOLZWFYMWNKH-CMKMFDCUSA-N,norhydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5)C=C1,JGORUXKMRLIJSV-ZWUPXRALSA-N,Cytochrome P450 3A4,0.98,
Zaleplon,CCN(C(C)=O)C1=CC=CC(C2=CC=NC3=C(C#N)C=NN23)=C1,HUNXMJYCHXQEGX-UHFFFAOYSA-N,desethylzaleplon,CCNC1=CC=CC(C2=CC=NC3=C(C#N)C=NN23)=C1,QIBDHPGCTQWVTR-UHFFFAOYSA-N,Cytochrome P450 3A4,0.93,
Methyldopa,CC(N)(CC1=CC=C(O)C(O)=C1)C(=O)O,CJCSPKMFHVPWAR-JTQLQIEISA-N,Alpha-methyldopamine,CC(N)CC1=CC(O)=C(O)C=C1,KSRGADMGIRTXAF-UHFFFAOYSA-N,Aromatic-L-amino-acid decarboxylase,0.66,
Methyldopa,CC(N)(CC1=CC=C(O)C(O)=C1)C(=O)O,CJCSPKMFHVPWAR-JTQLQIEISA-N,"3,4-Dihydroxyphenylacetone",CC(=O)CC1=CC(O)=C(O)C=C1,JQXBETDGCMQLMK-UHFFFAOYSA-N,,0.51,
Methyldopa,CC(N)(CC1=CC=C(O)C(O)=C1)C(=O)O,CJCSPKMFHVPWAR-JTQLQIEISA-N,3-O-methyl-alpha-methyldopa,COC1=C(O)C=CC(CC(N)C(=O)O)=C1,PFDUUKDQEHURQC-ZETCQYMHSA-N,Catechol O-methyltransferase,0.74,
,CN1CCCC(N2N=C(CC3=CC=C(Cl)C=C3)C3=CC=CC=C3C2=O)CC1,MBUVEWMHONZEQD-UHFFFAOYSA-N,Desmethylazelastine,O=C1C2=CC=CC=C2C(CC2=CC=C(Cl)C=C2)=NN1C1CCCNCC1,WRYCMIFVXDQIKN-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C19",0.98,
Ethinylestradiol,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4)C3CCC21C,BFPYWIDHMRZLRN-SLHNCBLASA-N,2-hydroxyethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=C(O)C=C4C3CCC21C,KQJCDKMHNQVWDV-GJRSTEQNSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 1A2, Cytochrome P450 3A5",0.96,
Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,Diphenhydramine N-glucuronide,C[N+](C)(CCOC(C1=CC=CC=C1)C1=CC=CC=C1)C1OC(C(=O)O)C(O)C(O)C1O,OAIGZXXQYIJBLR-VAUIJEFBSA-O,UDP-glucuronosyltransferases (UGTs),0.28,
Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,N-Desmethyldiphenhydramine,CNCCOC(C1=CC=CC=C1)C1=CC=CC=C1,AGSLYHYWLYGAOU-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2C19",0.96,
Dopamine,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,6-Hydroxydopamine,NCCC1=C(O)C=C(O)C(O)=C1,DIVDFFZHCJEHGG-UHFFFAOYSA-N,,0.73,
Dopamine,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Dopamine 4-sulfate,NCCC1=CC(O)=C(OS(=O)(=O)O)C=C1,DEKNNWJXAQTLFA-UHFFFAOYSA-N,,0.54,
Dopamine,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Dopamine 3-O-sulfate,NCCC1=CC(OS(=O)(=O)O)=C(O)C=C1,NZKRYJGNYPYXJZ-UHFFFAOYSA-N,,0.5,
Dopamine,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Dopamine glucuronide,NCCC1=CC(O)=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,CQASRCDNLNMIJY-BYNIDDHOSA-N,,0.22,
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,LMEKQMALGUDUQG-UHFFFAOYSA-N,6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,"Glutathione S-transferase Mu 1, Glutathione S-transferase A1, Glutathione S-transferase A2",0.23,
Doxorubicin,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3OC3CC(N)C(O)C(C)O3)C(O)=C1C2=O,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Doxorubicin-semiquinone,COC1=CC=CC2=C1C([O])C1=C(C(O)=C3CC(O)(C(=O)CO)CC(OC4CC(N)C(O)C(C)O4)C3=C1O)C2[O-],YKZNDFRCOGWQLG-UHFFFAOYSA-N,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial, NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial, NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial, Nitric oxide synthase, endothelial, Nitric oxide synthase, inducible, Nitric oxide synthase, brain, Xanthine dehydrogenase/oxidase, NAD(P)H dehydrogenase [quinone] 1",0.91,
Doxorubicin,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3OC3CC(N)C(O)C(C)O3)C(O)=C1C2=O,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Doxorubicine hydroxyaglycone,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3O)C(O)=C1C2=O,IBZGBXXTIGCACK-CWKPULSASA-N,,0.84,
Doxorubicin,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3OC3CC(N)C(O)C(C)O3)C(O)=C1C2=O,AOJJSUZBOXZQNB-TZSSRYMLSA-N,Doxorubicinol,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(O)CO)CC(OC3CC(N)C(O)C(C)O3)C2=C1O,NKZRZOVSJNSBFR-FEMMEMONSA-N,"Carbonyl reductase [NADPH] 1, Carbonyl reductase [NADPH] 3, Aldo-keto reductase family 1 member C3, Alcohol dehydrogenase [NADP(+)]",0.94,
Frovatriptan,CNC1CCC2=C(C1)C1=C(C=CC(C(N)=O)=C1)N2,XPSQPHWEGNHMSK-SECBINFHSA-N,desmethyl frovatriptan,N=C(O)C1=CC=C2NC3=C(CC(N)CC3)C2=C1,FPYHQGKIVXULKF-DDWIOCJRSA-N,,0.8,
Frovatriptan,CNC1CCC2=C(C1)C1=C(C=CC(C(N)=O)=C1)N2,XPSQPHWEGNHMSK-SECBINFHSA-N,Hydroxylated N-acetyl desmethyl frovatriptan,CC(=O)NC1CCC2NC3=C(O)C=C(C(N)=O)C=C3C2C1,CDCOGHQILPZANE-UHFFFAOYSA-N,,0.37,
Frovatriptan,CNC1CCC2=C(C1)C1=C(C=CC(C(N)=O)=C1)N2,XPSQPHWEGNHMSK-SECBINFHSA-N,N-acetyl desmethyl frovatriptan,CC(=O)NC1CCC2NC3=CC=C(C(N)=O)C=C3C2C1,CQIAKQMSTPQBAU-UHFFFAOYSA-N,,0.37,
Salbutamol,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,NDAUXUAQIAJITI-UHFFFAOYSA-N,Salbutamol 4-O-sulfate,CC(C)(C)NCC(O)C1=CC=C(OS(=O)(=O)O)C(CO)=C1,FPMLHYFHLRTRMB-UHFFFAOYSA-N,,0.68,
Ketoprofen,CC(C(=O)O)C1=CC(C(=O)C2=CC=CC=C2)=CC=C1,DKYWVDODHFEZIM-UHFFFAOYSA-N,Ketoprofen glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC(C(=O)C2=CC=CC=C2)=CC=C1,PBTXSZZKPHBHMA-LYFYOZKASA-N,,0.43,
Metyrapone,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1,FJLBFSROUSIWMA-UHFFFAOYSA-N,Metyrapol,CC(C)(C1=CN=CC=C1)C(O)C1=CN=CC=C1,DDFNHFXLQJLFSX-UHFFFAOYSA-N,,0.5,
Cinacalcet,CC(NCCCC1=CC(C(F)(F)F)=CC=C1)C1=CC=CC2=CC=CC=C12,VDHAWDNDOKGFTD-MRXNPFEDSA-N,Hydrocinnamic acid,O=C(O)CCC1=CC=CC=C1,XMIIGOLPHOKFCH-UHFFFAOYSA-N,,0.19,
Cinacalcet,CC(NCCCC1=CC(C(F)(F)F)=CC=C1)C1=CC=CC2=CC=CC=C12,VDHAWDNDOKGFTD-MRXNPFEDSA-N,hydroxy-hydrocinnamic acid,O=C(O)CCC1=CC=CC(O)=C1,QVWAEZJXDYOKEH-UHFFFAOYSA-N,,0.18,
Balsalazide,O=C(O)CCNC(=O)C1=CC=C(N=NC2=CC=C(O)C(C(=O)O)=C2)C=C1,IPOKCKJONYRRHP-FMQUCBEESA-N,5-aminosalicylic acid,NC1=CC(C(=O)O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,NADPH azoreductase,0.54,
Balsalazide,O=C(O)CCNC(=O)C1=CC=C(N=NC2=CC=C(O)C(C(=O)O)=C2)C=C1,IPOKCKJONYRRHP-FMQUCBEESA-N,4-aminobenzoyl-(beta)-alanine,NC1=CC=C(C(=O)NCCC(=O)O)C=C1,VHAXWROFYVPXMZ-UHFFFAOYSA-N,,0.5,
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,JLKIGFTWXXRPMT-UHFFFAOYSA-N,5-Hydroxysulfamethoxazole,NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,CECJOLRUXWTJHV-UHFFFAOYSA-N,,0.91,
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,JLKIGFTWXXRPMT-UHFFFAOYSA-N,N-acetylsulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(C)=C2)C=C1,GXPIUNZCALHVBA-UHFFFAOYSA-N,"Arylamine N-acetyltransferase 1, Arylamine N-acetyltransferase 2",0.88,
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,JLKIGFTWXXRPMT-UHFFFAOYSA-N,Sulfamethoxazole N4-hydroxylamine,CC1=CC(NS(=O)(=O)C2=CC=C(NO)C=C2)=NO1,MJAMPGKHIZXVFJ-UHFFFAOYSA-N,Cytochrome P450 2C9,0.95,
Glyburide,COC1=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)C=C(Cl)C=C1,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,3-trans-Hydroxycyclohexyl glyburide,COC1=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCCC(O)C3)C=C2)C=C(Cl)C=C1,,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A7, Cytochrome P450 3A5",0.48,
Isosorbide mononitrate,O=[N+]([O-])OC1COC2C(O)COC12,YWXYYJSYQOXTPL-SLPGGIOYSA-N,Isosorbide,OC1COC2C(O)COC12,KLDXJTOLSGUMSJ-JGWLITMVSA-N,,0.52,
Phylloquinone,CC(=CCC1=C(C)C(=O)C2=C(C=CC=C2)C1=O)CCCC(C)CCCC(C)CCCC(C)C,MBWXNTAXLNYFJB-NKFFZRIASA-N,Menatetrenone,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCC1=C(C)C(=O)C2=CC=CC=C2C1=O,"InChI=1S/C31H40O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,12,14,16,18-20H,9-11,13,15,17,21H2,1-6H3/b23-14+,24-16+,25-20+",UbiA prenyltransferase domain-containing protein 1,0.96,
Felodipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=C(Cl)C(Cl)=CC=C1,RZTAMFZIAATZDJ-UHFFFAOYSA-N,dehydrofelodipine,CCOC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=C(Cl)C(Cl)=CC=C1,REQRUBNOOIAHMG-UHFFFAOYSA-N,Cytochrome P450 3A4,0.33,
Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,HPNSFSBZBAHARI-RUDMXATFSA-N,6-O-desmethyl-mycophenolic acid,CC(=CCC1=C(O)C(C)=C2COC(=O)C2=C1O)CCC(=O)O,MHSRNZSBNXFMLF-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4, Cytochrome P450 3A5",0.91,
Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,HPNSFSBZBAHARI-RUDMXATFSA-N,Mycophenolic acid-7-O-glucuronide,COC1=C(CC=C(C)CCC(=O)O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)OCC2=C1C,BYFGTSAYQQIUCN-WTKPLQERSA-N,"UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 1-10, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-1",0.65,
Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,HPNSFSBZBAHARI-RUDMXATFSA-N,Mycophenolic acid-acyl glucuronide,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1CC=C(C)CCC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QBMSTEZXAMABFF-UEARNRKISA-N,UDP-glucuronosyltransferase 2B7,0.72,
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YOSHYTLCDANDAN-UHFFFAOYSA-N,SR 49498,CCCCC(O)=NC1(C(O)=NCC2=CC=C(C3=CC=CC=C3C3=NNN=N3)C=C2)CCCC1,PAKGYCNZUGIDHV-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.5,
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YOSHYTLCDANDAN-UHFFFAOYSA-N,Irbesartan derivative M4,CC(O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YASLDPAAWWZGIP-UHFFFAOYSA-N,Cytochrome P450 2C9,0.98,
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YOSHYTLCDANDAN-UHFFFAOYSA-N,Irbesartan derivative M5,CCCCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,SGLAKMDXJPVHBY-UHFFFAOYSA-N,Cytochrome P450 2C9,0.92,
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YOSHYTLCDANDAN-UHFFFAOYSA-N,Irbesartan derivative M3,O=C(O)CCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,SQPSUXCOWHFKKF-UHFFFAOYSA-N,,0.98,
Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Hypoxanthine-guanine phosphoribosyltransferase,0.19,
Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,8-hydroxythioguanine,OC1=NC2=C(N1)C(=S)N=CN2,OIZCDCVIFRRJFF-UHFFFAOYSA-N,Aldehyde oxidase,0.73,
Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,Thiouric acid,OC1=NC2=C(N=C(O)N2)C(S)=N1,SXHQUGJSTGOXMD-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.36,
Procainamide,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,REQCZEXYDRLIBE-UHFFFAOYSA-N,N-Acetyl-3-hydroxyprocainamide,CCN(CC)CCN=C(O)C1=CC(O)=C(N=C(C)O)C=C1,REELIONXYPAEGO-UHFFFAOYSA-N,Cytochrome P450 2D6,0.22,
Tolterodine,CC1=CC(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C(O)C=C1,OOGJQPCLVADCPB-HXUWFJFHSA-N,N-Dealkylated tolterodine,CC1=CC(C(CCNC(C)C)C2=CC=CC=C2)=C(O)C=C1,CPLYUIYTJCFQJD-KRWDZBQOSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.95,
Tolterodine,CC1=CC(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C(O)C=C1,OOGJQPCLVADCPB-HXUWFJFHSA-N,5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1)C(C)C,DUXZAXCGJSBGDW-FQEVSTJZSA-N,Cytochrome P450 2D6,0.92,
Selegiline,C#CCN(C)C(C)CC1=CC=CC=C1,MEZLKOACVSPNER-GFCCVEGCSA-N,Levmetamfetamine,CNC(C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-SECBINFHSA-N,"Cytochrome P450 2B6, Cytochrome P450 2C19, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 3A4",0.68,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,UEJJHQNACJXSKW-UHFFFAOYSA-N,"cis, trans-5'-Hydroxythalidomide",O=C1NC(=O)C(N2C(=O)C3=CC=CC=C3C2=O)CC1O,HHTOWVWIVBSOKC-UHFFFAOYSA-N,Cytochrome P450 2C19,0.88,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,UEJJHQNACJXSKW-UHFFFAOYSA-N,Thalidomide arene oxide,O=C1N=C(O)CCC1N1C(=O)C2=CC3OC3C=C2C1=O,MNALUCRLHVMELD-UHFFFAOYSA-N,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2E1",0.35,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,UEJJHQNACJXSKW-UHFFFAOYSA-N,4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,,0.84,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,UEJJHQNACJXSKW-UHFFFAOYSA-N,2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,,0.73,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,UEJJHQNACJXSKW-UHFFFAOYSA-N,alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)C2=C(C(=O)O)C=CC=C2)C(=O)N1,QTUSGYNZYGYXIN-UHFFFAOYSA-N,,0.7,
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,UEJJHQNACJXSKW-UHFFFAOYSA-N,5-Hydroxythalidomide,O=C1CCC(N2C(=O)C3=C(C=C(O)C=C3)C2=O)C(=O)N1,LJBQRRQTZUJWRC-UHFFFAOYSA-N,Cytochrome P450 2C19,0.9,
Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,HEFNNWSXXWATRW-UHFFFAOYSA-N,Ibuprofen glucuronide,CC(C)CC1=CC=C(C(C)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,ABOLXXZAJIAUGR-JPMMFUSZSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 2B7",0.29,
Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,HEFNNWSXXWATRW-UHFFFAOYSA-N,2-Hydroxyibuprofen,CC(C(=O)O)C1=CC=C(CC(C)(C)O)C=C1,UJHKVYPPCJBOSG-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.91,
Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,HEFNNWSXXWATRW-UHFFFAOYSA-N,3-Hydroxyibuprofen,CC(CO)CC1=CC=C(C(C)C(=O)O)C=C1,HFAIHLSDLUYLQA-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.92,
Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,HEFNNWSXXWATRW-UHFFFAOYSA-N,1-hydroxyibuprofen,CC(C(=O)O)C1=CC=C(C(O)C(C)C)C=C1,RMOQYHYFRKTDRI-UHFFFAOYSA-N,,0.78,
Benzylpenicillin,CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C(=O)O,JGSARLDLIJGVTE-MBNYWOFBSA-N,6-aminopenicillanic acid,CC1(C)SC2C(N)C(=O)N2C1C(=O)O,NGHVIOIJCVXTGV-ALEPSDHESA-N,,0.85,
Benzylpenicillin,CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C(=O)O,JGSARLDLIJGVTE-MBNYWOFBSA-N,Penicilloic acid,CC1(C)SC(C(NC(=O)CC2=CC=CC=C2)C(=O)O)NC1C(=O)O,HCYWNSXLUZRKJX-UHFFFAOYSA-N,,0.71,
Oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,XIQVNETUBQGFHX-UHFFFAOYSA-N,N-desethyloxybutynin,CCNCC#CCOC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,SNIBJKHIKIIGPR-UHFFFAOYSA-N,Cytochrome P450 3A4,0.99,
Melatonin,COC1=CC=C2NC=C(CCNC(C)=O)C2=C1,DRLFMBDRBRZALE-UHFFFAOYSA-N,6-Hydroxymelatonin,COC1=C(O)C=C2NC=C(CCN=C(C)O)C2=C1,OMYMRCXOJJZYKE-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 1A1, Cytochrome P450 2C19",0.75,
Melatonin,COC1=CC=C2NC=C(CCNC(C)=O)C2=C1,DRLFMBDRBRZALE-UHFFFAOYSA-N,5-Methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCN,JTEJPPKMYBDEMY-UHFFFAOYSA-N,,0.91,
Melatonin,COC1=CC=C2NC=C(CCNC(C)=O)C2=C1,DRLFMBDRBRZALE-UHFFFAOYSA-N,N-Acetyl-5-hydroxytryptamine,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,MVAWJSIDNICKHF-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 1A2",0.92,
Glipizide,CC1=NC=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)N=C1,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,3-cis-Hydroxyglipizide,CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCC(O)C3)C=C2)C=N1,GZLIUWBDTXQVBY-ZYMOGRSISA-N,,0.94,
Glipizide,CC1=NC=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)N=C1,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,4-trans-Hydroxyglipizide,CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(O)CC3)C=C2)C=N1,WPQWQJBFAJEUHS-FITNRVMRSA-N,Cytochrome P450 2C9,0.97,
Perhexiline,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,"InChI=1S/C19H35N/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18/h16-20H,1-15H2",cis-Hydroxy Perhexiline,OC1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,DZFRYNPJLZCKSC-BTRQGYIVSA-N,,0.8,
Atorvastatin,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,XUKUURHRXDUEBC-KAYWLYCHSA-N,ortho-hydroxyatorvastatin,CC(C)C1=C(C(O)=NC2=CC=CC=C2O)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,CZBPKFICAYVHHM-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.78,
Benzocaine,CCOC(=O)C1=CC=C(N)C=C1,BLFLLBZGZJTVJG-UHFFFAOYSA-N,Aminobenzoic acid,NC1=CC=C(C(=O)O)C=C1,ALYNCZNDIQEVRV-UHFFFAOYSA-N,,0.74,
Hesperetin,COC1=C(O)C=C(C2CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1,"InChI=1S/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1",eriodictyol,O=C1CC(C2=CC(O)=C(O)C=C2)OC2=C1C(O)=CC(O)=C2,SBHXYTNGIZCORC-ZDUSSCGKSA-N,Cytochrome P450 1A2,0.98,
Leflunomide,CC1=C(C(=O)NC2=CC=C(C(F)(F)F)C=C2)C=NO1,VHOGYURTWQBHIL-UHFFFAOYSA-N,A771726,CC(O)=C(C#N)C(=O)NC1=CC=C(C(F)(F)F)C=C1,UTNUDOFZCWSZMS-JXMROGBWSA-N,Cytochrome P450 1A2,0.31,
Rosuvastatin,CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC(O)CC(O)CC(=O)O,BPRHUIZQVSMCRT-VEUZHWNKSA-N,N-Desmethylrosuvastatin,CC(C)C1=C(C=CC(O)CC(O)CC(=O)O)C(C2=CC=C(F)C=C2)=NC(NS(C)(=O)=O)=N1,,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.93,
Rosuvastatin,CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC(O)CC(O)CC(=O)O,BPRHUIZQVSMCRT-VEUZHWNKSA-N,Rosuvastatin 5 S-lactone,CC(C)C1=C(C=CC2CC(O)CC(=O)O2)C(C2=CC=C(F)C=C2)=NC(N(C)S(C)(=O)=O)=N1,,Cytochrome P450 2C9,0.94,
Sertraline,CNC1CCC(C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C21,VGKDLMBJGBXTGI-SJCJKPOMSA-N,norsertraline,NC1CCC(C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C21,SRPXSILJHWNFMK-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2B6",0.91,
Nifedipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+](=O)[O-],HYIMSNHJOBLJNT-UHFFFAOYSA-N,dehydronifedipine,COC(=O)C1=C(C2=CC=CC=C2[N+](=O)[O-])C(C(=O)OC)=C(C)N=C1C,UMQHJQGNGLQJPF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.35,
Amiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(C=CC=C2)O1,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,Desethylamiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCNCC)C(I)=C2)C2=CC=CC=C2O1,VXOKDLACQICQFA-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A2, Cytochrome P450 2D6, Cytochrome P450 2C8, Cytochrome P450 3A4",0.99,
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,BOVGTQGAOIONJV-BETUJISGSA-N,7-β-Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CC(O)CC3C2)C=C1,JMHDCYDSYHLATB-ITGUQSILSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.51,
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,BOVGTQGAOIONJV-BETUJISGSA-N,6-β-Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCC(O)C3C2)C=C1,VUUZEWXIRFGRFE-IACUBPJLSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.48,
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,BOVGTQGAOIONJV-BETUJISGSA-N,Methylhydroxygliclazide,O=S(=O)(NC(O)=NN1CC2CCCC2C1)C1=CC=C(CO)C=C1,IHCHVBQHVIUSTM-BETUJISGSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18",0.54,
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,BOVGTQGAOIONJV-BETUJISGSA-N,7-α-Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CC(O)CC3C2)C=C1,JMHDCYDSYHLATB-CLLJXQQHSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.9,
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,BOVGTQGAOIONJV-BETUJISGSA-N,6-α-Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCC(O)C3C2)C=C1,VUUZEWXIRFGRFE-YUTCNCBUSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.82,
Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,JLRGJRBPOGGCBT-UHFFFAOYSA-N,4-Hydroxy tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(CO)C=C1,SJRHYONYKZIRPM-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2C9",0.93,
Rabeprazole,COCCCOC1=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=NC=C1,YREYEVIYCVEVJK-UHFFFAOYSA-N,Active Metabolite of Rabeprazole,COCCCOC1=C(C)C=[N+]2C3=NC4=C(C=CC=C4)N3SCC2=C1,HGSXCFCOXJLVEZ-UHFFFAOYSA-N,,0.45,
Proguanil,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,SSOLNOMRVKKSON-UHFFFAOYSA-N,cycloguanil,CC1(C)N=C(N)N=C(N)N1C1=CC=C(Cl)C=C1,QMNFFXRFOJIOKZ-UHFFFAOYSA-N,Cytochrome P450 2C19,0.31,
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,HYAFETHFCAUJAY-UHFFFAOYSA-N,Pioglitazone metabolite M-I,O=C1NC(=O)C(CC2=CC=C(O)C=C2)S1,NKOHRVBBQISBSB-UHFFFAOYSA-N,,0.67,
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,HYAFETHFCAUJAY-UHFFFAOYSA-N,Pioglitazone metabolite M-II,CCC1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,RMTFRGFLVHAYCI-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.89,
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,HYAFETHFCAUJAY-UHFFFAOYSA-N,Pioglitazone metabolite M-VI,O=C1NC(=O)C(CC2=CC=C(OCCC3=NC=C(C(=O)O)C=C3)C=C2)S1,SLOBZACXYXBLIT-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.87,
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,HYAFETHFCAUJAY-UHFFFAOYSA-N,Pioglitazone metabolite M-V,O=C(O)CC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OIQJTMMAMWFMQR-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.94,
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,HYAFETHFCAUJAY-UHFFFAOYSA-N,Pioglitazone metabolite M-IV,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OXVFDZYQLGRLCD-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.93,
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,OGHNVEJMJSYVRP-UHFFFAOYSA-N,8-Hydroxycarbazolylcarvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=C(N2)C(O)=CC=C1,GPPVNZVFGNMPNR-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1A1",0.91,
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,OGHNVEJMJSYVRP-UHFFFAOYSA-N,4'-Hydroxyphenylcarvedilol,COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC(O)=C1,ZCJHEORDHXCJNB-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 2E1, Cytochrome P450 2C9, Cytochrome P450 3A4",0.94,
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,OGHNVEJMJSYVRP-UHFFFAOYSA-N,5'-Hydroxyphenylcarvedilol,COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=C(O)C=C1,PVUVZUBTCLBJMT-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 3A4",0.93,
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,OGHNVEJMJSYVRP-UHFFFAOYSA-N,O-Desmethylcarvedilol,OC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,XAUKPPPYYOKVQJ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2E1",0.98,
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,OGHNVEJMJSYVRP-UHFFFAOYSA-N,1-Hydroxyphenylcarvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=C(O)C2=C1C1=CC=CC=C1N2,UQJJKVKQRTUYJW-UHFFFAOYSA-N,"Prostaglandin G/H synthase 1, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 1A1",0.89,
Sulfinpyrazone,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,MBGGBVCUIVRRBF-UHFFFAOYSA-N,Sulfinpyrazone sulfide,O=C1C(CCSC2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,PLGXGMUJUXKCDD-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.93,
Sulfinpyrazone,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,MBGGBVCUIVRRBF-UHFFFAOYSA-N,Sulfinpyrazone sulfone,O=C1C(CCS(=O)(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,DQUYGWDNTAETLI-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.97,
Cefapirin,CC(=O)OCC1=C(C(=O)O)N2C(=O)C(NC(=O)CSC3=CC=NC=C3)C2SC1,"InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1",Desacetylcephapirin,O=C(CSC1=CC=NC=C1)NC1C(=O)N2C(C(=O)O)=C(CO)CSC12,IOFHZPVEQXTSQW-UHFFFAOYSA-N,,0.95,
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,ODQWQRRAPPTVAG-UHFFFAOYSA-N,N-desmethyldoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HVKCEFHNSNZIHO-YBEGLDIGSA-N,"Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 3A4",0.99,
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,ODQWQRRAPPTVAG-UHFFFAOYSA-N,Doxepin N-oxide,C[N+](C)([O-])CCC=C1C2=C(C=CC=C2)COC2=C1C=CC=C2,QJCSDPQQGVJGQY-GZTJUZNOSA-N,,0.97,
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,ODQWQRRAPPTVAG-UHFFFAOYSA-N,(E)-2-hydroxydoxepin,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(O)C=C12,GRQPGTWGEQWMMM-IUXPMGMMSA-N,Cytochrome P450 2D6,0.93,
Nefazodone,CCC1=NN(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,hydroxynefazodone,CC(O)C1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,VKGQYGXMUUBRBD-UHFFFAOYSA-N,Cytochrome P450 3A4,0.91,
Nefazodone,CCC1=NN(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,VRBKIVRKKCLPHA-UHFFFAOYSA-N,m-Chlorophenylpiperazine,ClC1=CC(N2CCNCC2)=CC=C1,"InChI=1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2",Cytochrome P450 3A4,0.26,
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C21,HCYAFALTSJYZDH-UHFFFAOYSA-N,2-hydroxydesipramine,CNCCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,NVJBOLMRGMDGLD-UHFFFAOYSA-N,Cytochrome P450 2D6,0.86,
Gemifloxacin,CON=C1CN(C2=NC3=C(C=C2F)C(=O)C(C(=O)O)=CN3C2CC2)CC1CN,ZRCVYEYHRGVLOC-HYARGMPZSA-N,N-acetyl gemifloxacin,CON=C1CN(C2=NC3=C(C=C2F)C(=O)C(C(=O)O)=CN3C2CC2)CC1NC(C)=O,ZLRGFKRHAFQIIT-HZHRSRAPSA-N,,0.89,
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,SNPPWIUOZRMYNY-UHFFFAOYSA-N,S-Hydroxybupropion,CC(NC(C)(C)CO)C(=O)C1=CC(Cl)=CC=C1,AKOAEVOSDHIVFX-SECBINFHSA-N,"Cytochrome P450 2B6, Cytochrome P450 2E1, Cytochrome P450 3A4, Cytochrome P450 2C19",0.92,
Halothane,FC(F)(F)C(Cl)Br,BCQZXOMGPXTTIC-UHFFFAOYSA-N,trifluoroacetic acid,O=C(O)C(F)(F)F,DTQVDTLACAAQTR-UHFFFAOYSA-N,Cytochrome P450 2E1,0.19,
Procarbazine,CNNCC1=CC=C(C(=O)NC(C)C)C=C1,CPTBDICYNRMXFX-UHFFFAOYSA-N,N-isopropylterephthalamic acid,CC(C)NC(=O)C1=CC=C(C(=O)O)C=C1,PRCGIFCKPACTDG-UHFFFAOYSA-N,,0.73,
Orphenadrine,CC1=CC=CC=C1C(OCCN(C)C)C1=CC=CC=C1,QVYRGXJJSLMXQH-UHFFFAOYSA-N,N-demethyl orphenadrine,CNCCOC(C1=CC=CC=C1)C1=CC=CC=C1C,PNYKGCPSFKLFKA-UHFFFAOYSA-N,,0.97,
Orphenadrine,CC1=CC=CC=C1C(OCCN(C)C)C1=CC=CC=C1,QVYRGXJJSLMXQH-UHFFFAOYSA-N,"N,N-didemethyl orphenadrine",CC1=C(C(OCCN)C2=CC=CC=C2)C=CC=C1,BJVWYJOLTICWGB-UHFFFAOYSA-N,,0.94,
Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,DDBREPKUVSBGFI-UHFFFAOYSA-N,p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.94,
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,3-Dechloroethylifosfamide,O=P1(NCCCl)NCCCO1,DZKGMGPLDJOVCX-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2B6, Cytochrome P450 3A7",0.59,
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,Dechloroethylifosfamide,NP1(=O)OCCCN1CCCl,ROGLJLJCDSTWBN-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2B6, Cytochrome P450 3A7",0.83,
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,"Prostaglandin G/H synthase 1, Cytochrome P450 2B6, Cytochrome P450 3A4, Cytochrome P450 2A6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A7",0.68,
Propafenone,CCCNCC(O)COC1=C(C(=O)CCC2=CC=CC=C2)C=CC=C1,JWHAUXFOSRPERK-UHFFFAOYSA-N,N-desalkylpropafenone,NCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,HIGKMVIPYOFHBP-UHFFFAOYSA-N,Cytochrome P450 1A2,0.94,
Propafenone,CCCNCC(O)COC1=C(C(=O)CCC2=CC=CC=C2)C=CC=C1,JWHAUXFOSRPERK-UHFFFAOYSA-N,5-hydroxypropafenone,CCCNCC(O)COC1=C(C(=O)CCC2=CC=CC=C2)C=C(O)C=C1,LUTWDNUXHDYZRA-UHFFFAOYSA-N,Cytochrome P450 2D6,0.9,
Domperidone,O=C1NC2=CC=CC=C2N1CCCN1CCC(N2C(=O)NC3=C2C=CC(Cl)=C3)CC1,FGXWKSZFVQUSTL-UHFFFAOYSA-N,"5-Chloro-1,3-dihydro-1-(4-piperidinyl)-2H-benzimidazol-2-one",OC1=NC2=C(C=CC(Cl)=C2)N1C1CCNCC1,DOAYWDKFDPSTSV-UHFFFAOYSA-N,Cytochrome P450 3A4,0.7,
Desflurane,FC(F)OC(F)C(F)(F)F,DPYMFVXJLLWWEU-UHFFFAOYSA-N,trifluoroacetic acid,O=C(O)C(F)(F)F,DTQVDTLACAAQTR-UHFFFAOYSA-N,Cytochrome P450 2E1,0.24,
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,UQCNKQCJZOAFTQ-ISWURRPUSA-N,noroxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5)C=C1,RIKMCJUNPCRFMW-ISWURRPUSA-N,Cytochrome P450 3A4,0.98,
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,UQCNKQCJZOAFTQ-ISWURRPUSA-N,noroxymorphone,O=C1CCC2(O)C3CC4=C5C(=C(O)C=C4)OC1C52CCN3,HLMSIZPQBSYUNL-IPOQPSJVSA-N,Cytochrome P450 3A4,0.98,
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,UQCNKQCJZOAFTQ-ISWURRPUSA-N,alpha-noroxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5)C=C1,KFWOOLJUSYSBAD-NZQXGWJPSA-N,Cytochrome P450 3A4,0.91,
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,UQCNKQCJZOAFTQ-ISWURRPUSA-N,beta-oxymorphol,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)CCC3(O)C1C5,AABLHGPVOULICI-LQPBRMSDSA-N,Cytochrome P450 2D6,0.93,
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,UQCNKQCJZOAFTQ-ISWURRPUSA-N,alpha-oxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,LHTAJTFGGUDLRH-FHHXKLHRSA-N,Cytochrome P450 2D6,0.93,
Flecainide,O=C(NCC1CCCCN1)C1=C(OCC(F)(F)F)C=CC(OCC(F)(F)F)=C1,DJBNUMBKLMJRSA-UHFFFAOYSA-N,Meta-O-dealkylated flecainide,O=C(NCC1CCCCN1)C1=CC(O)=CC=C1OCC(F)(F)F,FVJPPEWHZCSTAC-UHFFFAOYSA-N,,0.96,
Captopril,CC(CS)C(=O)N1CCCC1C(=O)O,FAKRSMQSSFJEIM-RQJHMYQMSA-N,captopril-cysteine disulfide,CC(CSSCC(N)C(=O)O)C(=O)N1CCCC1C(=O)O,NEEBNBLVYKFVTK-VGMNWLOBSA-N,,0.81,
Clarithromycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C(O)C1(C)O,AGOYDEPGAOXOCK-KCBOHYOISA-N,N-desmethylclarithromycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(NC)C2O)C(C)(OC)CC(C)C(=O)C(C)C(O)C1(C)O,CIJTVUQEURKBDL-ZVGWNXEOSA-N,Cytochrome P450 3A4,0.97,
Finasteride,CC(C)(C)NC(=O)C1CCC2C3CCC4NC(=O)C=CC4(C)C3CCC12C,DBEPLOCGEIEOCV-WSBQPABSSA-N,omega-hydroxyfinasteride,CC(C)(O)N=C(O)C1CCC2C3CCC4N=C(O)C=CC4(C)C3CCC12C,LVMYOUOJYSDZSC-UHFFFAOYSA-N,Cytochrome P450 3A4,0.39,
Halofantrine,CCCCN(CCCC)CCC(O)C1=C2C=CC(C(F)(F)F)=CC2=C2C=C(Cl)C=C(Cl)C2=C1,FOHHNHSLJDZUGQ-UHFFFAOYSA-N,N-debutylhalofantrine,CCCCNCCC(O)C1=C2C=CC(C(F)(F)F)=CC2=C2C=C(Cl)C=C(Cl)C2=C1,FYHCHSNOXWVJJT-UHFFFAOYSA-N,Cytochrome P450 3A4,0.96,
Dantrolene,O=C1CN(N=CC2=CC=C(C3=CC=C([N+](=O)[O-])C=C3)O2)C(=O)N1,OZOMQRBLCMDCEG-VIZOYTHASA-N,5-hydroxydantrolene,O=C1N=C(O)C(O)N1N=CC1=CC=C(C2=CC=C([N+](=O)[O-])C=C2)O1,PGORTQZSSAZLCK-VIZOYTHASA-N,,0.65,
Levacetylmethadol,CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,"InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22-/m0/s1",noracymethadol,CCC(OC(C)=O)C(CC(C)NC)(C1=CC=CC=C1)C1=CC=CC=C1,VWCUGCYZZGRKEE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.97,
Paclitaxel,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C1C2(C)C,RCINICONZNJXQF-MZXODVADSA-N,"6α, 3'-p-dihydroxypaclitaxel",CC(=O)OC1C(=O)C2(C)C(O)C(O)C3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)C3=CC=CC=C3)C3=CC=C(O)C=C3)C(C)=C1C2(O)O,VCMRTKHRFJRAJE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.91,
Saquinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(CC1=CC=CC=C1)NC(=O)C(CC(N)=O)NC(=O)C1=NC2=C(C=CC=C2)C=C1,QWAXKHKRTORLEM-UGJKXSETSA-N,M2 di-hydroxylated metabolite,CN=C(O)C(O)C1=CC2=C(C=CN2C2CCN(CCC3=CC=CC=C3F)CC2)C(O)=C1,KMSSEFLPBNDJAH-UHFFFAOYSA-N,Cytochrome P450 3A4,0.41,
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,WTDRDQBEARUVNC-LURJTMIESA-N,Dopamine,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Aromatic-L-amino-acid decarboxylase,0.63,
Dopamine,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,3-Methoxytyramine,COC1=C(O)C=CC(CCN)=C1,,Catechol O-methyltransferase,0.76,
Dopamine,NCCC1=CC(O)=C(O)C=C1,VYFYYTLLBUKUHU-UHFFFAOYSA-N,Norepinephrine,NCC(O)C1=CC(O)=C(O)C=C1,SFLSHLFXELFNJZ-QMMMGPOBSA-N,Dopamine beta-hydroxylase,0.69,
Sevoflurane,FCOC(C(F)(F)F)C(F)(F)F,DFEYYRMXOJXZRJ-UHFFFAOYSA-N,Hexafluoroisopropanol,OC(C(F)(F)F)C(F)(F)F,BYEAHWXPCBROCE-UHFFFAOYSA-N,Cytochrome P450 2E1,0.59,
Epoprostenol,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,KAQKFAOMNZTLHT-OZUDYXHBSA-N,"6,15-Diketo-13,14-dihydro-PGF1-alpha",CCCCCC(=O)C=CC1C(O)CC(O)C1CC(=O)CCCCC(=O)O,VKPWUQVGTPVEMU-QVPQFPIISA-N,,0.47,
Epoprostenol,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,KAQKFAOMNZTLHT-OZUDYXHBSA-N,6-Keto-PGF1-alpha,CCCCCC(O)C=CC1C(O)CC(O)C1CC(=O)CCCCC(=O)O,KFGOFTHODYBSGM-ZUNNJUQCSA-N,,0.52,
Gemfibrozil,CC1=CC(OCCCC(C)(C)C(=O)O)=C(C)C=C1,HEMJJKBWTPKOJG-UHFFFAOYSA-N,Gemfibrozil 1-beta-glucuronide,CC1=CC(OCCCC(C)(C)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C(C)C=C1,CJMNXSKEVNPQOK-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B17",0.41,
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,8-hydroxyclomipramine,CN(C)CCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,PVKACZKLKCTAHR-UHFFFAOYSA-N,Cytochrome P450 2D6,0.89,
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,clomipramine N-oxide,C[N+](C)([O-])CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,ARNOTLDVJSFYBP-UHFFFAOYSA-N,,0.97,
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,2-hydroxyclomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,QXZNSJJZRXNDJQ-UHFFFAOYSA-N,Cytochrome P450 2D6,0.85,
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,GDLIGKIOYRNHDA-UHFFFAOYSA-N,Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,VPIXQGUBUKFLRF-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 3A4",0.99,
Isocarboxazid,CC1=CC(C(=O)NNCC2=CC=CC=C2)=NO1,XKFPYPQQHFEXRZ-UHFFFAOYSA-N,Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.19,
Olsalazine,O=C(O)C1=CC(N=NC2=CC=C(O)C(C(=O)O)=C2)=CC=C1O,QQBDLJCYGRGAKP-FOCLMDBBSA-N,Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,,0.77,
Olsalazine,O=C(O)C1=CC(N=NC2=CC=C(O)C(C(=O)O)=C2)=CC=C1O,QQBDLJCYGRGAKP-FOCLMDBBSA-N,Olsalazine-O-sulfate,O=C(O)C1=C(O)C=CC(N=NC2=CC(C(=O)O)=C(OS(=O)(=O)O)C=C2)=C1,VMGXLRXDXJZSTP-UHFFFAOYSA-N,,0.67,
Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,N-acetyl-5-aminosalicylic acid,CC(=O)NC1=CC=C(O)C(C(=O)O)=C1,,,0.72,
Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(N)CCCCN,VOBHXZCDAVEXEY-JSGCOSHPSA-N,Dextroamphetamine,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-QMMMGPOBSA-N,,0.36,
Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(N)CCCCN,VOBHXZCDAVEXEY-JSGCOSHPSA-N,Lysine,NCCCCC(N)C(=O)O,KDXKERNSBIXSRK-YFKPBYRVSA-N,,0.17,
Hydralazine,NNC1=NN=CC2=CC=CC=C12,RPTUSVTUFVMDQK-UHFFFAOYSA-N,Hydralazine acetone hydrazone,CC(C)=NNC1=NN=CC2=C1C=CC=C2,AKFJXINWDQGPHO-UHFFFAOYSA-N,,0.8,
Hydralazine,NNC1=NN=CC2=CC=CC=C12,RPTUSVTUFVMDQK-UHFFFAOYSA-N,Hydralazine pyruvate hydrazone,CC(=NNC1=NN=CC2=CC=CC=C12)C(=O)O,CXGHHASVNBBLOU-NTUHNPAUSA-N,,0.67,
Nelarabine,COC1=NC(N)=NC2=C1N=CN2C1OC(CO)C(O)C1O,IXOXBSCIXZEQEQ-UHTZMRCNSA-N,9-β-D-arabinofuranosylguanine,NC1=NC2=C(N=[C]N2C2OC(CO)C(O)C2O)C(=O)N1,QFXYYZOMRMBRPL-FJFJXFQQSA-N,Adenosine deaminase,0.81,
Cilazapril,CCOC(=O)C(CCC1=CC=CC=C1)NC1CCCN2CCCC(C(=O)O)N2C1=O,HHHKFGXWKKUNCY-FHWLQOOXSA-N,Cilazaprilat,O=C(O)C(CCC1=CC=CC=C1)NC1CCCN2CCCC(C(=O)O)N2C1=O,UVAUYSRYXACKSC-ULQDDVLXSA-N,,0.94,
Spirapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,"InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1",Spiraprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1CC2(CC1C(=O)O)SCCS2,FMMDBLMCSDRUPA-BPUTZDHNSA-N,,0.94,
Hexobarbital,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,"InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17)",3'-Hydroxyhexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(O)CCC2)C1=O,YHCGILGEMWNROZ-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2C9",0.48,
Hexobarbital,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,"InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17)",Epoxy-hexobarbital,CN1C(=O)N=C(O)C(C)(C23CCCCC2O3)C1=O,WOWLNDOPAUTOTH-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.34,
Mestranol,C#CC1(O)CCC2C3CCC4=C(C=CC(OC)=C4)C3CCC21C,IMSSROKUHAOUJS-MJCUULBUSA-N,Ethinylestradiol,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4)C3CCC21C,BFPYWIDHMRZLRN-SLHNCBLASA-N,Cytochrome P450 2C9,0.94,
Ephedrine,CNC(C)C(O)C1=CC=CC=C1,KWGRBVOPPLSCSI-WPRPVWTQSA-N,Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,,0.85,
Colchicine,COC1=CC2=C(C3=CC=C(OC)C(=O)C=C3C(NC(C)=O)CC2)C(OC)=C1OC,IAKHMKGGTNLKSZ-INIZCTEOSA-N,Colchiceine,COC1=C(OC)C(OC)=C2C(=C1)CCC(NC(C)=O)C1=CC(=O)C(O)=CC=C12,PRGILOMAMBLWNG-UHFFFAOYSA-N,,0.99,
Drospirenone,CC12CCC(=O)C=C1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,METQSPRSQINEEU-HXCATZOESA-N,"4,5-dihydro-drospirenone-3-sulfate",CC12CCC(S(=O)(=O)O)CC1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,ZHIWICDXDMTIEM-AAQOLUSRSA-N,,0.59,
Danazol,C#CC1(O)CCC2C3CCC4=CC5=C(C=NO5)CC4(C)C3CCC21C,POZRVZJJTULAOH-LHZXLZLDSA-N,Ethisterone,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,CHNXZKVNWQUJIB-CEGNMAFCSA-N,,0.4,
Danazol,C#CC1(O)CCC2C3CCC4=CC5=C(C=NO5)CC4(C)C3CCC21C,POZRVZJJTULAOH-LHZXLZLDSA-N,17-hydroxymethylethisterone,C#CC1(O)CCC2C3CCC4=CC(=O)C(CO)CC4(C)C3CCC21C,JGJFMZZHCOKXHX-RIONBYPISA-N,,0.41,
Bambuterol,CN(C)C(=O)OC1=CC(C(O)CNC(C)(C)C)=CC(OC(=O)N(C)C)=C1,"InChI=1S/C18H29N3O5/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7/h8-10,15,19,22H,11H2,1-7H3",Terbutaline,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,XWTYSIMOBUGWOL-UHFFFAOYSA-N,Cholinesterase,0.64,
Acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC=CC=C2OC1=O,VABCILAOYCMVPS-UHFFFAOYSA-N,6-Hydroxy-R-acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC=CC(O)=C2OC1=O,RXFXXWMNPIVMHP-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A2, Cytochrome P450 2C19",0.93,
Acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC=CC=C2OC1=O,VABCILAOYCMVPS-UHFFFAOYSA-N,7-Hydroxy-R-acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC=C(O)C=C2OC1=O,JTCREUDLEYTCAB-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.99,
Acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC=CC=C2OC1=O,VABCILAOYCMVPS-UHFFFAOYSA-N,8-Hydroxy-R-acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC(O)=CC=C2OC1=O,SUHPKJKJROTWOQ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.97,
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,PDMMFKSKQVNJMI-BLQWBTBKSA-N,Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,,0.78,
Aminophenazone,CC1=C(N(C)C)C(=O)N(C2=CC=CC=C2)N1C,"InChI=1S/C13H17N3O/c1-10-12(14(2)3)13(17)16(15(10)4)11-8-6-5-7-9-11/h5-9H,1-4H3",N-Desmethylaminopyrine,CNC1=C(C)N(C)N(C2=CC=CC=C2)C1=O,JILCEWWZTBBOFS-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 2C18, Cytochrome P450 2C19, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2D6",0.96,
Metamfetamine,CNC(C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.46,
Metamfetamine,CNC(C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,,0.56,
Metamfetamine,CNC(C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,Dextroamphetamine,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-QMMMGPOBSA-N,Cytochrome P450 2D6,0.84,
Metamfetamine,CNC(C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,,0.64,
Metamfetamine,CNC(C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,4-hydroxymethamphetamine,CNC(C)CC1=CC=C(O)C=C1,SBUQZKJEOOQSBV-UHFFFAOYSA-N,,0.77,
Phendimetrazine,CC1C(C2=CC=CC=C2)OCCN1C,MFOCDFTXLCYLKU-CMPLNLGQSA-N,Phenmetrazine,CC1NCCOC1C1=CC=CC=C1,OOBHFESNSZDWIU-UHFFFAOYSA-N,,0.86,
Solifenacin,O=C(OC1CN2CCC1CC2)N1CCC2=CC=CC=C2C1C1=CC=CC=C1,FBOUYBDGKBSUES-VXKWHMMOSA-N,4R-hydroxy solifenacin,O=C(OC1CN2CCC1CC2)N1CC(O)C2=C(C=CC=C2)C1C1=CC=CC=C1,LRNNBJBAUXSVMH-NHNZYLEHSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A1, Cytochrome P450 2D6",0.88,
Hydroxychloroquine,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,Desethylchloroquine,CCNCCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,,Cytochrome P450 3A4,0.94,
Etoricoxib,CC1=NC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",Etoricoxib 1'-N'-oxide,CC1=[N+]([O-])C=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,KMLFAHIIJSUUPX-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2",0.89,
Etoricoxib,CC1=NC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2",0.95,
Genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,TZBJGXHYKVUXJN-UHFFFAOYSA-N,3'-hydroxygenistein,O=C1C(C2=CC=C(O)C(O)=C2)=COC2=C1C(O)=CC(O)=C2,IOYHCQBYQJQBSK-UHFFFAOYSA-N,Cytochrome P450 1A2,0.94,
Roflumilast,O=C(NC1=C(Cl)C=NC=C1Cl)C1=CC(OCC2CC2)=C(OC(F)F)C=C1,MNDBXUUTURYVHR-UHFFFAOYSA-N,Roflumilast N-oxide,O=C(NC1=C(Cl)C=[N+]([O-])C=C1Cl)C1=CC(OCC2CC2)=C(OC(F)F)C=C1,PCGSQNPMMSALEJ-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A2",0.93,
Prasterone,CC12CCC3C(CC=C4CC(O)CCC43C)C1CCC2=O,FMGSKLZLMKYGDP-USOAJAOKSA-N,Dehydroepiandrosterone sulfate,CC12CCC3C(CC=C4CC(OS(=O)(=O)O)CCC43C)C1CCC2=O,CZWCKYRVOZZJNM-USOAJAOKSA-N,,0.77,
Prasterone,CC12CCC3C(CC=C4CC(O)CCC43C)C1CCC2=O,FMGSKLZLMKYGDP-USOAJAOKSA-N,Dehydroepiandrosterone 3-glucuronide,CC12CCC3C(CC=C4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2=O,GLONBVCUAVPJFV-PCDHEYSGSA-N,,0.5,
Camphor,CC12CCC(CC1=O)C2(C)C,DSSYKIVIOFKYAU-XCBNKYQSSA-N,5-Exo-Hydroxycamphor,CC12CC(O)C(CC1=O)C2(C)C,"InChI=1S/C10H16O2/c1-9(2)6-4-8(12)10(9,3)5-7(6)11/h6-7,11H,4-5H2,1-3H3/t6-,7+,10-/m0/s1",Cytochrome P450 2D6,0.62,
Vorinostat,O=C(CCCCCCC(=O)NC1=CC=CC=C1)NO,WAEXFXRVDQXREF-UHFFFAOYSA-N,4-anilino-4-oxobutanoic acid,O=C(O)CCC(O)=NC1=CC=CC=C1,KTFGFGGLCMGYTP-UHFFFAOYSA-N,,0.17,
Cholic Acid,CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,BHQCQFFYRZLCQQ-OELDTZBJSA-N,Cholic acid glucuronide,CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC4(C)C3CC(O)C12C,RBLDVEUUCHVWMW-SXYQVCRBSA-N,,0.34,
Fusidic acid,CC(=O)OC1CC2(C)C(CC(O)C3C4(C)CCC(O)C(C)C4CCC32C)C1=C(CCC=C(C)C)C(=O)O,IECPWNUMDGFDKC-MZJAQBGESA-N,3-keto fusidic acid,CC(=O)OC1CC2(C)C(CC(O)C3C4(C)CCC(O)C(C)C4CCC32C)C1=C(C(=O)O)C(=O)CC=C(C)C,LOVQKVDREFGPKC-COCAZOITSA-N,,0.91,
Pregnenolone,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,ORNBQBCIOKFOEO-QGVNFLHTSA-N,17-Hydroxypregnenolone sulfate,CC(=O)C1(O)CCC2C3CC=C4CC(OS(=O)(=O)O)CCC4(C)C3CCC21C,OMOKWYAQVYBHMG-QUPIPBJSSA-N,,0.64,
Pregnenolone,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,ORNBQBCIOKFOEO-QGVNFLHTSA-N,Pregnenolone sulfate,CC(=O)C1CCC2C3CC=C4CC(OS(=O)(=O)O)CCC4(C)C3CCC12C,DIJBBUIOWGGQOP-QGVNFLHTSA-N,,0.76,
Stanolone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",11-Oxo-androsterone glucuronide,CC12CC(=O)C3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2=O,QTXWOOLAHRQMGZ-UHFFFAOYSA-N,,0.28,
Stanolone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",3-alpha-Androstanediol glucuronide,CC12CCC3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2O,GYNWSIBKBBWJJW-YMRFBRODSA-N,,0.3,
Stanolone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",11-beta-Hydroxyandrosterone-3-glucuronide,CC12CC(O)C3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2=O,BRPLOVMHAFXVOQ-HUMIJZDLSA-N,,0.3,
Propanoyl-CoA,CCC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O,"InChI=1S/C24H40N7O17P3S/c1-4-15(33)52-8-7-26-14(32)5-6-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-13-18(47-49(37,38)39)17(34)23(46-13)31-12-30-16-20(25)28-11-29-21(16)31/h11-13,17-19,23,34-35H,4-10H2,1-3H3,(H,26,32)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/t13-,17-,18-,19+,23-/m1/s1",(R)-methylmalonyl-CoA,CC(C(=O)O)C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O,"InChI=1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t12-,13-,16-,17-,18+,22-/m1/s1",,0.98,
(R)-methylmalonyl-CoA,CC(C(=O)O)C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O,"InChI=1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t12-,13-,16-,17-,18+,22-/m1/s1",Succinyl-Coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O)C(O)C(=O)NCCC(=O)NCCSC(=O)CCC(=O)O,"InChI=1S/C25H40N7O19P3S/c1-25(2,20(38)23(39)28-6-5-14(33)27-7-8-55-16(36)4-3-15(34)35)10-48-54(45,46)51-53(43,44)47-9-13-19(50-52(40,41)42)18(37)24(49-13)32-12-31-17-21(26)29-11-30-22(17)32/h11-13,18-20,24,37-38H,3-10H2,1-2H3,(H,27,33)(H,28,39)(H,34,35)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t13-,18-,19-,20+,24-/m1/s1",,0.97,
Phenacetin,CCOC1=CC=C(NC(C)=O)C=C1,"InChI=1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)",Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,RZVAJINKPMORJF-UHFFFAOYSA-N,Cytochrome P450 1A2,0.77,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",5-HETE,CCCCCC=CCC=CCC=CC=CC(O)CCCC(=O)O,,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9",0.51,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",7-HETE,CCCCCC=CCC=CCC=CC(O)C=CCCCC(=O)O,,"Cytochrome P450 1A2, Cytochrome P450 3A4",0.74,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",10-HETE,CCCCCC=CCC=CC(O)C=CCC=CCCCC(=O)O,,"Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 3A4",0.77,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",13-HETE,CCCCCC=CC(O)C=CCC=CCC=CCCCC(=O)O,,"Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 3A4",0.74,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",17-HETE,CCCC(O)CC=CCC=CCC=CCC=CCCCC(=O)O,,"Cytochrome P450 1A1, Cytochrome P450 1A2",0.75,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",15-HETE,CCCCCC(O)C=CC=CCC=CCC=CCCCC(=O)O,,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C8",0.62,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",12-HETE,CCCCCC=CCC(O)C=CC=CCC=CCCCC(=O)O,,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C9",0.62,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",9-HETE,CCCCCC=CCC=CCC(O)C=CC=CCCCC(=O)O,,"Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9",0.63,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",8-HETE,CCCCCC=CCC=CC=CC(O)CC=CCCCC(=O)O,,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9",0.62,
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.83,
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.65,
Quinestrol,C#CC1(O)CCC2C3CCC4=C(C=CC(OC5CCCC5)=C4)C3CCC21C,"InChI=1S/C25H32O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,9,11,16,18,21-23,26H,4-8,10,12-15H2,2H3/t21-,22-,23+,24+,25+/m1/s1",Ethinylestradiol,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4)C3CCC21C,BFPYWIDHMRZLRN-SLHNCBLASA-N,,0.87,
Aldosterone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C=O)C(C(=O)CO)CCC12,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",Aldosterone 18-glucuronide,CC12CCC(=O)C=C1CCC1C2C2CC3(C(OC4OC(C(=O)O)C(O)C(O)C4O)O2)C(C(=O)CO)CCC13,OMRIQCUHVVBJKI-ACOLCOCVSA-N,,0.52,
Aldosterone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C=O)C(C(=O)CO)CCC12,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",Tetrahydroaldosterone-3-glucuronide,CC12CCC(OC3OC(C(=O)O)C(O)C(O)C3O)CC1CCC1C2C2CC3(C(O)O2)C(C(=O)CO)CCC13,CGIURIOFMWUPSV-RUQPETGGSA-N,,0.38,
Licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,"InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27)",Licofelone metabolite M4,CC1(C)CC2=C(C3=CC=C(O)C=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,OCECVTMNVSFNIW-UHFFFAOYSA-N,"Cytochrome P450 2J2, Cytochrome P450 3A4, Cytochrome P450 2C8, Cytochrome P450 2C19, Cytochrome P450 2D6",0.98,
Licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,"InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27)",Licofelone metabolite M2,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC(O)=C(Cl)C=C3)=C(CC(=O)O)N2C1,QUCLYFKWRYCDCG-UHFFFAOYSA-N,"Cytochrome P450 2J2, Cytochrome P450 2C9, Cytochrome P450 2C8",0.94,
Tienilic acid,O=C(O)COC1=C(Cl)C(Cl)=C(C(=O)C2=CC=CS2)C=C1,"InChI=1S/C13H8Cl2O4S/c14-11-7(13(18)9-2-1-5-20-9)3-4-8(12(11)15)19-6-10(16)17/h1-5H,6H2,(H,16,17)",Ticrynafen S-oxide,O=C(O)COC1=C(Cl)C(Cl)=C(C(=O)C2=CC=C([O-])S2)C=C1,WBHMKGJXNGKCIY-UHFFFAOYSA-M,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.93,
Tienilic acid,O=C(O)COC1=C(Cl)C(Cl)=C(C(=O)C2=CC=CS2)C=C1,"InChI=1S/C13H8Cl2O4S/c14-11-7(13(18)9-2-1-5-20-9)3-4-8(12(11)15)19-6-10(16)17/h1-5H,6H2,(H,16,17)","Thiophene-4,5-epoxide",CC(C(=O)O)C1=CC=C(C(=O)C2=CC3OC3S2)C=C1,SDGBIPHZPNRUFG-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C18, Cytochrome P450 2C19",0.25,
Cyproterone acetate,CC(=O)OC1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC21C,UWFYSQMTEOIJJG-FDTZYFLXSA-N,15beta-hydroxycyproterone acetate,CC(=O)OC1(C(C)=O)CC(O)C2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC21C,HRANPRDGABOKNQ-RXHWKJIASA-N,,0.91,
Flunarizine,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,SMANXXCATUTDDT-QPJJXVBHSA-N,Flunarizine metabolite M1,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCNCC2)C=C1,TTXIFFYPVGWLSE-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2A6, Cytochrome P450 1A1, Cytochrome P450 1A2",0.79,
Flunarizine,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,SMANXXCATUTDDT-QPJJXVBHSA-N,Flunarizine metabolite M2,OC1=CC=C(C=CCN2CCN(C(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C=C1,BORXUYRMIOAMIE-OWOJBTEDSA-N,Cytochrome P450 2D6,0.91,
Flunarizine,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,SMANXXCATUTDDT-QPJJXVBHSA-N,Flunarizine metabolite M3,O=C(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1,LSQARZALBDFYQZ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2A6",0.28,
Tetrabenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(=O)CC21,MKJIEFSOBYUXJB-UHFFFAOYSA-N,b-dihydrotetrabenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(O)CC21,WEQLWGNDNRARGE-UHFFFAOYSA-N,,0.84,
Lorcaserin,CC1CNCCC2=CC=C(Cl)C=C21,XTTZERNUQAFMOF-QMMMGPOBSA-N,Lorcaserin sulfamate,CC1CN(S(=O)(=O)O)CCC2=C1C=C(Cl)C=C2,YZUNJIOOIHWHGQ-UHFFFAOYSA-N,,0.64,
Lorcaserin,CC1CNCCC2=CC=C(Cl)C=C21,XTTZERNUQAFMOF-QMMMGPOBSA-N,N-carbamoyl glucuronide lorcaserin,CC1CN(C(=O)OC2OC(C(=O)O)C(C)C(C)C2C)CCC2=C1C=C(Cl)C=C2,DGFKLWZCLRDMAF-IJQUCLSUSA-N,,0.37,
Rotigotine,CCCN(CCC1=CC=CS1)C1CCC2=C(O)C=CC=C2C1,KFQYTPMOWPVWEJ-INIZCTEOSA-N,N-despropyl-rotigotine,OC1=CC=CC2=C1CCC(NCCC1=CC=CS1)C2,RDMWWGLKUMLLTG-UHFFFAOYSA-N,,0.91,
Rotigotine,CCCN(CCC1=CC=CS1)C1CCC2=C(O)C=CC=C2C1,KFQYTPMOWPVWEJ-INIZCTEOSA-N,N-desthienylethyl-rotigotine,CCCNC1CCC2=C(C=CC=C2O)C1,VCYPZWCFSAHTQT-UHFFFAOYSA-N,,0.77,
Vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,UHTHHESEBZOYNR-UHFFFAOYSA-N,N-desmethyl vandetanib,COC1=C(OCC2CCNCC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,HTCPERSEGREUFC-UHFFFAOYSA-N,,0.99,
Apremilast,CCOC1=CC(C(CS(C)(=O)=O)N2C(=O)C3=CC=CC(NC(C)=O)=C3C2=O)=CC=C1OC,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,O-desmethyl Apremilast,CCOC1=C(O)C=CC(C(CS(C)(=O)=O)N2C(=O)C3=C(C2=O)C(N=C(C)O)=CC=C3)=C1,PEUJABWEZWJNBO-MRXNPFEDSA-N,"Cytochrome P450 3A4, Cytochrome P450 2A6, Cytochrome P450 1A2",0.83,
Abiraterone,CC12CCC(O)CC1=CCC1C2CCC2(C)C(C3=CC=CN=C3)=CCC12,GZOSMCIZMLWJML-VJLLXTKPSA-N,N-oxide abiraterone sulfate,CC12CCC(OS(=O)(=O)O)CC1=CCC1C2CCC2(C)C(C3=CC=C[N+]([O-])=C3)=CCC12,AEEMBGRHVQPUBV-VJLLXTKPSA-N,Bile salt sulfotransferase,0.82,
Acetylcysteine,CC(=O)NC(CS)C(=O)O,PWKSKIMOESPYIA-BYPYZUCNSA-N,Cysteine,NC(CS)C(=O)O,XUJNEKJLAYXESH-REOHCLBHSA-N,Aminoacylase-1,0.39,
Pentaerythritol tetranitrate,O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-],TZRXHJWUDPFEEY-UHFFFAOYSA-N,Pentaerithrityl,OCC(CO)(CO)CO,"InChI=1S/C5H12O4/c6-1-5(2-7,3-8)4-9/h6-9H,1-4H2",Pentaerythritol tetranitrate reductase,0.28,
Romidepsin,CC=C1NC(=O)C2CSSCCC=CC(CC(=O)NC(C(C)C)C(=O)N2)OC(=O)C(C(C)C)NC1=O,OHRURASPPZQGQM-GCCNXGTGSA-N,Romidepsin (active),CC=C1N=C(O)C(CS)N=C(O)C(C(C)C)CC(=O)CC(C=CCCS)OC(=O)C(C(C)C)N=C1O,UPCFDQLGZODPFB-BXJZLCHMSA-N,,0.41,
Rufinamide,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,POGQSBRIGCQNEG-UHFFFAOYSA-N,CGP-47292,O=C(O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,OPJHWTKDQYKYHL-UHFFFAOYSA-N,,0.75,
Tapentadol,CCC(C1=CC(O)=CC=C1)C(C)CN(C)C,KWTWDQCKEHXFFR-SMDDNHRTSA-N,N-Desmethyl tapentadol,CCC(C1=CC(O)=CC=C1)C(C)CNC,PQQINTFVECNXLC-GXFFZTMASA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.94,
Prasugrel,CC(=O)OC1=CC2=C(CCN(C(C(=O)C3CC3)C3=CC=CC=C3F)C2)S1,DTGLZDAWLRGWQN-UHFFFAOYSA-N,R-95913,O=C(C1CC1)C(C1=CC=CC=C1F)N1CCC2=C(C=C(O)S2)C1,MPLQNQUWLWGOET-UHFFFAOYSA-N,Cholinesterase,0.9,
Doripenem,CC(O)C1C(=O)N2C(C(=O)O)=C(SC3CNC(CNS(N)(=O)=O)C3)C(C)C12,AVAACINZEOAHHE-VFZPANTDSA-N,doripenem-M1,CC(O)C(C(=O)O)C1NC(C(=O)O)C(SC2CNC(CNS(N)(=O)=O)C2)C1C,PJNKVKHAJNEENW-OZULOKFQSA-N,Dipeptidase 1,0.52,
Lacosamide,COCC(NC(C)=O)C(=O)NCC1=CC=CC=C1,VPPJLAIAVCUEMN-GFCCVEGCSA-N,O-Desmethyl lacosamide,CC(=O)NC(CO)C(=O)NCC1=CC=CC=C1,XRKSCJLQKGLSKU-LLVKDONJSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19",0.88,
Udenafil,CCCOC1=C(C2=NC(=O)C3=C(N2)C(CCC)=NN3C)C=C(S(=O)(=O)NCCC2CCCN2C)C=C1,"InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32)",N-desalkyludenafil,CCCOC1=C(C2=NC3=C(C(=O)N2)N(C)N=C3CCC)C=C(S(N)(=O)=O)C=C1,WQAFYWMRZOZKJD-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.93,
Dapagliflozin,CCOC1=CC=C(CC2=C(Cl)C=CC(C3OC(CO)C(O)C(O)C3O)=C2)C=C1,JVHXJTBJCFBINQ-ADAARDCZSA-N,Dapagliflozin 3-O-glucuronide,CCOC1=CC=C(CC2=CC(C3OC(CO)C(O)C(OC4OC(C(=O)O)C(O)C(O)C4O)C3O)=CC=C2Cl)C=C1,ZYZULHSUKTZGTR-PTNNFGGUSA-N,UDP-glucuronosyltransferase 1-9,0.79,
Saxagliptin,N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2,QGJUIPDUBHWZPV-SGTAVMJGSA-N,5-hydroxy saxagliptin,N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(O)(CC(O)(C3)C1)C2,GAWUJFVQGSLSSZ-HREDRMPBSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.98,
Ceftaroline fosamil,CCON=C(C(=O)NC1C(=O)N2C(C(=O)[O-])=C(SC3=NC(C4=CC=[N+](C)C=C4)=CS3)CSC12)C1=NSC(NP(=O)(O)O)=N1,ZCCUWMICIWSJIX-NQJJCJBVSA-N,ceftaroline,CCON=C(C(O)=NC1C(=O)N2C(C(=O)O)=C(SC3=NC(C4=CC=[N+](C)C=C4)=CS3)CSC12)C1=NC(=NP(=O)(O)O)SN1,ZCCUWMICIWSJIX-NQJJCJBVSA-O,,0.86,
Midostaurin,COC1C(N(C)C(=O)C2=CC=CC=C2)CC2OC1(C)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C31,BMGQWWVMWDBQGC-IIFHNQTCSA-N,CGP 52421,COC1C(N(C)C(=O)C2=CC=CC=C2)CC2OC1(C)N1C3=C(C=CC=C3)C3=C4C(=C5C6=C(C=CC=C6)N2C5=C31)C(=O)NC4O,ZZSBPGIGIUFJRA-YMZPHHGTSA-N,Cytochrome P450 3A4,0.97,
Midostaurin,COC1C(N(C)C(=O)C2=CC=CC=C2)CC2OC1(C)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C31,BMGQWWVMWDBQGC-IIFHNQTCSA-N,CGP 62221,CN(C(=O)C1=CC=CC=C1)C1CC2OC(C)(C1O)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C31,PXOCRDZEEXVZQC-AFUPZKSLSA-N,Cytochrome P450 3A4,0.98,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",O-Desmethylvicriviroc,CC1=C(C(=O)N2CCC(C)(N3CCN(C(CO)C4=CC=C(C(F)(F)F)C=C4)C(C)C3)CC2)C(C)=NC=N1,KKISTQPVRGXETN-MBSDFSHPSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 3A5",0.97,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",Vicriviroc hydroxylamine,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN(O)C3C)CC2)CC1C,CKBGTTZQHDIDOD-YZARGUDJSA-N,Cytochrome P450 3A4,0.58,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",Vicriviroc N-oxide,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)[N+]([O-])=CN=C3C)CC2)CC1C,FJGWJMSLTFKZKY-CYFREDJKSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.88,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",N-Desalkylvicriviroc,CC1=C(C(=O)N2CCC(C)(N3CCNC(C)C3)CC2)C(C)=NC=N1,JBIGWLFHMIEHKP-ZDUSSCGKSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.69,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1","N,N-Desalkylvicriviroc",COCC(NCCNC1(C)CCN(C(=O)C2=C(C)N=CN=C2C)CC1)C1=CC=C(C(F)(F)F)C=C1,VYTNUMGJUZTAEH-NRFANRHFSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.88,
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",Vicriviroc carboxylic acid,CC1=C(C(=O)N2CCC(C)(N3CCN(C(C(=O)O)C4=CC=C(C(F)(F)F)C=C4)C(C)C3)CC2)C(C)=NC=N1,MBIPBXMGYUYGFC-NVHKAFQKSA-N,Cytochrome P450 3A4,0.91,
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M6 (Odanacatib),CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C2=NC(C(=O)NCC(=O)O)CS2)CC1,UEBZMZSLTYWZTH-WKJLPXBYSA-N,,0.67,
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M9 (Odanacatib),CS(=O)(=O)C1=CC=C(C2=CC=C(C(OC3OC(C(=O)O)C(O)C(O)C3O)C(F)(F)F)C=C2)C=C1,ARJFPVWOMJKCQD-DOZWFGMRSA-N,,0.43,
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M10 (Odanacatib),CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,CLXDIFUURVULNN-WTOYAVKFSA-N,,0.58,
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M8 (Odanacatib),CC(F)(CO)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,JCZDLZKSPMKOPS-MMBKUXRPSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C8",0.95,
Betahistine,CNCCC1=CC=CC=N1,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,2-pyridylacetic acid,O=C(O)CC1=CC=CC=N1,BPSNETAIJADFTO-UHFFFAOYSA-N,Monoamine oxidase,0.49,
Dexmethylphenidate,COC(=O)C(C1=CC=CC=C1)C1CCCCN1,DUGOZIWVEXMGBE-CHWSQXEVSA-N,Ritalinic acid,O=C(O)C(C1=CC=CC=C1)C1CCCCN1,INGSNVSERUZOAK-UHFFFAOYSA-N,Carboxylesterase,0.89,
Lumefantrine,CCCCN(CCCC)CC(O)C1=C2C(=CC(Cl)=C1)C(=CC1=CC=C(Cl)C=C1)C1=C2C=CC(Cl)=C1,DYLGFOYVTXJFJP-MYYYXRDXSA-N,desbutyl-lumefantrine,CCCCNCC(O)C1=CC(Cl)=CC2=C1C1=C(C=C(Cl)C=C1)C2=CC1=CC=C(Cl)C=C1,YLBUTQNEBVPTES-NHDPSOOVSA-N,Cytochrome P450 3A4,0.98,
Fospropofol,CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O,QVNNONOFASOXQV-UHFFFAOYSA-N,Propofol,CC(C)C1=CC=CC(C(C)C)=C1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,0.57,
Lornoxicam,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O,"InChI=1S/C13H10ClN3O4S2/c1-17-10(13(19)16-9-4-2-3-5-15-9)11(18)12-7(23(17,20)21)6-8(14)22-12/h2-6,18H,1H3,(H,15,16,19)",5'-Hydroxylornoxicam,CN1C(=C(O)NC2=NC=C(O)C=C2)C(=O)C2=C(C=C(Cl)S2)S1(=O)=O,CDAPXAMBZODQBD-JLHYYAGUSA-N,Cytochrome P450 2C9,0.68,
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Dihydroxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCN(C)CC1,MDTMDEIAXKFDTH-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.94,
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Reduced ketobemidone,CCC(O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,CUWNYXLTWXEDNK-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.61,
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Norketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCNCC1,BJTDPLRIKDSWIS-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.95,
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Ketobemidone N-oxide,CCC(=O)C1(C2=CC(O)=CC=C2)CC[N+](C)([O-])CC1,HFMYBXUKKOZQHG-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.89,
Betaine,C[N+](C)(C)CC(=O)[O-],KWIUHFFTVRNATP-UHFFFAOYSA-N,"N,N-dimethylglycine",CN(C)CC(=O)O,"InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)",Betaine--homocysteine S-methyltransferase 1,0.81,
Bendamustine,CN1C(CCCC(=O)O)=NC2=CC(N(CCCl)CCCl)=CC=C21,YTKUWDBFDASYHO-UHFFFAOYSA-N,γ-hydroxybendamustine (Bendamustine metabolite M3),CN1C(C(O)CCC(=O)O)=NC2=C1C=CC(N(CCCl)CCCl)=C2,GPYWLSZJZNELNN-UHFFFAOYSA-N,Cytochrome P450 1A2,0.88,
Bendamustine,CN1C(CCCC(=O)O)=NC2=CC(N(CCCl)CCCl)=CC=C21,YTKUWDBFDASYHO-UHFFFAOYSA-N,N-desmethyl-bendamustine (Bendamustine metabolite M4),O=C(O)CCCC1=NC2=C(C=CC(N(CCCl)CCCl)=C2)N1,BPZIKXXNXMYQPN-UHFFFAOYSA-N,Cytochrome P450 1A2,0.76,
Bendamustine,CN1C(CCCC(=O)O)=NC2=CC(N(CCCl)CCCl)=CC=C21,YTKUWDBFDASYHO-UHFFFAOYSA-N,monohydroxy-bendamustine (bendamustine metabolite HP1),CN1C(CCCC(=O)O)=NC2=C1C=CC(N(CCO)CCCl)=C2,PFTRYOMJJKBZKV-UHFFFAOYSA-N,,0.96,
Cabazitaxel,COC1C(=O)C2(C)C(OC)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C3=CC=CC=C3)C(C)=C1C2(C)C,BMQGVNUXMIRLCK-OAGWZNDDSA-N,Docetaxel,CC(=O)OC12COC1CC(O)C1(C)C(=O)C(O)C3=C(C)C(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C4=CC=CC=C4)CC(O)(C(OC(=O)C4=CC=CC=C4)C21)C3(C)C,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2C8",0.99,
Cabazitaxel,COC1C(=O)C2(C)C(OC)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C3=CC=CC=C3)C(C)=C1C2(C)C,BMQGVNUXMIRLCK-OAGWZNDDSA-N,RPR123142,COC1CC2OCC2(OC(C)=O)C2C(OC(=O)C3=CC=CC=C3)C3(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C(C(O)C(=O)C12C)C3(C)C,CIHAXHLPSYZREI-BGKJQISDSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2C8",0.99,
Phenylbutyric acid,O=C(O)CCCC1=CC=CC=C1,OBKXEAXTFZPCHS-UHFFFAOYSA-N,Phenylacetic acid,O=C(O)CC1=CC=CC=C1,WLJVXDMOQOGPHL-UHFFFAOYSA-N,,0.41,
Tiopronin,CC(S)C(=O)NCC(=O)O,YTGJWQPHMWSCST-UHFFFAOYSA-N,2-mercaptopropionic acid,CC(S)C(=O)O,PMNLUUOXGOOLSP-UHFFFAOYSA-N,,0.21,
Triethylenetetramine,NCCNCCNCCN,VILCJCGEZXAXTO-UHFFFAOYSA-N,N1-acetyltriethylenetetramine,CC(=O)NCCNCCNCCN,GMXQUOKWLVCFEG-UHFFFAOYSA-N,Diamine acetyltransferase 1,0.52,
Chloramphenicol succinate,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)C1=CC=C([N+](=O)[O-])C=C1,LIRCDOVJWUGTMW-ZWNOBZJWSA-N,Chloramphenicol,O=C(NC(CO)C(O)C1=CC=C([N+](=O)[O-])C=C1)C(Cl)Cl,WIIZWVCIJKGZOK-RKDXNWHRSA-N,,0.78,
Harmine,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1,"InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3",Harmol,CC1=C2NC3=C(C=CC(O)=C3)C2=CC=N1,,"Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 1A2",0.93,
Nandrolone decanoate,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,JKWKMORAXJQQSR-MOPIKTETSA-N,Nandrolone,CC12CCC3C4CCC(=O)C=C4CCC3C1CCC2O,"InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1","cAMP-specific 3',5'-cyclic phosphodiesterase 7B",0.76,
Nandrolone,CC12CCC3C4CCC(=O)C=C4CCC3C1CCC2O,"InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1",19-Norandrosterone,CC12CCC3C4CCC(O)CC4CCC3C1CCC2=O,,,0.39,
Bupranolol,CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1,"InChI=1S/C14H22ClNO2/c1-10-5-6-12(15)13(7-10)18-9-11(17)8-16-14(2,3)4/h5-7,11,16-17H,8-9H2,1-4H3","carboxybupranolol, 4-chloro-3-[3-(1,1-dimethylethylamino)-2-hydroxy-propyloxy]benzoic acid",CCCCNCC(O)COC1=C(Cl)C=CC(C(=O)O)=C1,IZPPAHZRVDTEHO-UHFFFAOYSA-N,,0.71,
Triflusal,CC(=O)OC1=C(C(=O)O)C=CC(C(F)(F)F)=C1,"InChI=1S/C10H7F3O4/c1-5(14)17-8-4-6(10(11,12)13)2-3-7(8)9(15)16/h2-4H,1H3,(H,15,16)",2-hydroxy-4-trifluoromethyl benzoic acid,O=C(O)C1=C(O)C=C(C(F)(F)F)C=C1,XMLFPUBZFSJWCN-UHFFFAOYSA-N,,0.66,
Lurasidone,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(C2=NSC3=CC=CC=C23)CC1,PQXKDMSYBGKCJA-CVTJIBDQSA-N,ID14326,O=C1C2C3CCC(C3O)C2C(=O)N1CC1CCCCC1CN1CCN(C2=NSC3=C2C=CC=C3)CC1,VKVBDORNIIAKBR-UJKUZCFGSA-N,,0.91,
Tafluprost,CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1C=CC(F)(F)COC1=CC=CC=C1,WSNODXPBBALQOF-VEJSHDCNSA-N,Tafluprost free acid,O=C(O)CCCC=CCC1C(O)CC(O)C1C=CC(F)(F)COC1=CC=CC=C1,KIQXRQVVYTYYAZ-MTNCBHNASA-N,,0.92,
Icosapent ethyl,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC,SSQPWTVBQMWLSZ-AAQCHOMXSA-N,EPA,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,JAZBEHYOTPTENJ-JLNKQSITSA-N,,0.69,
Formestane,CC12CCC3C(CCC4=C(O)C(=O)CCC43C)C1CCC2=O,OSVMTWJCGUFAOD-KZQROQTASA-N,4-Hydroxyandrostenedione glucuronide,CC12CCC3C(CCC4=C(OC5OC(C(=O)O)C(O)C(O)C5O)C(=O)CCC43C)C1CCC2=O,JIKFCHILHFFTSH-NRIFOQJISA-N,,0.49,
Dimethyl fumarate,COC(=O)C=CC(=O)OC,LDCRTTXIJACKKU-ONEGZZNKSA-N,Monomethyl fumarate,COC(=O)C=CC(=O)O,NKHAVTQWNUWKEO-NSCUHMNNSA-N,,0.97,
(4R)-limonene,C=C(C)C1CC=C(C)CC1,XMGQYMWWDOXHJM-JTQLQIEISA-N,Perillyl alcohol,C=C(C)C1CC=C(CO)CC1,NDTYTMIUWGWIMO-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.76,
(4R)-limonene,C=C(C)C1CC=C(C)CC1,XMGQYMWWDOXHJM-JTQLQIEISA-N,Uroterpenol,CC1=CCC(C(C)(O)CO)CC1,ZJALAEQNHJQSTN-UHFFFAOYSA-N,,0.38,
(4R)-limonene,C=C(C)C1CC=C(C)CC1,XMGQYMWWDOXHJM-JTQLQIEISA-N,Carveol,C=C(C)C1CC=C(C)C(O)C1,,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.58,
Sofosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O)OC1=CC=CC=C1,TTZHDVOVKQGIBA-IQWMDFIBSA-N,GS-56650,CC(C)OC(=O)C(C)NP(=O)(O)OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O,IPNWIJCJSQLNQC-YAWKKRDBSA-N,"Carboxylesterase, Lysosomal protective protein",0.93,
Vorapaxar,CCOC(=O)NC1CCC2C(C1)CC1C(=O)OC(C)C1C2C=CC1=CC=C(C2=CC(F)=CC=C2)C=N1,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,amine metabolite (M19),CC1OC(=O)C2CC3CC(N)CCC3C(C=CC3=NC=C(C4=CC(F)=CC=C4)C=C3)C12,GTYWVNGLHQVHBJ-FRGGEYDCSA-N,Cytochrome P450 3A4,0.91,
Vorapaxar,CCOC(=O)NC1CCC2C(C1)CC1C(=O)OC(C)C1C2C=CC1=CC=C(C2=CC(F)=CC=C2)C=N1,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,monohydroxy-vorapaxar (M20),CC1OC(=O)C2CC3CC(N=C(O)OCCO)CCC3C(C=CC3=NC=C(C4=CC(F)=CC=C4)C=C3)C12,ZHYYTGYLGLSISZ-VERGWIBFSA-N,"Cytochrome P450 3A4, Cytochrome P450 2J2",0.85,
Miltefosine,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,PQLXHQMOHUQAKB-UHFFFAOYSA-N,Choline,C[N+](C)(C)CCO,OEYIOHPDSNJKLS-UHFFFAOYSA-N,Phospholipase D1,0.17,
Tedizolid phosphate,CN1N=NC(C2=CC=C(C3=CC=C(N4CC(COP(=O)(O)O)OC4=O)C=C3F)C=N2)=N1,QCGUSIANLFXSGE-GFCCVEGCSA-N,Tedizolid,CN1N=NC(C2=NC=C(C3=C(F)C=C(N4CC(CO)OC4=O)C=C3)C=C2)=N1,"InChI=1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m1/s1",,0.93,
Netupitant,CC1=CC=CC=C1C1=CC(N2CCN(C)CC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,WAXQNWCZJDTGBU-UHFFFAOYSA-N,Desmethyl Netupitant,CC1=CC=CC=C1C1=CC(N2CCNCC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,SRVSDBHUBFLSFE-UHFFFAOYSA-N,Cytochrome P450 3A43,0.99,
Netupitant,CC1=CC=CC=C1C1=CC(N2CCN(C)CC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,WAXQNWCZJDTGBU-UHFFFAOYSA-N,N-oxide Netupitant,CC1=CC=CC=C1C1=CC(N2CCC(C)(O)CC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,GMWVPBPDWXVQEG-UHFFFAOYSA-N,Cytochrome P450 3A43,0.91,
Idelalisib,CCC(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,IFSDAJWBUCMOAH-HNNXBMFYSA-N,GS-563117,CCC(NC1=NC=NC2NC(=O)N=C12)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,MMFWEWZUIJPIPC-KTQQKIMGSA-N,"Aldehyde oxidase, Cytochrome P450 3A Subfamily",0.74,
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,Vortioxetine Metabolite 1,CC1=C(SC2=CC=CC=C2N2CC[NH2+]CC2)C=CC(CO)=C1,INVFGIUFVDSKAT-UHFFFAOYSA-O,"Cytochrome P450 2D6, Cytochrome P450 2C9",0.93,
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,YQNWZWMKLDQSAC-UHFFFAOYSA-N,M8,CC1=CC(C)=C(SC2=CC(O)=CC=C2N2CC[NH2+]CC2)C=C1,GZGSAICCNTYGOF-UHFFFAOYSA-O,"Cytochrome P450 2D6, Cytochrome P450 2C9",0.87,
Nintedanib,COC(=O)C1=CC=C2C(=C(NC3=CC=C(N(C)C(=O)CN4CCN(C)CC4)C=C3)C3=CC=CC=C3)C(=O)NC2=C1,XZXHXSATPCNXJR-ZIADKAODSA-N,BIBF 1202,CN1CCN(CC(=O)N(C)C2=CC=C(NC(=C3C(O)=NC4=C3C=CC(C(=O)O)=C4)C3=CC=CC=C3)C=C2)CC1,KEHNCEDHZGQSNP-DQSJHHFOSA-N,,0.69,
Olodaterol,COC1=CC=C(CC(C)(C)NCC(O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1,COUYJEVMBVSIHV-SFHVURJKSA-N,O-demethylated olodaterol,CC(C)(CC1=CC=C(O)C=C1)NCC(O)C1=C2OCC(O)=NC2=CC(O)=C1,OSJGFHCFUOVFPN-KRWDZBQOSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8",0.68,
Vilanterol,OCC1=C(O)C=CC(C(O)CNCCCCCCOCCOCC2=C(Cl)C=CC=C2Cl)=C1,DAFYYTQWSAWIGS-DEOSSOPVSA-N,M29 (GW630200),OCCOCCCCCCNCC(O)C1=CC(CO)=C(O)C=C1,BOBWIDWDXFEGNK-KRWDZBQOSA-N,,0.76,
Tetracaine,CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1,GKCBAIGFKIBETG-UHFFFAOYSA-N,para-aminobenzoic acid,NC1=CC=C(C(=O)O)C=C1,ALYNCZNDIQEVRV-UHFFFAOYSA-N,,0.48,
Benzoyl peroxide,O=C(OOC(=O)C1=CC=CC=C1)C1=CC=CC=C1,OMPJBNCRMGITSC-UHFFFAOYSA-N,Benzoyloxyl radical,O=C([O-])C1=CC=CC=C1,WPYMKLBDIGXBTP-UHFFFAOYSA-M,,0.54,
Coenzyme M,O=S(=O)(O)CCS,ZNEWHQLOPFWXOF-UHFFFAOYSA-N,dimesna,O=S(=O)(O)CCSSCCS(=O)(=O)O,BYUKOOOZTSTOOH-UHFFFAOYSA-N,,0.54,
Eslicarbazepine acetate,CC(=O)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C21,QIALRBLEEWJACW-INIZCTEOSA-N,Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,,0.81,
Brexpiprazole,O=C1C=CC2=CC=C(OCCCCN3CCN(C4=C5C=CSC5=CC=C4)CC3)C=C2N1,ZKIAIYBUSXZPLP-UHFFFAOYSA-N,DM-3411,O=C1C=CC2=C(C=C(OCCCCN3CCN(C4=CC=CC5=C4C=C[S+]5[O-])CC3)C=C2)N1,VJYXYAVCCLPIPM-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6",0.91,
Uridine triacetate,CC(=O)OCC1OC(N2C=CC(=O)NC2=O)C(OC(C)=O)C1OC(C)=O,AUFUWRKPQLGTGF-FMKGYKFTSA-N,Uridine,O=C1C=CN(C2OC(CO)C(O)C2O)C(=O)N1,DRTQHJPVMGBUCF-XVFCMESISA-N,,0.82,
Florbetapir (18F),CNC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,YNDIAUKFXKEXSV-CRYLGTRXSA-N,[18F]AV-160 (desmethyl-[18F]AV-45),NC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,HWDCMGOFOLKQBU-YHRRMKGCSA-N,,0.95,
Florbetapir (18F),CNC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,YNDIAUKFXKEXSV-CRYLGTRXSA-N,[18F]AV-267 (N-acetyl–[18F]AV-160),CC(=O)NC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,KWNBGGMKKPCFDH-FWZJPQCDSA-N,,0.91,
Etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,"InChI=1S/C19H28ClN5O/c1-3-18-21-25(19(26)24(18)4-2)10-6-9-22-11-13-23(14-12-22)17-8-5-7-16(20)15-17/h5,7-8,15H,3-4,6,9-14H2,1-2H3",m-Chlorophenylpiperazine,ClC1=CC(N2CCNCC2)=CC=C1,"InChI=1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2",,0.29,
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,BQJCRHHNABKAKU-KBQPJGBKSA-N,,0.98,
Droxicam,CN1C2=C(OC(=O)N(C3=CC=CC=N3)C2=O)C2=CC=CC=C2S1(=O)=O,"InChI=1S/C16H11N3O5S/c1-18-13-14(10-6-2-3-7-11(10)25(18,22)23)24-16(21)19(15(13)20)12-8-4-5-9-17-12/h2-9H,1H3",Piroxicam,CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O,QYSPLQLAKJAUJT-UHFFFAOYSA-N,,0.54,
Artesunate,CC1CCC2C(C)C(OC(=O)CCC(=O)O)OC3OC4(C)CCC1C32OO4,FIHJKUPKCHIPAT-AHIGJZGOSA-N,Dihydroartemisinin (DHA),CC1CCC2C(C)C(O)OC3OC4(C)CCC1C32OO4,BJDCWCLMFKKGEE-AGQWIWFJSA-N,,0.9,
Molsidomine,CCOC(=O)[N-]C1=C[N+](N2CCOCC2)=NO1,"InChI=1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3",Linsidomine,[NH-]C1=C[N+](N2CCOCC2)=NO1,"InChI=1S/C6H10N4O2/c7-6-5-10(8-12-6)9-1-3-11-4-2-9/h5,7H,1-4H2","cGMP-specific 3',5'-cyclic phosphodiesterase",0.64,
Propacetamol,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,"InChI=1S/C14H20N2O3/c1-4-16(5-2)10-14(18)19-13-8-6-12(7-9-13)15-11(3)17/h6-9H,4-5,10H2,1-3H3,(H,15,17)",Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,RZVAJINKPMORJF-UHFFFAOYSA-N,Cholinesterase,0.5,
Rolapitant,CC(OCC1(C2=CC=CC=C2)CCC2(CCC(=O)N2)CN1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,FIVSJYGQAIEMOC-ZGNKEGEESA-N,Rolapitant metabolite M19,CC(OCC1(C2=CC=CC=C2)CCC2(CN1)NC(=O)CC2O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,FCWJCWUZMPITLV-OYGALRCHSA-N,Cytochrome P450 3A4,0.92,
Sacubitril,CCOC(=O)C(C)CC(CC1=CC=C(C2=CC=CC=C2)C=C1)NC(=O)CCC(=O)O,PYNXFZCZUAOOQC-UTKZUKDTSA-N,Sacubitrilat (LBQ657),CC(CC(CC1=CC=C(C2=CC=CC=C2)C=C1)NC(=O)CCC(=O)O)C(=O)O,DOBNVUFHFMVMDB-BEFAXECRSA-N,,0.91,
Dexpanthenol,CC(C)(CO)C(O)C(=O)NCCCO,SNPLKNRPJHDVJA-ZETCQYMHSA-N,Pantothenic acid,CC(C)(CO)C(O)C(=O)NCCC(=O)O,GHOKWGTUZJEAQD-ZETCQYMHSA-N,,0.9,
Xylose,O=CC(O)C(O)C(O)CO,PYMYPHUHKUWMLA-VPENINKCSA-N,Xylitol,OCC(O)C(O)C(O)CO,HEBKCHPVOIAQTA-SCDXWVJYSA-N,,0.58,
Xylitol,OCC(O)C(O)C(O)CO,HEBKCHPVOIAQTA-SCDXWVJYSA-N,D-Xylulose,O=C(CO)C(O)C(O)CO,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5-/m0/s1",,0.44,
Methyl salicylate,COC(=O)C1=CC=CC=C1O,OSWPMRLSEDHDFF-UHFFFAOYSA-N,Salicylic acid,COC(=O)C1=C(O)C=C(C)C=C1,UITFCFWKYAOJEJ-UHFFFAOYSA-N,Liver esterases,0.84,
Arbutin,OCC1OC(OC2=CC=C(O)C=C2)C(O)C(O)C1O,BJRNKVDFDLYUGJ-RMPHRYRLSA-N,D-glucose,O=CC(O)C(O)C(O)C(O)CO,GZCGUPFRVQAUEE-SLPGGIOYSA-N,,0.16,
Prezatide,NCCCCC(NC(=O)C(CC1=CNC=N1)NC(=O)CN)C(=O)O,"InChI=1S/C14H24N6O4/c15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9/h7-8,10-11H,1-6,15-16H2,(H,17,18)(H,19,21)(H,20,22)(H,23,24)/t10-,11-/m0/s1",Histidyl-lysine,NCCCCC(NC(=O)C(N)CC1=CNC=N1)C(=O)O,,,0.8,
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",Prostaglandin E1,CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(=O)O,,"Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2",0.22,
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",Fatty acid desaturase 2,0.75,
Selexipag,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=NC(C2=CC=CC=C2)=C(C2=CC=CC=C2)N=C1,QXWZQTURMXZVHJ-UHFFFAOYSA-N,ACT-333679,CC(C)N(CCCCOCC(=O)O)C1=NC(C2=CC=CC=C2)=C(C2=CC=CC=C2)N=C1,OJQMKCBWYCWFPU-UHFFFAOYSA-N,Liver carboxylesterase 1,0.87,
Alectinib,CCC1=CC2=C(C=C1N1CCC(N3CCOCC3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2N1,KDGFLJKFZUIJMX-UHFFFAOYSA-N,M4,CCC1=CC2=C(C=C1N1CCC(NCCO)CC1)C(C)(C)C1=C(C2=O)C2=C(C=C(C#N)C=C2)N1,XNKBNGIKXNABDO-UHFFFAOYSA-N,Cytochrome P450 3A4,0.99,
Sennosides,O=C(O)C1=CC2=C(C(=O)C3=C(OC4OC(CO)C(O)C(O)C4O)C=CC=C3C2C2C3=C(C(=O)C4=C(OC5OC(CO)C(O)C(O)C5O)C=CC=C42)C(O)=CC(C(=O)O)=C3)C(O)=C1,IPQVTOJGNYVQEO-UHFFFAOYSA-N,Sennidin A,O=C(O)C1=CC(O)=C2C(=O)C3=C(O)C=CC=C3C(C3C4=CC=CC(O)=C4C(=O)C4=C(O)C=C(C(=O)O)C=C43)C2=C1,JPMRHWLJLNKRTJ-UHFFFAOYSA-N,,0.67,
Benzyl alcohol,OCC1=CC=CC=C1,WVDDGKGOMKODPV-UHFFFAOYSA-N,Benzoic acid,O=C(O)C1=CC=CC=C1,WPYMKLBDIGXBTP-UHFFFAOYSA-N,,0.6,
Levoleucovorin,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C3)N2C=O)N1,VVIAGPKUTFNRDU-STQMWFEESA-N,5-Methyltetrahydrofolate,CN1C2=C(N=C(N)NC2=O)NCC1CNC1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1,ZNOVTXRBGFNYRX-ZGTCLIOFSA-N,,0.95,
Latanoprostene bunod,O=C(CCCC=CCC1C(O)CC(O)C1CCC(O)CCC1=CC=CC=C1)OCCCCO[N+](=O)[O-],LOVMMUBRQUFEAH-UIEAZXIASA-N,Latanoprost,CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1CCC(O)CCC1=CC=CC=C1,GGXICVAJURFBLW-CEYXHVGTSA-N,Carboxylesterase,0.86,
Fostemsavir,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(C(=O)C(=O)N1CCN(C(=O)C3=CC=CC=C3)CC1)=CN2COP(=O)(O)O,SWMDAPWAQQTBOG-UHFFFAOYSA-N,Temsavir,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(C(=O)C(=O)N1CCN(C(=O)C3=CC=CC=C3)CC1)=CN2,"InChI=1S/C24H23N7O4/c1-15-27-14-31(28-15)22-20-19(18(35-2)13-26-22)17(12-25-20)21(32)24(34)30-10-8-29(9-11-30)23(33)16-6-4-3-5-7-16/h3-7,12-14,25H,8-11H2,1-2H3",Intestinal-type alkaline phosphatase,0.88,
Valbenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)C)CC21,GEJDGVNQKABXKG-CFKGEZKQSA-N,NBI-136110,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)(C)O)CC21,RPHPRWCGGJGIHI-WGQQHEPDSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.97,
Valbenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)C)CC21,GEJDGVNQKABXKG-CFKGEZKQSA-N,[+]-α-HTBZ,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(O)CC21,WEQLWGNDNRARGE-DJIMGWMZSA-N,,0.85,
Diacerein,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C(=O)O)C=C1C2=O,"InChI=1S/C19H12O8/c1-8(20)26-13-5-3-4-11-15(13)18(23)16-12(17(11)22)6-10(19(24)25)7-14(16)27-9(2)21/h3-7H,1-2H3,(H,24,25)",Rhein,O=C(O)C1=CC2C(=O)C3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,HHQNGUQUHZYDEP-UHFFFAOYSA-N,,0.37,
Telotristat ethyl,CCOC(=O)C(N)CC1=CC=C(C2=NC(N)=NC(OC(C3=CC=C(Cl)C=C3N3C=CC(C)=N3)C(F)(F)F)=C2)C=C1,MDSQOJYHHZBZKA-GBXCKJPGSA-N,Telotristat,CC1=NN(C2=CC(Cl)=CC=C2C(OC2=NC(N)=NC(C3=CC=C(CC(N)C(=O)O)C=C3)=C2)C(F)(F)F)C=C1,"InChI=1S/C25H22ClF3N6O3/c1-13-8-9-35(34-13)20-11-16(26)6-7-17(20)22(25(27,28)29)38-21-12-19(32-24(31)33-21)15-4-2-14(3-5-15)10-18(30)23(36)37/h2-9,11-12,18,22H,10,30H2,1H3,(H,36,37)(H2,31,32,33)/t18-,22+/m0/s1","Liver carboxylesterase 1, Cocaine esterase",0.98,
Brincidofovir,CCCCCCCCCCCCCCCCOCCCOP(=O)(O)COC(CO)CN1C=CC(N)=NC1=O,WXJFKKQWPMNTIM-VWLOTQADSA-N,Cidofovir,NC1=NC(=O)N(CC(CO)OCP(=O)(O)O)C=C1,VWFCHDSQECPREK-LURJTMIESA-N,,0.83,
Lisofylline,CC(O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m1/s1",Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,Cytochrome P450 1A2,0.97,
Oxetacaine,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC1=CC=CC=C1,FTLDJPRFCGDUFH-UHFFFAOYSA-N,Mephentermine,CNC(C)(C)CC1=CC=CC=C1,RXQCGGRTAILOIN-UHFFFAOYSA-N,,0.43,
Oxetacaine,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC1=CC=CC=C1,FTLDJPRFCGDUFH-UHFFFAOYSA-N,Phentermine,CC(C)(N)CC1=CC=CC=C1,DHHVAGZRUROJKS-UHFFFAOYSA-N,,0.35,
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,HOMGKSMUEGBAAB-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6",0.96,
Nicoboxil,CCCCOCCOC(=O)C1=CN=CC=C1,IZJRISIINLJVBU-UHFFFAOYSA-N,Niacin,O=C(O)C1=CN=CC=C1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,Serum albumin,0.58,
Darolutamide,CC(CN1C=CC(C2=CC=C(C#N)C(Cl)=C2)=N1)NC(=O)C1=NNC(C(C)O)=C1,BLIJXOOIHRSQRB-PXYINDEMSA-N,Ketodarolutamide,CC(=O)C1=CC(C(=O)NC(C)CN2C=CC(C3=CC=C(C#N)C(Cl)=C3)=N2)=NN1,"InChI=1S/C19H17ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-/m0/s1","Cytochrome P450 3A4, UDP-glucuronosyltransferase 1-9",0.91,
Rheinanthrone,O=C(O)C1=CC(O)=C2C(=O)C3=C(C=CC=C3O)CC2=C1,"InChI=1S/C15H10O5/c16-10-3-1-2-7-4-8-5-9(15(19)20)6-11(17)13(8)14(18)12(7)10/h1-3,5-6,16-17H,4H2,(H,19,20)",Rhein,O=C(O)C1=CC2C(=O)C3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,HHQNGUQUHZYDEP-UHFFFAOYSA-N,,0.31,
Rheinanthrone,O=C(O)C1=CC(O)=C2C(=O)C3=C(C=CC=C3O)CC2=C1,"InChI=1S/C15H10O5/c16-10-3-1-2-7-4-8-5-9(15(19)20)6-11(17)13(8)14(18)12(7)10/h1-3,5-6,16-17H,4H2,(H,19,20)",Sennidin A,O=C(O)C1=CC(O)=C2C(=O)C3=C(O)C=CC=C3C(C3C4=CC=CC(O)=C4C(=O)C4=C(O)C=C(C(=O)O)C=C43)C2=C1,JPMRHWLJLNKRTJ-UHFFFAOYSA-N,,0.74,
Oxabolone cipionate,CC12CCC3C4CCC(=O)C(O)=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H38O4/c1-26-15-14-18-17-9-11-22(27)25(29)20(17)8-7-19(18)21(26)10-12-23(26)30-24(28)13-6-16-4-2-3-5-16/h16-19,21,23,29H,2-15H2,1H3/t17-,18-,19-,21+,23+,26+/m1/s1",Oxabolone,CC12CCC3C4CCC(=O)C(O)=C4CCC3C1CCC2O,"InChI=1S/C18H26O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h10-12,14,16,20-21H,2-9H2,1H3/t10-,11-,12-,14+,16+,18+/m1/s1",,0.81,
Dichlorobenzyl alcohol,OCC1=C(Cl)C=C(Cl)C=C1,DBHODFSFBXJZNY-UHFFFAOYSA-N,Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.15,
Acemetacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(=O)O,"InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)",Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,CGIGDMFJXJATDK-UHFFFAOYSA-N,,0.96,
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",Dinoprostone,CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(=O)O,XEYBRNLFEZDVAW-ARSRFYASSA-N,"Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Phospholipase A2, membrane associated",0.2,
Harmaline,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NCC1,"InChI=1S/C13H14N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-4,7,15H,5-6H2,1-2H3",Harmalol,CC1=NCCC2=C1NC1=C2C=CC(O)=C1,,"Cytochrome P450 2D6, Cytochrome P450 1A2",0.96,
Methyl nicotinate,COC(=O)C1=CN=CC=C1,YNBADRVTZLEFNH-UHFFFAOYSA-N,Niacin,O=C(O)C1=CN=CC=C1,PVNIIMVLHYAWGP-UHFFFAOYSA-N,,0.8,
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,HPFVBGJFAYZEBE-ZLQWOROUSA-N,Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,,0.77,
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,VOCBWIIFXDYGNZ-IXKNJLPQSA-N,Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,,0.77,
Testosterone undecanoate,CCCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,UDSFVOAUHKGBEK-CNQKSJKFSA-N,Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,,0.77,
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,FHXBMXJMKMWVRG-SLHNCBLASA-N,Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.86,
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,UYIFTLBWAOGQBI-BZDYCCQFSA-N,Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.78,
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,UOACKFBJUYNSLK-XRKIENNPSA-N,Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.85,
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,OVAHZPTYWMWNKO-CAHAWPIUSA-N,Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.74,
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,RSEPBGGWRJCQGY-RBRWEJTLSA-N,Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.85,
alpha-Linolenic acid,CCC=CCC=CCC=CCCCCCCCC(=O)O,DTOSIQBPPRVQHS-PDBXOOCHSA-N,Docosahexaenoic acid,CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)O,,,0.56,
alpha-Linolenic acid,CCC=CCC=CCC=CCCCCCCCC(=O)O,DTOSIQBPPRVQHS-PDBXOOCHSA-N,Eicosapentaenoic acid,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,,,0.71,
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,OYHQOLUKZRVURQ-HZJYTTRNSA-N,Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",,0.73,
Isopropyl myristate,CCCCCCCCCCCCCC(=O)OC(C)C,AXISYYRBXTVTFY-UHFFFAOYSA-N,Myristic acid,CCCCCCCCCCCCCC(=O)O,TUNFSRHWOTWDNC-UHFFFAOYSA-N,Carboxylesterase,0.5,
Baloxavir marboxil,COC(=O)OCOC1=C2C(=O)N3CCOCC3N(C3C4=CC=CC=C4SCC4=C(F)C(F)=CC=C43)N2C=CC1=O,RZVPBGBYGMDSBG-GGAORHGYSA-N,Baloxavir,O=C1C2=C(O)C(=O)C=CN2N(C2C3=C(C=CC=C3)SCC3=C2C=CC(F)=C3F)C2COCCN12,"InChI=1S/C24H19F2N3O4S/c25-16-6-5-13-15(20(16)26)12-34-18-4-2-1-3-14(18)21(13)29-19-11-33-10-9-27(19)24(32)22-23(31)17(30)7-8-28(22)29/h1-8,19,21,31H,9-12H2/t19-,21+/m1/s1",,0.97,
Tenofovir,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,"InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1",Tenofovir Monophosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)O,BQDRSOMUPPCKPB-ZCFIWIBFSA-N,"Adenylate kinase isoenzyme 1, Adenylate kinase 2, mitochondrial",0.88,
Cinnamyl alcohol,OCC=CC1=CC=CC=C1,OOCCDEMITAIZTP-QPJJXVBHSA-N,Cinnamaldehyde,O=CC=CC1=CC=CC=C1,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,,0.72,
Mometasone furoate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,WOFMFGQZHJDGCX-ZULDAHANSA-N,6-beta-hydroxy-mometasone furoate,CC1CC2C3C(O)CC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,NVZADOUZVHKHSK-PWHXNIGKSA-N,,0.96,
Mometasone furoate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,WOFMFGQZHJDGCX-ZULDAHANSA-N,Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CCl,"InChI=1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",,0.74,
Betamethasone phosphate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,"InChI=1S/C22H30FO8P/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30)/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1",Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,UREBDLICKHMUKA-DVTGEIKXSA-N,,0.9,
Diroximel fumarate,COC(=O)C=CC(=O)OCCN1C(=O)CCC1=O,YIMYDTCOUQIDMT-SNAWJCMRSA-N,Monomethyl fumarate,COC(=O)C=CC(=O)O,NKHAVTQWNUWKEO-NSCUHMNNSA-N,Liver esterases,0.24,
Monomethyl fumarate,COC(=O)C=CC(=O)O,NKHAVTQWNUWKEO-NSCUHMNNSA-N,Fumaric acid,O=C(O)C=CC(=O)O,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+",,0.65,
Benzhydrocodone,COC1=C2OC3C(OC(=O)C4=CC=CC=C4)=CCC4C5CC(=C2C34CCN5C)C=C1,VPMRSLWWUXNYRY-NDOYXKHWSA-N,Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,LLPOLZWFYMWNKH-CMKMFDCUSA-N,,0.8,
Prednisolone acetate,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,LRJOMUJRLNCICJ-JZYPGELDSA-N,Prednisolone,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,OIGNJSKKLXVSLS-VWUMJDOOSA-N,,0.89,
Melphalan flufenamide,CCOC(=O)C(CC1=CC=C(F)C=C1)NC(=O)C(N)CC1=CC=C(N(CCCl)CCCl)C=C1,YQZNKYXGZSVEHI-VXKWHMMOSA-N,Melphalan,NC(CC1=CC=C(N(CCCl)CCCl)C=C1)C(=O)O,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,Aminopeptidase N,0.5,
Serdexmethylphenidate,COC(=O)C(C1=CC=CC=C1)C1CCCCN1C(=O)OC[N+]1=CC=CC(C(=O)NC(CO)C(=O)[O-])=C1,UBZPNQRBUOBBLN-PWRODBHTSA-N,Dexmethylphenidate,COC(=O)C(C1=CC=CC=C1)C1CCCCN1,DUGOZIWVEXMGBE-CHWSQXEVSA-N,,0.54,
Dihydrolipoamide,N=C(O)CCCCC(S)CCS,,Lipoic acid,O=C(O)CCCCC1CCSS1,AGBQKNBQESQNJD-SSDOTTSWSA-N,"Dihydrolipoyl dehydrogenase, mitochondrial, Glycine cleavage system H protein, mitochondrial",0.4,
4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.67,
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Cotinine N-oxide,CN1C(=O)CCC1C1=C[N+]([O-])=CC=C1,CIPULDKLIIVIER-VIFPVBQESA-N,,0.88,
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,3'-Hydroxycotinine,CN1C(=O)C(O)CC1C1=CN=CC=C1,XOKCJXZZNAUIQN-IENPIDJESA-N,Cytochrome P450 2A6,0.8,
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Nornicotine,C1=CN=CC(C2CCCN2)=C1,MYKUKUCHPMASKF-UHFFFAOYSA-N,,0.67,
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Nicotine-1'-N-oxide,C[N+]1([O-])CCCC1C1=CN=CC=C1,RWFBQHICRCUQJJ-UHFFFAOYSA-N,Dimethylaniline monooxygenase [N-oxide-forming] 3,0.65,
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Cotinine glucuronide,CN1C(=O)CCC1C1=C[N+](C2OC(C(=O)[O-])C(O)C(O)C2O)=CC=C1,XWZCZWKUGIQPJD-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 1-9",0.46,
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M3,NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,KTQJEBWLYWKXRA-NSHDSACASA-N,,0.76,
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M5,CC(C)(O)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,OPMJHASCCIGLJS-GOEBONIOSA-N,,0.95,
Bortezomib metabolite M2,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-RDJZCZTQSA-N,Bortezomib metabolite M8,CC(C)CC(O)NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,BLVVPFHWFHYTBM-PYNWJHIZSA-N,Cytochrome P450 3A4,0.83,
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M25,CC(C)C(O)C(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,IVVZGLULYNUZDU-BZELLKQSSA-N,,0.91,
O-Desmethyltramadol,CN(C)CC1CCCCC1(O)C1=CC(O)=CC=C1,UWJUQVWARXYRCG-UHFFFAOYSA-N,O-Desmethyl-tramado glucuronide,CN(C)CC1CCCCC1(O)C1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1,DSBGQRZOJXSECT-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-8",0.56,
O-Desmethyltramadol,CN(C)CC1CCCCC1(O)C1=CC(O)=CC=C1,UWJUQVWARXYRCG-UHFFFAOYSA-N,"N,O-didesmethyltramadol",CNCC1CCCCC1(O)C1=CC(O)=CC=C1,CJXNQQLTDXASSR-OCCSQVGLSA-N,Cytochrome P450 2D6,0.97,
N-Desmethyltramadol,CNCC1CCCCC1(O)C1=CC(OC)=CC=C1,VUMQHLSPUAFKKK-UHFFFAOYSA-N,"N,O-didesmethyltramadol",CNCC1CCCCC1(O)C1=CC(O)=CC=C1,CJXNQQLTDXASSR-OCCSQVGLSA-N,Cytochrome P450 2D6,0.93,
N-Desmethyltramadol,CNCC1CCCCC1(O)C1=CC(OC)=CC=C1,VUMQHLSPUAFKKK-UHFFFAOYSA-N,"N,N-didesmethyltramadol",COC1=CC=CC(C2(C)CCCCC2CN)=C1,ZEXALIOABWHLJM-UKRRQHHQSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6",0.6,
"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,"1,7-Dimethyluric acid",CN1C(=O)NC2=C(C1=O)N(C)C(=O)N2,NOFNCLGCUJJPKU-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2A6",0.95,
"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,5-Acetylamino-6-formylamino-3-methyluracil,CC(=O)NC1=C(NC=O)NC(=O)N(C)C1=O,RDZNZFGKEVDNPK-UHFFFAOYSA-N,Arylamine N-acetyltransferase 2,0.34,
"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,1-Methylxanthine,CN1C(=O)NC2=C(NC=N2)C1=O,MVOYJPOZRLFTCP-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.88,
1-Methylxanthine,CN1C(=O)NC2=C(NC=N2)C1=O,MVOYJPOZRLFTCP-UHFFFAOYSA-N,1-Methyluric acid,CN1C(=O)NC2=C(NC(=O)N2)C1=O,QFDRTQONISXGJA-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.94,
2-Oxoticlopidine,O=C1C=C2CN(CC3=CC=CC=C3Cl)CCC2S1,DJZQIXWGIZIETJ-UHFFFAOYSA-N,Active metabolite of Ticlopidine,O=C(O)CC1CN(CC2=CC=CC=C2Cl)CCC1S,LDXFVLBQZWBGBA-UHFFFAOYSA-N,,0.44,
Ticlopidine S-oxide,O=S1C=CC2=C1CCN(CC1=CC=CC=C1Cl)C2,SSVDYGNPKZJQKO-UHFFFAOYSA-N,Ticlopidine S-oxide dimer,O=S1C2=C(CN(CC3=C(Cl)C=CC=C3)CC2)C2C1C1C3=C(CCN(CC4=C(Cl)C=CC=C4)C3)C2S1=O,YIQPCHDIFABADG-UHFFFAOYSA-N,,0.42,
Thienodihydropyridinium,ClC1=CC=CC=C1CN1C=C2C=C[S+]=C2CC1,RLTCLQFOWWSHJX-UHFFFAOYSA-N,Thienopyridinium,ClC1=CC=CC=C1C[N+]1=CC2=C(C=C1)SC=C2,OQXLLGWEACZMFD-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Myeloperoxidase",0.24,
Thienodihydropyridinium,ClC1=CC=CC=C1CN1C=C2C=C[S+]=C2CC1,RLTCLQFOWWSHJX-UHFFFAOYSA-N,Ticlopidine lactam analog (M8),O=C1C2=C(CCN1CC1=CC=CC=C1Cl)SC=C2,KQQBLQBNIVSMLU-UHFFFAOYSA-N,Cytochrome P450 3A4,0.32,
Cyclohexyl hydroxymethyl glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(CO)CC3)C=C2)C1=O,YUNQMQLWOOVHKI-UHFFFAOYSA-N,Cyclohexyl carboxyl glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C(=O)O)CC3)C=C2)C1=O,MMZLACCSCMGVHL-UHFFFAOYSA-N,Alcohol dehydrogenase [NADP(+)],0.97,
2-Hydroxynevirapine,CC1=CC(O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,LFZSOJABLBVGRJ-UHFFFAOYSA-N,2-hydroxynevirapine glucuronide,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,RNMZKTLILDCQOC-KUSYAZKWSA-N,,0.82,
8-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC(O)=C3)N(C3CC3)C2=NC=C1,DZPVEPLRIKDBFC-UHFFFAOYSA-N,8-hydroxynevirapine glucuronide,CC1=CC=NC2=C1NC(=O)C1=C(N=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C1)N2C1CC1,IVZWGLRSSHUFTI-WCYOCWRHSA-N,,0.66,
3-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,DANIONWINZEYME-UHFFFAOYSA-N,3-hydroxynevirapine glucuronide,CC1=C2N=C(OC3OC(C(=O)O)C(O)C(O)C3O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,GDAAYOYNGMRKSI-IQSUWLOCSA-N,,0.81,
dapsone hydroxylamine,NC1=CC=C(S(=O)(=O)C2=CC=C(NO)C=C2)C=C1,IYDSJDWESCGRKW-UHFFFAOYSA-N,Nitroso-dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N=O)C=C2)C=C1,UAQFAHXMXOCEAD-UHFFFAOYSA-N,,0.78,
3-hydroxylidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC(O)=C1C,PMGUCIDDSCRAMY-UHFFFAOYSA-N,3-Hydroxymonoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC(O)=C1C,YITCMQBVWIHTTA-UHFFFAOYSA-N,,0.95,
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,3-Hydroxymonoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC(O)=C1C,YITCMQBVWIHTTA-UHFFFAOYSA-N,,0.7,
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,,0.37,
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,,0.88,
"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,2-Amino-3-methylbenzoate,CC1=C(N)C(C(=O)O)=CC=C1,WNAJXPYVTFYEST-UHFFFAOYSA-N,,0.43,
"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,"4-Hydroxy-2,6-dimethylaniline",CC1=CC(O)=CC(C)=C1N,GCWYXRHXGLFVFE-UHFFFAOYSA-N,,0.61,
N-Desmethylvenlafaxine,CNCC(C1=CC=C(OC)C=C1)C1(O)CCCCC1,MKAFOJAJJMUXLW-UHFFFAOYSA-N,"N,O-Didesmethylvenlafaxine",CNCC(C1=CC=C(O)C=C1)C1(O)CCCCC1,MMSWXJSQCAEDLK-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19",0.96,
"N,O-Didesmethylvenlafaxine",CNCC(C1=CC=C(O)C=C1)C1(O)CCCCC1,MMSWXJSQCAEDLK-UHFFFAOYSA-N,"N,O-didesmethylvenlafaxine glucuronide",CNCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,UDNAJOOLWIWCAW-SQBZNDFJSA-N,,0.52,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.74,
Tenofovir Monophosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)O,BQDRSOMUPPCKPB-ZCFIWIBFSA-N,Tenofovir Diphosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,IACQCQDWSIQSRP-ZCFIWIBFSA-N,"Nucleoside diphosphokinase, Creatine Kinases",0.92,
3alpha-Hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,ZMLDTNLDYRJTAZ-JASYKLOUSA-N,Etonogestrel,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3C(=C)CC21CC,GCKFUYQCUCGESZ-BPIQYHPVSA-N,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,0.8,
4-ene-Valproic acid,C=CCC(CCC)C(=O)O,UMYDNZXEHYSVFY-UHFFFAOYSA-N,"2,4-Diene-VPA",C=CC=C(CCC)C(=O)O,UUILWXIBBZVJDU-FNORWQNLSA-N,,0.25,
4-Hydroxyvalproic acid,CCCC(CC(C)O)C(=O)O,OASKNPCLIHUTTL-UHFFFAOYSA-N,2-n-Propyl-4-oxopentanoic acid,CCCC(CC(C)=O)C(=O)O,HJRMYVTYHORJKC-UHFFFAOYSA-N,,0.54,
5-Hydroxyvalproic acid,CCCC(CCCO)C(=O)O,ZIWBCJXKYKOLJK-UHFFFAOYSA-N,2-Propylglutaric acid,CCCC(CCC(=O)O)C(=O)O,IFNXFIJXYVEYLF-UHFFFAOYSA-N,,0.85,
3-Hydroxyvalproic acid,CCCC(C(=O)O)C(O)CC,LLPFTSMZBSRZDV-UHFFFAOYSA-N,3-Oxovalproic acid,CCCC(C(=O)O)C(=O)CC,PPYHXKUZTSZTQU-UHFFFAOYSA-N,,0.45,
2-ene-Valproic acid,CCC=C(CCC)C(=O)O,ZKNJEOBYOLUGKJ-FNORWQNLSA-N,3-Hydroxyvalproic acid,CCCC(C(=O)O)C(O)CC,LLPFTSMZBSRZDV-UHFFFAOYSA-N,,0.19,
E-10-Hydroxyamitriptyline,CN(C)CCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,GHWBJXOKAFHZAI-SFQUDFHCSA-N,E-10-Hydroxynortriptyline,CNCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,VAGXZGJKNUNLHK-LFIBNONCSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 3A4",0.99,
E-10-Hydroxynortriptyline,CNCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,VAGXZGJKNUNLHK-LFIBNONCSA-N,E-10-Hydroxydesmethylnortriptyline,NCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,PIEVJGJKDMQGSG-XNTDXEJSSA-N,,0.99,
Desmethylnortriptyline,NCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PTQFRALDEONNOA-UHFFFAOYSA-N,E-10-Hydroxydesmethylnortriptyline,NCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,PIEVJGJKDMQGSG-XNTDXEJSSA-N,Cytochrome P450 2D6,0.72,
Deacyl indomethacin,COC1=CC2=C(C=C1)NC(C)=C2CC(=O)O,TXWGINUZLBAKDF-UHFFFAOYSA-N,O-Desmethyl-N-deschlorobenzoyl indomethacin,CC1=C(CC(=O)O)C2=C(C=CC(O)=C2)N1,FDADMESSMPJUJC-UHFFFAOYSA-N,,0.94,
"2-Ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium (EDDP)",CC=C1N(C)C(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,AJRJPORIQGYFMT-RMOCHZDMSA-N,"2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP)",CCC1=NC(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,UPZKJIHNKKJIKX-UHFFFAOYSA-N,Cytochrome P450 3A7,0.4,
Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Methyl-thioguanosine monophosphate,CSC1N=C(N)NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,VLFVFMNOAJKLEN-AFPKLJJXSA-N,Thiopurine S-methyltransferase,0.61,
Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,,0.96,
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,,0.55,
ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,,0.6,
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,,0.56,
para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,,0.59,
ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,ortho-O-Glucuronide rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=NC=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,YDRMOALONMVDNG-TUCRDTSBSA-N,,0.52,
ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,ortho-O-Sulfate rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=C(OS(=O)(=O)O)C=CC=N1,ZVSPRKOUHTZIGH-UHFFFAOYSA-N,,0.6,
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl glucuronide rosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=NC=CC=C3OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)S1,NLGMKXBTZZJJFK-UHFFFAOYSA-N,,0.54,
para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,para-O-Glucuronide rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=N1,QGESYIGEZXWVIN-AZNQAGSMSA-N,,0.52,
para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,para-O-Sulfate rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=C(OS(=O)(=O)O)C=N1,WAGUBJKZLRLKGR-UHFFFAOYSA-N,,0.61,
Methoxyzolpidem derivative (M4),CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(CO)C=CC3=N2)C=C1,OIIJRMHQIDOMPL-UHFFFAOYSA-N,Zolpidem carboxylic acid derivative (M2),CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C(=O)O)C=CC3=N2)C=C1,RFUGIBAONXDHRM-UHFFFAOYSA-N,,0.95,
Gemcitabine Monophosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)O)C(O)C2(F)F)C=C1,KNTREFQOVSMROS-QPPQHZFASA-N,"2′,2′-difluorodeoxyuridine monophosphate",O=C1C=CN(C2OC(COP(=O)(O)O)C(O)C2(F)F)C(=O)N1,APSMIPKDENVCML-WETFRILZSA-N,Deoxycytidylate deaminase,0.89,
Gemcitabine Monophosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)O)C(O)C2(F)F)C=C1,KNTREFQOVSMROS-QPPQHZFASA-N,Gemcitabine diphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,FRQISCZGNNXEMD-QPPQHZFASA-N,UMP-CMP kinase,0.95,
Teniposide catechol derivative,COC1=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C6=CC=CS6)OC5C(O)C3O)C3COC(=O)C23)OCO4)=CC(O)=C1O,HFNGFXBXLSRAKX-LRXLMJOTSA-N,Teniposide o-quinone derivative,COC1=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C6=CC=CS6)OC5C(O)C3O)C3COC(=O)C23)OCO4)=CC(=O)C1=O,SUZOUIWTKWTHGX-LRXLMJOTSA-N,Myeloperoxidase,0.79,
8-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(C)=CC21,INKUWBOHCFHXTJ-UHFFFAOYSA-N,"8,11-Dihydroxy-delta-9-THC",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(CO)=CC21,XTDYIISRNODHHT-UHFFFAOYSA-N,,0.98,
11-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,YCBKSSAWEUDACY-UHFFFAOYSA-N,"8,11-Dihydroxy-delta-9-THC",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(CO)=CC21,XTDYIISRNODHHT-UHFFFAOYSA-N,,0.92,
11-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,YCBKSSAWEUDACY-UHFFFAOYSA-N,11-Nor-9-carboxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C(=O)O)=CC21,YOVRGSHRZRJTLZ-UHFFFAOYSA-N,Cytochrome P450 2C9,0.94,
Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,Norfluoxetine alcohol,OCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WMLVVHKCLDWGLW-UHFFFAOYSA-N,,0.86,
4-Trifluoromethylphenol,OC1=CC=C(C(F)(F)F)C=C1,BAYGVMXZJBFEMB-UHFFFAOYSA-N,Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4",0.15,
Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,4-Trifluoromethylphenol,OC1=CC=C(C(F)(F)F)C=C1,BAYGVMXZJBFEMB-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4",0.34,
Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,Norfluoxetine glucuronide,O=C(O)C1OC(ONCCC(OC2=CC=C(C(F)(F)F)C=C2)C2=CC=CC=C2)C(O)C(O)C1O,LUIHTMWIRNJSNW-FRYOACGXSA-N,UDP-glucuronosyltransferases (UGTs),0.46,
Hydroxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1,ICRSYPPLGADZKA-UHFFFAOYSA-N,Carboxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O)C=C2)C=C1,WTHNOVFEXONZMI-UHFFFAOYSA-N,"Alcohol dehydrogenase 1A, Alcohol dehydrogenase 1B",0.96,
noroxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5)C=C1,RIKMCJUNPCRFMW-ISWURRPUSA-N,alpha-noroxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5)C=C1,KFWOOLJUSYSBAD-NZQXGWJPSA-N,,0.92,
Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,Haloperidol reduced pyridinium ion derivative,OC(CCC[N+]1=CC=C(C2=CC=C(Cl)C=C2)C=C1)C1=CC=C(F)C=C1,CESYFZMRVQIRNB-UHFFFAOYSA-N,,0.39,
"Haloperidol 1,2,3,6-tetrahydropyridine",O=C(CCCN1CC=C(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,ZNOLNAPJKOYTHY-UHFFFAOYSA-N,Haloperidol pyridinium ion derivative,O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)C1=CC=C(F)C=C1,KAPIKUHBALFONG-UHFFFAOYSA-N,,0.45,
(+)-3-Methoxymorphinan,COC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,ILNSWVUXAPSPEH-PVAVHDDUSA-N,3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,Cytochrome P450 2D6,0.96,
3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,3-Hydroxymorphinan O-glucuronide,O=C(O)C1OC(OC2=CC3=C(C=C2)CC2NCCC34CCCCC24)C(O)C(O)C1O,QYVMECDBFFRIEZ-DESFNQSRSA-N,"UDP-glucuronosyltransferases (UGTs), UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 2B17",0.65,
3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,3-Hydroxymorphinan sulfate,O=S(=O)(O)OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,KYOWUZONPGRBFN-KBMXLJTQSA-N,,0.87,
4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,4-Ketocyclophosphamide,O=C1CCOP(=O)(N(CCCl)CCCl)N1,VBMZHOCORXMDJU-UHFFFAOYSA-N,Cytochrome P450 3A7,0.62,
4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,,0.52,
5-Hydroxyrofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2O)C=C1,NCBVUSNBLYMFPP-UHFFFAOYSA-N,5-Hydroxyrofecoxib O-glucuronide,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,LHTQNDXIYIUWMV-JSXGDUDQSA-N,UDP-glucuronosyltransferases (UGTs),0.64,
Zafirlukast metabolite M5,COC1=C(CC2=CN(CO)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HZAQOSFFIGVMDH-UHFFFAOYSA-N,Zafirlukast metabolite M8,COC1=C(CC2=CNC3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,FJVVJMGKCIJNGX-UHFFFAOYSA-N,,0.91,
Bosentan metabolite Ro 48-5033,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)CO)C=C1,FAJQMBCLPZWTQJ-UHFFFAOYSA-N,Bosentan metabolite Ro 64-1056,CC(C)(CO)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,JXXCMZWROOURSZ-UHFFFAOYSA-N,,0.99,
Bosentan metabolite Ro 47-8634,CC(C)(C)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,STTLKJGYAWXIPP-UHFFFAOYSA-N,Bosentan metabolite Ro 64-1056,CC(C)(CO)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,JXXCMZWROOURSZ-UHFFFAOYSA-N,,0.98,
3-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=C(O)C=C21,QQCFBZCATDIWTH-UHFFFAOYSA-N,"2,3-Dihydroxycarbamazepine",NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O)C=C21,YITIUNLDWDJVSI-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 3A5",0.89,
"Carbamazepine 2,3-epoxide",NC(=O)N1C2=CC3OC3C=C2C=CC2=CC=CC=C21,AUCXBTOAZTYKIN-UHFFFAOYSA-N,2-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=CC=C21,VPZIYMMSJFWLSP-UHFFFAOYSA-N,,0.33,
"10,11-Epoxycarbamazepine",NC(=O)N1C2=CC=CC=C2C2OC2C2=CC=CC=C21,ZRWWEEVEIOGMMT-UHFFFAOYSA-N,"10,11-Dihydroxycarbamazepine",N=C(O)N1C2=CC=CC=C2C(O)C(O)C2=CC=CC=C21,PRGQOPPDPVELEG-KBPBESRZSA-N,Epoxide hydrolase 1,0.66,
Valdecoxib metabolite M2,CC1=C(C2=CC=C(S(=O)(=O)NO)C=C2)C(C2=CC=CC=C2)=NO1,ONTHNDYCEKOFIC-UHFFFAOYSA-N,Valdecoxib metabolite M7,CC1=C(C2=CC=C(S(=O)O)C=C2)C(C2=CC=CC=C2)=NO1,MCGQPKHGAPQIDC-UHFFFAOYSA-N,,0.84,
Valdecoxib metabolite M2,CC1=C(C2=CC=C(S(=O)(=O)NO)C=C2)C(C2=CC=CC=C2)=NO1,ONTHNDYCEKOFIC-UHFFFAOYSA-N,Valdecoxib metabolite M5,O=S(=O)(NO)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,QUJNXRZCTHMBKO-UHFFFAOYSA-N,,0.92,
Valdecoxib metabolite M1,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,UJSFKTUZOASIPA-UHFFFAOYSA-N,Valdecoxib metabolite M5,O=S(=O)(NO)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,QUJNXRZCTHMBKO-UHFFFAOYSA-N,,0.96,
Valdecoxib metabolite M1,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,UJSFKTUZOASIPA-UHFFFAOYSA-N,Valdecoxib metabolite M4,NS(=O)(=O)C1=CC=C(C2=C(C(=O)O)ON=C2C2=CC=CC=C2)C=C1,AEAVMNLZENBJSN-UHFFFAOYSA-N,,0.87,
Valdecoxib metabolite M1,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,UJSFKTUZOASIPA-UHFFFAOYSA-N,Valdecoxib metabolite M3,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC(O)=CC=C2)C=C1,PESVSSPYDIXETJ-UHFFFAOYSA-N,,0.92,
Valdecoxib metabolite M9,CC1=C(C2=CC=C(S(N)(=O)=O)C=C2)C(C2=CC(O)=CC=C2)=NO1,IAVWHASLRCBDDK-UHFFFAOYSA-N,Valdecoxib metabolite M3,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC(O)=CC=C2)C=C1,PESVSSPYDIXETJ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.92,
4-Hydroxyvoriconazole,OCC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,BGPPSFHHAYWTMX-LRDDRELGSA-N,4-Hydroxyvoriconazole 4-O-glucuronide,O=C(O)C1OC(OCC(C2=NC=NC=C2F)C(O)(CN2C=NC=N2)C2=C(F)C=C(F)C=C2)C(O)C(O)C1O,RTNOBOYTQNLUHP-ORKWUBDLSA-N,,0.84,
Voriconazole N-Oxide,CC(C1=C(F)C=[N+]([O-])C=N1)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,KPLFPLUCFPRUHU-MGPLVRAMSA-N,"UK-51,060",O=C(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,XCHRPVARHBCFMJ-UHFFFAOYSA-N,,0.32,
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,5-alpha-Dihydrotestosterone glucuronide,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,CLQMBSSRTBUNDV-CPKOJWPQSA-N,,0.33,
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,5a-Dihydrotestosterone sulfate,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,KYVPWJSGFKNNLD-ABEVXSGRSA-N,,0.62,
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,"5alpha-androstane-3alpha,17beta-diol",CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O,"InChI=1S/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13+,14-,15-,16-,17-,18-,19-/m0/s1",,0.77,
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.78,
Inosine,O=C1N=CNC2=C1N=CN2C1OC(CO)C(O)C1O,UGQMRVRMYYASKQ-KQYNXXCUSA-N,Hypoxanthine,O=C1N=CNC2=C1NC=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,Purine nucleoside phosphorylase,0.28,
Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,Uric acid,O=C1NC(=O)C2=C(N1)NC(=O)N2,LEHOTFFKMJEONL-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.92,
O-Desmethylverapamil (D-702),COC1=C(O)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,OAAPYTCHFIIVON-UHFFFAOYSA-N,Verapamil metabolite D-620,COC1=C(OC)C=C(C(C#N)(CCCN)C(C)C)C=C1,UCWOSFAANAZHKR-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.86,
Verapamil metabolite D-617,CNCCCC(C#N)(C1=CC(OC)=C(OC)C=C1)C(C)C,WLOBUUJURNEQCL-UHFFFAOYSA-N,Verapamil metabolite D-620,COC1=C(OC)C=C(C(C#N)(CCCN)C(C)C)C=C1,UCWOSFAANAZHKR-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.98,
Verapamil metabolite D-617,CNCCCC(C#N)(C1=CC(OC)=C(OC)C=C1)C(C)C,WLOBUUJURNEQCL-UHFFFAOYSA-N,Verapamil metabolite PR-25,CNCCCC(C#N)(C1=CC(OC)=C(O)C=C1)C(C)C,VNRFDZGJCSCHFU-UHFFFAOYSA-N,,0.98,
Norverapamil,COC1=C(OC)C=C(CCNCCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,UPKQNCPKPOLASS-UHFFFAOYSA-N,Verapamil metabolite D-715 (PR-22),COC1=C(O)C=C(C(C#N)(CCCNCCC2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,VAUMWVGUBVPENJ-UHFFFAOYSA-N,Cytochrome P450 2C8,0.99,
Norverapamil,COC1=C(OC)C=C(CCNCCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,UPKQNCPKPOLASS-UHFFFAOYSA-N,Verapamil metabolite D-620,COC1=C(OC)C=C(C(C#N)(CCCN)C(C)C)C=C1,UCWOSFAANAZHKR-UHFFFAOYSA-N,Cytochrome P450 2C8,0.9,
4-Hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,TXUZVZSFRXZGTL-OCEACIFDSA-N,Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,MHJBZVSGOZTKRH-IZHYLOQSSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.98,
4-Hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,TXUZVZSFRXZGTL-OCEACIFDSA-N,4-hydroxytamoxifen sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,CFSXIBDXCWVFJR-QPLCGJKRSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase",0.84,
Losartan carboxaldehyde,CCCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,FQZSMTSTFMNWQF-UHFFFAOYSA-N,Losartan carboxylic acid,CCCCC1=NC(Cl)=C(C(=O)O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,ZEUXAIYYDDCIRX-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.9,
Adefovir,NC1=C2N=CN(CCOCP(=O)(O)O)C2=NC=N1,SUPKOOSCJHTBAH-UHFFFAOYSA-N,Adefovir monophosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)O)C2=NC=N1,VQIHLCFUFNQXPS-UHFFFAOYSA-N,"Adenylate kinase isoenzyme 1, Adenylate kinase 2, mitochondrial",0.87,
Nateglinide metabolite M1,CC(C)(O)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IUMHIIXPABZGRF-YTPLPTRZSA-N,Nateglinide metabolite M11/M12,CC(O)(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IQRZZFUXRZWAPZ-XZZQLLPFSA-N,,0.96,
Nateglinide metabolite M7,C=C(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,QKNIFXOGUWQRIF-YJEKIOLLSA-N,Nateglinide metabolite M11/M12,CC(O)(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IQRZZFUXRZWAPZ-XZZQLLPFSA-N,,0.81,
Dehydroxyzyleuton,CC(NC(=N)O)C1=CC2=CC=CC=C2S1,CKVDCQYUEYONIA-UHFFFAOYSA-N,Dehydroxyzileuton sulfoxide,CC(NC(N)=O)C1=CC2=CC=CC=C2S1=O,KGUIRZVMBWMQQZ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.19,
4-Hydroxyretinoic acid,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,KGUMXGDKXYTTEY-FRCNGJHJSA-N,4-Oxoretinoic acid,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,GGCUJPCCTQNTJF-FRCNGJHJSA-N,"Cytochrome P450 3A7, Cytochrome P450 2C18, Cytochrome P450 4A11, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2A6, Cytochrome P450 26A1",0.61,
"5,6-Epoxyretinoic acid",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)O,KEEHJLBAOLGBJZ-WEDZBJJJSA-N,"rac-5,6-Epoxy-retinoyl-beta-D-glucuronide",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,,0.59,
2-Oxoclopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N1CCC2SC(=O)C=C2C1,JBSAZVIMJUOBNB-WUJWULDRSA-N,Active Metabolite of Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N1CCC(S)=C(CC(=O)O)C1,CXPJTQJWJQRBOF-HNNXBMFYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2C9, Cytochrome P450 2C19",0.72,
Etoposide catechol,COC1=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)=CC(O)=C1O,CYOJPLOJEPTJMM-FMEAWWTOSA-N,Etoposide ortho-quinone,COC1=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)=CC(=O)C1=O,SBLYXIKLMHGUJZ-FMEAWWTOSA-N,Myeloperoxidase,0.76,
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Cytochrome P450 1A2,0.61,
4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.82,
2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,Catechol O-methyltransferase,0.79,
O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,O-Desmethylnaproxen sulfate,CC(C(=O)O)C1=CC2=C(C=C1)C=C(OS(=O)(=O)O)C=C2,BNKMSCMOWGCUOF-UHFFFAOYSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase, Sulfotransferase family cytosolic 1B member 1",0.74,
O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,O-Desmethylnaproxen acyl glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC2=C(C=C1)C=C(O)C=C2,WKYUVCYFVJKWHF-FVNSOWSRSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-6, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-10, UDP-glucuronosyltransferase 2B7",0.35,
O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,O-Desmethylnaproxen O-glucuronide,CC(C(=O)O)C1=CC2=C(C=C1)C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,BFGOTVVWSNGSME-FVNSOWSRSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-10",0.34,
Indapamide metabolite M5,CC1=CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,LWCDXWWLUHMMJI-UHFFFAOYSA-N,Indapamide metabolite M4,CC1C(=O)C2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,WTWDWHYDLVHLPL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.48,
Indapamide metabolite M1,CC1CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ARPVNNMMMDXBBF-UHFFFAOYSA-N,Indapamide metabolite M3,CC1=CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,NYONMYACEVMMGW-UHFFFAOYSA-N,Cytochrome P450 3A4,0.5,
Indapamide epoxide intermediate,CC1CC2=C(C=CC3OC23)N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ZDRCVKKLZHUQLV-UHFFFAOYSA-N,Indapamide metabolite M6,CC1CC2=C(C=CC(O)C2O)N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,CZPZKXRBEJAROA-UHFFFAOYSA-N,Epoxide hydrolase 1,0.93,
Propofol glucuronide,CC(C)C1=CC=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,JZSJIASBMOIIKI-RUKPJNHUSA-N,1-Quinol glucuronide,CC(C)C1=CC(O)=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,OCSNDZGMSQTRGL-RUKPJNHUSA-N,,0.96,
4-Hydroxypropofol,CC(C)C1=CC(O)=CC(C(C)C)=C1O,UFWIJKBKROBWTG-UHFFFAOYSA-N,1-Quinol glucuronide,CC(C)C1=CC(O)=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,OCSNDZGMSQTRGL-RUKPJNHUSA-N,"UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 1-9",0.29,
4-Hydroxypropofol,CC(C)C1=CC(O)=CC(C(C)C)=C1O,UFWIJKBKROBWTG-UHFFFAOYSA-N,4-Quinol sulfate,CC(C)C1=CC(OS(=O)(=O)O)=CC(C(C)C)=C1O,RKAQPQOYAJQIAA-UHFFFAOYSA-N,,0.65,
Hydroxyterbinafine,CN(CC=CC#CC(C)(C)CO)CC1=CC=CC2=CC=CC=C12,GPEJUKJZTGFNKY-XBXARRHUSA-N,Carboxyterbinafine,CN(CC=CC#CC(C)(C)C(=O)O)CC1=CC=CC2=CC=CC=C12,DSPCPJFHUUUMEV-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19",0.89,
Hydroxyterbinafine,CN(CC=CC#CC(C)(C)CO)CC1=CC=CC2=CC=CC=C12,GPEJUKJZTGFNKY-XBXARRHUSA-N,N-Desmethylhydroxyterbinafine,CC(C)(C#CC=CCNCC1=CC=CC2=CC=CC=C12)CO,CKGLMMKXUSSSAA-XVNBXDOJSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2C8, Cytochrome P450 2C19",0.89,
N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,N-Desmethylhydroxyterbinafine,CC(C)(C#CC=CCNCC1=CC=CC2=CC=CC=C12)CO,CKGLMMKXUSSSAA-XVNBXDOJSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19",0.92,
1-Naphthaldehyde,O=CC1=CC=CC2=CC=CC=C12,SQAINHDHICKHLX-UHFFFAOYSA-N,1-Naphthoic acid,O=C(O)C1=C2C=CC=CC2=CC=C1,LNETULKMXZVUST-UHFFFAOYSA-N,,0.7,
1-Naphthaldehyde,O=CC1=CC=CC2=CC=CC=C12,SQAINHDHICKHLX-UHFFFAOYSA-N,1-Naphthalenemethanol,OCC1=CC=CC2=CC=CC=C12,PBLNHHSDYFYZNC-UHFFFAOYSA-N,,0.58,
N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,N-Desmethylterbinafine dihydrodiol derivative (1),CC(C)(C)C#CC=CCNCC1=CC(O)=C(O)C2=CC=CC=C12,PQMBQNSIJJFKTL-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C9",0.63,
N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,N-Desmethylterbinafine dihydrodiol derivative (2),CC(C)(C)C#CC=CCNCC1=CC=CC2=C(O)C(O)=CC=C12,QNITXIUZLIXMAL-GQCTYLIASA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C9",0.68,
Terbinafine dihydrodiol derivative (1),CN(CC=CC#CC(C)(C)C)CC1=CC(O)=C(O)C2=CC=CC=C12,BSCJZDRHKPMNFX-WEVVVXLNSA-N,N-Desmethylterbinafine dihydrodiol derivative (1),CC(C)(C)C#CC=CCNCC1=CC(O)=C(O)C2=CC=CC=C12,PQMBQNSIJJFKTL-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.92,
Terbinafine dihydrodiol derivative (2),CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=C(O)C(O)=CC=C12,OZUIZHMLRLTKOH-FNORWQNLSA-N,N-Desmethylterbinafine dihydrodiol derivative (2),CC(C)(C)C#CC=CCNCC1=CC=CC2=C(O)C(O)=CC=C12,QNITXIUZLIXMAL-GQCTYLIASA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.92,
Hydroxybuprenorphine,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1CC4=CC=C(O)C5=C4C3(CCN1CC1CC1)C2O5,CWQOOBMAWVNZSC-RZIPZOSSSA-N,Hydroxynorbuprenorphine,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1CC4=CC=C(O)C5=C4C3(CCN1)C2O5,LHQZGKOEAFHWBM-GAZCGFTGSA-N,,0.98,
"2-Phenyl-1,3-propanediol monocarbamate",N=C(O)OCC(CO)C1=CC=CC=C1,JQVQIZWJBLGVRW-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,Alcohol dehydrogenase 1A,0.71,
3-O-methyl-alpha-methyldopa,COC1=C(O)C=CC(CC(N)C(=O)O)=C1,PFDUUKDQEHURQC-ZETCQYMHSA-N,3-O-methyl-alpha-methyldopa sulfate,COC1=CC=C(CC(C)(N)C(=O)O)C=C1OS(=O)(=O)O,NKCGFFAMYYALPZ-NSHDSACASA-N,Sulfotransferase,0.56,
N-Desmethyldiphenhydramine,CNCCOC(C1=CC=CC=C1)C1=CC=CC=C1,AGSLYHYWLYGAOU-UHFFFAOYSA-N,"N,N-Didesmethyldiphenhydramine",NCCOC(C1=CC=CC=C1)C1=CC=CC=C1,NFJFUDGBWGXTHS-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2C19",0.94,
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Hypoxanthine-guanine phosphoribosyltransferase,0.19,
Doxorubicine hydroxyaglycone,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3O)C(O)=C1C2=O,IBZGBXXTIGCACK-CWKPULSASA-N,Doxirubicinol hydroxyaglycone,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(O)CO)CC3O)C(O)=C1C2=O,CGVVIRBOJFDFBH-PTIJRGHASA-N,"Carbonyl reductase [NADPH] 1, Carbonyl reductase [NADPH] 3, Aldo-keto reductase family 1 member C3, Alcohol dehydrogenase [NADP(+)]",0.9,
Doxorubicinol,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(O)CO)CC(OC3CC(N)C(O)C(C)O3)C2=C1O,NKZRZOVSJNSBFR-FEMMEMONSA-N,Doxorubicinol deoxaglycone,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(O)CO)CC3)C(O)=C1C2=O,IGJIPNOEJDYNRR-QUXALOBESA-N,"NADPH--cytochrome P450 reductase, Xanthine dehydrogenase/oxidase, NAD(P)H dehydrogenase [quinone] 1",0.73,
Doxorubicinol,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(O)CO)CC(OC3CC(N)C(O)C(C)O3)C2=C1O,NKZRZOVSJNSBFR-FEMMEMONSA-N,Doxorubicine hydroxyaglycone,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3O)C(O)=C1C2=O,IBZGBXXTIGCACK-CWKPULSASA-N,,0.78,
5-Hydroxysulfamethoxazole,NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,CECJOLRUXWTJHV-UHFFFAOYSA-N,N4-Acetyl-5-OH-sulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,YKWZTWOYFWCVKH-UHFFFAOYSA-N,"Arylamine N-acetyltransferase 1, Arylamine N-acetyltransferase 2",0.89,
N-acetylsulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(C)=C2)C=C1,GXPIUNZCALHVBA-UHFFFAOYSA-N,N4-Acetyl-5-OH-sulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,YKWZTWOYFWCVKH-UHFFFAOYSA-N,,0.92,
Sulfamethoxazole N4-hydroxylamine,CC1=CC(NS(=O)(=O)C2=CC=C(NO)C=C2)=NO1,MJAMPGKHIZXVFJ-UHFFFAOYSA-N,Nitroso-sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N=O)C=C2)=NO1,GHNQGDUYHCZZPT-UHFFFAOYSA-N,,0.92,
Irbesartan derivative M4,CC(O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YASLDPAAWWZGIP-UHFFFAOYSA-N,Irbesartan derivative M1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,LIDZWACDVHJFLD-UHFFFAOYSA-N,Cytochrome P450 2C9,0.94,
Irbesartan derivative M7,CCCCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,SGLAKMDXJPVHBY-UHFFFAOYSA-N,Irbesartan derivative M1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,LIDZWACDVHJFLD-UHFFFAOYSA-N,Cytochrome P450 2C9,0.99,
Irbesartan derivative M4,CC(O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YASLDPAAWWZGIP-UHFFFAOYSA-N,Irbesartan derivative M6,CC(=O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,MIGTZGLTQNODIS-UHFFFAOYSA-N,,0.97,
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Thioxanthine monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,GMP synthase [glutamine-hydrolyzing],0.93,
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Methyl-thioinosine 5'-monophospate,CSC1=NC=NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,BMYFUCYXRGTQQL-IOSLPCCCSA-N,Thiopurine S-methyltransferase,0.96,
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,6-Mercaptopurine riboside,OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,NKGPJODWTZCHGF-KQYNXXCUSA-N,,0.93,
N-Dealkylated tolterodine,CC1=CC(C(CCNC(C)C)C2=CC=CC=C2)=C(O)C=C1,CPLYUIYTJCFQJD-KRWDZBQOSA-N,N-Dealkylated 5-hydroxymethyl tolterodine,CC(C)NCCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1,CCZYBOXFQXWQIF-QGZVFWFLSA-N,,0.91,
5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1)C(C)C,DUXZAXCGJSBGDW-FQEVSTJZSA-N,N-Dealkylated 5-hydroxymethyl tolterodine,CC(C)NCCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1,CCZYBOXFQXWQIF-QGZVFWFLSA-N,,0.95,
5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1)C(C)C,DUXZAXCGJSBGDW-FQEVSTJZSA-N,5-Carboxylic acid tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(C(=O)O)=C1)C(C)C,NKTNTJFTBRPQIZ-LJQANCHMSA-N,,0.9,
Thalidomide arene oxide,O=C1N=C(O)CCC1N1C(=O)C2=CC3OC3C=C2C1=O,MNALUCRLHVMELD-UHFFFAOYSA-N,5-Hydroxythalidomide,O=C1CCC(N2C(=O)C3=C(C=C(O)C=C3)C2=O)C(=O)N1,LJBQRRQTZUJWRC-UHFFFAOYSA-N,,0.35,
5-Hydroxythalidomide,O=C1CCC(N2C(=O)C3=C(C=C(O)C=C3)C2=O)C(=O)N1,LJBQRRQTZUJWRC-UHFFFAOYSA-N,"5,6-dihydroxythalidomide",O=C1CCC(N2C(=O)C3=CC(O)=C(O)C=C3C2=O)C(=O)N1,JBCNYDFXFUMCRO-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 1A1",0.98,
3-Hydroxyibuprofen,CC(CO)CC1=CC=C(C(C)C(=O)O)C=C1,HFAIHLSDLUYLQA-UHFFFAOYSA-N,Carboxy-ibuprofen,CC(CC1=CC=C(C(C)C(=O)O)C=C1)C(=O)O,DIVLBIVDYADZPL-UHFFFAOYSA-N,Cytochrome P450 2C9,0.9,
6-Hydroxymelatonin,COC1=C(O)C=C2NC=C(CCN=C(C)O)C2=C1,OMYMRCXOJJZYKE-UHFFFAOYSA-N,6-Hydroxymelatonin sulfate,COC1=C(OS(=O)(=O)O)C=C2NC=C(CCN=C(C)O)C2=C1,QQEILXDLZRLTME-UHFFFAOYSA-N,,0.81,
N-Acetyl-5-hydroxytryptamine,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,MVAWJSIDNICKHF-UHFFFAOYSA-N,N-Acetyl-5-hydroxytryptamine sulfate,CC(=O)NCCC1=CNC2=C1C=C(OS(=O)(=O)O)C=C2,UCAJZNVFRVLULS-UHFFFAOYSA-N,,0.83,
N-Acetyl-5-hydroxytryptamine,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,MVAWJSIDNICKHF-UHFFFAOYSA-N,N-Acetyl-5-hydroxytryptamine glucuronide,CC(=O)NCCC1=CNC2=C1C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,DRKQFNYKSNWOTC-PDHYLSHYSA-N,UDP-glucuronosyltransferases (UGTs),0.5,
6-Hydroxymelatonin,COC1=C(O)C=C2NC=C(CCN=C(C)O)C2=C1,OMYMRCXOJJZYKE-UHFFFAOYSA-N,6-Hydroxymelatonin glucuronide,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)NC=C2CCNC(C)=O,BIRHYNBRXCOXLU-OOHXRKOZSA-N,UDP-glucuronosyltransferases (UGTs),0.53,
5-Methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCN,JTEJPPKMYBDEMY-UHFFFAOYSA-N,Pinoline,COC1=CC2=C(C=C1)NC1=C2CCNC1,QYMDEOQLJUUNOF-UHFFFAOYSA-N,,0.67,
5-Methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCN,JTEJPPKMYBDEMY-UHFFFAOYSA-N,Bufotenine,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,,0.86,
Methylhydroxygliclazide,O=S(=O)(NC(O)=NN1CC2CCCC2C1)C1=CC=C(CO)C=C1,IHCHVBQHVIUSTM-BETUJISGSA-N,Carboxygliclazide,O=C(NN1CC2CCCC2C1)NS(=O)(=O)C1=CC=C(C(=O)O)C=C1,DSNDPTBTZSQWJS-TXEJJXNPSA-N,,0.56,
Pioglitazone metabolite M-II,CCC1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,RMTFRGFLVHAYCI-UHFFFAOYSA-N,Mitoglitazone,CCC1=CN=C(C(=O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,IRNJSRAGRIZIHD-UHFFFAOYSA-N,,0.8,
Pioglitazone metabolite M-II,CCC1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,RMTFRGFLVHAYCI-UHFFFAOYSA-N,Pioglitazone metabolite M-XI,CC(O)C1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,YYDPBNAZWVLEQF-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.97,
Pioglitazone metabolite M-V,O=C(O)CC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OIQJTMMAMWFMQR-UHFFFAOYSA-N,Pioglitazone metabolite M-VI,O=C1NC(=O)C(CC2=CC=C(OCCC3=NC=C(C(=O)O)C=C3)C=C2)S1,SLOBZACXYXBLIT-UHFFFAOYSA-N,,0.83,
Pioglitazone metabolite M-IV,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Pioglitazone metabolite M-III,CC(=O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,JMLKLMFMQRAJNI-UHFFFAOYSA-N,,0.87,
Pioglitazone metabolite M-IV,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Pioglitazone metabolite M-XI,CC(O)C1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,YYDPBNAZWVLEQF-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.92,
N-desmethyldoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HVKCEFHNSNZIHO-YBEGLDIGSA-N,Didesmethyl doxepin,NCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HLUSHBJOSPBFOC-OQLLNIDSSA-N,,0.99,
Doxepin N-oxide,C[N+](C)([O-])CCC=C1C2=C(C=CC=C2)COC2=C1C=CC=C2,QJCSDPQQGVJGQY-GZTJUZNOSA-N,Doxepin N-oxide glucuronide,C[N+](C)(CCC=C1C2=C(C=CC=C2)COC2=C1C=CC=C2)OC1OC(C(=O)O)C(O)C(O)C1O,NLZMYODDTAMNJM-GOSZAKIASA-O,,0.65,
(E)-2-hydroxydoxepin,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(O)C=C12,GRQPGTWGEQWMMM-IUXPMGMMSA-N,Hydroxydoxepin glucuronide,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,RECOUBTVNVWWDB-IUXPMGMMSA-N,,0.64,
N-desmethyldoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HVKCEFHNSNZIHO-YBEGLDIGSA-N,Hydroxydesmethyl doxepin,CNCCC=C1C2=C(C=CC=C2)COC2=C1C=C(O)C=C2,LUWRONBNZDYVBL-APSNUPSMSA-N,Cytochrome P450 2D6,0.93,
(E)-2-hydroxydoxepin,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(O)C=C12,GRQPGTWGEQWMMM-IUXPMGMMSA-N,(E)-2-hydroxy-N-desmethyldoxepin,CNCCC=C1C2=C(C=CC=C2)COC2=C1C=C(O)C=C2,LUWRONBNZDYVBL-FRKPEAEDSA-N,,0.99,
2-hydroxydesipramine,CNCCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,NVJBOLMRGMDGLD-UHFFFAOYSA-N,2-hydroxy-desipramine glucuronide,CNCCCN1C2=CC=CC=C2CCC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C21,XJHAOJJEVSPMBA-QMDPOKHVSA-N,,0.56,
p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,Phenobarbital O-sulfate,CCC1(C2=CC=C(OS(=O)(=O)O)C=C2)C(=O)NC(=O)NC1=O,SBVMQBDFNZJWGL-UHFFFAOYSA-N,,0.88,
p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,Phenobarbital O-glucuronide,CCC1(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(=O)NC(=O)NC1=O,RQTUXVFRLKPUJG-ZAOAHOKWSA-N,,0.59,
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,4-Ketoifosfamide,O=C1CCOP(=O)(NCCCl)N1CCCl,PEZLCTIXHCOEOG-UHFFFAOYSA-N,,0.56,
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,,0.32,
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,4-Thioifosfamide,NC(CCC(=O)NC(CSC1CCOP(=O)(NCCCl)N1CCCl)C(=O)NCC(=O)O)C(=O)O,UINSPYHKZALITP-XNZWOTSQSA-N,,0.42,
Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,4-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,SNESGYGKISOJIN-UHFFFAOYSA-N,,0.84,
Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,5-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,JNIMTHZVAYLUSL-UHFFFAOYSA-N,,0.87,
Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,,NC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,CFBVGSWSOJBYGC-UHFFFAOYSA-N,,0.81,
6-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,WAXHSFGMMWDOAE-UHFFFAOYSA-N,6-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,CFBVGSWSOJBYGC-UHFFFAOYSA-N,,0.86,
5-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,GJRAGJDIUMHOLU-UHFFFAOYSA-N,5-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,JNIMTHZVAYLUSL-UHFFFAOYSA-N,,0.86,
4-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,RHZRNGQIDYHQPV-UHFFFAOYSA-N,4-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,SNESGYGKISOJIN-UHFFFAOYSA-N,,0.86,
Nor-levomethadyl acetate (nor-LAAM),CCC(OC(C)=O)C(CC(C)NC)(C1=CC=CC=C1)C1=CC=CC=C1,VWCUGCYZZGRKEE-UWJYYQICSA-N,Dinor-levomethadyl acetate,CCC(OC(C)=O)C(CC(C)N)(C1=CC=CC=C1)C1=CC=CC=C1,FYQILXMAOLDNOY-JXFKEZNVSA-N,Cytochrome P450 3A7,0.94,
Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,VPIXQGUBUKFLRF-UHFFFAOYSA-N,didesmethylclomipramine,NCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,LHDZEFLZJRLKPT-UHFFFAOYSA-N,Cytochrome P450 1A2,0.99,
2-hydroxyclomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,QXZNSJJZRXNDJQ-UHFFFAOYSA-N,2-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C(O)=C2,BTEFPKOBUHDJSN-UHFFFAOYSA-N,Cytochrome P450 2D6,0.99,
2-hydroxyclomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,QXZNSJJZRXNDJQ-UHFFFAOYSA-N,2-hydroxyclomipramine glucuronide,CN(C)CCCN1C2=C(C=C(O)C(Cl)=C2)CCC2=C1C=CC=C2OC1OC(C(=O)O)C(O)C(O)C1O,FHDAIUXAPWZOKI-LYVDORBWSA-N,,0.56,
8-hydroxyclomipramine,CN(C)CCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,PVKACZKLKCTAHR-UHFFFAOYSA-N,8-hydroxyclomipramine glucuronide,CN(C)CCCN1C2=C(C=CC(Cl)=C2)CCC2=C1C=CC(O)=C2OC1OC(C(=O)O)C(O)C(O)C1O,UQBOPEJATBRQRS-MDYSUIJBSA-N,,0.53,
8-hydroxyclomipramine,CN(C)CCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,PVKACZKLKCTAHR-UHFFFAOYSA-N,8-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,MRLCQGACIDFFSH-UHFFFAOYSA-N,,0.99,
9-β-D-arabinofuranosylguanine,NC1=NC2=C(N=[C]N2C2OC(CO)C(O)C2O)C(=O)N1,QFXYYZOMRMBRPL-FJFJXFQQSA-N,Guanine,NC1=NC(=O)C2=C(N=CN2)N1,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",,0.36,
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,4'-Carboxylumiracoxib glucuronide (M22),CC1=CC=C(NC2=C(Cl)C=C(O)C=C2F)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,SEZLIFDZXOQYCW-DAZJWRSOSA-N,UDP-glucuronosyltransferases (UGTs),0.62,
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,Lumiracoxib metabolite M25,CC1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,RVWXBXJNQUDTIJ-UHFFFAOYSA-N,,0.61,
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,Lumiracoxib metabolite M9,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=C(O)C=C1F,CTTBSLWMGLKKJO-UHFFFAOYSA-N,,0.96,
Lumiracoxib metabolite M9,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=C(O)C=C1F,CTTBSLWMGLKKJO-UHFFFAOYSA-N,4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,,0.93,
3'-Hydroxyhexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(O)CCC2)C1=O,YHCGILGEMWNROZ-UHFFFAOYSA-N,3'-Oxohexobarbital,CN1C(=O)NC(=O)C(C)(C2=CC(=O)CCC2)C1=O,JLDHHLBFGIBRGN-UHFFFAOYSA-N,,0.49,
Epoxy-hexobarbital,CN1C(=O)N=C(O)C(C)(C23CCCCC2O3)C1=O,WOWLNDOPAUTOTH-UHFFFAOYSA-N,Hexobarbital dihydrodiol derivative,CN1C(=O)NC(=O)C(C)(C2(O)CCCCC2O)C1=O,QNNYKMMUZSTIDB-UHFFFAOYSA-N,,0.51,
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,BQJCRHHNABKAKU-PKBQDISRSA-N,"Liver carboxylesterase 1, Cocaine esterase",0.94,
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,6-Hydroxymethyletoricoxib 1'-N'-oxide,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=C[N+]([O-])=C(CO)C=C2)C=C1,SSTJTMIIIMAQMR-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2",0.89,
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,6-Carboxy-etoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(C(=O)O)C=C2)C=C1,QIHJKHCGJLIAGS-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.93,
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,6-Hydroxymethyletoricoxib glucuronide,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(COC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,UJWKCNOGFMSHNK-NDUFDKTRSA-N,UDP-glucuronosyltransferases (UGTs),0.68,
Trabectedin metabolite M8a,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(O)C3CC4=CC(CC(=O)O)=C(OC)C(O)=C4C(C21)N3C,JJILVPKJCPIGNI-PBCNNVIESA-N,Trabectedin metabolite M16e,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(=O)C3CC4=CC(CC(=O)O)=C(OC)C(O)=C4C(C21)N3C,YHFJTMUFTQMMMD-PSCCWZGDSA-N,,0.97,
R-95913,O=C(C1CC1)C(C1=CC=CC=C1F)N1CCC2=C(C=C(O)S2)C1,MPLQNQUWLWGOET-UHFFFAOYSA-N,R-138727,O=C(O)CC1=C(S)CCN(C(C(=O)C2CC2)C2=CC=CC=C2F)C1,HLJDDPUMYDOUGR-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2D6",0.57,
4-hydroxymethyl ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(CO)=N1)C(=O)O,PDUAYPFMBRYSNN-LJQANCHMSA-N,4-hydroxymethyl ambrisentan glucuronide,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(CO)=CC(C)=N1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,HYNPRXQATWYSER-UDFRSJDBSA-N,,0.74,
M8 (Odanacatib),CC(F)(CO)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,JCZDLZKSPMKOPS-MMBKUXRPSA-N,M3 (Odanacatib),CC(F)(COC1OC(C(=O)O)C(O)C(O)C1O)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,XHSMOYVDHUJUTE-XNMFSWTPSA-N,,0.75,
M8 (Odanacatib),CC(F)(CO)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,JCZDLZKSPMKOPS-MMBKUXRPSA-N,M7-B (Odanacatib),CC(F)(C=O)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,HJVPPQGUHTYYIX-MMBKUXRPSA-N,,0.91,
Norketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCNCC1,BJTDPLRIKDSWIS-UHFFFAOYSA-N,Dihydroxy norketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCNCC1,XOZROGPZDNSCPU-UHFFFAOYSA-N,,0.94,
Dihydroxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCN(C)CC1,MDTMDEIAXKFDTH-UHFFFAOYSA-N,p-Hydroxymethoxy ketobemidone,CCC(=O)C1(C2=CC(OC)=C(O)C=C2)CCN(C)CC1,QNSHRSXJXIHEDC-UHFFFAOYSA-N,,0.91,
Dihydroxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCN(C)CC1,MDTMDEIAXKFDTH-UHFFFAOYSA-N,m-Hydroxymethoxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(OC)C=C2)CCN(C)CC1,YMCUUJLOWHXMHJ-UHFFFAOYSA-N,,0.94,
monohydroxy-bendamustine (bendamustine metabolite HP1),CN1C(CCCC(=O)O)=NC2=C1C=CC(N(CCO)CCCl)=C2,PFTRYOMJJKBZKV-UHFFFAOYSA-N,dihydroxy-bendamustine (bendamustine metabolite HP2),CN1C(CCCC(=O)O)=NC2=C1C=CC(N(CCO)CCO)=C2,XQMDIDKYVZPCNV-UHFFFAOYSA-N,,0.96,
Phenylacetic acid,O=C(O)CC1=CC=CC=C1,WLJVXDMOQOGPHL-UHFFFAOYSA-N,Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.24,
Perillyl alcohol,C=C(C)C1CC=C(CO)CC1,NDTYTMIUWGWIMO-UHFFFAOYSA-N,Perillyl acid,C=C(C)C1=CCC(CO)CC1,HBYMEORZYADIJJ-UHFFFAOYSA-N,,0.43,
Uroterpenol,CC1=CCC(C(C)(O)CO)CC1,ZJALAEQNHJQSTN-UHFFFAOYSA-N,Uroterpenol-O-glucuronide,CC1=CCC(C(C)(O)COC2OC(C(=O)O)C(O)C(O)C2O)CC1,QLUXQCRCCGIUTP-LVSORJHWSA-N,,0.34,
GS-56650,CC(C)OC(=O)C(C)NP(=O)(O)OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O,IPNWIJCJSQLNQC-YAWKKRDBSA-N,GS-606965,CC1(F)C(O)C(COP(=O)(O)O)OC1N1C=CC(=O)NC1=O,JAJZLQMRDFLNSW-WDKMEHGUSA-N,Histidine triad nucleotide-binding protein 1,0.87,
Biocytin,NC(CCCCNC(=O)CCCCC1SCC2NC(=O)NC21)C(=O)O,,Biotin,O=C(O)CCCCC1SCC2NC(=O)NC21,YBJHBAHKTGYVGT-ZKWXMUAHSA-N,,0.88,
Bortezomib metabolite M3,NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,KTQJEBWLYWKXRA-NSHDSACASA-N,Bortezomib metabolite M4,O=C(NC(CC1=CC=CC=C1)C(=O)O)C1=CN=CC=N1,DWYZPDHMMZGQAP-NSHDSACASA-N,,0.74,
Bortezomib metabolite M8,CC(C)CC(O)NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,BLVVPFHWFHYTBM-PYNWJHIZSA-N,Bortezomib metabolite M33,NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,ASDAHTNZOSVDNQ-PXYINDEMSA-N,,0.79,
"N,O-didesmethyltramadol",CNCC1CCCCC1(O)C1=CC(O)=CC=C1,CJXNQQLTDXASSR-OCCSQVGLSA-N,"N,N,O-tridesmethyl-tramadol",NCC1CCCCC1(O)C1=CC(O)=CC=C1,MJTYLDGVLFSXDG-YPMHNXCESA-N,,0.92,
"N,N-didesmethyltramadol",COC1=CC=CC(C2(C)CCCCC2CN)=C1,ZEXALIOABWHLJM-UKRRQHHQSA-N,"N,N,O-tridesmethyl-tramadol",NCC1CCCCC1(O)C1=CC(O)=CC=C1,MJTYLDGVLFSXDG-YPMHNXCESA-N,,0.59,
Nitroso-dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N=O)C=C2)C=C1,UAQFAHXMXOCEAD-UHFFFAOYSA-N,Dapsone mercaptal intermediate,NC1=CC=C(S(=O)(=O)C2=CC=C(N(O)SSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,ILXGRDMMHISXAH-ROUUACIJSA-N,,0.31,
Hydroxyphenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,XEEDURHPFVXALT-UHFFFAOYSA-N,Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A5, Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 3A7, Cytochrome P450 2B6, Cytochrome P450 2D6",0.37,
Phenytoin dihydrodiol,O=C1NC(=O)C(C2=CC(O)C(O)C=C2)(C2=CC=CC=C2)N1,FEEKFEKCXIDMIS-UHFFFAOYSA-N,Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,,0.44,
Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,,0.42,
2-n-Propyl-4-oxopentanoic acid,CCCC(CC(C)=O)C(=O)O,HJRMYVTYHORJKC-UHFFFAOYSA-N,2-Propylsuccinic acid,CCCC(CC(=O)O)C(=O)O,QLTZBYGZXPKHLF-UHFFFAOYSA-N,,0.65,
Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,Thioguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,QENYANNAQSWPLM-UUOKFMHZSA-N,,0.98,
Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,,0.93,
N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,N-Desmethyl-ortho-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(OS(=O)(=O)O)C=CC=N3)C=C2)S1,HOMPAUSQZJYDFA-UHFFFAOYSA-N,,0.82,
N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,N-Desmethyl para-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(OS(=O)(=O)O)C=N3)C=C2)S1,ULPCBLHRDLQTTD-UHFFFAOYSA-N,,0.86,
Gemcitabine diphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,FRQISCZGNNXEMD-QPPQHZFASA-N,Gemcitabine triphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,YMOXEIOKAJSRQX-QPPQHZFASA-N,Nucleoside diphosphate kinase A,0.97,
Norfluoxetine alcohol,OCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WMLVVHKCLDWGLW-UHFFFAOYSA-N,Norfluoxetine acid,O=C(O)CC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,QXMMAJMDXZHOET-UHFFFAOYSA-N,,0.88,
Carboxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O)C=C2)C=C1,WTHNOVFEXONZMI-UHFFFAOYSA-N,Celecoxib glucuronide,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,BMBHPAUFWUKYDR-AVPDHNOJSA-N,UDP-glucuronosyltransferases (UGTs),0.69,
Haloperidol reduced pyridinium ion derivative,OC(CCC[N+]1=CC=C(C2=CC=C(Cl)C=C2)C=C1)C1=CC=C(F)C=C1,CESYFZMRVQIRNB-UHFFFAOYSA-N,Haloperidol pyridinium ion derivative,O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)C1=CC=C(F)C=C1,KAPIKUHBALFONG-UHFFFAOYSA-N,Cytochrome P450 3A4,0.27,
Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,Carboxyphosphamide,NP(=O)(OCCC(=O)O)N(CCCl)CCCl,QLAKAJLYYGOZQL-UHFFFAOYSA-N,,0.92,
Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,Alcophosphamide,NP(=O)(OCCCO)N(CCCl)CCCl,BZGFIGVSVQRQBJ-UHFFFAOYSA-N,"Alcohol dehydrogenase 1A, Alcohol dehydrogenase [NADP(+)]",0.89,
Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,Phosphoramide Mustard,NP(=O)(O)N(CCCl)CCCl,RJXQSIKBGKVNRT-UHFFFAOYSA-N,,0.56,
Zafirlukast metabolite M2,COC1=C(CC2=CN(C)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,XZEKBYKKJYHZAZ-UHFFFAOYSA-N,Zafirlukast metabolite M4,COC1=C(CC2=CN(CO)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,NWOVAURISFBNOF-UHFFFAOYSA-N,,0.97,
Zafirlukast metabolite M8,COC1=C(CC2=CNC3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,FJVVJMGKCIJNGX-UHFFFAOYSA-N,Zafirlukast metabolite M3,COC1=C(CC2=CNC3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,TVYYLXWJXOTTDN-UHFFFAOYSA-N,,0.92,
2-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=CC=C21,VPZIYMMSJFWLSP-UHFFFAOYSA-N,2-hydroxyiminostilbene,OC1=CC=C2NC3=CC=CC=C3C=CC2=C1,FKCUOSGTQJAUQX-UHFFFAOYSA-N,Cytochrome P450 3A4,0.62,
Valdecoxib metabolite M7,CC1=C(C2=CC=C(S(=O)O)C=C2)C(C2=CC=CC=C2)=NO1,MCGQPKHGAPQIDC-UHFFFAOYSA-N,Valdecoxib metabolite M8,CC1=C(C2=CC=C(S(=O)(=O)O)C=C2)C(C2=CC=CC=C2)=NO1,LLWOSCPRJRUVST-UHFFFAOYSA-N,,0.96,
"UK-51,060",O=C(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,XCHRPVARHBCFMJ-UHFFFAOYSA-N,"UK-215,364",OC(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,NQNSXRYFTHGTTO-UHFFFAOYSA-N,,0.59,
4-hydroxytamoxifen sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,CFSXIBDXCWVFJR-QPLCGJKRSA-N,Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,MHJBZVSGOZTKRH-IZHYLOQSSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase",0.82,
Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,MHJBZVSGOZTKRH-IZHYLOQSSA-N,4-hydroxytamoxifen sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,CFSXIBDXCWVFJR-QPLCGJKRSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase",0.82,
Indapamide metabolite M4,CC1C(=O)C2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,WTWDWHYDLVHLPL-UHFFFAOYSA-N,Indapamide metabolite M2,CC1C(=O)C2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,AHVOGCBKNVSCRL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,
Indapamide metabolite M3,CC1=CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,NYONMYACEVMMGW-UHFFFAOYSA-N,Indapamide metabolite M2,CC1C(=O)C2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,AHVOGCBKNVSCRL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.49,
3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,Atropaldehyde,C=C(C=O)C1=CC=CC=C1,ZFBRJUBOJXNIQM-UHFFFAOYSA-N,,0.29,
3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",OC1=NC(O)C(C2=CC=CC=C2)CO1,XZZMJRBYVRSAOS-UHFFFAOYSA-N,,0.41,
3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionic acid,N=C(O)OCC(C(=O)O)C1=CC=CC=C1,AYRIVCKWIAUVOO-UHFFFAOYSA-N,"Aldehyde dehydrogenase, dimeric NADP-preferring",0.81,
"N,N-Didesmethyldiphenhydramine",NCCOC(C1=CC=CC=C1)C1=CC=CC=C1,NFJFUDGBWGXTHS-UHFFFAOYSA-N,Diphenylmethoxyacetic acid,O=C(O)COC(C1=CC=CC=C1)C1=CC=CC=C1,KWGQOJWITMQEOT-UHFFFAOYSA-N,,0.77,
6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,6-thioxanthylic acid,O=P(O)(O)C(O)C1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,GRTRLPZIJODDLV-BQGLTYQTSA-N,"Inosine-5'-monophosphate dehydrogenase 1, Inosine-5'-monophosphate dehydrogenase 2",0.83,
Irbesartan derivative M1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,LIDZWACDVHJFLD-UHFFFAOYSA-N,Irbesartan derivative M2,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,VYPCFUKCQSQGKN-UHFFFAOYSA-N,,0.98,
Irbesartan derivative M6,CC(=O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,MIGTZGLTQNODIS-UHFFFAOYSA-N,Irbesartan derivative M2,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,VYPCFUKCQSQGKN-UHFFFAOYSA-N,,0.93,
Thioxanthine monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,GMP synthase [glutamine-hydrolyzing],0.79,
6-Mercaptopurine riboside,OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,NKGPJODWTZCHGF-KQYNXXCUSA-N,6-Methylmercaptopurine-riboside,CSC1=NC=NC2=C1N=CN2C1OC(CO)C(O)C1O,ZDRFDHHANOYUTE-IOSLPCCCSA-N,Thiopurine S-methyltransferase,0.96,
2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.68,
Bufotenine,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,"N,N-Dimethyltryptamine",CN(C)CCC1=CNC2=CC=CC=C12,DMULVCHRPCFFGV-UHFFFAOYSA-N,,0.81,
Hydroxydesmethyl doxepin,CNCCC=C1C2=C(C=CC=C2)COC2=C1C=C(O)C=C2,LUWRONBNZDYVBL-APSNUPSMSA-N,Hydroxydesmethyl doxepin glucuronide,CN(C)CCC=C1C2=C(C=CC=C2)COC2=C1C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,RECOUBTVNVWWDB-CAOOACKPSA-N,,0.64,
aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,Alcoifosfamide,O=P(NCCCl)(NCCCl)OCCCO,JOAQXFLTMDRBOD-UHFFFAOYSA-N,,0.86,
aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,Carboxylifosfamide,O=C(O)CCOP(=O)(NCCCl)NCCCl,DNDBVHDNSYHKLI-UHFFFAOYSA-N,Retinal dehydrogenase 1,0.89,
aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,Isophosphamide mustard,O=P(O)(NCCCl)NCCCl,BKCJZNIZRWYHBN-UHFFFAOYSA-N,,0.5,
2-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C(O)=C2,BTEFPKOBUHDJSN-UHFFFAOYSA-N,2-hydroxydesmethyl clomipramine glucuronide,CNCCCN1C2=C(C=C(O)C(Cl)=C2)CCC2=C1C=CC=C2OC1OC(C(=O)O)C(O)C(O)C1O,FFAZHDSFJXPRMI-QMDPOKHVSA-N,,0.56,
8-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,MRLCQGACIDFFSH-UHFFFAOYSA-N,8-hyroxydesmethyl clomipramine glucuronide,CNCCCN1C2=C(C=CC(Cl)=C2)CCC2=C1C=CC(O)=C2OC1OC(C(=O)O)C(O)C(O)C1O,RWAXEUMRTYEJDL-MJRVOHGCSA-N,,0.52,
5-Carboxylumiracoxib (M11),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=CC=C1F,BXCHBMAYKCJHJB-UHFFFAOYSA-N,Lumiracoxib metabolite M15,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=CC=C1F,CYWNCAUMMWNHKA-UHFFFAOYSA-N,,0.62,
Lumiracoxib metabolite M25,CC1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,RVWXBXJNQUDTIJ-UHFFFAOYSA-N,Lumiracoxib metabolite M25 glucuronide (M20),CC1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1F,SETAFJOLASRPRK-DAZJWRSOSA-N,UDP-glucuronosyltransferases (UGTs),0.73,
5-Carboxylumiracoxib (M11),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=CC=C1F,BXCHBMAYKCJHJB-UHFFFAOYSA-N,4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,,0.9,
4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,Lumiracoxib metabolite M2,O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,NDKGEYRNJBCHHS-UHFFFAOYSA-N,Sulfotransferase,0.88,
4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,,0.65,
3'-Oxohexobarbital,CN1C(=O)NC(=O)C(C)(C2=CC(=O)CCC2)C1=O,JLDHHLBFGIBRGN-UHFFFAOYSA-N,Hexobarbital glutathione conjugate derivative,CN1C(=O)NC(=O)C(C)(C2(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)CCCC(=O)C2)C1=O,KOIDTVHMKHPOSM-CVXASFDDSA-N,,0.46,
GS-606965,CC1(F)C(O)C(COP(=O)(O)O)OC1N1C=CC(=O)NC1=O,JAJZLQMRDFLNSW-WDKMEHGUSA-N,GS-461203,CC1(F)C(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)OC1N1C=CC(O)=NC1=O,IPHULAIUXUVCHH-WDKMEHGUSA-N,"UMP-CMP kinase, Nucleoside diphosphate kinase A",0.85,
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,Eslicarbazepine,NC(=O)N1C2=C(C=CC=C2)CC(O)C2=C1C=CC=C2,"InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1",,0.64,
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,10-hydroxycarbazepine sulfate,NC(=O)N1C2=CC=CC=C2CC(OS(=O)(=O)O)C2=CC=CC=C21,DQCMJSSQBFEDHL-UHFFFAOYSA-N,,0.57,
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,10-hydroxycarbazepine glucuronide,NC(=O)N1C2=CC=CC=C2CC(NC(C=O)CCC(=O)O)C2=CC=CC=C21,NRSIPYUVLOFFHV-LBAUFKAWSA-N,,0.54,
Rheinanthrone,O=C(O)C1=CC2CC3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,RRMMJVMTHXZXEG-UHFFFAOYSA-N,Rhein,O=C(O)C1=CC2C(=O)C3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,HHQNGUQUHZYDEP-UHFFFAOYSA-N,,0.95,
Dapsone mercaptal intermediate,NC1=CC=C(S(=O)(=O)C2=CC=C(N(O)SSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,ILXGRDMMHISXAH-ROUUACIJSA-N,Dapsone GSH conjugate,NC1=CC=C(S(=O)(=O)C2=CC=C(NS(=O)SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,IHKJTFLXUFDQKZ-OZTHWQDPSA-N,,0.85,
Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,Phenytoin quinone,O=C1NC(=O)C(C2=CC(=O)C(=O)C=C2)(C2=CC=CC=C2)N1,AWCFFJFKIPSEFH-UHFFFAOYSA-N,NAD(P)H dehydrogenase [quinone] 1,0.43,
Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,Phenytoin methylcatechol,O=CC1=C(O)C=CC(C2(C3=CC=CC=C3)NC(=O)NC2=O)=C1,IVKHYRHKQDQYFC-UHFFFAOYSA-N,Catechol O-methyltransferase,0.76,
Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,Thiodeoxyguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1)C=N2,BXZRFHUVVWIHMV-KVQBGUIXSA-N,,0.98,
Zafirlukast metabolite M4,COC1=C(CC2=CN(CO)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,NWOVAURISFBNOF-UHFFFAOYSA-N,Zafirlukast metabolite M3,COC1=C(CC2=CNC3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,TVYYLXWJXOTTDN-UHFFFAOYSA-N,,0.9,
"UK-215,364",OC(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,NQNSXRYFTHGTTO-UHFFFAOYSA-N,Voriconazole O-glucuronide derivative (1),O=C(O)C1OC(OC2=CC(F)=C(C(O)CN3C=NC=N3)C=C2)C(O)C(O)C1O,XNZQDIJYTGCNLO-SHIOMWLHSA-N,,0.43,
"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",OC1=NC(O)C(C2=CC=CC=C2)CO1,XZZMJRBYVRSAOS-UHFFFAOYSA-N,"5-Phenyl-1,3-oxazinane-2,4-dione",O=C1N=C(O)C(C2=CC=CC=C2)CO1,YPIQXPKZXKWWSZ-UHFFFAOYSA-N,Alcohol dehydrogenase 1A,0.37,
6-Methylmercaptopurine-riboside,CSC1=NC=NC2=C1N=CN2C1OC(CO)C(O)C1O,ZDRFDHHANOYUTE-IOSLPCCCSA-N,Methyl-thioinosine 5'-monophospate,CSC1=NC=NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,BMYFUCYXRGTQQL-IOSLPCCCSA-N,Adenosine kinase,0.93,
2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,Glutamic acid,NC(CCC(=O)O)C(=O)O,WHUUTDBJXJRKMK-VKHMYHEASA-N,,0.18,
2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.32,
Isophosphamide mustard,O=P(O)(NCCCl)NCCCl,BKCJZNIZRWYHBN-UHFFFAOYSA-N,Ifosforamide Aziridinium,O=P(O)(NCCCl)[NH+]1CC1,NAFVGKNCETZZFN-UHFFFAOYSA-O,,0.65,
Lumiracoxib metabolite M15,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=CC=C1F,CYWNCAUMMWNHKA-UHFFFAOYSA-N,Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,,0.94,
Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,Lumiracoxib metabolite M4/M6,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,YMUCSRFAMQITFI-UHFFFAOYSA-N,,0.92,
"5-Phenyl-1,3-oxazinane-2,4-dione",O=C1N=C(O)C(C2=CC=CC=C2)CO1,YPIQXPKZXKWWSZ-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionic acid,N=C(O)OCC(C(=O)O)C1=CC=CC=C1,AYRIVCKWIAUVOO-UHFFFAOYSA-N,,0.34,
acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,N-Acetyl-p-benzoquinone,CC(=O)N=C1C=CC(=O)C=C1,,CYP1A2; CYP2E1; CYP3A4; CYP2A6; CYP2C9; CYP2D6; CYP1A1,0.06,Oxidation of p-substituted anilides
acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,3-Hydroxyacetaminophen,CC(O)=NC1=CC=C(O)C(O)=C1,,CYP2A6 (major); CYP2E1; CYP1A2; CYP2C8; CYP2C9; CYP3A4,0.7,Hydroxylation of benzene on carbon orhto to a strongly electron donating group
pinoline,COC1=CC=C2NC3=C(CCNC3)C2=C1,,"1H,2H,3H,4H,9H‐pyrido[3,4‐b]indol‐6‐ol",OC1=CC=C2NC3=C(CCNC3)C2=C1,,CYP2D6,0.95,O-aryl demethylation
1-(3-Trifluoromethylphenyl)piperazine,FC(F)(F)C1=CC=CC(N2CCNCC2)=C1,,HO-TFMPP,OC1=CC=C(N2CCNCC2)C=C1C(F)(F)F,,CYP2D6; CYP1A2; CYP3A4,0.77,Aromatic Hydroxylation
"2-Amino-3-methylimidazo(4,5-F)quinoline",CN1C(=N)NC2=C3C=CC=NC3=CC=C21,,"N-OH-2-amino-3-methylimidazo[4,5-f]quinoline (N-OH-IQ)",CN1C(NO)=NC2=C3C=CC=NC3=CC=C21,,CYP1A2; CYP1A1,0.65,N-Hydroxylation
"5-Methoxy-N,N-diisopropyltryptamine",COC1=CC=C2NC=C(CCN(C(C)C)C(C)C)C2=C1,,5-OH-DIPT,CC(C)N(CCC1=CNC2=CC=C(O)C=C12)C(C)C,,CYP2D6,0.92,O-Demethylation
"5-Methoxy-N,N-diisopropyltryptamine",COC1=CC=C2NC=C(CCN(C(C)C)C(C)C)C2=C1,,5-MeO-IPT,COC1=CC=C2NC=C(CCNC(C)C)C2=C1,,CYP1A2;CYP3A4;CYP2C9;CYP2C19,0.95,N-deisopropylation
(R)-halothane,FC(F)(F)C(Cl)Br,,"1-chloro-2,2,2-trifluoroethanide",FC(F)(F)[CH-]Cl,,CYP2A6; CYP3A4; CYP2B6; CYP2C9; CYP2D6,0.55,Reduction of terminal aliphatic trihalide
"(R)-3,4-Methylenedioxymethamphetamine",CNC(C)CC1=CC=C2OCOC2=C1,,"N-Methyl-3,4- dihydroxyamphetamine",CNC(C)CC1=CC=C(O)C(O)=C1,,CYP1A2; CYP2D6,0.69,Methylenedioxy ring opening
"(R)-3,4-Methylenedioxymethamphetamine",CNC(C)CC1=CC=C2OCOC2=C1,,"3,4-Methylenedioxymethamphetamine",CC(N)CC1=CC=C2OCOC2=C1,,CYP2D6 (major); CYP1A2; CYP2B6; CYP3A4,0.95,N-dealkylation of acyclic secondary amine
"(4R)-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid",COC(=O)C1=C(C)NC(C)=C(C(=O)O)C1C1=CC=CC([N+](=O)[O-])=C1,,OPC-13463,COC(=O)C1=C(C)N=C(C)C(C(=O)O)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.32,Dehydrogenation
Homo-Tienilic Alcohol,O=C(C1=CC=CS1)C1=CC=C(OCCCO)C(Cl)=C1Cl,,,O=C(C1=CC=C(O)S1)C1=CC=C(OCCCO)C(Cl)=C1Cl,,CYP2C8;CYP2C9;CYP2C19,0.93,Aliphatic Hydroxylation
Homo-Tienilic Alcohol,O=C(C1=CC=CS1)C1=CC=C(OCCCO)C(Cl)=C1Cl,,,O=C(C1=CC=CS1)C1=CC=C(O)C(Cl)=C1Cl,,CYP2C8;CYP2C9;CYP2C19,0.86,O-Demethylation
"1-Methyl-10-alpha-methoxy-9,10-dihydrolysergol",COC12CC(CO)CN(C)C1CC1=CN(C)C3=CC=CC2=C13,,MDL,COC12CC(CO)CN(C)C1CC1=CNC3=CC=CC2=C13,,CYP2D6,0.94,N-Demethylation
"(S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid",COC1=CC=CC(OC)=C1C1=CC=C(CC(N=C(O)C2=C(Cl)C=CC=C2Cl)C(=O)O)C=C1,,,COC1=CC=CC(O)=C1C1=CC=C(CC(N=C(O)C2=C(Cl)C=CC=C2Cl)C(=O)O)C=C1,,CYP2C9,0.99,O-Desmethylation
Dehydroxyzyleuton,CC(NC(=N)O)C1=CC2=CC=CC=C2S1,,Dehydroxyzyleuton sulfoxide,CC(NC(=N)O)C1=CC2=CC=CC=C2S1=O,,CYP3A4,0.2,Thiohene S-oxidation
Dehydroxyzyleuton,CC(NC(=N)O)C1=CC2=CC=CC=C2S1,,(1S)â€1â€(6â€hydroxyâ€1â€benzothiophenâ€2â€yl)ethylurea,CC(NC(=N)O)C1=CC2=CC=C(O)C=C2S1,,CYP1A2; CYP2C9,0.86,Aromatic hydroxylation of fused benzene ring
"(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine",CC(OC1OCCNC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,aprepitant_M2,CC(OC1OCC=NC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,CYP3A4,0.72,Dehydrogenation
2-Methoxy-5-trifluoromethoxybenzylamine,COC1=CC=C(OC(F)(F)F)C=C1CN,,"CP-919,230",NCC1=CC(OC(F)(F)F)=CC=C1O,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.93,O-Demethylation
"3-(furan-2-ylmethyl)-1,7,8-trimethylpurine-2,6-dione",CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC=CO2)N1C,,,CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC(O)=CO2)N1C,,CYP1A2,0.98,Aliphatic Hydroxylation
"3-(furan-2-ylmethyl)-1,7,8-trimethylpurine-2,6-dione",CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC=CO2)N1C,,,CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=C(O)C=CO2)N1C,,CYP1A2,0.96,Aliphatic Hydroxylation
"3-(furan-2-ylmethyl)-1,7,8-trimethylpurine-2,6-dione",CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC=CO2)N1C,,,CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC=C(O)O2)N1C,,CYP1A2,0.96,Aliphatic Hydroxylation
"3-(furan-2-ylmethyl)-1,7,8-trimethylpurine-2,6-dione",CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC=CO2)N1C,,,CN1C(=O)C2=C(N=C(CO)N2C)N(CC2=CC=CO2)C1=O,,CYP1A2,0.96,Aliphatic Hydroxylation
(-)-ethosuximide,CCC1(C)CC(O)=NC1=O,,,CC(O)C1(C)CC(O)=NC1=O,,CYP2E1;CYP3A4,0.69,Alphatic Hydroxylation
(-)-etodolac,CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,,6-Hydroxyetodolac,CCC1=CC(O)=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,,CYP2C9,0.94,Aromatic hydroxylation of fused benzene ring
(-)-etodolac,CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,,7-Hydroxyetodolac,CCC1=C(O)C=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,,CYP2C9,0.93,Aromatic hydroxylation of fused benzene ring
(-)-pseudococaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,,Norcocaine,COC(=O)C1C2CCC(CC1OC(=O)C1=CC=CC=C1)N2,,CYP3A4,0.94,N-dealkylation of alicyclic tertiary amine
(+)-3-carene,CC1=CCC2C(C1)C2(C)C,,3-Caren-10-ol,CC1(C)C2CC=C(CO)CC21,,CYP2B6; CYP2C19; CYP2D6,0.78,Hydroxlation of methyl carbon adjacent to an aliphatic ring
(+)-3-carene,CC1=CCC2C(C1)C2(C)C,,Carene epoxide,CC12CC3C(CC1O2)C3(C)C,,CYP1A2,0.24,EPOXIDATION_OF_112_TRISUBSTITUTED_ALKLENE
(+)-bisoprolol,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,,"(+)-bisoprolol, O-deisopropyl",CC(C)NCC(O)COC1=CC=C(COCCO)C=C1,,CYP2D6; CYP3A4,0.94,O-deisopropylation
(+)-fipronil,N#CC1=NN(C2=C(Cl)C=C(C(F)(F)F)C=C2Cl)C(N)=C1S(=O)C(F)(F)F,,f ipronil sulfone,N#CC1=NN(C2=C(Cl)C=C(C(F)(F)F)C=C2Cl)C(N)=C1S(=O)(=O)C(F)(F)F,,CYP3A4,0.96,S-oxidation of sulfoxide to sulfone
(+)-halofantrine,CCCCN(CCCC)CCC(O)C1=CC2=C(Cl)C=C(Cl)C=C2C2=CC(C(F)(F)F)=CC=C12,,"(+)-halofantrine, N-desbutyl",CCCCNCCC(O)C1=CC2=C(Cl)C=C(Cl)C=C2C2=CC(C(F)(F)F)=CC=C12,,CYP3A4,0.96,N-dealkylation of acyclic tertiary amine
(+)-isothujone,CC1C(=O)CC2(C(C)C)CC12,,4-hydroxy-isothujone,CC(C)C12CC(=O)C(C)(O)C1C2,,CYP2A6; CYP2B6; CYP2D6; CYP3A4,0.55,Hydroxylation of penultimate aliphatic tertiary carbon
(+)-isothujone,CC1C(=O)CC2(C(C)C)CC12,,7-hydroxy-isothujone,CC1C(=O)CC2(C(C)(C)O)CC12,,CYP2A6; CYP2B6; CYP2D6; CYP3A4,0.61,Hydroxylation of penultimate aliphatic tertiary carbon
"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",COC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,Estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,CYP2C19(major);CYP2C9;CYP1A2;CYP3A4,0.94,O-Demethylation
(2r)-1-(2-methoxyphenyl)propan-2-amine,COC1=CC=CC=C1CC(C)N,,,CC(N)CC1=CC=CC=C1O,,CYP2D6,0.77,O-Demethylation
(2r)-1-(2-methoxyphenyl)propan-2-amine,COC1=CC=CC=C1CC(C)N,,,COC1=C(O)C=CC=C1CC(C)N,,CYP2D6,0.76,Aromatic Hydroxylation
(2r)-1-(2-methoxyphenyl)propan-2-amine,COC1=CC=CC=C1CC(C)N,,,COC1CCC(O)CC1CC(C)N,,CYP2D6,0.08,Aromatic Hydroxylation
(2r)-2-[4-(3-methylthiophen-2-yl)phenyl]propanoic acid,CC1=C(C2=CC=C(C(C)C(=O)O)C=C2)SC=C1,,,CC1=C(C2=CC=C(C(C)C(=O)O)C=C2)SC(=O)C1,,CYP2C9,0.3,C-Oxidation
Saquinavir,CC(C)(C)N=C(O)C1CC2CCCCC2CN1CC(O)C(CC1=CC=CC=C1)N=C(O)C(CC(=N)O)NC(=O)C1=CC=C2C=CC=CC2=N1,,"(2S)-N-[(2S,3R)-4-[(3S,4aR,8aS)-3-(tert-butylcarbamoyl)-6-hydroxy-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide",CC(C)(C)N=C(O)C1CC2CC(O)CCC2CN1CC(O)C(CC1=CC=CC=C1)N=C(O)C(CC(=N)O)NC(=O)C1=CC=C2C=CC=CC2=N1,,CYP3A4,0.99,Hydroxylation of alicyclic secondary carbon
Saquinavir,CC(C)(C)N=C(O)C1CC2CCCCC2CN1CC(O)C(CC1=CC=CC=C1)N=C(O)C(CC(=N)O)NC(=O)C1=CC=C2C=CC=CC2=N1,,"(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-7-hydroxy-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide",CC(C)(C)N=C(O)C1CC2CCC(O)CC2CN1CC(O)C(CC1=CC=CC=C1)N=C(O)C(CC(=N)O)NC(=O)C1=CC=C2C=CC=CC2=N1,,CYP3A4,0.98,Hydroxylation of alicyclic secondary carbon
"(3z)-5-[(1alpha,4alpha)-3beta-[(phenylsulfonyl)amino]bicyclo[2.2.1]heptan-2alpha-yl]-3-pentenoic acid",O=C(O)CC=CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,(3Z)â€5â€{3â€benzenesulfonamidoâ€6â€hydroxybicyclo[2.2.1]heptanâ€2â€yl}pentâ€3â€enoic acid,O=C(O)CC=CCC1C2CC(CC2O)C1NS(=O)(=O)C1=CC=CC=C1,,CYP2C9;CYP3A4,0.85,Aliphatic Hydroxylation
"(3z)-5-[(1alpha,4alpha)-3beta-[(phenylsulfonyl)amino]bicyclo[2.2.1]heptan-2alpha-yl]-3-pentenoic acid",O=C(O)CC=CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,(3Z)â€5â€{3â€benzenesulfonamidoâ€5â€hydroxybicyclo[2.2.1]heptanâ€2â€yl}pentâ€3â€enoic acid,O=C(O)CC=CCC1C2CC(O)C(C2)C1NS(=O)(=O)C1=CC=CC=C1,,CYP3A4,0.82,Aliphatic Hydroxylation
(r)-(+)-felodipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl,,Dehydrofelodipine,CCOC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=CC=CC(Cl)=C1Cl,,CYP3A4,0.33,"Dehydrogenation of 4-aryl substituted 1,4-dihydropyridine"
(R)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(R)-(-)-Mexiletine, p-hydroxyl",CC1=CC(O)=CC(C)=C1OCC(C)N,,CYP1A2 (minor); CYP2D6 (major),0.85,HYDROXYLATION_OF_AROMATIC_CARBON; HYDROXYLATION_OF_BENZENE_PARA_TO_EDG
(R)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(R)-(-)-Mexiletine, m-hydroxyl",CC1=CC=C(O)C(C)=C1OCC(C)N,,CYP1A2 (minor); CYP2D6 (major),0.78,HYDROXYLATION_OF_AROMATIC_CARBON; HYDROXYLATION_OF_BENZENE_ORTHO_TO_EDG
(R)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(R)-(-)-Mexiletine, 2-OH-hydroxymethyl",CC1=CC=CC(CO)=C1OCC(C)N,,CYP1A2 (minor); CYP2D6 (major),0.77,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
(R)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(R)-(-)-Mexiletine, N-hydroxy",CC1=CC=CC(C)=C1OCC(C)NO,,CYP1A2 (major); CYP2B6; CYP2E1,0.91,N-hydroxylation of primary or secondary aliphatic amine
(r)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2R)-1-(3-chlorophenyl)-2-[(1-hydroxy-2-methylpropan-2-yl)amino]propan-1-one,CC(NC(C)(C)CO)C(=O)C1=CC=CC(Cl)=C1,,CYP2B6; CYP3A4,0.92,Hydroxylation of terminal methyl
(r)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2R)-2-(tert-butylamino)-1-(3-chlorophenyl)-3-hydroxypropan-1-one,CC(C)(C)NC(CO)C(=O)C1=CC=CC(Cl)=C1,,CYP2C19,0.86,Hydroxylation of terminal methyl
(r)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2R)-2-(tert-butylamino)-1-(3-chloro-4-hydroxyphenyl)propan-1-one,CC(NC(C)(C)C)C(=O)C1=CC=C(O)C(Cl)=C1,,CYP2B6;CYP2C19; CYP2E1,0.82,Hydroxylation of aromatic carbon ortho to halide group
(r)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2R)â€2â€(tertâ€butylamino)â€1â€(3â€chloroâ€5â€hydroxyphenyl)propanâ€1â€one,CC(NC(C)(C)C)C(=O)C1=CC(O)=CC(Cl)=C1,,CYP2B6;CYP2C19; CYP2E1,0.78,Hydroxylation of aromatic carbon meta to halide group
(r)-chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,,"(r)-chloroquine, N-desethyl",CCNCCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,,CYP2C8; CYP2D6; CYP3A4; CYP3A5,0.97,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES
(r)-enflurane,FC(F)OC(F)(F)C(F)Cl,,"2-(difluoromethoxy)-2,2-difluoroacetyl fluoride",O=C(F)C(F)(F)OC(F)F,,CYP2E1,0.45,Oxidation of halotrifluoroethane
(r)-mda,CC(N)CC1=CC=C2OCOC2=C1,,Alpha-methyldopamine,CC(N)CC1=CC=C(O)C(O)=C1,,CYP2D6;CYP3A4,0.66,O-Demethylation
(r)-metoprolol,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,,O-Demethylmetoprolol,CC(C)NCC(O)COC1=CC=C(CCO)C=C1,,CYP2D6; CYP3A4,0.96,O-dealkylation of dialkylether
(r)-metoprolol,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,,N_DEISOPROPYLATION,COCCC1=CC=C(OCC(O)CN)C=C1,,CYP2C19,0.87,N-deisopropylation
(r)-trimipramine,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C21,,,CNCC(C)CN1C2=CC=CC=C2CCC2=CC=CC=C21,,CYP2C19,0.98,N-demethylation
(r)-trimipramine,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C21,,,CC(CN(C)C)CN1C2=CC=CC=C2CC(O)C2=CC=CC=C21,,CYP2D6,0.76,Aliphatic Hydroxylation
(r)-trimipramine,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C21,,,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,,CYP2D6,0.87,Aliphatic Hydroxylation
(s)-(-)-carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,4'-OH-carvedilol,COC1=CC(O)=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,CYP2D6 (major); CYP2E1 (minor); CYP2C9 (minor); CYP3A4 (minor),0.94,Hydroxylation of benzene on carbon para to a strongly electron donating group
(s)-(-)-carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,5'-OH-carvedilol,COC1=CC=C(O)C=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,CYP2D6 (major); CYP2E1 (minor); CYP2C9 (minor); CYP3A4 (minor),0.93,Hydroxylation of benzene on carbon para to a strongly electron donating group
(s)-(-)-carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,8-OH-carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1N2,,CYP1A2 (major); CYP3A4 (minor); CYP1A1 (minor),0.91,Aromatic hydroxylation of fused benzene ring
(s)-fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,3-(methylamino)-1-phenylpropan-1-one,CNCCC(=O)C1=CC=CC=C1,,CYP2C19; CYP3A4,0.27,O-dealkylation
(s)-flurbiprofen,CC(C(=O)O)C1=CC=C(C2=CC=CC=C2)C(F)=C1,,4-OH-S-flurbiprofen,CC(C(=O)O)C1=CC=C(C2=CC=C(O)C=C2)C(F)=C1,,CYP2C9,0.92,p-Hydroxylation of monosubstituted benzene
(s)-mephobarbital,CCC1(C2=CC=CC=C2)C(=O)N(C)C(=O)N=C1O,,4-hydroxymephobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)N(C)C(=O)N=C1O,,CYP2C19,0.97,Aromatic Hydroxylation
(s)-mephobarbital,CCC1(C2=CC=CC=C2)C(=O)N(C)C(=O)N=C1O,,phenobarbital,CCC1(C2=CC=CC=C2)C(O)=NC(=O)N=C1O,,CYP2B6,0.46,N-demethylation
(s)-norfenfluramine,CC(N)CC1=CC=CC(C(F)(F)F)=C1,,,NCCC1=CC=CC(C(F)(F)F)=C1,,CYP1A2,0.83,C-DEALKLYATION
(s)-oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,2-cyclohexyl-2-phenylglycolic acid,O=C(O)C(O)(C1=CC=CC=C1)C1CCCCC1,,CYP3A4,0.76,HYDROLYSIS_OF_CARBOXYLIC_ESTER
(s)-oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,4-(diethylamino)but-2-yn-1-ol,CCN(CC)CC#CCO,,CYP3A4,0.08,HYDROLYSIS_OF_CARBOXYLIC_ESTER
(s)-propafenone,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,(S)-5-Hydroxypropafenone,CCCNCC(O)COC1=CC=C(O)C=C1C(=O)CCC1=CC=CC=C1,,CYP2D6,0.9,Hydroxylation of benzene on carbon para to a strongly electron donating group
(s)-propafenone,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,(S)-N-Despropylpropafenone,NCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,CYP1A2; CYP3A4,0.94,N-dealkylation of acyclic secondary amine
(s)-propafenone,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,(S)-4'-Hydroxypropafenone,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=C(O)C=C1,,CYP2D6 (implied),0.98,p-Hydroxylation of monosubstituted benzene
[2-methyl-4-(o-tolylazo)phenyl]amine,CC1=CC(N=NC2=CC=CC=C2C)=CC=C1N,,4'-hydroxy-o-aminoazotoJuene,CC1=CC(N=NC2=CC=C(O)C=C2C)=CC=C1N,,CYP1A2,0.77,AROMATIC HYDROXYLATION
[2-methyl-4-(o-tolylazo)phenyl]amine,CC1=CC(N=NC2=CC=CC=C2C)=CC=C1N,,2'-hydroxymethyl-3-raethyl-4-aminoazoberizene,CC1=CC(N=NC2=CC=CC=C2CO)=CC=C1N,,CYP1A2,0.81,ALIPHATIC HYDROXYLATION
[2-methyl-4-(o-tolylazo)phenyl]amine,CC1=CC(N=NC2=CC=CC=C2C)=CC=C1N,,N-hydroxy-oaminoazotohiene,CC1=CC=CC=C1N=NC1=CC=C(NO)C(C)=C1,,CYP1A2,0.83,N-HYDROXYLATION
1_4_cineole,CC(C)C12CCC(C)(CC1)O2,,,CC(C)C12CCC(C)(O1)C(O)C2,,CYP3A4,0.59,Hydroxylation of alicyclic secondary carbon
1_8_cineole,CC12CCC(CC1)C(C)(C)O2,,"2alpha-hydroxy-1,8-cineole",CC1(C)OC2(C)CCC1CC2O,,CYP3A4,0.67,Hydroxylation of alicyclic secondary carbon
1_8_cineole,CC12CCC(CC1)C(C)(C)O2,,"3alpha-hydroxy-1,8-cineole",CC12CCC(C(O)C1)C(C)(C)O2,,CYP3A4,0.71,Hydroxylation of alicyclic secondary carbon
1-(3-chlorophenyl)piperazine,ClC1=CC=CC(N2CCNCC2)=C1,,2‐chloro‐4‐(piperazin‐1‐yl)phenol,OC1=CC=C(N2CCNCC2)C=C1Cl,,CYP2D6,0.77,Hydroxylation of aromatic carbon ortho to halide group
1-(4-methoxyphenyl)piperazine,COC1=CC=C(N2CCNCC2)C=C1,,1-(4-hydroxyphenyl)piperazine,OC1=CC=C(N2CCNCC2)C=C1,,CYP2D6,0.87,O-aryl dealkylation not adjacent to substituted carbon
"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",CN1CC=C(C2=CC=CC=C2)CC1,,1-methyl-4-phenylpyridin-1-ium,C[N+]1=CC=C(C2=CC=CC=C2)C=C1,,CYP2D6,0.08,N_DEHYDROGENATION_OF_ALICYCLIC_TERTIARY_AMINES_PATTERN1
"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",CN1CC=C(C2=CC=CC=C2)CC1,,pOH-MPTP,CN1CC=C(C2=CC=C(O)C=C2)CC1,,CYP2D6,0.87,Aromatic Hydroxylation
1-nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,3-OH-1-nitropyrene,O=[N+]([O-])C1=CC(O)=C2C=CC3=CC=CC4=CC=C1C2=C34,,CYP3A4,0.66,HYDROXYLATION_OF_AROMATIC_CARBON
1-nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,"trans-4,5- Dihydrodiol- 1-nitropyrene",O=[N+]([O-])C1=CC=C2C3=C1C=CC1=CC=CC(=C13)C1OC21,,CYP3A4,0.39,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
1-nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,6-OH-1- nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=C(O)C=CC4=CC=C1C2=C43,,CYP3A4; CYP1A2,0.78,HYDROXYLATION_OF_AROMATIC_CARBON
1-nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,8-OH-1-nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=CC=C(O)C4=CC=C1C2=C34,,CYP1A2,0.78,HYDROXYLATION_OF_AROMATIC_CARBON
"1-propanol, 3-[3-(1-piperidinylmethyl)phenoxy]-",OCCCOC1=CC=CC(CN2CCCCC2)=C1,,,OC1=CC=CC(CN2CCCCC2)=C1,,CYP2D6,0.74,O-dealkylation
"1-propanol, 3-[3-(1-piperidinylmethyl)phenoxy]-",OCCCOC1=CC=CC(CN2CCCCC2)=C1,,,OCCCOC1=CC=CC(CN2CCCCC2O)=C1,,CYP2D6,0.78,Aliphatic Hydroxylation
"1,2-dichlorobenzene",ClC1=CC=CC=C1Cl,,"2,3-dichlorophenol",OC1=CC=CC(Cl)=C1Cl,,CYP1A1; CYP1A2; CYP2E1 (major); CYP3A4,0.42,Hydroxylation of aromatic carbon ortho to halide group
"1,2-dichlorobenzene",ClC1=CC=CC=C1Cl,,"3,4-dichlorophenol",OC1=CC=C(Cl)C(Cl)=C1,,CYP1A1; CYP1A2; CYP2E1 (major); CYP3A4,0.47,Hydroxylation of aromatic carbon para to halide group
"1,2,4-trichlorobenzene",ClC1=CC=C(Cl)C(Cl)=C1,,"2,3,5-trichlorophenol",OC1=CC(Cl)=CC(Cl)=C1Cl,,CYP2E1 (major),0.48,Hydroxylation of aromatic carbon ortho to halide group
"1,2,4-trichlorobenzene",ClC1=CC=C(Cl)C(Cl)=C1,,"2,3,6-trichlorophenol",OC1=C(Cl)C=CC(Cl)=C1Cl,,CYP3A4 (major),0.47,Hydroxylation of aromatic carbon ortho to halide group
"1,2,4-trichlorobenzene",ClC1=CC=C(Cl)C(Cl)=C1,,"2,4,5-trichlorophenol",OC1=CC(Cl)=C(Cl)C=C1Cl,,CYP2E1 (major); CYP1A1,0.48,Hydroxylation of aromatic carbon ortho to halide group
1'-nitrosonornicotine,O=NN1CCCC1C1=CC=CN=C1,,,O=NN1C(O)CCC1C1=CC=CN=C1,,CYP2A6;CYP2D6;CYP2E1;CYP3A4,0.79,Aliphatic Hydroxylation
1'-nitrosonornicotine,O=NN1CCCC1C1=CC=CN=C1,,,O=NN1CCCC1(O)C1=CC=CN=C1,,CYP2A6;CYP2D6;CYP2E1;CYP3A4,0.67,Aliphatic Hydroxylation
2-(1-piperazinyl)pyrimidine,C1=CN=C(N2CCNCC2)N=C1,,,OC1=CN=C(N2CCNCC2)N=C1,,CYP2D6,0.82,Aromatic Hydroxylation
2-acetamidofluorene,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC=C12,,N-Hydroxy-2-acetamidofluorene,CC(=O)N(O)C1=CC=C2C(=C1)CC1=CC=CC=C12,,CYP1A2,0.59,N-hydroxylation of secondary arylamide
2-acetamidofluorene,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC=C12,,1-OH-AFF,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC(O)=C12,,CYP1A2,0.77,Aromatic Hydroxylation
2-acetamidofluorene,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC=C12,,5-OH-AFF,CC(O)=NC1=CC=C2C3=CC=CCC3(O)CC2=C1,,CYP1A2,0.3,Aromatic Hydroxylation
2-acetamidofluorene,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC=C12,,N-Hydroxy-2-acetamidofluorene,CC(=O)N(O)C1=CC=C2C(=C1)CC1=CC=CC=C12,,CYP1A2,0.59,Aromatic Hydroxylation
2-acetylbenzothiophene,CC(=O)C1=CC2=CC=CC=C2S1,,,CC(O)C1CC2CCCCC2S1=O,,CYP1A2;CYP2B6;CYP2E1;CYP3A4,0.09,S-Oxidation
"2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide",N=C(O)C1=C2CCCCN2C(C2=CC=CN=C2)=C1Cl,,rac-RPR 127025,N=C(O)C1=C2C(O)CCCN2C(C2=CC=CN=C2)=C1Cl,,CYP1A2;CYP2C8;CYP2C9;CYP3A4,0.92,Aliphatic Hydroxylation
"2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide",N=C(O)C1=C2CCCCN2C(C2=CC=CN=C2)=C1Cl,,RPR 122701,N=C(O)C1=C2CCCCN2C(C2=CC=C[N+]([O-])=C2)=C1Cl,,CYP2C8,0.97,N-Oxidation
2-naphthylamine,NC1=CC=C2C=CC=CC2=C1,,N-Hydroxy-2-naphthalenamine,ONC1=CC=C2C=CC=CC2=C1,,CYP1A2,0.75,N-hydroxylation of primary arylamine
2-nitropyrene,O=[N+]([O-])C1=CC2=CC=C3C=CC=C4C=CC(=C1)C2=C34,,2-aminopyrene,NC1=CC2=CC=C3C=CC=C4C=CC(=C1)C2=C34,,CYP1A1; CYP1A2,0.56,REDUCTION_OF_NITRO_TO_AMINE
2-oxoquazepam,O=C1CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C2N1CC(F)(F)F,,3-Hydroxy-2-oxoquazepam,O=C1C(O)N=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C2N1CC(F)(F)F,,CYP3A4; CYP2C9,0.9,"3-Hydroxylation of 5-aryl-1,4-benzodiazepine"
2-oxoquazepam,O=C1CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C2N1CC(F)(F)F,,N-Desalkyl-2-oxoquazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2F)=NC1,,CYP3A4; CYP2C9,0.55,N-dealkylation of tertiary carboxamide
2-phenylphenol,OC1=CC=CC=C1C1=CC=CC=C1,,"2,5-dihydroxybiphenyl",OC1=CC=C(O)C(C2=CC=CC=C2)=C1,,CYP1A2; CYP2B6; CYP2D6; CYP2E1; CYP3A4,0.81,Hydroxylation of benzene on carbon para to a strongly electron donating group
2-propylquinoline,CCCC1=CC=C2C=CC=CC2=N1,,,CCCC1=CC=C2C(=N1)C=CC1OC21,,CYP2C9;CYP2E1;CYP3A4,0.22,Epoxidation
2-propylquinoline,CCCC1=CC=C2C=CC=CC2=N1,,,CCCC1=CC=C2C=CC3OC3C2=N1,,CYP2C9;CYP2E1;CYP3A4,0.24,Epoxidation
2-propylquinoline,CCCC1=CC=C2C=CC=CC2=N1,,,OCCCC1=CC=C2C=CC=CC2=N1,,CYP2A6;CYP2C9;CYP2C19;CYP2E1;CYP3A4,0.94,Aliphatic Hydroxylation
2-propylquinoline,CCCC1=CC=C2C=CC=CC2=N1,,,CCC(O)C1=CC=C2C=CC=CC2=N1,,CYP2A6;CYP2C9;CYP2C19;CYP2E1;CYP3A4,0.77,Aliphatic Hydroxylation
"2,2',4,5,5'-pentachlorobiphenyl",ClC1=CC=C(Cl)C(C2=CC(Cl)=C(Cl)C=C2Cl)=C1,,"2,2',4',5,5'-pentachloro-[1,1'-biphenyl]-4-ol",OC1=CC(Cl)=C(C2=CC(Cl)=C(Cl)C=C2Cl)C=C1Cl,,CYP2A6; CYP3A4; CYP2C18,0.74,Hydroxylation of aromatic carbon meta to halide group
"2,2',4,5,5'-pentachlorobiphenyl",ClC1=CC=C(Cl)C(C2=CC(Cl)=C(Cl)C=C2Cl)=C1,,"2,2',4',5,5'-pentachloro-[1,1'-biphenyl]-4-ol",OC1=CC(Cl)=C(C2=CC(Cl)=C(Cl)C=C2Cl)C=C1Cl,,CYP2A6; CYP3A4; CYP2C18,0.74,Hydroxylation of aromatic carbon ortho to halide group
"2,6-dichlorobenzonitrile",N#CC1=C(Cl)C=CC=C1Cl,,,N#CC1=C(Cl)C2OC2C=C1Cl,,CYP2A6,0.06,Epoxidation
"2,6-dichlorobenzonitrile",N#CC1=C(Cl)C=CC=C1Cl,,,N#CC1C(Cl)=CC=C2OC21Cl,,CYP2A6,0.06,Epoxidation
2'-methoxyacetophenone,COC1=CC=CC=C1C(C)=O,,2'-Hydroxyacetophenone,CC(=O)C1=CC=CC=C1O,,CYP2A6,0.75,O-Demethylation
"2h-1-benzopyran-2-one, 4-(chloromethyl)-7-ethoxy-",CCOC1=CC=C2C(CCl)=CC(=O)OC2=C1,,4-(Chloromethyl)-7-hydroxychromen-2-one,O=C1C=C(CCl)C2=CC=C(O)C=C2O1,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.89,O-Deethylation
"2h-1-benzopyran-2-one, 7-(pentyloxy)-",CCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CCC(O)CCOC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.96,Aliphatic Hydroxylation
"2h-1-benzopyran-2-one, 7-(pentyloxy)-",CCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CC(O)CCCOC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.97,Aliphatic Hydroxylation
"2h-1-benzopyran-2-one, 7-(pentyloxy)-",CCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CCCCC(O)OC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.9,Aliphatic Hydroxylation
3-cyano-7-ethoxycoumarin,CCOC1=CC=C2C=C(C#N)C(=O)OC2=C1,,3-Cyano-7-hydroxycoumarin,N#CC1=CC2=CC=C(O)C=C2OC1=O,,"CYP1A2;CYP2A6;CYP2B6;CYP2C9;CYP2C19,CYP2D6;CYP2E1",0.89,O-Demethylation
3-cyano-7-methoxycoumarin,COC1=CC=C2C=C(C#N)C(=O)OC2=C1,,3-Cyano-7-hydroxycoumarin,N#CC1=CC2=CC=C(O)C=C2OC1=O,,CYP1A2;CYP2B6;CYP2C19;CYP2E1,0.92,O-Demethylation
"3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester, (4r)-",CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC([N+](=O)[O-])=C1,,,CCOC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP3A4 ,0.32,Dehydrogenation
"3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid",CC(CCC(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C,,hyocholic acid (HCA),CC(CCC(=O)O)C1CCC2C3C(O)C(O)C4CC(O)CCC4(C)C3CC(O)C12C,,CYP3A4 ,0.8,Aliphatic Hydroxylation
"3alpha,7beta,12beta-trihydroxy-5alpha-cholan-24-oic acid",CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,,,CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(=O)CCC4(C)C3CC(O)C12C,,CYP3A4,0.85,Dehydrogenation
3s14s-ochratoxin a,CC1CC2=C(Cl)C=C(C(O)=NC(CC3=CC=CC=C3)C(=O)O)C(O)=C2C(=O)O1,,,CC1OC(=O)C2=C(O)C(C(O)=NC(CC3=CC=CC=C3)C(=O)O)=CC(Cl)=C2C1O,,CYP1A2;CYP2C9;CYP3A4,0.9,ALIPHATIC HYDROXYLATION
4-(butylaminomethyl)-7-methoxycoumarin,CCCCNCC1=CC(=O)OC2=CC(OC)=CC=C12,,BHAMC,CCCCNCC1=CC(=O)OC2=CC(O)=CC=C12,,CYP1A2;CYP2C9;CYP2C19;CYP2D6,0.94,O-Demethylation
4-(butylaminomethyl)-7-methoxycoumarin,CCCCNCC1=CC(=O)OC2=CC(OC)=CC=C12,,,COC1=CC=C2C(CN)=CC(=O)OC2=C1,,CYP1A2,0.89,N-Demethylation
4-(ethylaminomethyl)-7-methoxycoumarin,CCNCC1=CC(=O)OC2=CC(OC)=CC=C12,,EHAMC,CCNCC1=CC(=O)OC2=CC(O)=CC=C12,,CYP1A2;CYP2C19;CYP2D6,0.93,O-Demethylation
4-(ethylaminomethyl)-7-methoxycoumarin,CCNCC1=CC(=O)OC2=CC(OC)=CC=C12,,MAMC,COC1=CC=C2C(CN)=CC(=O)OC2=C1,,CYP1A2,0.92,N-Dealkylation
"4-(trifluoromethyl)-7-[2,5-bis(trifluoromethyl)benzyloxy]coumarin",O=C1C=C(C(F)(F)F)C2=CC=C(OCC3=CC(C(F)(F)F)=CC=C3C(F)(F)F)C=C2O1,,HFC,O=C1C=C(C(F)(F)F)C2=CC=C(O)C=C2O1,,CYP3A4,0.72,O-Dealklyation
"4-[(s)-alpha-(trichloromethyl)-4-methoxybenzyl]-1,2-benzenediol",COC1=CC=C(C(C2=CC=C(O)C(O)=C2)C(Cl)(Cl)Cl)C=C1,,Tris-OH-M methoxychlor,OC1=CC=C(C(C2=CC=C(O)C(O)=C2)C(Cl)(Cl)Cl)C=C1,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.92,O-demethylation
4-aminobiphenyl,NC1=CC=C(C2=CC=CC=C2)C=C1,,"4-aminobiphenyl, N-oxide",ONC1=CC=C(C2=CC=CC=C2)C=C1,,CYP1A2,0.78,N-hydroxylation of primary arylamine
4-Hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,"3,4-Dihydroxy-Tamoxifen",CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(O)C(O)=C1)C1=CC=CC=C1,,CYP3A4,0.86,Aromatic Hydroxylation
4-methylaminomethyl-7-methoxycoumarin,CNCC1=CC(=O)OC2=CC(OC)=CC=C12,,N-methyl 7-hydroxy-4-(aminomethyl)-coumarin,CNCC1=CC(=O)OC2=CC(O)=CC=C12,,CYP1A2;CYP2D6,0.93,N-Dealkylation
4-nitro-3-(trifluoromethyl)aniline,NC1=CC=C([N+](=O)[O-])C(C(F)(F)F)=C1,,2-amino5-nitro-4-(trifluoromethyl)phenol,NC1=CC(C(F)(F)F)=C([N+](=O)[O-])C=C1O,,CYP1A2;CYP2A6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.75,Aromatic Hydroxylation
4-nitro-3-(trifluoromethyl)aniline,NC1=CC=C([N+](=O)[O-])C(C(F)(F)F)=C1,,N-[4-nitro-3-(trifluoromethyl)phenyl]-acetamide,C[NH+]([O-])C1=CC=C([N+](=O)[O-])C(C(F)(F)F)=C1,,CYP1A2;CYP2A6;CYP2C9;CYP3A4,0.8,N-Hydroxylation; N-Oxidation
4-nitroanisole,COC1=CC=C([N+](=O)[O-])C=C1,,P-Nitrophenol,O=[N+]([O-])C1=CC=C(O)C=C1,,CYP1A2;CYP2A6;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.83,O-Demethylation
4-nitropyrene,O=[N+]([O-])C1=CC2=CC=CC3=CC=C4C=CC=C1C4=C32,,4-aminopyrene,NC1=CC2=CC=CC3=CC=C4C=CC=C1C4=C32,,CYP1A2; CYP3A4,0.53,REDUCTION_OF_NITRO_TO_AMINE
4-nitropyrene,O=[N+]([O-])C1=CC2=CC=CC3=CC=C4C=CC=C1C4=C32,,,O=[N+]([O-])C1=CC2=CC=CC3=C2C2=C(C=CC=C12)C(O)C3O,,CYP1A2,0.41,Epoxidation of arene
"4,4'-methylenebis(2-chloroaniline)",NC1=CC=C(CC2=CC=C(N)C(Cl)=C2)C=C1Cl,,,NC1=CC=C(CC2=CC=C(N[O-])C(Cl)=C2)C=C1Cl,,CYP2A6;CYP3A4,0.84,N-Oxidation
"4'-hydroxy-5,6,7,8-tetramethoxyflavone (tangeretin_T27)",COC1=C(OC)C(OC)=C2C(=O)C=C(C3=CC=C(O)C=C3)OC2=C1OC,,OROBOL,COC1=C(OC)C(OC)=C2C(=O)C=C(C3=CC=C(O)C(O)=C3)OC2=C1OC,,CYP1A2;CYP3A4,0.97,Aromatic Hydroxylation
5-hydroxydiclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,"4',5-Dihydroxydiclofenac",O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,CYP2C9,0.94,Aromatic Hydroxylation
5-methoxytryptamine,COC1=CC=C2NC=C(CCN)C2=C1,,Serotonin,NCCC1=CNC2=CC=C(O)C=C12,,CYP2D6,0.91,O-demethylation
5-methylchrysene,CC1=CC2=CC=CC=C2C2=CC=C3C=CC=CC3=C12,,"5-Methyl-1,2-dihydrochrysene-1,2-diol",CC1=CC2=CC=CC=C2C2=CC=C3C(=C12)C=CC(O)C3O,,CYP1A2;CYP2D6;CYP2E1;CYP3A4,0.19,Aromatic Hydroxylation
58c80,CC(C)(C)C1CCC(C2=C(O)C(=O)C3=CC=CC=C3C2=O)CC1,,298C84,CC(C)(CO)C1CCC(C2=C(O)C(=O)C3=CC=CC=C3C2=O)CC1,,CYP2C9,0.98,Hydroxylation of terminal methyl
6-chrysenamine,NC1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,"6-MeC-1,2-diol",NC1=CC2=C3C=CC(O)C(O)C3=CC=C2C2=CC=CC=C12,,CYP1A2;CYP2A6;CYP2B6;CYP2D6;CYP3A4,0.19,Aromatic Hydroxylation
6-methylchrysene,CC1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,"6-MeC-1,2-diol",CC1=CC2=C3C=CC(O)C(O)C3=CC=C2C2=CC=CC=C12,,CYP1A2;CYP2D6;CYP2E1;CYP3A4,0.2,Epoxidation
6-nitrochrysene,O=[N+]([O-])C1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,N-hydroxy-6-AC,O[NH2+]C1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,CYP1A2;CYP3A4,0.71,Aromatic Hydroxylation
6-nitrochrysene,O=[N+]([O-])C1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,"1,2-DHD-6-NC ",O=[N+]([O-])C1=CC2=C3C=CC(O)C(O)C3=CC=C2C2=CC=CC=C12,,CYP2E1;CYP3A4,0.32,Reduction
7-benzyloxy-4-trifluoromethylcoumarin,O=C1C=C(C(F)(F)F)C2=CC=C(OCC3=CC=CC=C3)C=C2O1,,7-hydroxy-4-triuoromethylcoumarin (HFC),O=C1C=C(C(F)(F)F)C2=CC=C(O)C=C2O1,,CYP2A6;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP2E1,0.85,O-Deethylation
7-benzyloxyquinoline,C1=CC=C(COC2=CC=C3C=CC=NC3=C2)C=C1,,7-Hydroxyquinoline,O=C1C=CC2=CC=CN=C2C1,,CYP1A2;CYP3A4,0.17,O-dealkylation
7-butoxy-2h-chromen-2-one,CCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CCCC(O)OC1CCC2CCC(O)OC2C1,,CYP3A4,0.09,Aliphatic Hydroxylation
7-butoxy-2h-chromen-2-one,CCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CC(O)CCOC1CCC2CCC(O)OC2C1,,CYP3A4,0.09,Aliphatic Hydroxylation
7-butoxy-2h-chromen-2-one,CCCCOC1=CC=C2C=CC(=O)OC2=C1,,,OCCCCOC1CCC2CCC(O)OC2C1,,CYP3A4,0.09,Aliphatic Hydroxylation
7-ethoxycoumarin,CCOC1=CC=C2C=CC(=O)OC2=C1,,Umbelliferone,O=C1C=CC2=CC=C(O)C=C2O1,,CYP1A1 (major); CYP2B6; CYP2E1; CYP1A2; CYP2A6; CYP3A7; CYP2C9; CYP2C19,0.82,O-aryl dealkylation not adjacent to substituted carbon
7-ethoxycoumarin,CCOC1=CC=C2C=CC(=O)OC2=C1,,,CCOC1=CC=C2C(O)=CC(=O)OC2=C1,,CYP1A1 (major); CYP2B6; CYP2E1; CYP1A2; CYP2A6; CYP3A7; CYP2C9; CYP2C19,0.87,Aromatic Hydroxylation
7-methoxycoumarin,COC1=CC=C2C=CC(=O)OC2=C1,,Umbelliferone,O=C1C=CC2=CC=C(O)C=C2O1,,CYP1A2;CYP2A6,0.87,O-dealkylation
7-methoxycoumarin,COC1=CC=C2C=CC(=O)OC2=C1,,4-Hydroxy-7-methoxycoumarin,COC1=CC=C2C(O)=CC(=O)OC2=C1,,CYP1A2;CYP2A6,0.86,Aromatic Hydroxylation
7-methylbenz(c)acridine,CC1=C2C=CC=CC2=NC2=C1C=CC1=CC=CC=C12,,,CC1=C2C(=NC3=C1C=CC1=CC=CC=C13)C=CC(O)C2O,,CYP1A2;CYP3A4,0.31,Aromatic Hydroxylation
7-methylbenz(c)acridine,CC1=C2C=CC=CC2=NC2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=NC2=C1C(O)=C(O)C1=CC=CC=C12,,CYP1A2;CYP3A4,0.58,Aromatic Hydroxylation
7-methylbenz(c)acridine,CC1=C2C=CC=CC2=NC2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=NC2=C1C=CC1=C(O)C(O)=CC=C12,,CYP1A2;CYP3A4,0.73,Aromatic Hydroxylation
7-methylbenz(c)acridine,CC1=C2C=CC=CC2=NC2=C1C=CC1=CC=CC=C12,,,OCC1=C2C=CC=CC2=NC2=C1C=CC1=CC=CC=C12,,CYP1A2;CYP3A4,0.84,Aliphatic Hydroxylation
8-hydroxyefavirenz,OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,"8,14-diOH-efavirenz",OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2(O)CC2)(C(F)(F)F)O1,,CYP2B6,0.97,HYDROXYLATION_OF_ALICYCLIC_SECONDARY_CARBON; HYDROXYLATION_OF_ALICYCLIC_SECONDARY_CARBON_PATTERN1
9-anthraldehyde,O=CC1=C2C=CC=CC2=CC2=CC=CC=C12,,,O=C(O)C1=C2C=CC=CC2=CC2=CC=CC=C12,,CYP2A6;CYP2B6;CYP2C19;CYP2E1;CYP3A4,0.71,Aliphatic Hydroxylation
9-cis-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,4-hydroxy-9-cis-retinals,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,CYP1A2;CYP2C19;CYP3A4,0.9,Aliphatic Hydroxylation
"Lopinavir, D-valine diastereomer-",CC1=CC=CC(C)=C1OCC(O)=NC(CC1=CC=CC=C1)C(O)CC(CC1=CC=CC=C1)N=C(O)C(C(C)C)N1CCCN=C1O,,,CC1=CC=CC(C)=C1OCC(O)=NC(CC1=CC=CC=C1)C(O)CC(CC1=CC=CC=C1)N=C(O)C(C(C)C)N1CCC(O)N=C1O,,CYP3A4,0.95,Aliphatic Hydroxylation
abt_378,CC1=CC=CC(C)=C1OCC(O)=NC(CC1=CC=CC=C1)C(O)CC(CC1=CC=CC=C1)N=C(O)C(C(C)C)N1CCCN=C1O,,,CC1=CC=CC(C)=C1OCC(O)=NC(CC1=CC=CC=C1)C(O)CC(CC1=CC=CC=C1)N=C(O)C(C(C)C)N1CCC(O)=NC1=O,,CYP3A4,0.75,C-Oxidation
1â€[(2S)â€4â€(5â€benzylthiophenâ€2â€yl)butâ€3â€ynâ€2â€yl]â€1â€hydroxyurea,CC(C#CC1=CC=C(CC2=CC=CC=C2)S1)N(O)C(=N)O,,ABT-515,CC(C#CC1=CC=C(C(O)C2=CC=CC=C2)S1)N(O)C(=N)O,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.81,Aliphatic Hydroxylation
"1-[Amino-(3,4-dichloroanilino)methylidene]-2-propan-2-ylguanidine",CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C(Cl)=C1,,,CC(C)(O)NC(=N)NC(=N)NC1=CC=C(Cl)C(Cl)=C1,,CYP2C19;,0.88,Aliphatic Hydroxylation
ac1ldic9,COC(=O)C(C1=CC=CC=C1Cl)N1CCC2=C(C=CS2)C1,,2-oxo-clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N1CCC2=C(CC(=O)S2)C1,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2D6;CYP2C1;CYP3A4,0.54,C-Oxidation
ac1mip3e,CCN(CC)CC#CC(C)(C)OC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,N-deethylated  ac1mip3e,CCNCC#CC(C)(C)OC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,CYP3A4,0.99,N-deethylation
[5-(Diethylamino)-2-methylpent-3-yn-2-yl] (2S)-2-cyclohexyl-2-hydroxy-2-phenylacetate,CCN(CC)CC#CC(C)(C)OC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,4-cis-OH ac1mip3e,CCN(CC)CC#CC(C)(C)OC(=O)C(O)(C1=CC=CC=C1)C1CCC(O)CC1,,CYP3A4,0.98,Aliphatic Hydroxylation
ac1ocg1j,CNC(C)CC1=CC=CC=C1OC,,,CNC(C)CC1=CC=CC=C1O,,CYP2D6,0.79,O-demethylation
ac1ocg1j,CNC(C)CC1=CC=CC=C1OC,,,CNC(C)CC1=CC(O)=CC=C1OC,,CYP2D6,0.86,Aromatic Hydroxylation
pimobendan,COC1=CC=C(C2=NC3=CC(C4=NN=C(O)CC4C)=CC=C3N2)C=C1,,,CC1CC(O)=NN=C1C1=CC=C2NC(C3=CC=C(O)C=C3)=NC2=C1,,CYP1A2;CYP3A4,0.98,N-demethylation
acetanilide,CC(O)=NC1=CC=CC=C1,,Acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,CYP1A2; CYP2E1,0.73,p-Hydroxylation of anilide
acetanilide,CC(O)=NC1=CC=CC=C1,,N-Hydroxy-N-phenylacetamide,CC(=O)N(O)C1=CC=CC=C1,,CYP2E1,0.16,N-hydroxylation of anilide
adinazolam,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N21,,N-demethyladinazolam,CNCC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N21,,CYP2C19;CYP3A4,0.98,N-demethylation
aflatoxin b1,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C=COC1O2,," Aflatoxin B1- exo-8,9-oxide ",COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C(O2)OC2OC21,,CYP1A2; CYP3A5; CYP3A4; CYP2A13 ,0.88,Epoxidation of vinyl ether
aflatoxin b1,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C=COC1O2,,Aflatoxin M1 ,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1(O)C=COC1O2,,CYP1A2 ,0.92,Allylic hydroxylation
aflatoxin b1,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C=COC1O2,,Aflatoxin Q1 ,COC1=CC2=C(C3=C1C1=C(C(=O)CC1O)C(=O)O3)C1C=COC1O2,,CYP3A4 ,0.95,Allylic hydroxylation
albendazole,CCCSC1=CC=C2N=C(N=C(O)OC)NC2=C1,,,CCCS(=O)C1=CC=C2N=C(N=C(O)OC)NC2=C1,,CYP1A2;CYP3A4,0.85,S-Oxidation
alfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCN2N=NN(CC)C2=O)CC1,,N-phenylpropionamide,CCC(O)=NC1=CC=CC=C1,,CYP3A4,0.09,N-dealkylation of tertiary carboxamide
alfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCN2N=NN(CC)C2=O)CC1,,"2‐(4‐ethyl‐5‐oxo‐1,2,3,4‐tetrazol‐1‐yl)acetaldehyde",CCN1N=NN(CC=O)C1=O,,CYP3A4,0.25,N-dealkylation of alicyclic tertiary amine
alilusem,CC1=CC=CC=C1C(=O)N1CCC(=NOS(=O)(=O)O)C2=CC=C(Cl)C=C21,,,O=C(C1=CC=CC=C1CO)N1CCC(=NOS(=O)(=O)O)C2=CC=C(Cl)C=C21,,CYP2C9;CYP3A4,0.97,Aliphatic Hydroxylation
almotriptan,CN(C)CCC1=CNC2=CC=C(CS(=O)(=O)N3CCCC3)C=C12,,2-OH-almotriptan,CN(C)CCC1=CNC2=CC=C(CS(=O)(=O)N3CCCC3O)C=C12,,CYP2D6; CYP3A4,0.87,Hydroxylation of heteroalicyclic secondary carbon
almotriptan,CN(C)CCC1=CNC2=CC=C(CS(=O)(=O)N3CCCC3)C=C12,,methyl(2-{5-[(pyrrolidine-1-sulfonyl)methyl]-1H-indol-3-yl}ethyl)amine,CNCCC1=CNC2=CC=C(CS(=O)(=O)N3CCCC3)C=C12,,CYP1A2; CYP2C8; CYP2E1; CYP2D6; CYP3A4,0.99,N-dealkylation of acyclic tertiary amine
alpha_dihydroergocryptine,CC(C)C1(N=C(O)C2CC3C4=CC=CC5=C4C(=CN5)CC3N(C)C2)OC2(O)C3CCCN3C(=O)CN2C1=O,,,CC(C)C1(N=C(O)C2CC3C4=CC=CC5=C4C(=CN5)CC3N(C)C2)OC2(O)C3CCC(O)N3C(=O)CN2C1=O,,CYP3A4,0.99,Aliphatic Hydroxylation
alpha-thujone,CC1C(=O)CC2(C(C)C)CC12,,4-hydroxy-alpha-thujone,CC(C)C12CC(=O)C(C)(O)C1C2,,CYP2A6; CYP2B6; CYP2D6; CYP3A4,0.55,Hydroxylation of penultimate aliphatic tertiary carbon
alpha-thujone,CC1C(=O)CC2(C(C)C)CC12,,7-hydroxy-alpha-thujone,CC1C(=O)CC2(C(C)(C)O)CC12,,CYP2A6; CYP2B6; CYP2D6; CYP3A4,0.61,Hydroxylation of penultimate aliphatic tertiary carbon
alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,,4-Hydroxyalprazolam,CC1=NN=C2C(O)N=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,,CYP3A4 (major); CYP2C9 (minor),0.87,Hydroxylation of heteroalicyclic secondary carbon
alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,,Beta-Hydroxyalprazolam,OCC1=NN=C2C(O)N=C(C3=CC=CC=C3)C3=CC=CC=C3N12,,CYP2C9 (minor); CYP2C19 (minor); CYP3A4 (minor),0.8,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
ambroxol,NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1,,"4-Aminocyclohexanol, cis-",NC1CCC(O)CC1,,CYP3A4,0.17,N-dealkylation of acyclic secondary amine
ambroxol,NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1,,"2-Amino-3,5-dibromobenzaldehyde",NC1=C(Br)C=C(Br)C=C1C=O,,CYP3A4,0.46,N-dealkylation of acyclic secondary amine
Ametryn,CCN=C1N=C(SC)NC(=NC(C)C)N1,,,CSC1=NC(=N)NC(=NC(C)C)N1,,CYP1A1; CYP1A2; CYP2C19; CYP3A4,0.98,N-dealkylation of secondary arylalkylamine
Ametryn,CCN=C1N=C(SC)NC(=NC(C)C)N1,,,CCN=C1NC(SC)=NC(=N)N1,,CYP1A1; CYP1A2; CYP2C8; CYP2C9; CYP2C19; CYP3A4,0.91,N-deisopropylation
aminopyrine,CN(C)C1=CN(C)N(C2=CC=CC=C2)C1=O,,"4-(Dimethylamino)-5-methyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one",CN(C)C1=CNN(C2=CC=CC=C2)C1=O,,CYP2C19; CYP2C8; CYP2D6; CYP2C18; CYP1A2,0.76,N-dealkylation of hydrazide
aminopyrine,CN(C)C1=CN(C)N(C2=CC=CC=C2)C1=O,,N-Desmethylaminopyrine,CNC1=CN(C)N(C2=CC=CC=C2)C1=O,,CYP1A2; CYP3A4; CYP2C18; CYP2C19; CYP2C8; CYP2C9; CYP2D6,0.95,N-dealkylation of acyclic tertiary amine
amiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=CC=CC=C2O1,,N-Desethylamiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCNCC)C(I)=C2)C2=CC=CC=C2O1,,CYP3A4; CYP2C8; CYP2C9; CYP1A2; CYP2D6,0.99,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES
androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,,6beta-hydroxy-androstenedione,CC12CCC3C(CC(O)C4=CC(=O)CCC43C)C1CCC2=O,,CYP3A4,0.73,Hydroxylation of carbon gamma to conjugated carbonyl
aprepitant,CC(OC1OCCN(CC2=NC(O)=NN2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,"5‐oxo‐1,4‐dihydro‐1,2,4‐triazole‐3‐carbaldehyde",O=CC1=NNC(O)=N1,,CYP3A4; CYP3A5; CYP1A2; CYP2C19,0.13,N-dealkylation of alicyclic tertiary amine
aprepitant,CC(OC1OCCN(CC2=NC(O)=NN2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,"(2R,3S)‐2‐[(1R)‐1‐[3,5‐bis(trifluoromethyl)phenyl]ethoxy]‐3‐(4‐fluorophenyl)morpholine",CC(OC1OCCNC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,CYP3A4; CYP3A5; CYP1A2; CYP2C19,0.74,N-dealkylation of alicyclic tertiary amine
aprepitant,CC(OC1OCCN(CC2=NC(O)=NN2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,"1‐[3,5‐bis(trifluoromethyl)phenyl]ethanone",CC(=O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,CYP3A4; CYP3A5; CYP1A2; CYP2C19,0.21,O-dealkylation of dialkylether
aprepitant,CC(OC1OCCN(CC2=NC(O)=NN2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,"5‐{[(2S,3S)‐3‐(4‐fluorophenyl)‐2‐hydroxymorpholin‐4‐yl]methyl}‐2,4‐dihydro‐1,2,4‐triazol‐3‐one",OC1=NNC(CN2CCOC(O)C2C2=CC=C(F)C=C2)=N1,,CYP3A4; CYP3A5; CYP1A2; CYP2C19,0.75,O-dealkylation of dialkylether
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,20-HETE,O=C(O)CCCC=CCC=CCC=CCC=CCCCCCO,,CYP1A1; CYP1A2; CYP2A6,0.96,Hydroxylation of terminal methyl
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,19-HETE,CC(O)CCCC=CCC=CCC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2C8; CYP2C9; CYP2C19; CYP2E1,0.89,Hydroxylation of penultimate aliphatic secondary carbon
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,18-HETE,CCC(O)CCC=CCC=CCC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2E1,0.81,Hydroxylation of acyclic aliphatic secondary carbon
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,16-HETE,CCCCC(O)C=CCC=CCC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2,0.72,Allylic hydroxylation
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,"14,15-EET",CCCCCC1OC1CC=CCC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6,0.47,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,"11,12-EET",CCCCCC=CCC1OC1CC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6,0.53,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,"8,9-EET",CCCCCC=CCC=CCC1OC1CC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6,0.53,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,"5,6-EET",CCCCCC=CCC=CCC=CCC1OC1CCCC(=O)O,,CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6,0.38,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,11-HETE,CCCCCC=CC=CC(O)CC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2C8,0.63,"Aliphatic hydroxylation of acyclic 1,2-disubstituted alkene"
aripiprazole,OC1=NC2=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=CC=C2CC1,,dehydro-aripiprazole,OC1=CC=C2C=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=CC2=N1,,CYP3A4,0.54,"Dehydrogenation of alpha,beta-unsaturated amide"
aripiprazole,OC1=NC2=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=CC=C2CC1,,4-Hydroxyaripiprazole,OC1=NC2=CC(OCCCCN3CCN(C4=CC=C(O)C(Cl)=C4Cl)CC3)=CC=C2CC1,,CYP2D6,0.94,Hydroxylation of aromatic carbon ortho to halide group
aripiprazole,OC1=NC2=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=CC=C2CC1,,"2,3‐dichlorophenylpiperazine",ClC1=CC=CC(N2CCNCC2)=C1Cl,,CYP3A4,0.41,N-dealkylation of alicyclic tertiary amine
aripiprazole,OC1=NC2=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=CC=C2CC1,,"4‐[(2‐oxo‐3,4‐dihydro‐1H‐quinolin‐7‐yl)oxy]butanal",O=CCCCOC1=CC=C2CCC(O)=NC2=C1,,CYP3A4,0.66,N-dealkylation of alicyclic tertiary amine
arverapamil,COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,"(2R)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(3-methoxyphenyl)-2-(propan-2-yl)pentanenitrile",COC1=CC=CC(C(C#N)(CCCNCCC2=CC=C(OC)C(OC)=C2)C(C)C)=C1,,CYP2C8; CYP3A4; CYP2D6,0.99,O-aryl dealkylation adjacent to substituted carbon
arverapamil,COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,(2R)-5-amino-2-(3-methoxyphenyl)-2-(propan-2-yl)pentanenitrile,COC1=CC=CC(C(C#N)(CCCN)C(C)C)=C1,,CYP2C8; CYP3A4; CYP2D6,0.79,N-dealkylation of acyclic secondary amine
arverapamil,COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,"2-(3,4-dimethoxyphenyl)acetaldehyde",COC1=CC=C(CC=O)C=C1OC,,CYP2C8; CYP3A4; CYP2D6,0.41,N-dealkylation of acyclic secondary amine
astemizole,COC1=CC=C(CCN2CCC(N=C3NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,6-Hydroxyastemizole,COC1=CC=C(CCN2CCC(N=C3NC4=CC=C(O)C=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,CYP2D6; CYP3A4 (minor),0.93,Aromatic hydroxylation of fused benzene ring
astemizole,COC1=CC=C(CCN2CCC(N=C3NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,6-desmethylastermizole,OC1=CC=C(CCN2CCC(N=C3NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,CYP2D6,0.98,O-aryl dealkylation not adjacent to substituted carbon
astemizole,COC1=CC=C(CCN2CCC(N=C3NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,norastemizole,FC1=CC=C(CN2C(=NC3CCNCC3)NC3=CC=CC=C32)C=C1,,CYP3A4 (minor),0.85,N-dealkylation of alicyclic tertiary amine
astemizole,COC1=CC=C(CCN2CCC(N=C3NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,2-(4-hydroxyphenyl)acetaldehyde,O=CCC1=CC=C(O)C=C1,,CYP3A4 (minor),0.13,N-dealkylation of alicyclic tertiary amine
atorvastatin,CC(C)C1=C(C(O)=NC2=CC=CC=C2)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,,,CC(C)C1=C(C(O)=NC2=CC=CC=C2O)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,,CYP3A4,0.99,Aromatic Hydroxylation
atorvastatin,CC(C)C1=C(C(O)=NC2=CC=CC=C2)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,,,CC(C)C1=C(C(=O)NC2=CC=C(O)C=C2)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,,CYP3A4,0.78,Aromatic Hydroxylation
barnidipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(CC3=CC=CC=C3)C2)C1C1=CC=CC([N+](=O)[O-])=C1,,,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCNC2)C1C1=CC=CC([N+](=O)[O-])=C1,,CYP2A6;CYP2D6;CYP3A4,0.93,N-dealkylation
barnidipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(CC3=CC=CC=C3)C2)C1C1=CC=CC([N+](=O)[O-])=C1,,,COC(=O)C1=C(C)NC(C)=C(C(=O)O)C1C1=CC=CC([N+](=O)[O-])=C1,,CYP2A6;CYP2D6;CYP3A4,0.83,O-dealkylation
barnidipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(CC3=CC=CC=C3)C2)C1C1=CC=CC([N+](=O)[O-])=C1,,,COC(=O)C1=C(C)N=C(C)C(C(=O)OC2CCN(CC3=CC=CC=C3)C2)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP2A6;CYP2D6;CYP3A4,0.45,Dehydrogenation
"benzeneethanol, 2-[(2,6-dichlorophenyl)amino]- (reduced_diclofenac)",OCCC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,,,OCCC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,CYP1A2;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.84,Aromatic Hydroxylation
"benzo(a)pyrene-7,8-diol",OC1=CC=C2C(=C1O)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,,OC1=C(O)C2=C(O2)C2=C1C=C1C=CC3=CC=CC4=CC=C2C1=C34,,CYP1A2,0.36,Epoxidation
bergapten,COC1=C2C=COC2=CC2=C1C=CC(=O)O2,,,COC1=C2C(=CC3=C1C=CC(=O)O3)OC1OC21,,CYP2D6,0.44,Epoxidation
beta_arteether,CCOC1OC2OC3(C)CCCC4C(C)CCC(C1C)C24OO3,,DIHYDROQINGHAOSU,CC1CCC2C(C)C(O)OC3OC4(C)CCCC1C32OO4,,CYP2B6;CYP3A4,0.99,O-dealkylation
beta-artelinic acid,CC1CCC2C(C)C(OCC3=CC=C(C(=O)O)C=C3)OC3OC4(C)CCC1C32OO4,,Dihydroqinghaosu (DQHS),CC1CCC2C(C)C(O)OC3OC4(C)CCC1C32OO4,,CYP3A4,0.81,O-Debenzylation
beta-methylstyrene,CC=CC1=CC=CC=C1,,2-methyl-3-phenyloxirane,CC1OC1C1=CC=CC=C1,,CYP1A2;CYP2E1;CYP3A4,0.18,Epoxidation
beta-methylstyrene,CC=CC1=CC=CC=C1,,,OCC=CC1=CC=CC=C1,,CYP1A2;CYP2E1;CYP3A4,0.83,Aliphatic Hydroxylation
bms_275183,COC(=O)OC12COC1CC(O)C1(C)C(=O)C(OC(C)=O)C3=C(C)C(OC(=O)C(O)C(N=C(O)OC(C)(C)C)C(C)(C)C)CC(O)(C(OC(=O)C4=CC=CC=C4)C21)C3(C)C,,,COC(=O)OC12COC1CC(O)C1(C)C(=O)C(OC(C)=O)C3=C(C)C(OC(=O)C(O)C(N=C(O)OC(C)(C)C)C(C)(C)CO)CC(O)(C(OC(=O)C4=CC=CC=C4)C21)C3(C)C,,CYP3A4,0.99,Aliphatic Hydroxylation
brn 4201400,CC1=NC2=C(N1)N(CC1CCCCC1)C(=O)N(C)C2=O,,,CN1C(=O)C2=C(NC(CO)=N2)N(CC2CCCCC2)C1=O,,CYP1A2,0.96,Aliphatic Hydroxylation
brofaromine,COC1=CC(Br)=C2OC(C3CCNCC3)=CC2=C1,,O-desmethyl-brofaromine,OC1=CC(Br)=C2OC(C3CCNCC3)=CC2=C1,,CYP2D6,0.95,O-aryl demethylation
bromocriptine,CC(C)CC1C(=O)N2CCCC2C2(O)OC(N=C(O)C3C=C4C5=CC=CC6=C5C(=C(Br)N6)CC4N(C)C3)(C(C)C)C(=O)N12,,,CC(C)CC1C(=O)N2CC(O)CC2C2(O)OC(N=C(O)C3C=C4C5=CC=CC6=C5C(=C(Br)N6)CC4N(C)C3)(C(C)C)C(=O)N12,,CYP3A4,0.99,Aliphatic Hydroxylation
bropirimine,N=C1N=C(O)C(Br)=C(C2=CC=CC=C2)N1,,m-hydroxybropirimine,N=C1N=C(O)C(Br)=C(C2=CC=CC(O)=C2)N1,,CYP1A2,0.88,m-Hydroxylation of monosubstituted benzene
bropirimine,N=C1N=C(O)C(Br)=C(C2=CC=CC=C2)N1,,p-hydroxybropirimine,N=C1NC(C2=CC=C(O)C=C2)=C(Br)C(=O)N1,,CYP1A2,0.61,p-Hydroxylation of monosubstituted benzene
brotizolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(SC(Br)=C3)N12,,alpha-OH-BRT,OCC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(SC(Br)=C3)N12,,CYP3A4,0.95,Aliphatic Hydroxylation
brotizolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(SC(Br)=C3)N12,,6-OH-BRT,CC1=NN=C2C(O)N=C(C3=CC=CC=C3Cl)C3=C(SC(Br)=C3)N12,,CYP3A4,0.91,Aliphatic Hydroxylation
caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,,Paraxanthine,CN1C(O)=NC2=C(C1=O)N(C)C=N2,,CYP1A2,0.62,N-dealkylation of N-acylurea
caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,,Theobromine,CC1C(O)=NC(=O)C2=C1N=CN2C,,CYP1A2 (major); CYP2E1 (minor),0.27,N-dealkylation of N-acylurea
caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,,Theophylline,CN1C(=O)C2=C(NC=N2)N(C)C1=O,,CYP1A2 (major); CYP2C8 (minor); CYP2C9 (minor); CYP3A4 (minor); CYP2E1 (minor),0.91,N-dealkylation of mixed tertiary amine
caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,,"1,3,7-Trimethyluric acid",CN1C(=O)C2=C(N=C(O)N2C)N(C)C1=O,,CYP1A2 (major); CYP2C8 (minor); CYP2C9 (minor); CYP3A4 (minor); CYP2E1 (minor),0.85,HYDROXYLATION_OF_AROMATIC_CARBON_ADJACENT_TO_N
carbamazepine,N=C(O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,," Carbamazepine 10,11-epoxide ",N=C(O)N1C2=CC=CC=C2C2OC2C2=CC=CC=C21,,CYP3A4; CYP2C8 ,0.51,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
carbamazepine,N=C(O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,,2-Hydroxycarbamazepine ,N=C(O)N1C2=CC=CC=C2C=CC2=CC(O)=CC=C21,,CYP3A4; CYP2C8,0.87,Aromatic hydroxylation of fused benzene ring
carbamazepine,N=C(O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,,3-Hydroxycarbamazepine ,N=C(O)N1C2=CC=CC=C2C=CC2=CC=C(O)C=C21,,CYP3A4; CYP2C8 ,0.85,Aromatic hydroxylation of fused benzene ring
carbamazepine,N=C(O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,,9-Hydroxycarbamazepine ,N=C(O)N1C2=CC=CC=C2C=CC2=C(O)C=CC=C21,,CYP3A4; CYP2C8 ,0.78,Aromatic hydroxylation of fused benzene ring
carbaryl,CN=C(O)OC1=CC=CC2=CC=CC=C12,,4-hydroxycarbaryl,CN=C(O)OC1=CC=CC2=C(O)C=CC=C12,,CYP1A2;CYP2B6;CYP2C19;CYP3A4,0.91,Aromatic Hydroxylation
carbaryl,CN=C(O)OC1=CC=CC2=CC=CC=C12,,5-hydroxycarbaryl,CN=C(O)OC1=CC=C(O)C2=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C19;CYP3A4,0.92,Aromatic Hydroxylation
carbaryl,CN=C(O)OC1=CC=CC2=CC=CC=C12,,carbaryl methylol,OCN=C(O)OC1=CC=CC2=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C19;CYP3A4,0.93,Aliphatic Hydroxylation
Carbofuran,CN=C(O)OC1=CC=CC2=C1OC(C)(C)C2,,e-hydroxy-carbofuran,CN=C(O)OC1=CC=CC2=C1OC(C)(C)C2O,,CYP1A2; CYP2C19; CYP3A4,0.79,Hydroxylation of alicyclic secondary carbon
cerivastatin,COCC1=C(C(C)C)N=C(C(C)C)C(C=CC(O)CC(O)CC(=O)O)=C1C1=CC=C(F)C=C1,,,CC(C)C1=NC(C(C)C)=C(CO)C(C2=CC=C(F)C=C2)=C1C=CC(O)CC(O)CC(=O)O,,CYP2C8;CYP3A4,0.96,O-Demethylation 
cerivastatin,COCC1=C(C(C)C)N=C(C(C)C)C(C=CC(O)CC(O)CC(=O)O)=C1C1=CC=C(F)C=C1,,,COCC1=C(C(C)CO)N=C(C(C)C)C(C=CC(O)CC(O)CC(=O)O)=C1C1=CC=C(F)C=C1,,CYP2C8,0.95,Aliphatic Hydroxylation
cevimeline,CC1OC2(CS1)CN1CCC2CC1,,,CC1OC2(CN3CCC2CC3)CS1=O,,CYP2C19;CYP2D6;CYP3A4;CYP1A2;CYP2A6;CYP2E1,0.82,S-Oxidation
(R)-colchicine,COC1=CC2=C(C3=CC=C(OC)C(=O)C=C3C(N=C(C)O)CC2)C(OC)=C1OC,,2-demethyicolchicine,COC1=CC2=C(C3=CC=C(OC)C(=O)C=C3C(N=C(C)O)CC2)C(OC)=C1O,,CYP3A4,0.99,O-demethylation 
(R)-colchicine,COC1=CC2=C(C3=CC=C(OC)C(=O)C=C3C(N=C(C)O)CC2)C(OC)=C1OC,,Colchiceine,COC1=CC2=C(C3=CC=C(O)C(=O)C=C3C(N=C(C)O)CC2)C(OC)=C1OC,,CYP3A4,0.99,O-demethylation 
{4-[5-(4-Fluoro-phenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenyl-ethyl)-amine,CSC1=NC(C2=CC=C(F)C=C2)=C(C2=CC=NC(NC(C)C3=CC=CC=C3)=C2)N1,,,CC(NC1=CC(C2=C(C3=CC=C(F)C=C3)N=C(S(C)(=O)=O)N2)=CC=N1)C1=CC=CC=C1,,CYP1A2;CYP2C19;CYP2D6;CYP3A4,0.92,S-OXIDATION
{4-[5-(4-Fluoro-phenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenyl-ethyl)-amine,CSC1=NC(C2=CC=C(F)C=C2)=C(C2=CC=NC(NC(C)C3=CC=CC=C3)=C2)N1,,,CS(=O)C1=NC(C2=CC=C(F)C=C2)=C(C2=CC(=N)NC=C2)N1,,CYP3A4,0.57,N-dealkylation
{4-[5-(4-Fluoro-phenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenyl-ethyl)-amine,CSC1=NC(C2=CC=C(F)C=C2)=C(C2=CC=NC(NC(C)C3=CC=CC=C3)=C2)N1,,,CC(NC1=CC(C2=C(C3=CC=C(F)C=C3)N=C(S(C)=O)N2)=CC=[N+]1O)C1=CC=CC=C1,,CYP3A4,0.86,N-oxidation
reduced_haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,,CPHP,OC1(C2=CC=C(Cl)C=C2)CCNCC1,,CYP3A4,0.72,N-Demethylation
reduced_haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,,haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,,CYP3A4,0.84,Dehydrogenation
DRF_4367,COC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(N)(=O)=O)C(CO)=C2)C=C1,,,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(O)C=C2)C=C1CO,,CYP2C19;CYP2D6,0.99,O-demethylation
benzodioxolyl-butanamine (BDB),CCC(N)CC1=CC=C2OCOC2=C1,,DHABB,CCC(N)CC1=CC=C(O)C(O)=C1,,CYP2C19;CYP2D6;CYP3A4,0.69,O-demethylenation
itraconazole,CCC(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=CC=C(Cl)C=C6Cl)O5)C=C4)CC3)C=C2)C1=O,,Hydroxy-iteraconazole,CC(O)C(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=CC=C(Cl)C=C6Cl)O5)C=C4)CC3)C=C2)C1=O,,CYP3A4,0.98,Aliphatic Hydroxylation
itraconazole,CCC(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=CC=C(Cl)C=C6Cl)O5)C=C4)CC3)C=C2)C1=O,,keto-iteraconazole ,CC(=O)C(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=CC=C(Cl)C=C6Cl)O5)C=C4)CC3)C=C2)C1=O,,CYP3A4,0.97,C-Oxidation
itraconazole,CCC(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=CC=C(Cl)C=C6Cl)O5)C=C4)CC3)C=C2)C1=O,,N-Desalkyl-iteraconazole,OC1=NN=CN1C1=CC=C(N2CCN(C3=CC=C(OCC4COC(CN5C=NC=N5)(C5=CC=C(Cl)C=C5Cl)O4)C=C3)CC2)C=C1,,CYP3A4,0.85,N-Desalkylation
NE-100,CCCN(CCC)CCC1=CC=C(OC)C(OCCC2=CC=CC=C2)=C1,,,CCCN(CCC)CCC1=CC=C(OC)C(OCCC2=CC=CC(O)=C2)=C1,,CYP2D6;CYP3A4,0.98,Aromatic Hydroxylation
NE-100,CCCN(CCC)CCC1=CC=C(OC)C(OCCC2=CC=CC=C2)=C1,,,CCCNCCC1=CC=C(OC)C(OCCC2=CC=CC=C2)=C1,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.93,N-DEMETHYLATION
NE-100,CCCN(CCC)CCC1=CC=C(OC)C(OCCC2=CC=CC=C2)=C1,,,CCCN(CCC)CCC1=CC=C(O)C(OCCC2=CC=CC=C2)=C1,,CYP2C9;CYP2C19;CYP2D6,0.96,O-DEMETHYLATION
(R)-m-Methoxyamphetamine,COC1=CC=CC(CC(C)N)=C1,,,CC(N)CC1=CC=CC(O)=C1,,CYP2D6,0.8,O-DEMETHYLATION
(R)-m-Methoxyamphetamine,COC1=CC=CC(CC(C)N)=C1,,,COC1=CC(CC(C)N)=CC=C1O,,CYP2D6,0.8,Aromatic Hydroxylation
(R)-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,,,CCC(C1=CC=C(O)C=C1)C1=C(O)C2=CC=CC=C2OC1=O,,CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.98,Aromatic Hydroxylation
(R)-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,,,CCC(C1=CC=CC=C1)C1=C(O)C2=CC(O)=CC=C2OC1=O,,CYP2C9;CYP2C19;CYP3A4,0.96,Aromatic Hydroxylation
(R)-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,,,CCC(C1=CC=CC=C1)C1=C(O)C2=CC=C(O)C=C2OC1=O,,CYP2C9;CYP2C19;CYP3A4,0.98,Aromatic Hydroxylation
pantoprazole,COC1=CC=NC(CS(=O)C2=NC3=CC=C(OC(F)F)C=C3N2)=C1OC,,,COC1=C(OCO)C=CN=C1CS(=O)C1=NC2=CC=C(OC(F)F)C=C2N1,,CYP2C19,0.98,Aliphatic Hydroxylation
"(2S,3R)-3-(4-Hydroxy-phenyl)-2-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-2,3-dihydro-benzo[1,4]oxathiin-6-ol",OC1=CC=C(C2SC3=CC(O)=CC=C3OC2C2=CC=C(OCCN3CCCCC3)C=C2)C=C1,,,O=S1C2=CC(O)=CC=C2OC(C2=CC=C(OCCN3CCCCC3)C=C2)C1C1=CC=C(O)C=C1,,CYP3A4,0.84,S-Oxidation
"(2S,3R)-3-(4-Hydroxy-phenyl)-2-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-2,3-dihydro-benzo[1,4]oxathiin-6-ol",OC1=CC=C(C2SC3=CC(O)=CC=C3OC2C2=CC=C(OCCN3CCCCC3)C=C2)C=C1,,,CCCCCNCCOC1=CC=C(C2OC3=CC=C(O)C=C3SC2C2=CC=C(O)C=C2)C=C1,,CYP3A4,0.98,S-Dealkylation
PNU-96391,CCCN1CCCC(C2=CC=CC(S(C)(=O)=O)=C2)C1,,,CS(=O)(=O)C1=CC=CC(C2CCCNC2)=C1,,CYP1A2;CYP2C19;CYP2D6;CYP3A4,0.9,N-dealkylation
4Ã¢â‚¬Â[(dimethylamino)methyl]Ã¢â‚¬Â7Ã¢â‚¬ÂmethoxychromenÃ¢â‚¬Â2Ã¢â‚¬Âone,COC1=CC=C2C(CN(C)C)=CC(=O)OC2=C1,,,CNCC1=CC(=O)OC2=CC(OC)=CC=C12,,CYP1A2,0.98,N-dealkylation
4Ã¢â‚¬Â[(dimethylamino)methyl]Ã¢â‚¬Â7Ã¢â‚¬ÂmethoxychromenÃ¢â‚¬Â2Ã¢â‚¬Âone,COC1=CC=C2C(CN(C)C)=CC(=O)OC2=C1,,,CN(C)CC1=CC(=O)OC2=CC(O)=CC=C12,,CYP1A2;CYP2C19;CYP2D6,0.93,N-dealkylation
bpr-0L075,COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC(C(=O)C2=CNC3=CC(O)=CC=C23)=CC(O)=C1OC,,CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.98,O-Demethylation
bpr-0L075,COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC(C(=O)C2=CNC3=CC(O)=CC=C23)=CC(O)=C1OC,,CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.98,O-Demethylation
bpr-0L075,COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC=C2C(C(=O)C3=CC(OC)=C(O)C(OC)=C3)=CNC2=C1,,CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.98,O-Demethylation
bpr-0L075,COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC(C(=O)C2=CNC3=CC(O)=CC=C23)=CC(OC)=C1OC,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.98,O-Demethylation
"(6-methoxy-1H-indol-3-yl)-(3,4,5-trimethoxyphenyl)methanone",COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC(C(=O)C2=CNC3=C(O)C(OC)=CC=C23)=CC(OC)=C1OC,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.9,Aliphatic Hydroxylation
"(6-methoxy-1H-indol-3-yl)-(3,4,5-trimethoxyphenyl)methanone",COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC2=C(C=C1O)C(C(=O)C1=CC(OC)=C(OC)C(OC)=C1)=CN2,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.95,Aliphatic Hydroxylation
CTK0G1203,CC(NC(=NC#N)N=C1C=CNC=C1)C(C)(C)C,,,CC(NC(=NC#N)NC1=CC=[N+]([O-])C=C1)C(C)(C)C,,CYP3A4,0.39,N-Oxidation
CTK0G1203,CC(NC(=NC#N)N=C1C=CNC=C1)C(C)(C)C,,,CC(N=C(N=C1C=CNC=C1)NC(=N)O)C(C)(C)C,,CYP3A4,0.52,C-Oxidation
N-(1-Phenyl-1H-pyrazole-5-yl)-p-toluenesulfonamide,CC1=CC=C(S(=O)(=O)NC2=CC=NN2C2=CC=CC=C2)C=C1,,,O=S(=O)(NC1=CC=NN1C1=CC=CC=C1)C1=CC=C(CO)C=C1,,CYP2C8;CYP2C9;CYP2C19,0.97,Aliphatic Hydroxylation
N-(1-Phenyl-1H-pyrazole-5-yl)-p-toluenesulfonamide,CC1=CC=C(S(=O)(=O)NC2=CC=NN2C2=CC=CC=C2)C=C1,,,CC1=CC=C(S(=O)(=O)NC2=CC=NN2C2=CC=C(O)C=C2)C=C1,,CYP2C8;CYP2C19,0.95,Aliphatic Hydroxylation
terfenadine,CC(C)(C)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,,hydroxyterfenadine,CC(C)(CO)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,,CYP2D6;CYP3A4,0.93,Aliphatic Hydroxylation
terfenadine,CC(C)(C)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,,azacyclonol,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C1CCNCC1,,CYP3A4,0.86,N-Dealkylation
2prime_hydroxy_indomethacin_phenethylamide,COC1=CC=C2C(=C1)C(CC(O)=NCC(O)C1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,CC1=C(CC(O)=NCC(O)C2=CC=CC=C2)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,CYP2C19;CYP2D6,0.98,O-Demethylation
2prime_hydroxy_indomethacin_phenethylamide,COC1=CC=C2C(=C1)C(CC(O)=NCC(O)C1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,COC1=CC=C2C(=C1)C(CC(O)=NCC(=O)C1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,CYP3A4,0.95,Dehydrogenation
"(2S)-1-(1,3-Benzodioxol-5-yl)-N-methyl-2-butanamine",CCC(CC1=CC=C2OCOC2=C1)NC,,,CCC(N)CC1=CC=C2OCOC2=C1,,CYP1A2;CYP2B6;CYP2C19;CYP2D6;CYP3A4,0.94,N-Demethylation
"(2S)-1-(1,3-Benzodioxol-5-yl)-N-methyl-2-butanamine",CCC(CC1=CC=C2OCOC2=C1)NC,,,CCC(CC1=CC=C(O)C(O)=C1)NC,,CYP1A2;CYP2B6;CYP2C19;CYP2D6;CYP3A4,0.71,O-Demethylation
Seratrodast,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)C2=CC=CC=C2)=C(C)C1=O,,5-OH-seratrodast,CC1=C(CO)C(=O)C(C)=C(C(CCCCCC(=O)O)C2=CC=CC=C2)C1=O,,CYP2C19; CYP2C9; CYP2C8; CYP3A4; CYP2B6,0.91,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
Seratrodast,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)C2=CC=CC=C2)=C(C)C1=O,,4'-OH-seratrodast,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)C2=CC=C(O)C=C2)=C(C)C1=O,,CYP2C19; CYP2C9; CYP2C8,0.95,p-Hydroxylation of monosubstituted benzene
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21,,7-Hydroxychlorpromazine,CN(C)CCCN1C2=CC=C(O)C=C2SC2=CC=C(Cl)C=C21,,CYP2D6; CYP1A2,0.89,Aromatic hydroxylation of fused benzene ring
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21,,Chlorpromazine S-oxide,CN(C)CCCN1C2=CC=CC=C2S(=O)C2=CC=C(Cl)C=C21,,CYP3A4,0.84,S-oxidation of diarylthioether to sulfoxide
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21,,"Chlorpromazine, N-desmethyl",CNCCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21,,CYP1A2,0.99,N-dealkylation of acyclic tertiary amine
chlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC=C(Cl)C=C1,,2-OH-chlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC=C(Cl)C=C1O,,CYP2C9 (major); CYP2C19 (minor); CYP2C8 (minor); CYP1A2 (minor); CYP3A4 (minor),0.72,Hydroxylation of benzene on carbon ortho to an electron donating group
chlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC=C(Cl)C=C1,,3-OH-chlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC=C(Cl)C(O)=C1,,CYP2D6,0.77,Hydroxylation of aromatic carbon ortho to halide group
chlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC=C(Cl)C=C1,,p-Chlorobenzene sulfonylurea,N=C(O)NS(=O)(=O)C1=CC=C(Cl)C=C1,,CYP2D6,0.81,N-dealkylation of urea
Chlorpyrifos,CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,"3,5,6-Trichloro-2-pyridinol",OC1=NC(Cl)=C(Cl)C=C1Cl,,CYP2C19; CYP2B6; CYP3A4,0.47,Dearylation of organphosphosulfur compound
Chlorpyrifos,CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,Diethyl phosphorothioate,CCOP(=O)(O)OCC,,CYP2C19; CYP2B6; CYP3A4,0.07,Dearylation of organphosphosulfur compound
Chlorpyrifos,CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,Chlorpyrifos-oxon,CCOP(=O)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,CYP1A2; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP2D6; CYP3A4,0.71,Desulfuration of organophosphothioates
chlorzoxazone,OC1=NC2=CC(Cl)=CC=C2O1,,6-Hydroxychlorzoxazone,OC1=NC2=CC(Cl)=C(O)C=C2O1,,CYP2E1; CYP1A2; CYP1A1; CYP2A6; CYP2D6; CYP3A4,0.77,Aromatic hydroxylation of fused benzene ring
cilostazol,O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C2N1,,OPC-13326,OC1=NC2=CC=C(OCCCCC3=NN=NN3C3CCCCC3)C=C2C(O)C1,,CYP1A2;CYP2D6;CYP3A4,0.67,Aliphatic Hydroxylation
cilostazol,O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C2N1,,OPC-13217,O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCC(O)CC3)=CC=C2N1,,CYP2C19;CYP3A4,0.96,Aliphatic Hydroxylation
cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,,1-Cinnamylpiperazine,C(=CC1=CC=CC=C1)CN1CCNCC1,,CYP2C9; CYP1A2; CYP2A6,0.45,OXIDATIVE_DEAMINATION_OF_TERTIARY_AMINES; N_DEALKYLATION_OF_ALICYCLIC_TERTIARY_AMINES_PATTERN1
cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,Norcisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCNCC1OC,,CYP3A4; CYP2C8; CYP2B6,0.9,N-dealkylation of alicyclic tertiary amine
cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,3-(4-fluorophenoxy)propanal,O=CCCOC1=CC=C(F)C=C1,,CYP3A4; CYP2C8; CYP2B6,0.17,N-dealkylation of alicyclic tertiary amine
cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,3-Fluoro-4-hydroxycisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(O)C(F)=C2)CC1OC,,CYP2C8,0.94,Hydroxylation of benzene on carbon para to an electron donating group
cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,4-Fluoro-2- hydroxycisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2O)CC1OC,,CYP3A4,0.95,Hydroxylation of benzene on carbon ortho to an electron donating group
(+-)-Cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,Norcisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCNCC1OC,,CYP3A4; CYP2C8; CYP2B6 ,0.9,N-dealkylation of mixed tertiary amine
(+-)-Cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,3-Fluoro-4-hydroxycisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(O)C(F)=C2)CC1OC,,CYP2C8,0.94,HYDROXYLATION_OF_AROMATIC_CARBON
(+-)-Cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,4-Fluoro-2-hydroxycisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2O)CC1OC,,CYP3A4,0.95,"2-Hydroxylation of 1,4-disubstituted benzene"
"(2R,3S)â€2â€(diphenylmethyl)â€Nâ€{[2â€methoxyâ€5â€(propâ€1â€enâ€2â€yl)phenyl]methyl}â€1â€azabicyclo[2.2.2]octanâ€3â€amine",C=C(C)C1=CC=C(OC)C(CNC2C3CCN(CC3)C2C(C2=CC=CC=C2)C2=CC=CC=C2)=C1,,"CP-611,781",COC1=CC=C(C(C)CO)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2D6;CYP3A4,0.92,Aliphatic Hydroxylation
"(2R,3S)â€2â€(diphenylmethyl)â€Nâ€{[2â€methoxyâ€5â€(propâ€1â€enâ€2â€yl)phenyl]methyl}â€1â€azabicyclo[2.2.2]octanâ€3â€amine",C=C(C)C1=CC=C(OC)C(CNC2C3CCN(CC3)C2C(C2=CC=CC=C2)C2=CC=CC=C2)=C1,,"CP-616,762",COC1=CC=C(C(C)(O)CO)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2D6;CYP3A4,0.86,Aliphatic Hydroxylation
clindamycin,CCCC1CC(C(O)=NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O)N(C)C1,,N-desmethyclindamycin,CCCC1CNC(C(O)=NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O)C1,,CYP3A4,0.97,N-Dealkylation
clindamycin,CCCC1CC(C(O)=NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O)N(C)C1,,clindamycin sulfoxide,CCCC1CC(C(O)=NC(C(C)Cl)C2OC(S(C)=O)C(O)C(O)C2O)N(C)C1,,CYP3A4,0.94,S-Oxidation
clobazam,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=CC(Cl)=CC=C21,,N-desmethylclobazam,O=C1CC(O)=NC2=CC=C(Cl)C=C2N1C1=CC=CC=C1,,CYP2C9;CYP2C19,0.58,N-desmethylation
clobazam,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=CC(Cl)=CC=C21,,4-Hydroxyclobazam,CN1C(=O)CC(=O)N(C2=CC=C(O)C=C2)C2=CC(Cl)=CC=C21,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.95,Aromatic Hydroxylation
clomethiazole,CC1=C(CCCl)SC=N1,,NLA-715,CC1=C(C(O)CCl)SC=N1,,CYP2A6,0.64,Aliphatic Hydroxylation
clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,2-OH-clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,,CYP2D6,0.85,Aromatic hydroxylation of fused benzene ring
clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,8-OH-clomipramine,CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C(O)C=CC=C21,,CYP2D6,0.81,Aromatic hydroxylation of fused benzene ring
clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,N-Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,CYP2C19; CYP3A4; CYP1A2,0.99,N-dealkylation of acyclic tertiary amine
clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,10-OH-clomipramine,CN(C)CCCN1C2=CC(Cl)=CC=C2CC(O)C2=CC=CC=C21,,CYP2D6,0.79,Hydroxylation of heteroalicyclic secondary carbon
clozapine,CN1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,,Clozapine-N-oxide,C[N+]1([O-])CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,,CYP3A4; CYP1A2; CYP2C8; CYP2C19; CYP3A5,0.95,N-oxidation of alicyclic tertiary amine
compound_1,O=S(=O)(NC1=CC=C(CCNCC(O)C2=CC=CN=C2)C=C1)C1=CC=C(C2=NC(C3=CC=C(C(F)(F)F)C=C3)=CC2)C=C1,,M2,O=S(=O)(NC1=CC=C(CCNCC(O)C2=CC=C[N+]([O-])=C2)C=C1)C1=CC=C(C2=NC(C3=CC=C(C(F)(F)F)C=C3)=CC2)C=C1,,CYP3A4,0.95,N-Oxidation
compound_1,O=S(=O)(NC1=CC=C(CCNCC(O)C2=CC=CN=C2)C=C1)C1=CC=C(C2=NC(C3=CC=C(C(F)(F)F)C=C3)=CC2)C=C1,,M4,NCCC1=CC=C(NS(=O)(=O)C2=CC=C(C3=NC(C4=CC=C(C(F)(F)F)C=C4)=CC3)C=C2)C=C1,,CYP3A4,0.86,N-Dealkylation
coumarin,O=C1C=CC2=CC=CC=C2O1,,7-Hydroxycoumarin,O=C1C=CC2=CC=C(O)C=C2O1,,CYP2A6; CYP2B6; CYP1A1; CYP1A2,0.73,7-Hydroxylation of coumarin
coumarin,O=C1C=CC2=CC=CC=C2O1,,3-Hydroxycoumarin,O=C1OC2=CC=CC=C2C=C1O,,CYP3A4,0.65,7-Hydroxylation of coumarin
coumarin,O=C1C=CC2=CC=CC=C2O1,,"Coumarin 3,4-epoxide",O=C1OC2=CC=CC=C2C2OC12,,CYP1A1; CYP1A2; CYP2E1,0.13,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
cp_122_721,COC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,,OC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,CYP2D6,0.97,O-Demethylation
cp_122_721,COC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,,COC1=CC=C(OC(F)(F)F)C=C1CN,,CYP3A4,0.42,N-Dealkylation
cp_125_611,OC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,"CP-919,230",NCC1=CC(OC(F)(F)F)=CC=C1O,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.41,N-Dealkylation
cp_125_611,OC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,quinone,O=C1CC=C(O)C=C1CNC1CCCNC1C1=CC=CC=C1,,CYP1A2;CYP3A4,0.53,O-Detrifluoromethylation
cp-199331,COC1=CC=C(NS(=O)(=O)C(F)(F)F)C=C1CC1COC2=CC=C(OCC3=NC4=CC(F)=C(F)C=C4S3)C=C2C1O,,,O=S(=O)(NC1=CC=C(O)C(CC2COC3=CC=C(OCC4=NC5=CC(F)=C(F)C=C5S4)C=C3C2O)=C1)C(F)(F)F,,CYP3A4,0.99,O-Demethylation
"cyclohexene, 4-ethenyl-, (s)-",C=CC1CC=CCC1,,,C1=CCC(C2CO2)CC1,,CYP2B6;CYP2E1,0.28,Epoxidation
"cyclohexene, 4-ethenyl-, (s)-",C=CC1CC=CCC1,,,C=CC1CCC2OC2C1,,CYP2B6;CYP2E1,0.22,Epoxidation
dacarbazine,CN(C)NN=C1N=CN=C1C(N)=O,,MTIC,CNNN=C1N=CN=C1C(N)=O,,CYP1A2;CYP2E1,0.96,N-demethylation
dehydroepiandrosterone,CC12CCC3C(CC=C4CC(O)CCC43C)C1CCC2=O,,,CC12CCC3C(CC=C4CC(O)CCC43C)C1CC(O)C2=O,,CYP3A4,0.88,Aliphatic Hydroxylation
dehydroepiandrosterone,CC12CCC3C(CC=C4CC(O)CCC43C)C1CCC2=O,,,CC12CCC3C(C(O)C=C4CC(O)CCC43C)C1CCC2=O,,CYP3A4,0.85,Aliphatic Hydroxylation
delavirdine,CC(C)NC1=CC=CN=C1N1CCN(C(=O)C2=CC3=CC(NS(C)(=O)=O)=CC=C3N2)CC1,,,CC(C)NC1=CC=C(O)N=C1N1CCN(C(=O)C2=CC3=CC(NS(C)(=O)=O)=CC=C3N2)CC1,,CYP3A4,0.94,Aromatic Hydroxylation
delavirdine,CC(C)NC1=CC=CN=C1N1CCN(C(=O)C2=CC3=CC(NS(C)(=O)=O)=CC=C3N2)CC1,,,CS(=O)(=O)NC1=CC=C2NC(C(=O)N3CCN(C4=NC=CC=C4N)CC3)=CC2=C1,,CYP2D6;CYP3A4,0.93,N-desalkylation
deramciclane,CN(C)CCOC1(C2=CC=CC=C2)CC2CCC1(C)C2(C)C,,,CNCCOC1(C2=CC=CC=C2)CC2CCC1(C)C2(C)C,,CYP3A4,0.99,N-demethylation
desmethylcitalopram,CNCCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,"N,N-Didesmethylcitalopram",N#CC1=CC=C2C(=C1)COC2(CCCN)C1=CC=C(F)C=C1,,CYP2D6,0.99,N-dealkylation of acyclic secondary amine
dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,,6-alpha-OH DEXAMETHASONE,CC1CC2C3CC(O)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,,CYP3A4,0.9,Hydroxylation of carbon gamma to conjugated carbonyl
dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,,6-beta-OH DEXAMETHASONE,CC1CC2C3CC(O)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,,CYP3A4,0.9,Hydroxylation of carbon gamma to conjugated carbonyl
dexfenfluramine,CCNC(C)CC1=CC=CC(C(F)(F)F)=C1,,nordexfenfluramine,CC(N)CC1=CC=CC(C(F)(F)F)=C1,,CYP1A2;CYP2D6,0.88,N-dealkylation
dexloxiglumide,CCCCCN(CCCOC)C(=O)C(CCC(=O)O)N=C(O)C1=CC=C(Cl)C(Cl)=C1,,,CCCCCN(CCCO)C(=O)C(CCC(=O)O)N=C(O)C1=CC=C(Cl)C(Cl)=C1,,CYP2B6;CYP2C8;CYP2C9;CYP3A4,0.98,O-demethylation
dexpropranolol (propranolol),CC(C)NCC(O)COC1=CC=CC2=CC=CC=C12,,,NCC(O)COC1=CC=CC2=CC=CC=C12,,CYP1A2;CYP2D6,0.86,N-DESISOPROPYLATION
dexpropranolol (propranolol),CC(C)NCC(O)COC1=CC=CC2=CC=CC=C12,,,CC(C)NCC(O)COC1=CC=CC2=C(O)C=CC=C12,,CYP1A2;CYP2D6,0.93,AROMATIC HYDROXYLATION
dexpropranolol (propranolol),CC(C)NCC(O)COC1=CC=CC2=CC=CC=C12,,,CC(C)NCC(O)COC1=CC=C(O)C2=CC=CC=C12,,CYP1A2;CYP2D6,0.94,AROMATIC HYDROXYLATION
dextromethorphan,COC1=CC=C2CC3C4CCCCC4(CCN3C)C2=C1,,Dextrorphan,CN1CCC23CCCCC2C1CC1=CC=C(O)C=C13,,CYP2D6 (major); CYP2C9 (minor); CYP3A4 (minor),0.96,O-dealkylation
dextromethorphan,COC1=CC=C2CC3C4CCCCC4(CCN3C)C2=C1,,3-methoxymorphinan,COC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,,CYP3A4 (major); CYP2D6 (minor); CYP2C9 (minor); CYP2B6 (minor); CYP2C19 (minor),0.94,N-dealkylation of alicyclic tertiary amine
dextropropoxyphene,CCC(=O)OC(CC1=CC=CC=C1)(C1=CC=CC=C1)C(C)CN(C)C,,Nordextropropoxyphene,CCC(=O)OC(CC1=CC=CC=C1)(C1=CC=CC=C1)C(C)CNC,,CYP3A4,0.98,N-demethylation
dexverapamil,COC1=CC=C(CCN(C)CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,"dexverapamil, N-demethyl",COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,CYP2C8; CYP1A2; CYP3A4; CYP3A5,0.95,N-dealkylation of acyclic tertiary amine
dexverapamil,COC1=CC=C(CCN(C)CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,"2-(3,4-dimethoxyphenyl)acetaldehyde",COC1=CC=C(CC=O)C=C1OC,,CYP2C8; CYP3A4; CYP1A2,0.39,N-dealkylation of acyclic secondary amine
dexverapamil,COC1=CC=C(CCN(C)CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,(R)-D-617,CNCCCC(C#N)(C1=CC=C(OC)C(OC)=C1)C(C)C,,CYP2C8; CYP3A4; CYP1A2,0.88,N-dealkylation of acyclic secondary amine
diallyl disulfide,C=CCSSCC=C,,DADSO,C=CCSS(=O)CC=C,,CYP2A6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1,0.46,S-Oxidation
diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21,,Nordiazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1,,CYP2B6; CYP3A4; CYP3A5; CYP2C19; CYP2C8; CYP2C9; CYP2C18,0.5,N-dealkylation of secondary carboxamide
diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21,,Temazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21,,CYP3A4; CYP3A5; CYP2C19 (minor),0.87,"3-Hydroxylation of 5-aryl-1,4-benzodiazepine"
"dibenzo[a,l]pyrene",C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=C5C=CC=CC5=C2C1=C34,,,C1=CC=C2C(=C1)C1=CC=CC3=CC=C4C=C5C(=C2C4=C31)C=CC1=C5O1,,CYP1A2;CYP2B6;CYP2C9;CYP3A4,0.28,Epoxidation
dibenzylfluorescein,O=C(OCC1=CC=CC=C1)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC(OCC3=CC=CC=C3)=CC=C12,,Fluorescein benzyl ester,O=C(OCC1=CC=CC=C1)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC(O)=CC=C12,,CYP2C8; CYP2C9; CYP2C19; CYP3A4,0.95,O-aryl dealkylation not adjacent to substituted carbon
dibenzylfluorescein,O=C(OCC1=CC=CC=C1)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC(OCC3=CC=CC=C3)=CC=C12,,2-[6-(benzyloxy)-3-oxo-3H-xanthen-9-yl]benzoic acid,O=C(O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC(OCC3=CC=CC=C3)=CC=C12,,CYP2C8; CYP2C9; CYP2C19; CYP3A4,0.95,HYDROLYSIS_OF_CARBOXYLIC_ESTER
diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,,5-OH-diclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,CYP2B6; CYP2C8; CYP2C19; CYP3A4,0.85,Hydroxylation of benzene on carbon para to a strongly electron donating group
digitoxin,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CCC5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,,Digoxigenin Bisdigitoxoside,CC1OC(OC2C(O)CC(OC3CCC4(C)C(CCC5C4CC(O)C4(C)C(C6=CC(=O)OC6)CCC54O)C3)OC2C)CC(O)C1O,,CYP3A4,0.97,O-dealkylation
dihydrocodeine,COC1=CC=C2CC3C4CCC(O)C5OC1=C2C45CCN3C,,,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)CCC3C1C5,,CYP2D6,0.99,O-dementhylation
dihydrocodeine,COC1=CC=C2CC3C4CCC(O)C5OC1=C2C45CCN3C,,,COC1=CC=C2CC3NCCC45C2=C1OC4C(O)CCC35,,CYP3A4,0.98,N-dementhylation
diltiazem,COC1=CC=C(C2SC3=CC=CC=C3N(CCN(C)C)C(=O)C2OC(C)=O)C=C1,,N-Demethyldiltiazem,CNCCN1C(=O)C(OC(C)=O)C(C2=CC=C(OC)C=C2)SC2=CC=CC=C21,,CYP3A4 (major); CYP2C8 (minor); CYP2C9 (minor),0.99,N-dealkylation of acyclic tertiary amine
diltiazem,COC1=CC=C(C2SC3=CC=CC=C3N(CCN(C)C)C(=O)C2OC(C)=O)C=C1,,O-Demethyldiltiazem,CC(=O)OC1C(=O)N(CCN(C)C)C2=CC=CC=C2SC1C1=CC=C(O)C=C1,,CYP2D6,0.98,O-aryl dealkylation not adjacent to substituted carbon
disopiramide,CC(C)N(CCC(C(=N)O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C,,mono-N-desalkyldisopyramide,CC(C)NCCC(C(=N)O)(C1=CC=CC=C1)C1=CC=CC=N1,,CYP3A4,0.97,N-desalkylation
domitroban,O=C(O)CCCC=CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,,O=C(O)CCCC=CCC1C2CC(CC2O)C1NS(=O)(=O)C1=CC=CC=C1,,CYP2C9,0.86,Aliphatic Hydroxylation
domitroban,O=C(O)CCCC=CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,,O=C(O)CCCC=CCC1C2CC(O)C(C2)C1NS(=O)(=O)C1=CC=CC=C1,,CYP3A4,0.82,Aliphatic Hydroxylation
doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,,2-OH-doxepin,CN(C)CCC=C1C2=CC(O)=CC=C2COC2=CC=CC=C12,,CYP2D6,0.93,Aromatic hydroxylation of fused benzene ring
ebastine,CC(C)(C)C1=CC=C(C(=O)CCCN2CCC(OC(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,,Deslakylebastine,CC(C)(C)C1=CC=C(C(=O)CCC=O)C=C1,,CYP3A4,0.42,N-dealkylation of alicyclic tertiary amine
ebastine,CC(C)(C)C1=CC=C(C(=O)CCCN2CCC(OC(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,,4-(4-tert-butylphenyl)-4-oxobutanal,C1=CC=C(C(OC2CCNCC2)C2=CC=CC=C2)C=C1,,CYP3A4,0.59,N-dealkylation of alicyclic tertiary amine
ecabapide,CN=C(O)C1=CC=CC(NCC(O)=NCCC2=CC=C(OC)C(OC)=C2)=C1,,6-hydroxy-ecabapide,CN=C(O)C1=CC(NCC(O)=NCCC2=CC=C(OC)C(OC)=C2)=CC=C1O,,CYP3A4,0.86,Hydroxylation of benzene on carbon orhto to a strongly electron donating group
ecabapide,CN=C(O)C1=CC=CC(NCC(O)=NCCC2=CC=C(OC)C(OC)=C2)=C1,,5-amino-2-hydroxy-N-methylbenzamide,CN=C(O)C1=CC(N)=CC=C1O,,CYP3A4,0.4,N-dealkylation of secondary arylalkylamine
ecabapide,CN=C(O)C1=CC=CC(NCC(O)=NCCC2=CC=C(OC)C(OC)=C2)=C1,,"N-[2-(3,4-dimethoxyphenyl)ethyl]-2-oxoacetamide",COC1=CC=C(CCNC(=O)C=O)C=C1OC,,CYP3A4,0.44,N-dealkylation of secondary arylalkylamine
efavirenz,OC1=NC2=CC=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,8-OH-efavirenz,OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,CYP2B6; CYP1A2; CYP3A4,0.89,Aromatic hydroxylation of fused benzene ring
eicosapentaenoic acid,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,,,CCC=CCC=CCC=CCCCCC=CCCCC(=O)O,,CYP2C8;CYP2C9;CYP2C11;CYP2C23,0.93,Epoxidation
eletriptan,CN1CCCC1CC1CNC2=CC=C(CCS(=O)(=O)C3=CC=CC=C3)C=C21,,N-Desmethyleletriptan,O=S(=O)(CCC1=CC=C2NCC(CC3CCCN3)C2=C1)C1=CC=CC=C1,,CYP2D6 (major); CYP3A4 (major); CYP2C9 (minor); CYP2C19 (minor); CYP1A2 (minor); CYP2C8 (minor),0.97,N-dealkylation of acyclic tertiary amine
eplerenone,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,,6beta-hydroxyeplerenone,COC(=O)C1C(O)C2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,,CYP3A4,0.9,Hydroxylation of carbon gamma to conjugated carbonyl
eplerenone,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,,21-hydroxyeplerenone,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CC(O)C(=O)O4)C13,,CYP3A4,0.94,Alpha hydroxylation of carbonyl group
erythromycin,CCC1OCC(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)CC(C)C(O)C1(C)O,,N-Desmethylerythromycin,CCC1OCC(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(NC)C2O)C(C)(O)CC(C)CC(C)C(O)C1(C)O,,CYP3A4; CYP2B6,0.97,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1
estazolam,ClC1=CC=C2C(=C1)C(C1=CC=CC=C1)=NCC1=NN=CN21,,4-hydroxyestazolam,OC1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N2C=NN=C12,,CYP3A4,0.88,Hydroxylation of heteroalicyclic secondary carbon
estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,2-Hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,CYP1A2; CYP3A4; CYP1A1,0.96,Aromatic hydroxylation of fused benzene ring
estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,4-Hydroxyestradiol ,CC12CCC3C4=CC=C(O)C(O)=C4CCC3C1CCC2O,,CYP1B1 ,0.85,Aromatic hydroxylation of fused benzene ring
eszopiclone,CN1CCN(C(=O)OC2C3=NC=CN=C3C(=O)N2C2=CC=C(Cl)C=N2)CC1,,N-oxide-zopiclone,C[N+]1([O-])CCN(C(=O)OC2C3=NC=CN=C3C(=O)N2C2=CC=C(Cl)C=N2)CC1,,CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.98,N-Oxidation
ethiprole,CCS(=O)C1=C(N)N(C2=C(Cl)C=C(C(F)(F)F)C=C2Cl)N=C1C#N,,Ethiprole Sulfone,CCS(=O)(=O)C1=C(N)N(C2=C(Cl)C=C(C(F)(F)F)C=C2Cl)N=C1C#N,,CYP3A4,0.96,S-oxidation of sulfoxide to sulfone
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,Norethylmorphine,CCOC1=CC=C2CC3NCCC45C2=C1OC4C(O)C=CC35,,CYP2D6,0.98,N-Demethylation
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,,CYP3A4,0.99,O-dealkylation
etizolam,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl,,,CCC1=CC2=C(S1)N1C(C)=NN=C1C(O)N=C2C1=CC=CC=C1Cl,,CYP2B6;CYP2C19;CYP3A4,0.91,Aliphatic Hydroxylation
etizolam,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl,,,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(SC(C(C)O)=C3)N12,,CYP2B6;CYP2C19;CYP3A4,0.96,Aliphatic Hydroxylation
etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,,,CCCN1N=C(CC)N(CC)C1=O,,CYP3A4,0.69,N-Dealkylation
etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,,,ClC1=CC=CC(N2CCNCC2)=C1,,CYP3A4,0.29,N-Dealkylation
etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,,,CCC1=NN(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)C(=O)N1CC,,CYP3A4,0.94,Aromatic Hydroxylation
etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,,,CCN1C(C(C)O)=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C1=O,,CYP3A4,0.9,Aliphatic Hydroxylation
etoricoxib,CC1=CC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=N1,,6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CC=C(CO)N=C2)C=C1,,CYP3A4 (major); CYP2C9 (minor); CYP2D6 (minor); CYP1A2 (minor),0.95,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
etoricoxib,CC1=CC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=N1,,Etoricoxib 1'-N'-oxide,CC1=CC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=[N+]1[O-],,CYP3A4 (major); CYP2C9 (minor); CYP2D6 (minor); CYP1A2 (minor),0.89,Pyridine N-oxidation
eugenol,C=CCC1=CC=C(O)C(OC)=C1,,Hydroxychavicol,C=CCC1=CC=C(O)C(O)=C1,,CYP1A2;CYP2C9;CYP2D6;CYP2E1,0.76,O-demethylation
eupatilin,COC1=CC=C(C2=CC(=O)C3=C(O)C(OC)=C(O)C=C3O2)C=C1OC,,Jaceosidine,COC1=CC(C2=CC(=O)C3=C(O)C(OC)=C(O)C=C3O2)=CC=C1O,,CYP1A2;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1,0.99,O-demethylation
ezlopitant,COC1=CC=C(C(C)C)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,,C=C(C)C1=CC=C(OC)C(CNC2C3CCN(CC3)C2C(C2=CC=CC=C2)C2=CC=CC=C2)=C1,,CYP2D6;CYP3A4,0.94,Dehydrogenation
ezlopitant,COC1=CC=C(C(C)C)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,,COC1=CC=C(C(C)(C)O)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2D6;CYP3A4,0.94,Dehydrogenation
fentanyl,CCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1,,Phenylacetaldehyde,O=CCC1=CC=CC=C1,,CYP3A4,0.13,N-dealkylation of alicyclic tertiary amine
finasteride,CC(C)(C)N=C(O)C1CCC2C3CCC4N=C(O)C=CC4(C)C3CCC12C,,,CC(C)(CO)N=C(O)C1CCC2C3CCC4N=C(O)C=CC4(C)C3CCC12C,,CYP3A4,0.98,Alipathic Hydroxylation
flosequinan,CN1C=C(S(C)=O)C(=O)C2=CC=C(F)C=C21,,flosequinan sulfone,CN1C=C(S(C)(=O)=O)C(=O)C2=CC=C(F)C=C21,,CYP3A4,0.95,S-oxidation of sulfoxide to sulfone
fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C(F)(F)F)C=C32)CC1,,10-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl}-2-(trifluoromethyl)-10H-5ÃŽÂ»Ã¢ÂÂ´-phenothiazin-5-one,O=S1C2=CC=CC=C2N(CCCN2CCN(CCO)CC2)C2=CC(C(F)(F)F)=CC=C21,,CYP2D6,0.87,S-oxidation of diarylthioether to sulfoxide
flunitrazepam,CN1C(=O)CN=C(C2=CC=CC=C2F)C2=CC([N+](=O)[O-])=CC=C21,,desmethylflunitrazepam,O=[N+]([O-])C1=CC=C2N=C(O)CN=C(C3=CC=CC=C3F)C2=C1,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.62,N-DEMETHYLATION 
flunitrazepam,CN1C(=O)CN=C(C2=CC=CC=C2F)C2=CC([N+](=O)[O-])=CC=C21,,3-hydroxyflunitrazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2F)C2=CC([N+](=O)[O-])=CC=C21,,CYP2A6;CYP3A4,0.91,Aliphatic Hydroxylation
flutamide,CC(C)C(O)=NC1=CC=C([N+](=O)[O-])C(C(F)(F)F)=C1,,2-OH-flutamide,CC(C)(O)C(O)=NC1=CC=C([N+](=O)[O-])C(C(F)(F)F)=C1,,CYP1A2; CYP1B1,0.92,Alpha hydroxylation of carbonyl group
fluvoxamine,COCCCCC(=NOCCN)C1=CC=C(C(F)(F)F)C=C1,,Fluvoxamino alcohol,NCCON=C(CCCCO)C1=CC=C(C(F)(F)F)C=C1,,CYP2D6 (major); CYP1A2 (minor),0.97,O-dealkylation of dialkylether
furafylline,CC1=NC2=C(N1)N(CC1=CC=CO1)C(=O)N(C)C2=O,,"3-[(furan-2-yl)methyl]-8-hydroxy-1-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione   ",CN1C(=O)C2=C(NC(CO)=N2)N(CC2=CC=CO2)C1=O,,CYP1A2,0.97,ALKYL_HYDROXYLATION
galangin,O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC(O)=C12,,4'-OH-galangin,O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC(O)=C12,,CYP1A2 ; CYP2C9,0.98,p-Hydroxylation of monosubstituted benzene
galantamine,COC1=CC=C2CN(C)CCC34C=CC(O)CC3OC1=C24,,O-Desmethylgalantamine,CN1CCC23C=CC(O)CC2OC2=C(O)C=CC(=C23)C1,,CYP2D6,0.99,O-aryl dealkylation not adjacent to substituted carbon
galantamine,COC1=CC=C2CN(C)CCC34C=CC(O)CC3OC1=C24,,Galantamine N-oxide,COC1=CC=C2C[N+](C)([O-])CCC34C=CC(O)CC3OC1=C24,,CYP3A4,0.96,N-oxidation of alicyclic tertiary amine
galantamine,COC1=CC=C2CN(C)CCC34C=CC(O)CC3OC1=C24,,N-desmethylgalantamine,COC1=CC=C2CNCCC34C=CC(O)CC3OC1=C24,,CYP2D6,0.98,N-dealkylation of alicyclic tertiary amine
gefitinib,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCOCC1,,,OC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCOCC1,,CYP2D6,0.97,O-dementhylation
gefitinib,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCOCC1,,,COC1=CC2=NC=NC(NC3=CC=C(O)C(Cl)=C3)=C2C=C1OCCCN1CCOCC1,,CYP3A4,0.91,oxidative defluorination
genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,Orobol,O=C1C(C2=CC=C(O)C(O)=C2)=COC2=CC(O)=CC(O)=C12,,CYP1A2;CYP2E1,0.94,Aromatic Hydroxylation
genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,,O=C1C(C2=CC=C(O)C(O)=C2)=COC2=CC(O)=CC(O)=C12,,CYP1A2,0.94,Aromatic Hydroxylation
gepirone,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1,,,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=C(O)C=N3)CC2)C(=O)C1O,,CYP3A4,0.69,Hydroxylation
gepirone,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1,,,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=C(O)C=N3)CC2)C(=O)C1,,CYP3A4,0.91,Aromatic Hydroxylation
gepirone,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1,,,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1O,,CYP3A4,0.74,Aliphatic Hydroxylation
gepirone,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1,,1-(2-pyrimidinyl)-piperazine (1-PP),C1=CN=C(N2CCNCC2)N=C1,,CYP3A4,0.46,N-Dealkylation
granisetron,CN1C2CCCC1CC(NC(=O)C1=NN(C)C3=CC=CC=C13)C2,,7-Hydroxygranisetron,CN1C2CCCC1CC(NC(=O)C1=NN(C)C3=CC=CC(O)=C13)C2,,CYP1A1,0.86,HYDROXYLATION_OF_AROMATIC_CARBON
granisetron,CN1C2CCCC1CC(NC(=O)C1=NN(C)C3=CC=CC=C13)C2,,9'-Desmethylgranisetron,CN1C2CCCC1CC(NC(=O)C1=NNC3=CC=CC=C13)C2,,CYP3A4 (major); CYP1A1; CYP2D6; CYP3A5,0.85,N-dealkylation of alicyclic tertiary amine
gts-21,COC1=CC=C(C=C2CCCN=C2C2=CC=CN=C2)C(OC)=C1,,4-OH-GTS-21,COC1=CC(O)=CC=C1C=C1CCCN=C1C1=CC=CN=C1,,CYP1A2;CYP2E1;CYP3A4,0.99,O-Demethylation
gts-21,COC1=CC=C(C=C2CCCN=C2C2=CC=CN=C2)C(OC)=C1,,2-OH-GTS-21,COC1=CC=C(C=C2CCCN=C2C2=CC=CN=C2)C(O)=C1,,CYP1A2;CYP2E1;CYP3A4,0.97,O-Demethylation
guanabenz,N=C(N)NN=CC1=C(Cl)C=CC=C1Cl,,Guanoxabenz,N=C(NO)NN=CC1=C(Cl)C=CC=C1Cl,,CYP1A2,0.93,N-hyroxylation of guanidine or aminohydrazone
haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,,p-Fluorobenzoylpropionic acid and 4-(4-chlorophenyl)-4-hydroxypiperidine,O=C(O)CCC(=O)C1=CC=C(F)C=C1,,CYP3A4; CYP2D6,0.4,N-dealkylation of alicyclic tertiary amine
harmaline,COC1=CC=C2C3=C(NC2=C1)C(C)=NCC3,,Harmalol,CC1=NCCC2=C1NC1=CC(O)=CC=C21,,CYP2D6 (major); CYP1A2 (minor),0.96,O-aryl demethylation
harmine,COC1=CC=C2C(=C1)NC1=C(C)N=CC=C12,,Harmol,COC1=CC2=C(C=C1O)C1=CC=NC(C)=C1N2,,CYP2D6 (major); CYP2C9 (minor); CYP2C19 (minor); CYP1A2 (minor),0.91,Aromatic hydroxylation of fused benzene ring
harmine,COC1=CC=C2C(=C1)NC1=C(C)N=CC=C12,,6-OH-harmaline,CC1=NC=CC2=C1NC1=CC(O)=CC=C12,,CYP2D6,0.93,O-aryl demethylation
hydrocodone,COC1=CC=C2CC3C4CCC(=O)C5OC1=C2C54CCN3C,,Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,,CYP2D6,0.99,O-dementhylation
hydrocodone,COC1=CC=C2CC3C4CCC(=O)C5OC1=C2C54CCN3C,,Norhydromorphone,COC1=CC=C2CC3NCCC45C2=C1OC4C(=O)CCC35,,CYP3A4,0.98,N-dementhylation
iloperidone,COC1=CC(C(C)=O)=CC=C1OCCCN1CCC(C2=NOC3=CC(F)=CC=C23)CC1,,"4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-a-methylbenzene methanol",COC1=CC(C(C)O)=CC=C1OCCCN1CCC(C2=NOC3=CC(F)=CC=C23)CC1,,CYP1A2;CYP2E1;CYP3A4,0.91,Reduction 
iloperidone,COC1=CC(C(C)=O)=CC=C1OCCCN1CCC(C2=NOC3=CC(F)=CC=C23)CC1,,"1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]- propoxy]-3-hydroxyphenyl]ethanone",CC(=O)C1=CC=C(OCCCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(O)=C1,,CYP3A4,0.97,O-Demethylation
iloperidone,COC1=CC(C(C)=O)=CC=C1OCCCN1CCC(C2=NOC3=CC(F)=CC=C23)CC1,,"1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]-2-hydroxyethanone",COC1=CC(C(=O)CO)=CC=C1OCCCN1CCC(C2=NOC3=CC(F)=CC=C23)CC1,,CYP2D6,0.97,Aliphatic Hydroxylation
imidacloprid,O=[N+]([O-])NC1=NCCN1CC1=CC=C(Cl)N=C1,,5-hydroxy-imidacloprid,O=[N+]([O-])NC1=NCC(O)N1CC1=CC=C(Cl)N=C1,,CYP3A4,0.82,Aliphatic Hydroxylation
imidacloprid,O=[N+]([O-])NC1=NCCN1CC1=CC=C(Cl)N=C1,,olefin,O=[N+]([O-])NC1=NC=CN1CC1=CC=C(Cl)N=C1,,CYP3A4,0.27,Dehydrogenation
indinavir,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,,CC(C)(C)N=C(O)C1CN(CC2=CC=C[N+]([O-])=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,CYP3A4,0.98,N-Oxidation
indinavir,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,,CC(C)(C)N=C(O)C1CNCCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,CYP3A4,0.91,N-Dealkylation
indinavir,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=C(O)C=C1)C(O)=NC1C2=CC=CC=C2CC1O,,CYP3A4,0.98,Aromatic Hydroxylation
indinavir,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2C(O)C1O,,CYP3A4,0.92,Aliphatic Hydroxylation
indiplon,CC(=O)N(C)C1=CC=CC(C2=CC=NC3=C(C(=O)C4=CC=CS4)C=NN23)=C1,,N-Desmethylindiplon,CC(O)=NC1=CC=CC(C2=CC=NC3=C(C(=O)C4=CC=CS4)C=NN23)=C1,,CYP3A4; CYP1A2,0.9,N-dealkylation of tertiary carboxamide
indole,C1=CC=C2NC=CC2=C1,,,OC1=CNC2=CC=CC=C12,,CYP2A6;CYP2C19;CYP2E1,0.57,Aliphatic Hydroxylation
indole,C1=CC=C2NC=CC2=C1,,,OC1=NC2=CC=CC=C2C1,,CYP2A6;CYP2C19;CYP2E1,0.06,C-Oxidation
indole,C1=CC=C2NC=CC2=C1,,,OC1=CC=C2C=CNC2=C1,,CYP2A6;CYP2C19;CYP2E1,0.64,Aromatic Hydroxylation
indomethacin,COC1=CC=C2C(=C1)C(CC(=O)O)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,O-Desmethylindomethacin,CC1=C(CC(=O)O)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,CYP2C9 (major); CYP2C19 (minor); CYP2D6 (minor); CYP1A2 (minor),0.97,O-aryl demethylation
"invega, invega sustenna, 9-hydroxyrisperidone, paliperidone",CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCC(O)C2=N1,,,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CC(O)CC(O)C2=N1,,CYP2D6,0.95,Aliphatic Hydroxylation
ipriflavone,CC(C)OC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1,,,O=C1C(C2=CC=CC=C2)=COC2=CC(O)=CC=C12,,CYP1A2;CYP2C9;CYP2C19;CYP3A4,0.89,O-dealkylation
ipriflavone,CC(C)OC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1,,,CC(CO)OC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1,,CYP1A2;CYP2C9;CYP2C19,0.98,Aliphatic Hydroxylation
ipriflavone,CC(C)OC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1,,,CC(C)OC1=CC=C2C(=O)C(C3=CC=C(O)C=C3)=COC2=C1,,CYP1A2;CYP2C9;CYP2C19,0.98,Aromatic Hydroxylation
isoquinoline,C1=CC=C2C=NC=CC2=C1,,isoquinoline N-oxide,[O-][N+]1=CC=C2C=CC=CC2=C1,,CYP3A4; CYP2E1,0.71,N-Oxidation
isotretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,,CC(C=CC(O)=C(C)C=CC1=C(C)CCCC1(C)C)=CC(=O)O,,CYP2B6;CYP2C8;CYP3A4,0.83,Hydroxylation
ivermectin,COC1CC(OC2C(C)OC(OC3C(C)=CCC4CCC(CC5(CCC(C(C)C)CO5)O4)OC(=O)C4C=C(C)C(O)C5CCC(=CC=CC3C)C45O)CC2OC)OC(C)C1O,,,COC1CC(OC2(O)C(C)OC(OC3C(C)=CCC4CCC(CC5(CCC(C(C)C)CO5)O4)OC(=O)C4C=C(C)C(O)C5CCC(=CC=CC3C)C45O)CC2OC)OC(C)C1O,,CYP3A4,0.95,Aliphatic Hydroxylation
k-11777,CN1CCN(C(O)=NC(CC2=CC=CC=C2)C(O)=NC(C=CS(=O)(=O)C2=CC=CC=C2)CCC2=CC=CC=C2)CC1,,N-oxide k-11777,C[N+]1([O-])CCN(C(O)=NC(CC2=CC=CC=C2)C(O)=NC(C=CS(=O)(=O)C2=CC=CC=C2)CCC2=CC=CC=C2)CC1,,CYP3A4,0.96,N-Oxidation
"N-[(2S)-1-[[(E,3S)-1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide",CN1CCN(C(O)=NC(CC2=CC=CC=C2)C(O)=NC(C=CS(=O)(=O)C2=CC=CC=C2)CCC2=CC=CC=C2)CC1,,b-hydroxy-homoPhe K11777,CN1CCN(C(O)=NC(CC2=CC=CC=C2)C(O)=NC(C=CS(=O)(=O)C2=CC=CC=C2)C(O)CC2=CC=CC=C2)CC1,,CYP3A4,0.91,Aliphatic Hydroxylation
ketobemidone,CCC(=O)C1(C2=CC=CC(O)=C2)CCN(C)CC1,,Norketobemidone,CCC(=O)C1(C2=CC=CC(O)=C2)CCNCC1,,CYP3A4; CYP2C9,0.95,N-dealkylation of alicyclic tertiary amine
kr-60436,COC1=CC=C(N2CCC3=C2C2=CC=CC(OC(F)(F)F)=C2NC3=NCCO)C(C)=C1,,O-demethyl-KR-60436,CC1=CC(O)=CC=C1N1CCC2=C1C1=CC=CC(OC(F)(F)F)=C1NC2=NCCO,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.99,O-Demethylation
kr-60436,COC1=CC=C(N2CCC3=C2C2=CC=CC(OC(F)(F)F)=C2NC3=NCCO)C(C)=C1,,,COC1=CC=C(N2CCC3=C2C2=CC=CC(OC(F)(F)F)=C2NC3=N)C(C)=C1,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.92,N-dehydroxyethylation
kr-60436,COC1=CC=C(N2CCC3=C2C2=CC=CC(OC(F)(F)F)=C2NC3=NCCO)C(C)=C1,,,COC1=CC=C(N2C=CC3=C2C2=CC=CC(OC(F)(F)F)=C2NC3=NCCO)C(C)=C1,,CYP2D6;CYP3A4,0.56,Hydrogenation
"2â€(3â€{4â€[2â€(3â€fluorophenyl)ethyl]piperazinâ€1â€yl}propyl)â€5â€(1,2,4â€triazolâ€4â€yl)â€1Hâ€indole",FC1=CC=CC(CCN2CCN(CCCC3=CC4=CC(N5C=NN=C5)=CC=C4N3)CC2)=C1,,,OC(CN1CCN(CCCC2=CC3=CC(N4C=NN=C4)=CC=C3N2)CC1)C1=CC=CC(F)=C1,,CYP2C8;CYP3A4,0.91,Aliphatic Hydroxylation
l_775606,FC1=CC=CC(CCN2CCN(CCCC3=CC4=CC(N5C=NN=C5)=CC=C4N3)CC2)=C1,,,CN1CCN(CCCC2=CC3=CC(N4C=NN=C4)=CC=C3N2)CC1,,CYP2C8;CYP3A4,0.85,N-dealkylation
l-trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,,l-ifosfamide,O=P1(N(CCCl)CCCl)OCCC(O)N1CCCl,,CYP3A4; CYP2B6; CYP2A6; CYP2C9,0.68,4-alkyl hydroxylation of oxoazaphosphorine
l-trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,,l-cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,,CYP3A4; CYP2B6,0.87,N-dechloroethylation
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-N-ethyl-4-hydroxy-N-(4-hydroxyphenyl)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamide",CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=C(O)C=C1,,CYP3A4,0.99,p-Hydroxylation of anilide
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN1C(=O)C(C(O)=NC2=CC=CC=C2)=C(O)C2=C(Cl)C=CC=C21,,CYP3A4,0.66,N-dealkylation of secondary carboxamide
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-N-ethyl-4-hydroxy-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CCN(C(=O)C1=C(O)N=C2C=CC=C(Cl)C2=C1O)C1=CC=CC=C1,,CYP3A4,0.74,N-dealkylation of secondary carboxamide
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-N-ethyl-4,8-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CCN(C(=O)C1=C(O)C2=C(Cl)C=CC(O)=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.95,Aromatic hydroxylation of fused benzene ring
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-N-ethyl-4,7-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CCN(C(=O)C1=C(O)C2=C(Cl)C=C(O)C=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.98,Aromatic hydroxylation of fused benzene ring
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-N-ethyl-4,6-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CCN(C(=O)C1=C(O)C2=C(Cl)C(O)=CC=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.97,Aromatic hydroxylation of fused benzene ring
levobupivacaine,CCCCN1CCCCC1C(O)=NC1=C(C)C=CC=C1C,,,CC1=CC=CC(C)=C1N=C(O)C1CCCCN1,,CYP2C19;CYP2D6;CYP3A4,0.88,N-demethylation
licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,,licofelone M2,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C(O)=C3)=C(CC(=O)O)N2C1,,CYP2C8; CYP2C9,0.94,Hydroxylation of aromatic carbon ortho to halide group
licofelone_M1,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)OCC3OC(O)C(O)C(O)C3O)N2C1,,,CC1(CO)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)OCC3OC(O)C(O)C(O)C3O)N2C1,,CYP2C8;CYP2C9,0.97,Aliphatic Hydroxylation
lidocaine,CCN(CC)CC(O)=NC1=C(C)C=CC=C1C,,Monoethylglycinexylidide,CCNCC(O)=NC1=C(C)C=CC=C1C,,CYP1A2; CYP3A4; CYP3A5; CYP2C8; CYP2C18; CYP2B6; CYP2A6,0.92,N-dealkylation of acyclic tertiary amine
lidocaine,CCN(CC)CC(O)=NC1=C(C)C=CC=C1C,,3-Hydroxylidocaine,CCN(CC)CC(O)=NC1=C(C)C=CC(O)=C1C,,CYP1A2; CYP2D6; CYP3A4,0.73,Hydroxylation of benzene on carbon ortho to an electron donating group
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4,8-dihydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN(C(=O)C1=C(O)C2=CC=CC(O)=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.93,Aromatic hydroxylation of fused benzene ring
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4,7-dihydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN(C(=O)C1=C(O)C2=CC=C(O)C=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.99,Aromatic hydroxylation of fused benzene ring
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4,6-dihydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN(C(=O)C1=C(O)C2=CC(O)=CC=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.97,Aromatic hydroxylation of fused benzene ring
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4-hydroxy-N-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN(C(=O)C1=C(O)N=C2C=CC=CC2=C1O)C1=CC=CC=C1,,CYP3A4,0.68,N-dealkylation of tertiary carboxamide
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN1C(=O)C(C(O)=NC2=CC=CC=C2)=C(O)C2=CC=CC=C21,,CYP3A4,0.6,N-dealkylation of tertiary carboxamide
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4-hydroxy-N-(4-hydroxyphenyl)-N,1-dimethyl-2-oxo-1,2-dihydroquinoline-3-carboxamide",CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=C(O)C=C1,,CYP3A4,0.99,Hydroxylation of benzene on carbon para to an electron donating group
lisofylline,CC(O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,,"lisofylline 4,5-diol",CC(O)C(O)CCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,,CYP3A4; CYP2A6,0.98,Hydroxylation of acyclic aliphatic secondary carbon
loperamide,CN(C)C(=O)C(CCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,,N-Desmethyloperamide,CN=C(O)C(CCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,,CYP3A4; CYP2D6; CYP2C8; CYP2B6,0.58,N-dealkylation of tertiary carboxamide
loratadine,CCOC(=O)N1CCC(=C2C3=CC=C(Cl)C=C3CCC3=CC=CN=C23)CC1,,,ClC1=CC=C2C(=C3CCNCC3)C3=NC=CC=C3CCC2=C1,,CYP1A2;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.91,N_DEALKYLATION
lornoxicam,CN1C(C(O)=NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O,,5'-Hydroxylornoxicam,CN1C(C(O)=NC2=CC=C(O)C=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O,,CYP2C9 ,0.99,HYDROXYLATION_OF_HETEROAROMATIC_CARBON
losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,E-3174,CCCCC1=NC(Cl)=C(C(=O)O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,CYP2C9; CYP3A4; CYP3A5,0.9,OXIDATION_OF_PRIM_ALCOHOL_TO_CARBOXYLIC_ACID
losartan carboxaldehyde,CCCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCCC(O)C1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,CYP3A4,0.89,Aliphatic Hydroxylation
losartan carboxaldehyde,CCCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCCCC1=NC(Cl)=C(C(=O)O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,CYP3A4,0.9,Aliphatic Hydroxylation
lovastatin,CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,6'beta-Hydroxylovastatin,CCC(C)C(=O)OC1CC(C)(O)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,CYP3A4,0.9,Hydroxylation of penultimate aliphatic tertiary carbon
lovastatin,CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,3-Hydroxylovastatin,CCC(O)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,CYP3A4,0.93,Hydroxylation of acyclic aliphatic secondary carbon
m-xylene,CC1=CC=CC(C)=C1,,"2,4-Dimethylphenol",CC1=CC=C(O)C(C)=C1,,CYP1A2,0.44,"2-Hydroxylation of 1,4-disubstituted benzene"
m-xylene,CC1=CC=CC(C)=C1,,3-Methylbenzylalcohol,CC1=CC=CC(CO)=C1,,CYP2E1,0.58,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C1=CC=CC=C12,,3-OH-maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C1=CC=C(O)C=C12,,CYP2D6; CYP1A2,0.85,Aromatic hydroxylation of fused benzene ring
maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C1=CC=CC=C12,,2-OH-maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C1=CC(O)=CC=C12,,CYP2D6; CYP1A2,0.85,Aromatic hydroxylation of fused benzene ring
mefenamic acid,CC1=CC=CC(NC2=CC=CC=C2C(=O)O)=C1C,,3-hydroxymethyl mefenamic aci,CC1=C(CO)C=CC=C1NC1=CC=CC=C1C(=O)O,,CYP2C9 ,0.91,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
meiqx,CC1=CN=C2C=CC3=C(NC(=N)N3C)C2=N1,,N-OH-MeIQX,CC1=CN=C2C=CC3=C(N=C(NO)N3C)C2=N1,,CYP1A2,0.67,N-hydroxylation of primary arylamine
meiqx,CC1=CN=C2C=CC3=C(NC(=N)N3C)C2=N1,,IQx-8-COOH,CN1C(=N)NC2=C3N=C(C(=O)O)C=NC3=CC=C21,,CYP1A2,0.86,OXIDATION_OF_METHYL_TO_CARBOXYLIC_ACID
melatonin,COC1=CC=C2NC=C(CCN=C(C)O)C2=C1,,6-Hydroxymelatonin,COC1=CC2=C(C=C1O)NC=C2CCN=C(C)O,,CYP1A1; CYP1A2; CYP2C19 (minor); CYP2E1,0.88,Aromatic hydroxylation of fused benzene ring
melatonin,COC1=CC=C2NC=C(CCN=C(C)O)C2=C1,,N-Acetyl-5-hydroxytryptamine,CC(O)=NCCC1=CNC2=CC=C(O)C=C12,,CYP2C19 (major); CYP1A2; CYP2E1,0.93,O-aryl demethylation
meloxicam,CC1=CN=C(N=C(O)C2=C(O)C3=CC=CC=C3S(=O)(=O)N2C)S1,,,CN1C(C(O)=NC2=NC=C(CO)S2)=C(O)C2=CC=CC=C2S1(=O)=O,,CYP2C9;CYP3A4,0.98,Aliphatic Hydroxylation
meperidine,CCOC(=O)C1(C2=CC=CC=C2)CCN(C)CC1,,normeperidine,CCOC(=O)C1(C2=CC=CC=C2)CCNCC1,,CYP1A2;CYP2B6;CYP2C8;CYP2C19;CYP2D6;CYP3A4,0.94,N-DEMETHYLATION
methaqualone,CC1=CC=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,,hydroxy-methaqualone,CC1=CC(O)=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,,CYP3A4,0.94,Aromatic Hydroxylation
methaqualone,CC1=CC=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,,hydroxy-methaqualone,CC1=C(O)C=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,,CYP3A4,0.91,Aromatic Hydroxylation
methaqualone,CC1=CC=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,,hydroxy-methaqualone,CC1=NC2=CC=CC=C2C(=O)N1C1=CC=CC=C1CO,,CYP3A4,0.95,Aliphatic Hydroxylation
methoxsalen,COC1=C2OC=CC2=CC2=C1OC(=O)C=C2,,,COC1=C2OC3OC3C2=CC2=C1OC(=O)C=C2,,CYP2A6,0.41,Epoxidation
methyleugenol,C=CCC1=CC=C(OC)C(OC)=C1,,1Ã¢â‚¬Ëœ-hydroxylate methyleugenol,C=CC(O)C1=CC=C(OC)C(OC)=C1,,CYP1A2;CYP2C9;CYP2C19;CYP2D6,0.75,Aliphatic Hydroxylation
metoclopramide,CCN(CC)CCN=C(O)C1=CC(Cl)=C(N)C=C1OC,,monodeethylmetoclopramide,CCNCCN=C(O)C1=CC(Cl)=C(N)C=C1OC,,CYP1A2;CYP2C8;CYP2C19;CYP2D6;CYP3A4,0.98,N-dealkylation
midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,1'-Hydroxymidazolam,OCC1=NC=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,CYP3A4; CYP3A5; CYP3A7; CYP2B6,0.95,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,4-Hydroxymidazolam,CC1=NC=C2C(O)N=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,CYP3A4; CYP3A5; CYP3A7,0.91,"3-Hydroxylation of 5-aryl-1,4-benzodiazepine"
mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(N(C)C)C=C3)CC21C,,Monodemethylated mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(NC)C=C3)CC21C,,CYP3A4,0.99,N-dealkylation of mixed tertiary amine
mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(N(C)C)C=C3)CC21C,,17alpha-hydroxymifepristone ,CN(C)C1=CC=C(C2CC3(C)C(CCC3(O)C#CCO)C3CCC4=CC(=O)CCC4=C23)C=C1,,CYP3A4,0.99,Aliphatic hydroxylation of methyl carbon adjacent to alkyne ring
minaprine,CC1=CC(C2=CC=CC=C2)=NNC1=NCCN1CCOCC1,,4-Hydroxyminaprine,CC1=CC(C2=CC=C(O)C=C2)=NNC1=NCCN1CCOCC1,,CYP2D6,0.94,p-Hydroxylation of monosubstituted benzene
miocamycin,CCC(=O)OC1CC(=O)OC(C)CC=CC=CC(OC(C)=O)C(C)CC(CC=O)C(OC2OC(C)C(OC3CC(C)(OC(C)=O)C(OC(=O)CC)C(C)O3)C(N(C)C)C2O)C1OC,,,CCC(=O)OC1CC(=O)OC(C)CC=CC=CC(OC(C)=O)C(C)CC(CC=O)C(OC2OC(C)C(OC3CC(C)(OC(C)=O)C(O)(OC(=O)CC)C(C)O3)C(N(C)C)C2O)C1OC,,CYP3A4,0.93,Aliphatic Hydroxylation
montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,montelukast sulfoxide,CC(C)(O)C1=CC=CC=C1CCC(C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1)S(=O)CC1(CC(=O)O)CC1,,CYP3A4; CYP2A6,0.91,S-oxidation of dialkylthioether to sulfoxide
montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,21-Hydroxymontelukast,CC(C)(O)C1=CC=CC=C1C(O)CC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,CYP3A4,0.94,Hydroxylation of acyclic aliphatic secondary carbon
montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,"[1Ã¢â‚¬Â({[(1R,3S)Ã¢â‚¬Â1Ã¢â‚¬Â{3Ã¢â‚¬Â[(E)Ã¢â‚¬Â2Ã¢â‚¬Â(7Ã¢â‚¬ÂchloroquinolinÃ¢â‚¬Â2Ã¢â‚¬Âyl)ethenyl]phenyl}Ã¢â‚¬Â3Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â3Ã¢â‚¬Â[2Ã¢â‚¬Â(2Ã¢â‚¬ÂhydroxypropanÃ¢â‚¬Â2Ã¢â‚¬Âyl)phenyl]propyl]sulfanyl}methyl)cyclopropyl]aceticacid",CC(C)(O)C1=CC=CC=C1C(O)CC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,CYP3A4,0.94,Hydroxylation of acyclic aliphatic secondary carbon
montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,"[1Ã¢â‚¬Â({[(1R)Ã¢â‚¬Â1Ã¢â‚¬Â{3Ã¢â‚¬Â[(E)Ã¢â‚¬Â2Ã¢â‚¬Â(7Ã¢â‚¬ÂchloroquinolinÃ¢â‚¬Â2Ã¢â‚¬Âyl)ethenyl]phenyl}Ã¢â‚¬Â3Ã¢â‚¬Â[2Ã¢â‚¬Â(1,2Ã¢â‚¬ÂdihydroxypropanÃ¢â‚¬Â2Ã¢â‚¬Âyl)phenyl]propyl]sulfanyl}methyl)cyclopropyl]aceticacid",CC(O)(CO)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,CYP2C9,0.95,Hydroxylation of terminal methyl
muraglitazar,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(CO)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.94,Aliphatic Hydroxylation
muraglitazar,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCC(O)C3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,CYP3A4,0.88,Aliphatic Hydroxylation
muraglitazar,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=C(O)C=C4)=N3)C=C2)C=C1,,CYP2C19,0.99,Aromatic Hydroxylation
muraglitazar,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(O)C=C2)C=C1,,CYP2C8;CYP2D6;CYP3A4,0.51,Aromatic Hydroxylation
mycophenolic acid,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1CC=C(C)CCC(=O)O,,6-O-desmethyl-MPA (DM-MPA),CC(=CCC1=C(O)C(C)=C2COC(=O)C2=C1O)CCC(=O)O,,CYP3A4,0.91,O-Desmethylation
myristicin,C=CCC1=CC(OC)=C2OCOC2=C1,,"5-allyl-1-methoxy-2,3-dihydroxybenzene",C=CCC1=CC(O)=C(O)C(OC)=C1,,CYP3A4;CYP1A2,0.75,Nifedipine Oxidation
n_ac_dfec,CC(O)=NC(CSC(F)(F)C(OCF)C(F)F)C(=O)O,,N-Ac-DFEC-SO,CC(O)=NC(CS(=O)C(F)(F)C(OCF)C(F)F)C(=O)O,,CYP3A4,0.76,S-Oxidation
n_ac_ffvc,CC(O)=NC(CSC(F)=C(OCF)C(F)F)C(=O)O,,N-Ac-FFVC-SO,CC(O)=NC(CS(=O)C(F)=C(OCF)C(F)F)C(=O)O,,CYP3A4,0.76,S-Oxidation
n_ac_pcbc,NC(CSC(Cl)=C(Cl)C(Cl)=C(Cl)Cl)C(=O)O,,N-Ac-PCBC-SO,NC(CS(=O)C(Cl)=C(Cl)C(Cl)=C(Cl)Cl)C(=O)O,,CYP3A4,0.71,S-Oxidation
n-({4-[(5-bromopyrimidin-2-yl)oxy]-3-methylphenyl}carbamoyl)-2-(dimethylamino)benzamide,CC1=CC(NC(=O)N=C(O)C2=CC=CC=C2N(C)C)=CC=C1OC1=NC=C(Br)C=N1,,mmBPU,CNC1=CC=CC=C1C(O)=NC(=O)NC1=CC=C(OC2=NC=C(Br)C=N2)C(C)=C1,,CYP1A1;CYP2D6;CYP2C9;CYP3A4;CYP3A5;CYP3A7,0.96,N-Demethylation
n-nitroso-n-methylaniline (NMPhA),CN(N=O)C1=CC=CC=C1,,,O=NN(CO)C1=CC=CC=C1,,CYP2A6,0.76,Aliphatic Hydroxylation
n-nitrosodibutylamine,CCCCN(CCCC)N=O,,,CCCCN(N=O)C(O)CCC,,CYP2A6;CYP2E1,0.47,Aliphatic Hydroxylation
"n,n-diethyl-n'-(1-ethyl-6-methylergolin-8alpha-yl)sulfamide",CCN(CC)S(=O)(=O)NC1CC2C3=CC=CC4=C3C(=CN4CC)CC2N(C)C1,,,CCNS(=O)(=O)NC1CC2C3=CC=CC4=C3C(=CN4CC)CC2N(C)C1,,CYP3A4,0.98,N-Dealkylation
"n,n-diethylformamide",CCN(C=O)CC,,,CCN(C=O)C(C)O,,CYP2E1;CYP3A4,0.47,Aliphatic Hydroxylation
"n,n-dimethyl-5-methoxytryptamine",COC1=CC=C2NC=C(CCN(C)C)C2=C1,,Bufotenine,CN(C)CCC1=CNC2=CC=C(O)C=C12,,CYP2D6,0.92,O-demethylation
nabumetone,COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1,,4Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â4Ã¢â‚¬Â(6Ã¢â‚¬ÂmethoxynaphthalenÃ¢â‚¬Â2Ã¢â‚¬Âyl)butanÃ¢â‚¬Â2Ã¢â‚¬Âone,COC1=CC=C2C=C(C(O)CC(C)=O)C=CC2=C1,,CYP1A2,0.77,Alpha hydroxylation of carbonyl group
naphthalene,C1=CC=C2C=CC=CC2=C1,,2-Naphthol,OC1=CC=C2C=CC=CC2=C1,,CYP3A4,0.48,Aromatic Hydroxylation
naphthalene,C1=CC=C2C=CC=CC2=C1,,1-Naphthol,OC1=CC=CC2=CC=CC=C12,,CYP1A2,0.42,Aromatic Hydroxylation
naphthalene,C1=CC=C2C=CC=CC2=C1,,dihydrodiol,OC1=CC=C2C=CC=CC2=C1O,,CYP1A2,0.32,Aromatic Hydroxylation
naphthalene,C1=CC=C2C=CC=CC2=C1,,"naphthalene-1,2 Expodation",C1=CC2OC2C2=CC=CC=C12,,CYP1A2;CYP3A4,0.05,Epoxidation
naproxen,COC1=CC=C2C=C(C(C)C(=O)O)C=CC2=C1,,Desmethylnaproxen ,CC(C(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,CYP2C9 (major); CYP1A2 ,0.91,O-aryl dealkylation not adjacent to substituted carbon
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,,CCC1=NN(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.96,Aromatic Hydroxylation
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,,CC(O)C1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.91,Aliphatic Hydroxylation
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,,ClC1=CC=CC(N2CCNCC2)=C1,,CYP3A4,0.26,N-Dealkylation
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,,CCC1=NN(CCCO)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.75,N-Dealkylation
nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,2-OH-nevirapine,CC1=CC(O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,CYP3A4,0.93,HYDROXYLATION_OF_HETEROAROMATIC_CARBON
nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,8-OH-nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC(O)=CN=C1N2C1CC1,,CYP2D6 (major); CYP2B6 (minor); CYP3A4 (minor),0.95,HYDROXYLATION_OF_HETEROAROMATIC_CARBON
nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,3-OH-nevirapine,CC1=C(O)C=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,CYP2B6,0.93,HYDROXYLATION_OF_HETEROAROMATIC_CARBON
nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,12-OH-nevirapine,OCCC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,CYP3A4 (major); CYP2D6 (minor); CYP2C9 (minor),0.96,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
nicotine,CN1CCCC1C1=CC=CN=C1,,"(S)-Nicotine ÃŽâ€1Ã¢â‚¬Â²,5Ã¢â‚¬Â²-iminium ion",C[N+]1=CCCC1C1=CC=CN=C1,,CYP2A6 (major); CYP2B6; CYP2A13,0.56,Formation of iminium from pyrrolidine ring
nicotine,CN1CCCC1C1=CC=CN=C1,,2Ã¢â‚¬Â²-Hydroxynicotine,CN1CCCC1(O)C1=CC=CN=C1,,CYP2A6,0.66,Hydroxylation of heteroalicyclic secondary carbon
nicotine,CN1CCCC1C1=CC=CN=C1,,Nornicotine,C1=CN=CC(C2CCCN2)=C1,,CYP2A6; CYP2B6; CYP2A13,0.86,N_DEALKYLATION_OF_CYCLIC_TERTIARY_AMINES; N_DEALKYLATION_OF_ALICYCLIC_TERTIARY_AMINES_PATTERN1
nifedipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+](=O)[O-],,Oxidized nifedipine,COC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=CC=CC=C1[N+](=O)[O-],,CYP3A4,0.35,"Dehydrogenation of 4-aryl substituted 1,4-dihydropyridine"
nnal,CN(CCC(O)C(=O)C1=CC=CN=C1)N=O,,,CN(CCC(O)C(=O)C1=CC=C[N+]([O-])=C1)N=O,,CYP3A4,0.86,N-Oxidation
nnal,CN(CCC(O)C(=O)C1=CC=CN=C1)N=O,,,CN(N=O)C(O)CC(O)C(=O)C1=CC=CN=C1,,CYP3A4,0.84,Aliphatic Hydroxylation
o-xylene,CC1=CC=CC=C1C,,"2,3-Dimethylphenol",CC1=CC=C(O)C=C1C,,CYP2E1,0.47,Aromatic Hydroxylation
o-xylene,CC1=CC=CC=C1C,,"3,4-Dimethylphenol",CC1=CC=CC(O)=C1C,,CYP2E1,0.42,Aromatic Hydroxylation
o-xylene,CC1=CC=CC=C1C,,2 Methylbenzylalcohol,CC1=CC=CC=C1CO,,CYP2E1,0.58,Aliphatic Hydroxylation
olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN(C)CC2)S1,,,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CC[N+](C)([O-])CC2)S1,,CYP1A2;CYP2D6;CYP3A4,0.97,N-OXIDATION
olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN(C)CC2)S1,,,CC1=CC2=C(NC3=CC=C(O)C=C3N=C2N2CCN(C)CC2)S1,,CYP1A2;CYP2D6,0.96,AROMATIC HYDROXYLATION
oleic acid,CCCCCCCCC=CCCCCCCCC(=O)O,,,CC(O)CCCCCCC=CCCCCCCCC(=O)O,,CYP2E1;CYP4A11,0.89,Aliphatic Hydroxylation
olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=C(CC(=O)O)C=C12,,N-monodemethylolopatadine,CNCCC=C1C2=CC=CC=C2COC2=CC=C(CC(=O)O)C=C12,,CYP3A4,0.99,N-Dementhylation
onapristone,CN(C)C1=CC=C(C2CC3(C)C(CCC3(O)CCCO)C3CCC4=CC(=O)CCC4=C23)C=C1,,,CNC1=CC=C(C2CC3(C)C(CCC3(O)CCCO)C3CCC4=CC(=O)CCC4=C23)C=C1,,CYP3A4,0.98,N-Demethylation
opc-13448,COC(=O)C1=C(C)N=C(C)C(C(=O)OCC=CC2=CC=CC=C2)=C1C1=CC=CC([N+](=O)[O-])=C1,,OPC-13463,COC(=O)C1=C(C)N=C(C)C(C(=O)O)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP1A2;CYP2D6;CYP3A4,0.92,N-Demethylation
org_30659,C#CC1(O)C=CC2C3CCC4=CC(=O)CCC4C3C(=C)CC21C,,,C#CC1(O)C=CC2C3C(O)CC4=CC(=O)CCC4C3C(=C)CC21C,,CYP3A4,0.92,Aliphatic Hydroxylation
oxycodone,COC1=CC=C2CC3N(C)CCC45C2=C1OC4C(=O)CCC35O,,noroxycodone,COC1=CC=C2CC3NCCC45C2=C1OC4C(=O)CCC35O,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.98,N-demethylation
p-cresol,CC1=CC=C(O)C=C1,,4-methyl-hydroquinone,CC1=CC=C(O)C(O)=C1,,CYP2E1,0.62,Aromatic Hydroxylation
p-cresol,CC1=CC=C(O)C=C1,,,CC1C=CC(=O)C=C1,,CYP1A2;CYP2C19;CYP2D6;CYP2E1,0.01,Dehydrogenation
p-cresol,CC1=CC=C(O)C=C1,,,OCC1=CC=C(O)C=C1,,CYP1A2;CYP2C19;CYP2D6;CYP2E1,0.71,Aliphatic Hydroxylation
p-xylene,CC1=CC=C(C)C=C1,,4-Methylbenzylalcohol,CC1=CC=C(CO)C=C1,,CYP2E1,0.6,Aliphatic Hydroxylation
p-xylene,CC1=CC=C(C)C=C1,,"2,5-dimethylphenol",CC1=CC=C(C)C(O)=C1,,CYP2E1,0.38,Aliphatic Hydroxylation
palmitic acid,CCCCCCCCCCCCCCCC(=O)O,,,CC(O)CCCCCCCCCCCCCC(=O)O,,CYP2E1;CYP4A11,0.84,Aliphatic Hydroxylation
parathion,CCOP(=S)(OCC)OC1=CC=C([N+](=O)[O-])C=C1,,Paraoxon,CCOP(=O)(OCC)OC1=CC=C([N+](=O)[O-])C=C1,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.65,Desulfation
pentachlorobenzene,ClC1=CC(Cl)=C(Cl)C(Cl)=C1Cl,,PCP,OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl,,CYP3A4,0.46,Aromatic Hydroxylation
pentoxyresorufin,CCCCCOC1=CC=C2N=C3C=CC(=O)C=C3OC2=C1,,Resorufin,O=C1C=CC2=NC3=CC=C(O)C=C3OC2=C1,,CYP1A1; CYP1A2; CYP1B1,0.91,O-aryl dealkylation not adjacent to substituted carbon
perazine,CN1CCN(CCCN2C3=CC=CC=C3SC3=CC=CC=C32)CC1,,,CN1CCN(CCCN2C3=CC=CC=C3S(=O)C3=CC=CC=C32)CC1,,CYP1A2;CYP2A6;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.83,S-Oxidation
perphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C32)CC1,,N-Dealkylated perphenazine,ClC1=CC=C2SC3=CC=CC=C3N(CCCN3CCNCC3)C2=C1,,CYP1A2; CYP3A4; CYP2C9; CYP2C19; CYP2D6 ,0.98,N-dealkylation of alicyclic tertiary amine
perphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C32)CC1,,Perphenazine sulfoxide,O=S1C2=CC=CC=C2N(CCCN2CCN(CCO)CC2)C2=CC(Cl)=CC=C21,,CYP2D6,0.85,S-oxidation of diarylthioether to sulfoxide
phenacetin,CCOC1=CC=C(N=C(C)O)C=C1,,Acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,CYP1A1; CYP1A2; CYP2E1; CYP2D6; CYP2C19; CYP2C9; CYP2A6,0.78,O-dealkylation
phenacetin,CCOC1=CC=C(N=C(C)O)C=C1,,N-OH-phenacetin,CCOC1=CC=C(N(O)C(C)=O)C=C1,,CYP1A1; CYP1A2,0.36,N-hydroxylation of secondary arylamide
phenanthrene,C1=CC=C2C(=C1)C=CC1=CC=CC=C12,,,OC1=CC=C2C(=C1O)C=CC1=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.37,Aromatic Hydroxylation
phenanthrene,C1=CC=C2C(=C1)C=CC1=CC=CC=C12,,,OC1=CC=C2C=CC3=CC=CC=C3C2=C1O,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.37,Aromatic Hydroxylation
phenanthrene,C1=CC=C2C(=C1)C=CC1=CC=CC=C12,,,OC1=C(O)C2=CC=CC=C2C2=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.37,Aromatic Hydroxylation
phencyclidine,C1=CC=C(C2(N3CCCCC3)CCCCC2)C=C1,,PCHP,OC1CCN(C2(C3=CC=CC=C3)CCCCC2)CC1,,CYP3A4,0.93,Aliphatic Hydroxylation
phencyclidine,C1=CC=C(C2(N3CCCCC3)CCCCC2)C=C1,,c-PPC/t-PPC,OC1CCC(C2=CC=CC=C2)(N2CCCCC2)CC1,,CYP3A4,0.89,Aliphatic Hydroxylation
phenformin,N=C(N)NC(=N)NCCC1=CC=CC=C1,,,N=C(N)NC(=N)NCCC1=CC=C(O)C=C1,,CYP2D6,0.81,Aromatic Hydroxylation
phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,3'-HPPH,OC1=NC(C2=CC=CC=C2)(C2=CC=CC(O)=C2)C(O)=N1,,CYP2C9; CYP2C19,0.86,m-Hydroxylation of monosubstituted benzene
phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,4'-HPPH,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,,CYP2C9 (major); CYP2C19 (minor),0.93,p-Hydroxylation of monosubstituted benzene
phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,"5Ã¢â‚¬Â(3,4Ã¢â‚¬ÂdihydroxycyclohexaÃ¢â‚¬Â1,5Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âyl)Ã¢â‚¬Â5Ã¢â‚¬ÂphenylimidazolidineÃ¢â‚¬Â2,4Ã¢â‚¬Âdione",OC1=NC(C2=CC(O)C(O)C=C2)(C2=CC=CC=C2)C(O)=N1,,CYP2C9; CYP2C19,0.4,DIHYDROXYLATION_OF_DOUBLE_BOND
pilocarpine,CCC1C(=O)OCC1CC1=CN=CN1C,,3-hydroxypilocarpine,CCC1(O)C(=O)OCC1CC1=CN=CN1C,,CYP2A6,0.82,Aliphatic Hydroxylation
pimozide,OC1=NC2=CC=CC=C2N1C1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1,,"1,3- dihydro-1-(4-piperidinyl)-2H-benzimidazol-2-one (DHPBI)",OC1=NC2=CC=CC=C2N1C1CCNCC1,,CYP1A2;CYP3A4,0.76,N-dealkylation
piroxicam,CN1C(C(O)=NC2=CC=CC=N2)=C(O)C2=CC=CC=C2S1(=O)=O,,5'-Hydroxypiroxicam,CN1C(C(O)=NC2=CC=C(O)C=N2)=C(O)C2=CC=CC=C2S1(=O)=O,,CYP2C9,0.98,HYDROXYLATION_OF_HETEROAROMATIC_CARBON
pradefovir,NC1=NC=NC2=C1N=CN2CCOCP1(=O)OCCC(C2=CC=CC(Cl)=C2)O1,,PMEA,NC1=NC=NC2=C1N=CN2CCOCP(=O)(O)O,,CYP3A4,0.63,Oxidation
pregnenolone,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,,,CC(=O)C1C(O)CC2C3CC=C4CC(O)CCC4(C)C3CCC21C,,CYP2C19;CYP3A4,0.85,Aliphatic Hydroxylation
pregnenolone,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,,,CC12CCC(O)CC1=CCC1C2CCC2(C)C(C(=O)CO)CCC12,,CYP2C19;CYP2D6,0.96,Aliphatic Hydroxylation
progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,2beta-OH-progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)C(O)CC4(C)C3CCC12C,,CYP3A4,0.73,Alpha hydroxylation of carbonyl group
progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,16beta-OH-progesterone,CC(=O)C1C(O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,,CYP3A4; CYP1A1; CYP2D6; CYP2C19,0.77,Hydroxylation of alicyclic secondary carbon
progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,17beta-OH-progesterone,CC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,,CYP2D4; CYP2D6; CYP2C19 ,0.71,Alpha hydroxylation of carbonyl group
progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,21-OH-progesterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(C(=O)CO)CCC12,,CYP2C9,0.9,Alpha hydroxylation of carbonyl group
psoralen,O=C1C=CC2=CC3=C(C=C2O1)OC=C3,,,O=C1C=CC2=CC3=C(C=C2O1)OC1OC31,,CYP2A6,0.3,Epoxidation
Stearic Acid,CCCCCCCCCCCCCCCCCC(=O)O,,,CC(O)CCCCCCCCCCCCCCCC(=O)O,,CYP2E1;CYP4A11,0.84,Aliphatic Hydroxylation
qttnoskslatgqb-uhfffaoysa-n,O=C(O)CCC1=C2CC3=C(CC(=O)O)C(CCC(=O)O)=C(CC4=C(CC(=O)O)C(CCC(=O)O)=C(CC5=C(CC(=O)O)C(CCC(=O)O)=C(CC(=C1CC(=O)O)N2)N5)N4)N3,,uroporphyrin,O=C(O)CCC1=C2CC3=C(CC(=O)O)C(CCC(=O)O)=C(N3)C(O)C3=C(CC(=O)O)C(CCC(=O)O)=C(CC4=C(CC(=O)O)C(CCC(=O)O)=C(CC(=C1CC(=O)O)N2)N4)N3,,CYP1A2;CYP2E1;CYP3A4,0.82,Aliphatic Hydroxylation
quazepam,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,,2-Oxoquazepam,O=C1CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C2N1CC(F)(F)F,,CYP2C9,0.8,Desulfurization of thioamide into amide
quazepam,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,,2-Oxoquazepam,O=C1CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C2N1CC(F)(F)F,,CYP2C19,0.8,Desulfurization of thioamide into amide
quazepam,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12,,2-Oxoquazepam,O=C1CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C2N1CC(F)(F)F,,CYP3A4,0.8,Desulfurization of thioamide into amide
quetiapine,OCCOCCN1CCN(C2=NC3=CC=CC=C3SC3=CC=CC=C23)CC1,,,O=S1C2=CC=CC=C2N=C(N2CCN(CCOCCO)CC2)C2=CC=CC=C21,,CYP3A4,0.88,S-Oxidation
quetiapine,OCCOCCN1CCN(C2=NC3=CC=CC=C3SC3=CC=CC=C23)CC1,,,OCCOCCN1CCN(C2=NC3=CC=C(O)C=C3SC3=CC=CC=C23)CC1,,CYP2D6,0.93,Aromatic Hydroxylation
quinidine,C=CC1CN2CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,,Quinidine-N-oxide,C=CC1C[N+]2([O-])CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,,CYP3A4; CYP2C9; CYP2E1,0.88,Oxidation of nitrogen in a strained ring system
quinoline,C1=CC=C2N=CC=CC2=C1,,"Q-8,6-epoxide",C1=CC2OC2C2=CC=CN=C12,,CYP1A2;CYP2A6;CYP2D6;CYP2E1;,0.09,EPOXIDATION
quinoline,C1=CC=C2N=CC=CC2=C1,,Quinoline 1-oxide,[O-][N+]1=CC=CC2=CC=CC=C21,,CYP1A2;CYP2A6;CYP2E1;CYP3A4,0.69,N-OXIDATION
quinoline,C1=CC=C2N=CC=CC2=C1,,3OHQ,OC1=CN=C2C=CC=CC2=C1,,CYP1A2;CYP2A6;CYP2E1,0.62,AROMATIC HYDROXYLATION
qun,CCN(CC)CCCC(C)N=C1C2=CC=C(Cl)C=C2NC2=CC=C(OC)C=C12,,,CCNCCCC(C)N=C1C2=CC=C(Cl)C=C2NC2=CC=C(OC)C=C12,,CYP3A4,0.98,N-desethylation
qun,CCN(CC)CCCC(C)N=C1C2=CC=C(Cl)C=C2NC2=CC=C(OC)C=C12,,,CCN(CC)CCCC(C)N=C1C2=CC=C(Cl)C=C2NC2=CC=C(O)C=C12,,CYP3A4,0.95,O-dementhylation
qun,CCN(CC)CCCC(C)N=C1C2=CC=C(Cl)C=C2NC2=CC=C(OC)C=C12,,,COC1=CC=C2NC3=CC(Cl)=CC=C3C(=N)C2=C1,,CYP3A4,0.73,O-dementhylation
(R)-mianserin,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,"(R)-mianserin, N-Desmethyl",C1=CC=C2C(=C1)CC1=CC=CC=C1N1CCNCC21,,CYP2D6; CYP1A2; CYP3A4; CYP2B6,0.96,N-dealkylation of alicyclic tertiary amine
(R)-mianserin,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,"(R)-mianserin, 8-hydroxy",CN1CCN2C3=CC(O)=CC=C3CC3=CC=CC=C3C2C1,,CYP2D6; CYP3A4,0.93,Aromatic hydroxylation of fused benzene ring
(R)-mianserin,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,"(R)-mianserin, N-oxide",C[N+]1([O-])CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,CYP3A4,0.91,N-oxidation of alicyclic tertiary amine
raloxifene,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C=C2)SC2=CC(O)=CC=C12,,,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C=C2)SC2=C(O)C(O)=CC=C12,,CYP2D6,0.92,Aromatic Hydroxylation
raloxifene,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C=C2)SC2=CC(O)=CC=C12,,,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C(O)=C2)SC2=CC(O)=CC=C12,,CYP2D6,0.95,Aromatic Hydroxylation
ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(CN(C)C)O1,,Desmethylranitidine,CNCC1=CC=C(CSCCNC(=C[N+](=O)[O-])NC)O1,,CYP2C19; CYP1A2; CYP2D6,0.96,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES
reboxetine,CCOC1=CC=CC=C1OC(C1=CC=CC=C1)C1CNCCO1,,O-desethylreboxetine,OC1=CC=CC=C1OC(C1=CC=CC=C1)C1CNCCO1,,CYP3A4,0.97,Desethylation
reboxetine,CCOC1=CC=CC=C1OC(C1=CC=CC=C1)C1CNCCO1,,Phenol B,CCOC1=CC(O)=CC=C1OC(C1=CC=CC=C1)C1CNCCO1,,CYP3A4,0.95,Aromatic Hydroxylation
reboxetine,CCOC1=CC=CC=C1OC(C1=CC=CC=C1)C1CNCCO1,,Phenol A,CCOC1=CC=C(O)C=C1OC(C1=CC=CC=C1)C1CNCCO1,,CYP3A4,0.94,Aromatic Hydroxylation
reduced_dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=CC=C12,,Dolasetron N-oxide,O=C(OC1CC2CC3CC(C1)[N+]2([O-])CC3O)C1=CNC2=CC=CC=C12,,CYP3A4,0.91,Oxidation of nitrogen in a strained ring system
reduced_dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=CC=C12,,6-Hydroxydolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC(O)=CC=C12,,CYP2D6 (major); CYP3A4; CYP2C9,0.93,Aromatic hydroxylation of fused benzene ring
reduced_dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=CC=C12,,5-Hydroxydolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=C(O)C=C12,,CYP2D6; CYP2C9,0.92,Aromatic hydroxylation of fused benzene ring
reduced_dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=CC=C12,,7-Hydroxydolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=C(O)C=CC=C12,,CYP2D6; CYP2C9,0.88,Aromatic hydroxylation of fused benzene ring
repaglinide,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)=CC=C1C(=O)O,,CYP2C8;CYP3A4,0.96,Aliphatic Hydroxylation
repaglinide,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,,CCOC1=CC(CC(O)=NC(CC(C)(C)O)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,CYP2C8;CYP3A4,0.95,Aliphatic Hydroxylation
repaglinide,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,,CC(C)CC(N=C(O)CC1=CC=C(C(=O)O)C(O)=C1)C1=CC=CC=C1N1CCCCC1,,CYP3A4,0.92,O-Demethylation
repaglinide,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N)=CC=C1C(=O)O,,CYP2C8;CYP3A4,0.82,N-dealkylation
repaglinide,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2NCCCCO)=CC=C1C(=O)O,,CYP2C8;CYP3A4,0.92,N-dealkylation
retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,all-trans retinoic acid,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,CYP1A2; CYP1A2; CYP1B1,0.9,Aldehyde oxidation
retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,CYP1A2; CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.9,Aliphatic Hydroxylation
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,All-trans-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,CYP1A1; CYP1A2; CYP3A4; CYP1B1,0.88,Oxidation of primary alcohol to aldehyde
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,4-Hydroxyretinol,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CCO,,CYP2C8,0.72,Aliphatic Hydroxylation
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,Retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,CYP1A1;CYP2C8; CYP2C9; CYP2C19;CYP2D6;CYP3A4,0.88,Aliphatic Hydroxylation
riddelliine,C=C1CC(=CC)C(=O)OC2CCN3CC=C(COC(=O)C1(O)CO)C23,,riddelliine N-Oxide,C=C1CC(=CC)C(=O)OC2CC[N+]3([O-])CC=C(COC(=O)C1(O)CO)C23,,CYP3A4,0.89,N-Oxidation
riddelliine,C=C1CC(=CC)C(=O)OC2CCN3CC=C(COC(=O)C1(O)CO)C23,,,C=C1CC(=CC)C(=O)OC2CCN3CC=C(COC(=O)C1(O)CO)C23O,,CYP3A4,0.84,Aliphatic Hydroxylation
riddelliine,C=C1CC(=CC)C(=O)OC2CCN3CC=C(COC(=O)C1(O)CO)C23,,,C=C1CC(=CC)C(=O)OC2CCN3C(O)C=C(COC(=O)C1(O)CO)C23,,CYP3A4,0.91,Aliphatic Hydroxylation
rifabutin,COC1C=COC2(C)OC3=C(C)C(O)=C4C(=O)C(=C5NC6(CCN(CC(C)C)CC6)N=C5C4=C3C2=O)CC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,,,COC1C=COC2(C)OC3=C(C)C(O)=C4C(=O)C(=C5NC6(CCN(CC(C)C)CC6)N=C5C4=C3C2=O)CC(=O)C(C)=CC=CC(C)(O)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,,CYP3A4,0.99,Aliphatic Hydroxylation
riluzole,N=C1NC2=CC=C(OC(F)(F)F)C=C2S1,,4-OH-riluzole,N=C1NC2=C(O)C=C(OC(F)(F)F)C=C2S1,,CYP1A1,0.82,Aromatic hydroxylation of fused benzene ring
riluzole,N=C1NC2=CC=C(OC(F)(F)F)C=C2S1,,5-OH-riluzole,N=C1NC2=CC(O)=C(OC(F)(F)F)C=C2S1,,CYP1A1,0.82,Aromatic hydroxylation of fused benzene ring
riluzole,N=C1NC2=CC=C(OC(F)(F)F)C=C2S1,,7-OH-riluzole,N=C1NC2=CC=C(OC(F)(F)F)C(O)=C2S1,,CYP1A2; CYP1A1,0.74,Aromatic hydroxylation of fused benzene ring
riluzole,N=C1NC2=CC=C(OC(F)(F)F)C=C2S1,,N-OH-riluzole,ONC1=NC2=CC=C(OC(F)(F)F)C=C2S1,,CYP1A1,0.66,N-hydroxylation of primary arylamine
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CC(O)CCC2=N1,,CYP2D6;CYP3A4,0.95,Aliphatic Hydroxylation
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCC(O)C2=N1,,CYP2D6,0.94,Aliphatic Hydroxylation
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,CC1=C(CCN2CCC(C3=C4C=CC(F)=CC4=[O+]N3O)CC2)C(=O)N2CCCC(C)C2=N1,,CYP2D6,0.92,N-Hydroxylation
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,FC1=CC=C2C(C3CCNCC3)=NOC2=C1,,CYP3A4,0.51,N-Dealkylation
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,CCC1=C(C)N=C2C(C)CCCN2C1=O,,CYP3A4,0.66,N-Dealkylation
ropinirole,CCCN(CCC)CCC1=CC=CC2=C1CC(O)=N2,,,CCCNCCC1=CC=CC2=C1CC(O)=N2,,CYP1A2;CYP3A4,0.96,N-Despropylation
ropinirole,CCCN(CCC)CCC1=CC=CC2=C1CC(O)=N2,,,CCCN(CCC)CCC1=CC=C(O)C2=C1CC(O)=N2,,CYP1A2;CYP3A4,0.79,Aromatic Hydroxylation
ropivacaine,CCCN1CCCCC1C(O)=NC1=C(C)C=CC=C1C,,3-OH-ropivacaine,CCCN1CCCCC1C(O)=NC1=C(C)C=CC(O)=C1C,,CYP1A2,0.84,Hydroxylation of benzene on carbon ortho to an electron donating group
ropivacaine,CCCN1CCCCC1C(O)=NC1=C(C)C=CC=C1C,,PPX,CC1=CC=CC(C)=C1N=C(O)C1CCCCN1,,CYP3A4,0.89,N-dealkylation of alicyclic tertiary amine
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC(O)=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,CYP1A2;CYP2C9;CYP2D6;CYP3A4,0.97,Aromatic Hydroxylation
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=C(O)C=CC=C1N3,,CYP1A2;CYP2C9;CYP2D6;CYP3A4,0.93,Aromatic Hydroxylation
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=C(O)C=C1N3,,CYP1A2;CYP2C9;CYP2D6;CYP3A4,0.97,Aromatic Hydroxylation
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC(O)=CC=C1N3,,CYP2C9;CYP2D6;CYP3A4,0.96,Aromatic Hydroxylation
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC(O)=C1N3,,CYP1A2;CYP2C9;CYP2D6;CYP3A4,0.93,Aromatic Hydroxylation
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC=CC=C2N=C2C3=C(C4=CC=CC=C4N3)C(O)CN21,,CYP3A4,0.9,Aliphatic Hydroxylation
s-methyl diethylthiocarbamate,CCN(CC)C(=O)SC,,MeDTC sulfoxide,CCN(CC)C(=O)S(C)=O,,CYP3A4; CYP2A6; CYP2C9; CYP1A2; CYP2B6; CYP2E1; CYP2D6,0.64,S-oxidation of thiocarbamate
s-metolachlor,CCC1=CC=CC(C)=C1N(C(=O)CCl)C(C)COC,,,CCC1=CC=CC(C)=C1N(C(=O)CCl)C(C)CO,,CYP2B6;CYP3A4,0.94,O-demethylation
salicylic acid,O=C(O)C1=CC=CC=C1O,,5-hydroxylation,O=C(O)C1=CC(O)=CC=C1O,,CYP2E1;CYP3A4,0.79,Aromatic Hydroxylation
salmeterol,OCC1=CC(C(O)CNCCCCCCOCCCCC2=CC=CC=C2)=CC=C1O,,,OCC1=CC(C(O)CNCCCCCCOCCCC(O)C2=CC=CC=C2)=CC=C1O,,CYP3A4,0.94,Aliphatic Hydroxylation
schembl12998564,COC1=CC=CC=C1N=C(O)C(=NNC1=CC=C([N+](=O)[O-])C=C1OC)C(C)=O,,py74-M1,COC1=CC(O)=CC=C1N=C(O)C(=NNC1=CC=C([N+](=O)[O-])C=C1OC)C(C)=O,,CYP3A4,0.95,Aromatic Hydroxylation
schembl14329530,CCCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CCCC(O)CCOC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.95,Aliphatic Hydroxylation
schembl14329530,CCCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CCC(O)CCCOC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.96,Aliphatic Hydroxylation
schembl14329530,CCCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CC(O)CCCCOC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.97,Aliphatic Hydroxylation
schembl149458,CN1CCCCC1CCN1C2=CC=CC=C2SC2=CC=C(S(C)=O)C=C21,,Sulphoridazine,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3C)C2=C1,,CYP2D6,0.92,S-REDUCTION
schembl17043265,CCC(C(=O)C1=CC=C(C)C=C1)N1CCCC1,,HO-MPBP,CCC(C(=O)C1=CC=C(CO)C=C1)N1CCCC1,,CYP1A2;CYP2C19;CYP2D6,0.94,Aliphatic Hydroxylation
schembl237672,CC[N+](C)(CC)CCC1=C(C)C2=CC=C(OC)C=C2OC1=O,,"AMHC (3-[2-(N,N-diethyl-Nmethylammonium)ethyl]-7-hydroxy-4-methylcoumarin)",CC[N+](C)(CC)CCC1=C(O)OC2=CC(=O)C=CC2=C1C,,CYP1A2;CYP2D6;CYP2B6,0.42,O-Demethylation
schembl29464,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21,,Oxazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1O,,CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.51,N-dementhylation
schembl3207291,CNC1CN(C2=CC=C3C(=O)C(C(=O)O)=CN(C4=NC=CS4)C3=N2)CC1OC,,,COC1CN(C2=CC=C3C(=O)C(C(=O)O)=CN(C4=NC=CS4)C3=N2)CC1N,,CYP1A2;CYP3A4,0.98,N-dealkylation
schembl3207291,CNC1CN(C2=CC=C3C(=O)C(C(=O)O)=CN(C4=NC=CS4)C3=N2)CC1OC,,,CNC1CN(C2=CC=C3C(=O)C(C(=O)O)=CN(C4=NC=CS4)C3=N2)CC1O,,CYP1A2;CYP3A4,0.98,O-dealkylation
schembl3207291,CNC1CN(C2=CC=C3C(=O)C(C(=O)O)=CN(C4=NC=CS4)C3=N2)CC1OC,,,CNC1CN(C2=CC=C3C(=O)C(C(=O)O)CN(C4=NC=CS4)C3=N2)CC1OC,,CYP1A2;CYP2D6;CYP3A4,0.62,Hydrogenation
schembl4023988,COC(OC)C1(C)OC2=CC=C(N)C=C2C(N(CC2=NN(C)N=N2)C2=CC=C(Cl)C=C2)C1O,,hydroxy-KR-31543,CN1N=NC(CNC2=CC=C(Cl)C=C2)=N1,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.21,N-Demethylation
schembl4023988,COC(OC)C1(C)OC2=CC=C(N)C=C2C(N(CC2=NN(C)N=N2)C2=CC=C(Cl)C=C2)C1O,,N-(4-chlorophenyl)-N-(2-methyl-2H-tetrazol-5-ylmethyl)amine,COC(OC)C1(C)OC2=CC(O)=C(N)C=C2C(N(CC2=NN(C)N=N2)C2=CC=C(Cl)C=C2)C1O,,CYP3A4,0.97,Aromatic Hydroxylation
schembl4081913,CN=C(O)CC1=CC=C2C=CN(C3CCN(CCC4=CC=CC=C4F)CC3)C2=C1,,,CN=C(O)CC1=CC=C2C=CN(C3CCN(C(O)CC4=CC=CC=C4F)CC3)C2=C1,,CYP3A4,0.92,Aliphatic Hydroxylation
schembl4081913,CN=C(O)CC1=CC=C2C=CN(C3CCN(CCC4=CC=CC=C4F)CC3)C2=C1,,,CN=C(O)CC1=CC=C2C=CN(C3CCN(CC(O)C4=CC=CC=C4F)CC3)C2=C1,,CYP3A4,0.91,Aliphatic Hydroxylation
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,DA-8164,CCCOC1=CC=C(S(N)(=O)=O)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,CYP3A4,0.93,N-Dealkylation
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,N-Demethyl-DA-8159,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(CCC)NN=C2C(=O)N1,,CYP3A4,0.93,N-Demethylation
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,Hydroxy-DA-8164,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2C(O)CC,,CYP3A4,0.95,Aliphatic Hydroxylation
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,Hydroxy-DA-8164,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CC(C)O,,CYP3A4,0.97,Aliphatic Hydroxylation
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,Hydroxy-DA-8164,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCCO,,CYP3A4,0.99,Aliphatic Hydroxylation
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,Hydroxy-DA-8164,CCCC1=NN(C)C2=C1N=C(C1=CC(S(=O)(=O)NCCC3CCCN3C)=CC=C1OC(O)CC)NC2=O,,CYP3A4,0.98,Aliphatic Hydroxylation
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,Hydroxy-DA-8164,CCCC1=NN(C)C2=C1N=C(C1=CC(S(=O)(=O)NCCC3CCCN3C)=CC=C1OCC(C)O)NC2=O,,CYP3A4,0.99,Aliphatic Hydroxylation
schembl7562446,CC(C)(C)C1=CC(CC2SCN=C2O)=CC(C(C)(C)C)=C1O,,,CC(C)(C)C1=CC(CC2C(O)=NCS2=O)=CC(C(C)(C)C)=C1O,,CYP3A4,0.84,S-Oxidation
schembl7750160,CN(C)CCCCCN1C2=CC=CC=C2SC2=CC=C(C(F)(F)F)C=C21,,,C[N+](C)([O-])CCCCCN1C2=CC=CC=C2SC2=CC=C(C(F)(F)F)C=C21,,CYP2D6,0.98,N-Oxidation
schembl7750160,CN(C)CCCCCN1C2=CC=CC=C2SC2=CC=C(C(F)(F)F)C=C21,,,CN(C)CCCCCN1C2=CC=CC=C2S(=O)C2=CC=C(C(F)(F)F)C=C21,,CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.87,S-Oxidation
schembl895799,CC(C#CC1=CC=C(CC2=CC=CC=C2)S1)NC(=N)O,,ABT-438 Hydroxy,CC(C#CC1=CC=C(C(O)C2=CC=CC=C2)S1)NC(=N)O,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP3A4;CYP2E1,0.79,Aliphatic Hydroxylation
schembl896413,COC1=CC(CC2SC(=O)N=C2O)=CC=C1C(O)=NCC1=CC=C(C(F)(F)F)C=C1,,M28,O=C1N=C(O)C(O)(CC2=CC=C(C(O)=NCC3=CC=C(C(F)(F)F)C=C3)C(O)=C2)S1,,CYP2C9;CYP2C19,0.79,O-Demethylation
schembl896413,COC1=CC(CC2SC(=O)N=C2O)=CC=C1C(O)=NCC1=CC=C(C(F)(F)F)C=C1,,M24,COC1=CC(CC2(O)SC(=O)N=C2O)=CC=C1C(O)=NCC1=CC=C(C(F)(F)F)C=C1,,CYP3A4,0.84,Aliphatic Hydroxylation
schembl896413,COC1=CC(CC2SC(=O)N=C2O)=CC=C1C(O)=NCC1=CC=C(C(F)(F)F)C=C1,,,COC1=CC(CC2C(O)=NC(=O)S2=O)=CC=C1C(O)=NCC1=CC=C(C(F)(F)F)C=C1,,CYP3A4,0.88,S-Oxidation
schembl9652240,CC1SC(C2=CC=CN=C2)N(C)C1=O,,,CC1C(=O)N(C)C(C2=CC=CN=C2)S1=O,,CYP2A6,0.79,S-Oxidation
selegiline,C#CCN(C)C(C)CC1=CC=CC=C1,,Desmethylselegiline,C#CCNC(C)CC1=CC=CC=C1,,CYP2B6 (major); CYP2C19; CYP2D6; CYP1A2; CYP2C9; CYP3A4,0.83,N-dealkylation of acyclic tertiary amine
sertindole,OC1=NCCN1CCN1CCC(C2=CN(C3=CC=C(F)C=C3)C3=CC=C(Cl)C=C23)CC1,,,OC1=NC(O)CN1CCN1CCC(C2=CN(C3=CC=C(F)C=C3)C3=CC=C(Cl)C=C23)CC1,,CYP2D6,0.94,Aliphatic Hydroxylation
sertindole,OC1=NCCN1CCN1CCC(C2=CN(C3=CC=C(F)C=C3)C3=CC=C(Cl)C=C23)CC1,,,FC1=CC=C(N2C=C(C3CCNCC3)C3=CC(Cl)=CC=C32)C=C1,,CYP2D6,0.88,N-dealkylation
sertraline,CNC1CCC(C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C21,,N-desmethylsertraline,NC1CCC(C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C21,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.91,N-desmethylation
sildenafil,CCCC1=NN(C)C2=C1N=C(C1=CC(S(=O)(=O)N3CCN(C)CC3)=CC=C1OCC)NC2=O,,N-Desmethyl sildenafil,CCCC1=NN(C)C2=C1N=C(C1=CC([SH](=O)=O)=CC=C1OCC)NC2=O,,CYP3A4; CYP2C9; CYP2C19; CYP2D6,0.9,N-dealkylation of sulfonamide
simvastatin,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,6'-ÃŽÂ²-Hydroxysimvastatin ,CCC(C)(C)C(=O)OC1CC(C)(O)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,CYP3A4; CYP3A5,0.91,Allylic hydroxylation
simvastatin,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,"3', 5'-Dihydrodiol",CCC(C)(C)C(=O)OC1CC(C)C(O)C2=CC(O)C(C)C(CCC3CC(O)CC(=O)O3)C21,,CYP3A4; CYP3A5,0.75,"Aliphatic hydroxylation of acyclic 1,2-disubstituted alkene"
simvastatin,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,6'-exomethylene,C=C1C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C2C(OC(=O)C(C)(C)CC)C1,,CYP3A4; CYP3A5,0.93,Terminal desaturation
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,16-O-Desmethylsirolimus,COC1CC(CC(C)C2CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C(C)C(O)CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)CCC1O,,CYP3A4,0.98,O-dealkylation of dialkylether
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,12-OH-sirolimus,COC1CC2CC(O)C(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,CYP3A4,0.97,Hydroxylation of heteroalicyclic secondary carbon
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,11-OH-sirolimus,COC1CC2CCC(C)(O)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,CYP3A4,0.93,Hydroxylation of alkyl methine
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,25-OH-sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)(O)CC(C)C=CC=CC=C1C,,CYP3A4,0.97,Hydroxylation of alkyl methine
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,24-OH-sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)C(O)C(C)C=CC=CC=C1C,,CYP3A4,0.98,Hydroxylation of heteroalicyclic secondary carbon
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,46-OH-sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(CO)CC(C)C=CC=CC=C1C,,CYP3A4,0.99,Hydroxylation of terminal methyl
sparteine,C1CCN2CC3CC(CN4CCCCC34)C2C1,,,OC12CCCCN1CC1CC2CN2CCCCC12,,CYP2D6,0.53,Aliphatic Hydroxylation
sparteine,C1CCN2CC3CC(CN4CCCCC34)C2C1,,,OC1CCCC2C3CC(CN12)C1CCCCN1C3,,CYP2D6,0.71,Aliphatic Hydroxylation
sparteine,C1CCN2CC3CC(CN4CCCCC34)C2C1,,,OC1CCCN2CC3CC(CN4CCCCC34)C12,,CYP2D6,0.65,Aliphatic Hydroxylation
styrene,C=CC1=CC=CC=C1,,"Styrene 7,8-oxide",C1=CC=C(C2CO2)C=C1,,CYP2E1,0.23,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
sulfadiazine,NC1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C1,,,O=S(=O)(NC1=NC=CC=N1)C1=CC=C(NO)C=C1,,CYP2B6;CYP2C8;CYP2C9;CYP2C19,0.93,Hydroxylation
tacrine,N=C1C2=C(CCCC2)NC2=CC=CC=C12,,N4-hydroxylamine,N=C1C2=C(CCCC2O)NC2=CC=CC=C12,,CYP1A2,0.82,Hydroxylation of alicyclic secondary carbon
tacrine,N=C1C2=C(CCCC2)NC2=CC=CC=C12,,4- Hydroxytacrine,NC1=C2CCCC(O)C2=NC2=CC=CC=C12,,CYP1A2,0.57,Hydroxylation of alicyclic secondary carbon
tacrine,N=C1C2=C(CCCC2)NC2=CC=CC=C12,,2-Hydroxytacrine,N=C1C2=C(CCC(O)C2)NC2=CC=CC=C12,,CYP1A2,0.88,Hydroxylation of alicyclic secondary carbon
tacrine,N=C1C2=C(CCCC2)NC2=CC=CC=C12,,7-Hydroxytacrine,NC1=C2CCCCC2=NC2=C(O)C=CC=C12,,CYP1A2,0.58,Aromatic hydroxylation of fused benzene ring
tamarixetin,COC1=CC=C(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,QUERCETIN,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,CYP1A2;CYP2C9;CYP3A4,0.97,O-dealkylation
tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,4'-Hydroxytamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(O)C=C1,,CYP2D6; CYP2B6,0.99,p-Hydroxylation of monosubstituted benzene
tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,alpha-Hydroxytamoxifen,CC(O)C(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,CYP3A4; CYP2D6; CYP2B6 (give smaller amounts of ÃŽÂ±-hydroxylation); CYP2C9  (give smaller amounts of ÃŽÂ±-hydroxylation); CYP2C19 (give smaller amounts of ÃŽÂ±-hydroxylation); CYP3A5 (give smaller amounts of ÃŽÂ±-hydroxylation),0.86,Hydroxylation of penultimate aliphatic secondary carbon
tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,3-Hydroxytamoxifen,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC(O)=C1)C1=CC=CC=C1,,CYP3A4; CYP3A5; CYP2B6,0.89,m-Hydroxylation of monosubstituted benzene
tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1,,,CCOC1=CC=C(O)C=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1,,CYP2D6,0.95,Aromatic Hydroxylation
tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1,,,CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(O)C(S(N)(=O)=O)=C1,,CYP2D6,0.94,O-Dementhylation
tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1,,,COC1=CC=C(CC(C)NCCOC2=CC=CC=C2O)C=C1S(N)(=O)=O,,CYP3A4,0.99,O-dealkylation
taxol,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(N=C(O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C1C2(C)C,,6ÃŽÂ±-Hydroxypaclitaxel ,CC(=O)OC1C(=O)C2(C)C(O)C(O)C3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(N=C(O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C1C2(C)C,,CYP2C8,0.99,Hydroxylation of alicyclic secondary carbon
taxol,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(N=C(O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C1C2(C)C,,3Ã¢â‚¬Â²-pHydroxypaclitaxel ,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(N=C(O)C3=CC=CC=C3)C3=CC=C(O)C=C3)C(C)=C1C2(C)C,,CYP3A4 ,0.98,p-Hydroxylation of monosubstituted benzene
tecalcet,COC1=CC=CC(C(C)NCCCC2=CC=CC=C2Cl)=C1,,,CC(NCCCC1=CC=CC=C1Cl)C1=CC=CC(O)=C1,,CYP2D6,0.88,O-Dementhylation
tegaserod,CCCCCNC(=N)NN=CC1=CNC2=CC=C(OC)C=C12,,,CCCCCNC(=N)NN=CC1=CNC2=CC=C(O)C=C12,,CYP1A2;CYP2D6,0.93,O-desmethylation
tenoxicam,CN1C(=C(O)NC2=CC=CC=N2)C(=O)C2=C(C=CS2)S1(=O)=O,,5'-Hydroxytenoxicam,CN1C(=C(O)NC2=CC=C(O)C=N2)C(=O)C2=C(C=CS2)S1(=O)=O,,CYP2C9,0.98,HYDROXYLATION_OF_HETEROAROMATIC_CARBON
tentoxin,CC(C)CC1N=C(O)C(C)N(C)C(=O)CN=C(O)C(=CC2=CC=CC=C2)N(C)C1=O,,,CC(C)CC1N=C(O)C(C)N(C)C(=O)CN=C(O)C(=CC2=CC=CC=C2)N=C1O,,CYP3A4,0.58,N-Dementhylation
terbuthylazine,CCN=C1N=C(Cl)N=C(NC(C)(C)C)N1,,,CC(O)N=C1N=C(Cl)N=C(NC(C)(C)C)N1,,CYP1A2;CYP3A4,0.9,Aliphatic Hydroxylation
terbuthylazine,CCN=C1N=C(Cl)N=C(NC(C)(C)C)N1,,,CCN=C1N=C(Cl)N=C(NC(C)(C)CO)N1,,CYP1A2,0.91,Aliphatic Hydroxylation
territrem a,COC1=CC(C2=CC3=C(CC4(O)C(C)(CCC5(O)C(C)(C)C=CC(=O)C54C)O3)C(=O)O2)=CC2=C1OCO2,,,COC1=CC(C2=CC3=C(CC4(O)C(C)(CCC5(O)C(C)(CO)C=CC(=O)C54C)O3)C(=O)O2)=CC2=C1OCO2,,CYP2C9;CYP2D6;CYP3A4,0.99,Aliphatic Hydroxylation
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,2ÃŽÂ±-Hydroxytestosterone ,CC12CC(O)C(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,CYP3A4 ,0.82,Alpha hydroxylation of carbonyl group
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,2ÃŽÂ²-Hydroxytestosterone ,CC12CC(O)C(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,CYP3A4 ,0.82,Alpha hydroxylation of carbonyl group
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,15ÃŽÂ±-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CC(O)C12,,CYP3A4,0.92,Hydroxylation of alicyclic secondary carbon
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,15ÃŽÂ²-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CC(O)C12,,CYP3A4,0.92,Hydroxylation of alicyclic secondary carbon
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,16ÃŽÂ±-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)C(O)CC12,,CYP3A4; CYP2B6 ,0.92,Hydroxylation of alicyclic secondary carbon
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,16ÃŽÂ²-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)C(O)CC12,,CYP3A4; CYP2B6 ,0.92,Hydroxylation of alicyclic secondary carbon
tetradecanoic acid,CCCCCCCCCCCCCC(=O)O,,,CC(O)CCCCCCCCCCCC(=O)O,,CYP2E1;CYP4A11,0.84,Aliphatic Hydroxylation
tetranor-(+)-s-145,O=C(O)CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,,O=C(O)CCC1C2CC(O)C(C2)C1NS(=O)(=O)C1=CC=CC=C1,,CYP2C9,0.83,Aliphatic Hydroxylation
tetranor-(+)-s-145,O=C(O)CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,,O=C(O)CCC1C2CC(CC2O)C1NS(=O)(=O)C1=CC=CC=C1,,CYP3A4,0.87,Aliphatic Hydroxylation
theobromine,CN1C=NC2=C1C(O)=NC(=O)N2C,,,CN1C=NC2=NC(O)=NC(O)=C21,,CYP1A2;CYP2E1,0.57,N-demethylation
theobromine,CN1C=NC2=C1C(O)=NC(=O)N2C,,,CN1C(=O)N=C(O)C2=C1NC=N2,,CYP2E1,0.87,N-demethylation
theobromine,CN1C=NC2=C1C(O)=NC(=O)N2C,,,CN1C(O)=NC2=C1C(O)=NC(=O)N2C,,CYP2E1,0.86,Aliphatic Hydroxylation
theophylline,CN1C(=O)C2=C(NC=N2)N(C)C1=O,,"1,3-Dimethyluric acid",CN1C(=O)C2=C(NC(O)=N2)N(C)C1=O,,CYP1A2; CYP1A1 ,0.87,HYDROXYLATION_OF_HETEROAROMATIC_CARBON; HYDROXYLATION_OF_AROMATIC_CARBON_ADJACENT_TO_N
theophylline,CN1C(=O)C2=C(NC=N2)N(C)C1=O,,1-Methylxanthine ,CN1C(O)=NC2=C(N=CN2)C1=O,,CYP1A2,0.58,N-dealkylation of N-acylurea
theophylline,CN1C(=O)C2=C(NC=N2)N(C)C1=O,,3-Methylxanthine ,CN1C(=O)N=C(O)C2=C1NC=N2,,CYP1A2,0.57,N-dealkylation of N-acylurea
thiabendazole,C1=CC=C2NC(C3=CSC=N3)=NC2=C1,,5-hydroxythiabendazole ,OC1=CC=C2N=C(C3=CSC=N3)NC2=C1,,CYP1A2,0.82,Aromatic hydroxylation of fused benzene ring
ticrynafen,O=C(O)COC1=CC=C(C(=O)C2=CC=CS2)C(Cl)=C1Cl,,Tienilic acid-s-oxide,O=C(O)COC1=CC=C(C(=O)C2=CC=CS2=O)C(Cl)=C1Cl,,CYP2C8; CYP2C9 (major),0.48,Thiohene S-oxidation
ticrynafen,O=C(O)COC1=CC=C(C(=O)C2=CC=CS2)C(Cl)=C1Cl,,"Thiophene-4,5-epoxide",O=C(O)COC1=CC=C(C(=O)C2=CC3OC3S2)C(Cl)=C1Cl,,CYP2C8; CYP2C9 (major); CYP2C18; CYP2C19,0.47,Epoxidation of thiophene
timolol,CC(C)(C)NCC(O)COC1=NSN=C1N1CCOCC1,,,CC(C)(C)NCC(O)COC1=NSN=C1N1CCOC(O)C1,,CYP2D6,0.92,Aliphatic Hydroxylation
tirilazad,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCCC3)=NC(N3CCCC3)=N2)CC1,,,CC1CC2C3CC(O)C4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCCC3)=NC(N3CCCC3)=N2)CC1,,CYP3A4,0.9,Aliphatic Hydroxylation
tirilazad,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCCC3)=NC(N3CCCC3)=N2)CC1,,,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCCC3)=NC(N3CCC(O)C3)=N2)CC1,,CYP3A4,0.95,Aliphatic Hydroxylation
tirilazad,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCCC3)=NC(N3CCCC3)=N2)CC1,,,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCC(O)C3)=NC(N3CCCC3)=N2)CC1,,CYP3A4,0.94,Aliphatic Hydroxylation
tolterodine,CC1=CC=C(O)C(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C1,,N-Dealkylated tolterodine,CC1=CC=C(O)C(C(CCNC(C)C)C2=CC=CC=C2)=C1,,CYP3A4 (major); CYP2C9 (minor); CYP2C19 (minor),0.95,N-deisopropylation
tolterodine,CC1=CC=C(O)C(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C1,,5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=CC(CO)=CC=C1O)C(C)C,,CYP2D6,0.92,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
tozasertib,CC1=CC(=NC2=CC(N3CCN(C)CC3)=NC(SC3=CC=C(NC(=O)C4CC4)C=C3)=N2)NN1,,,CC1=CC(=NC2=CC(N3CC[N+](C)([O-])CC3)=NC(SC3=CC=C(NC(=O)C4CC4)C=C3)=N2)NN1,,CYP3A4,0.96,N-Oxidation
tozasertib,CC1=CC(=NC2=CC(N3CCN(C)CC3)=NC(SC3=CC=C(NC(=O)C4CC4)C=C3)=N2)NN1,,,CC1=CC(=NC2=CC(N3CCNCC3)=NC(SC3=CC=C(NC(=O)C4CC4)C=C3)=N2)NN1,,CYP2C8;CYP3A4,0.98,N-demethylation
tpa-023,CCN1N=CN=C1COC1=NN2C(C3=CC=CC=C3F)=NN=C2C=C1C(C)(C)C,,,CCN1N=CN=C1COC1=NN2C(C3=CC=CC=C3F)=NN=C2C=C1C(C)(C)CO,,CYP3A4,0.97,Aliphatic Hydroxylation
tpa-023,CCN1N=CN=C1COC1=NN2C(C3=CC=CC=C3F)=NN=C2C=C1C(C)(C)C,,,CC(C)(C)C1=CC2=NN=C(C3=CC=CC=C3F)N2N=C1OCC1=NNC=N1,,CYP3A4,0.94,N-demethylation
tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,,N-desmethyltramadol,CNCC1CCCCC1(O)C1=CC=CC(OC)=C1,,CYP1A2;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.97,N-demethylation
tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,,O-desmethyl-tramadol,CN(C)CC1CCCCC1(O)C1=CC=CC(O)=C1,,CYP1A2;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.93,O-demethylation
traxoprodil,CC(C(O)C1=CC=C(O)C=C1)N1CCC(O)(C2=CC=CC=C2)CC1,,,CC(C(O)C1=CC=C(O)C(O)=C1)N1CCC(O)(C2=CC=CC=C2)CC1,,CYP2D6,0.88,Aromatic Hydroxylation
trazodone,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C=CC=CN12,,m-CPP,ClC1=CC=CC(N2CCNCC2)=C1,,CYP3A4,0.28,N-dealkylation of alicyclic tertiary amine
trazodone,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C=CC=CN12,,p-Hydroxytrazodone,O=C1N(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)N=C2C=CC=CN12,,CYP3A4,0.95,Hydroxylation of aromatic carbon ortho to halide group
trazodone,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C=CC=CN12,,Trazodone epoxide,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C3OC3C=CN21,,CYP3A4,0.47,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N12,,,OCC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N12,,CYP3A4,0.94,Aliphatic Hydroxylation
triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N12,,,CC1=NN=C2C(O)N=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N12,,CYP3A4,0.89,Aliphatic Hydroxylation
trihydroxycoprostane,CC(C)CCCC(C)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,,,CC(CCCC(C)(C)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,,CYP2B6;CYP2C19;CYP3A4,0.96,Aliphatic Hydroxylation
tropisetron,CN1C2CCC1CC(OC(=O)C1=CNC3=CC=CC=C13)C2,,,CN1C2CCC1CC(OC(=O)C1=CNC3=CC=C(O)C=C13)C2,,CYP2D6,0.91,Aromatic Hydroxylation
tropisetron,CN1C2CCC1CC(OC(=O)C1=CNC3=CC=CC=C13)C2,,,CN1C2CCC1CC(OC(=O)C1=CNC3=CC(O)=CC=C13)C2,,CYP2D6,0.92,Aromatic Hydroxylation
tropisetron,CN1C2CCC1CC(OC(=O)C1=CNC3=CC=CC=C13)C2,,,O=C(OC1CC2CCC(C1)N2)C1=CNC2=CC=CC=C12,,CYP3A4,0.95,N-demethylation
tyramine,NCCC1=CC=C(O)C=C1,,,NCCC1=CC=C(O)C(O)=C1,,CYP2D6,0.68,Aromatic Hydroxylation
MK-429,COC1=CC=C(C(CC(=O)O)N2CCN(CCCC3=CC=C4CCCNC4=N3)C2=O)C=N1,,,O=C(O)CC(C1=CC=C(O)N=C1)N1CCN(CCCC2=CC=C3CCCNC3=N2)C1=O,,CYP2D6,0.97,O-Demethylation
MK-429,COC1=CC=C(C(CC(=O)O)N2CCN(CCCC3=CC=C4CCCNC4=N3)C2=O)C=N1,,,O=C(O)CC(C1=CC=C(O)N=C1)N1CCN(CCCC2=CC=C3CCC(O)NC3=N2)C1=O,,CYP2D6;CYP3A4,0.92,Aromatic Hydroxylation
MK-429,COC1=CC=C(C(CC(=O)O)N2CCN(CCCC3=CC=C4CCCNC4=N3)C2=O)C=N1,,,O=C(O)CC(C1=CC=C(O)N=C1)N1CCN(CCCC2=CC=C3C(=N2)NCCC3O)C1=O,,CYP2D6;CYP3A4,0.91,Aromatic Hydroxylation
(R)-(+)-Rebamipide,O=C(NC(CC1=CC(O)=NC2=CC=CC=C12)C(=O)O)C1=CC=C(Cl)C=C1,,8-Hydroxyrebamipide,O=C(NC(CC1=CC(O)=NC2=C(O)C=CC=C12)C(=O)O)C1=CC=C(Cl)C=C1,,CYP3A4,0.9,Aromatic Hydroxylation
(R)-(+)-Rebamipide,O=C(NC(CC1=CC(O)=NC2=CC=CC=C12)C(=O)O)C1=CC=C(Cl)C=C1,,6-Hydroxyrebamipide,O=C(NC(CC1=CC(O)=NC2=CC=C(O)C=C12)C(=O)O)C1=CC=C(Cl)C=C1,,CYP3A4,0.93,Aromatic Hydroxylation
"p-Methoxymethamphetamine, R-(-)-",CNC(C)CC1=CC=C(OC)C=C1,,HO-MA,CNC(C)CC1=CC=C(O)C=C1,,CYP2D6,0.86,O-Demethylation
(S)-Methylenedioxyethylamphetamine,CCNC(C)CC1=CC=C2OCOC2=C1,,"3,4-methylenedioxyamphetamine",CC(N)CC1=CC=C2OCOC2=C1,,CYP1A2;CYP2B6;CYP3A4,0.92,N-Dealylation
(S)-Methylenedioxyethylamphetamine,CCNC(C)CC1=CC=C2OCOC2=C1,,"N-methyl-3,4-methylenedioxyamphetamine",CCNC(C)CC1=CC=C(O)C(O)=C1,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2D6;CYP2E1;CYP3A4,0.7,Demethylenation
unii-3es85mm31y,CCCOC1=CC=C(S(=O)(=O)N2CCN(CC)CC2)C=C1C1=NC2=C(CC)N(CC3=CC=CC=N3)N=C2C(=O)N1,,,CCCOC1=CC=C(S(=O)(=O)N2CCNCC2)C=C1C1=NC2=C(CC)N(CC3=CC=CC=N3)N=C2C(=O)N1,,CYP3A4,0.99,N-dealkylation
Fenproporex,CC(CC1=CC=CC=C1)NCCC#N,,amphetamine,CC(N)CC1=CC=CC=C1,,CYP1A2;CYP2B6;CYP2D6;CYP3A4,0.64,N-dealkylation
Desmethylescitalopram,CNCCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,,N#CC1=CC=C2C(=C1)COC2(CCCN)C1=CC=C(F)C=C1,,CYP2D6,0.99,N-Demethylation
RPR-106541,CCCC1OC2CC3C4CC(F)C5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(SC)O1,,,CCCC1OC2CC3C4CC(F)C5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(S(C)=O)O1,,CYP3A4;CYP3A5,0.91,S-Oxidation
"Desmethylsibutramine, (S)-",CNC(CC(C)C)C1(C2=CC=C(Cl)C=C2)CCC1,,1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine,CC(C)CC(N)C1(C2=CC=C(Cl)C=C2)CCC1,,CYP2B6,0.86,N-demethylation
"4'-Methoxy-alpha-pyrrolidinopropiophenone, (S)-",COC1=CC=C(C(=O)C(C)N2CCCC2)C=C1,,,CC(C(=O)C1=CC=C(O)C=C1)N1CCCC1,,CYP2C19;CYP2D6,0.93,O-demethylation
unii-s5969b6237 component anucdxcticzjrh-zmzpimszsa-n,CC1COC2(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N=C(O)CN12,,,CC1(O)COC2(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N=C(O)CN12,,CYP3A4,0.92,Aliphatic Hydroxylation
(S)-Sibutramine,CC(C)CC(N(C)C)C1(C2=CC=C(Cl)C=C2)CCC1,,,CNC(CC(C)C)C1(C2=CC=C(Cl)C=C2)CCC1,,CYP2B6;CYP2C19;CYP3A4,0.92,N-demethylation
CP-195543,O=C(O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C2C(=C1)OCC(CC1=CC=CC=C1)C2O,,M1 and M2,O=C(O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C2C(=C1)OCC(C(O)C1=CC=CC=C1)C2O,,CYP3A4 ,0.99,Aliphatic Hydroxylation
CP-195543,O=C(O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C2C(=C1)OCC(CC1=CC=CC=C1)C2O,,M3,O=C(O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C2C(=C1)OCC(CC1=CC=CC=C1O)C2O,,CYP3A4 ,0.99,Aromatic Hydroxylation
(R)-Bunitrolol,CC(C)(C)NCC(O)COC1=CC=CC=C1C#N,,,CC(C)(C)NCC(O)COC1=CC=C(O)C=C1C#N,,CYP2D6,0.89,Aromatic Hydroxylation
v11294,CCNC1=C2N=C(C(C)C)N=C2N(CC2=CC=C(OC)C(OC3CCCC3)=C2)C=N1,,,CCNC1=C2N=C(C(C)C)N=C2N(CC2=CC=C(OC)C(OC3CCC(O)C3)=C2)C=N1,,CYP2C9;CYP3A4;,0.98,Aliphatic Hydroxylation
v11294,CCNC1=C2N=C(C(C)C)N=C2N(CC2=CC=C(OC)C(OC3CCCC3)=C2)C=N1,,,CCNC1=C2N=C(C(C)(C)O)N=C2N(CC2=CC=C(OC)C(OC3CCCC3)=C2)C=N1,,CYP2C9;CYP3A4;,0.95,Aliphatic Hydroxylation
v11294,CCNC1=C2N=C(C(C)C)N=C2N(CC2=CC=C(OC)C(OC3CCCC3)=C2)C=N1,,,COC1=CC=C(CN2C=NC(N)=C3N=C(C(C)C)N=C32)C=C1OC1CCCC1,,CYP2C9;CYP2C19;CYP2D6;CYP3A4;,0.93,N-desethylation
vanoxerine,FC1=CC=C(C(OCCN2CCN(CCCC3=CC=CC=C3)CC2)C2=CC=C(F)C=C2)C=C1,,,OC1=CC=C(CCCN2CCN(CCOC(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C=C1,,CYP2D6,0.92,Aromatic Hydroxylation
vanoxerine,FC1=CC=C(C(OCCN2CCN(CCCC3=CC=CC=C3)CC2)C2=CC=C(F)C=C2)C=C1,,,OC(CCN1CCN(CCOC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1)C1=CC=CC=C1,,CYP2D6,0.9,Aromatic Hydroxylation
vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,,N-Desalkylvicriviroc ,CC1=NC=NC(C)=C1C(=O)N1CCC(C)(N2CCNC(C)C2)CC1,,CYP3A4; CYP3A5,0.69,N-dealkylation of alicyclic tertiary amine
vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,,O-Desmethylvicriviroc ,CC1=NC=NC(C)=C1C(=O)N1CCC(C)(N2CCN(C(CO)C3=CC=C(C(F)(F)F)C=C3)C(C)C2)CC1,,CYP2C9; CYP3A4; CYP3A5,0.97,O-dealkylation of dialkylether
vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,,Vicriviroc N-oxide ,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=C[N+]([O-])=C3C)CC2)CC1C,,CYP3A4; CYP3A5,0.88,N-oxidation of pyrimidine
vitamin_d2,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)C,,,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)(O)C(C)C,,CYP3A4,0.9,Aliphatic Hydroxylation
voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,,Hydroxymethyl Voriconazole,OCC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,,CYP3A4,0.96,Hydroxylation of terminal methyl
voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,,Voriconazole N-Oxide,CC(C1=NC=[N+]([O-])C=C1F)C(O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,,CYP2C9 (major); CYP2C19 (major); CYP3A4 (minor),0.96,N-oxidation of pyrimidine
warfarin-r,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,10-Hydroxywarfarin,CC(=O)C(O)C(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,CYP3A4,0.9,Alpha hydroxylation of carbonyl group
warfarin-r,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,6-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O,,CYP1A2; CYP1A1; CYP2C19,0.95,Aromatic hydroxylation of fused benzene ring
warfarin-r,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,8-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=C(O)C=CC=C2C1=O,,CYP1A2; CYP1A1; CYP2C19,0.9,HYDROXYLATION_OF_AROMATIC_CARBON
warfarin-r,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,#NAME?,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O,,CYP1A2; CYP1A1; CYP2C8,0.96,Aromatic hydroxylation of fused benzene ring
warfarin-r,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,4'- Hydroxywarfarin,CC(=O)CC(C1=CC=C(O)C=C1)C1=C(O)OC2=CC=CC=C2C1=O,,CYP2C9; CYP2C18,0.98,p-Hydroxylation of monosubstituted benzene
warfarin-s,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,7-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O,,CYP2C9,0.96,Aromatic hydroxylation of fused benzene ring
warfarin-s,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,4'-Hydroxywarfarin,CC(=O)CC(C1=CC=C(O)C=C1)C1=C(O)OC2=CC=CC=C2C1=O,,CYP2C9,0.98,p-Hydroxylation of monosubstituted benzene
warfarin-s,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,6-Hydroxylation,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O,,CYP2C9; CYP2C8; CYP2C18; CYP2C19; CYP3A4,0.95,Aromatic hydroxylation of fused benzene ring
warfarin-s,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,10-Hydroxylation,CC(=O)C(O)C(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,CYP3A4,0.9,Alpha hydroxylation of carbonyl group
7-Ethoxy-4-trifluoromethylcoumarin,CCOC1=CC=C2C(C(F)(F)F)=CC(=O)OC2=C1,,7-Hydroxy-4-trifluoromethylcourmarin,O=C1C=C(C(F)(F)F)C2=CC=C(O)C=C2O1,,CYP1A2; CYP2B6; CYP2E1; CYP2C9; CYP2C19,0.91,O-aryl dealkylation not adjacent to substituted carbon
7-methoxy-4-trifluoromethylcoumarin,COC1=CC=C2C(C(F)(F)F)=CC(=O)OC2=C1,,7-Hydroxy-4-(trifluoromethyl)chromen-2-one,O=C1C=C(C(F)(F)F)C2=CC=C(O)C=C2O1,,CYP1A2;CYP2A6;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP2E1,0.93,O-Demethylation 
7-Benzyloxyresorufin,O=C1C=CC2=NC3=CC=C(OCC4=CC=CC=C4)C=C3OC2=C1,,Resorufin,O=C1C=CC2=NC3=CC=C(O)C=C3OC2=C1,,CYP1A1; CYP1A2; CYP1B1,0.88,O-aryl dealkylation not adjacent to substituted carbon
"Dibenz[a,j]acridine",C1=CC=C2C(=C1)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,,ON1C2=CC=C3C=CC=CC3=C2C=C2C3=CC=CC=C3C=CC21,,CYP1A2;CYP3A4,0.11,N-Oxidation
"Dibenz[a,j]acridine",C1=CC=C2C(=C1)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,,O=C1C2=C(C=CC3=CC=CC=C23)N=C2C=CC3=CC=CC=C3C12,,CYP1A2;CYP3A4,0.09,Aromatic Oxidation 
"Dibenz[a,j]acridine",C1=CC=C2C(=C1)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,"3,4-DHD",OC1=CC=C2C(=C1O)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,CYP1A2;CYP3A4,0.68,Aromatic Hydroxylation
"Dibenz[a,j]acridine",C1=CC=C2C(=C1)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,"1,2-DHD",OC1=CC=C2C=CC3=NC4=CC=C5C=CC=CC5=C4C=C3C2=C1O,,CYP1A2;CYP3A4,0.62,Aromatic Hydroxylation
"Dibenz[a,j]acridine",C1=CC=C2C(=C1)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,"5,6-DHD",OC1=C(O)C2=NC3=CC=C4C=CC=CC4=C3C=C2C2=CC=CC=C12,,CYP1A2;CYP3A4,0.5,Aromatic Hydroxylation
"Methyl N,N-diethyldithiocarbamate",CCN(CC)C(=S)SC,,MeDDC sulfine ,CCN(CC)C(SC)=S=O,,CYP1A2; CYP2A6; CYP2B6; CYP2E1; CYP3A4; CYP3A5,0.7,S-oxidation of dithiocarbamate
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=C(C)C2=C1C(O)=C(O)C1=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.47,Aromatic Hydroxylation
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC3=CC=CC=C3C2=C(C)C2=CC=C(O)C(O)=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.47,Aromatic Hydroxylation
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=C(O)C(O)=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.59,Aromatic Hydroxylation
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=C(O)C=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.73,Aromatic Hydroxylation
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=C(CO)C2=CC=C3C=CC=CC3=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.74,Aliphatic Hydroxylation
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=C(CO)C2=C1C=CC1=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.74,Aliphatic Hydroxylation
DMXAA,CC1=CC=C2C(=O)C3=CC=CC(CC(=O)O)=C3OC2=C1C,,6-Hydroxy-MXAA,CC1=C(CO)C=CC2=C1OC1=C(CC(=O)O)C=CC=C1C2=O,,CYP1A2,0.92,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
4-(Aminomethyl)-7-methoxycoumarin,COC1=CC=C2C(CN)=CC(=O)OC2=C1,,7-hydroxy-4-(aminomethyl)-coumarin (HAMC),NCC1=CC(=O)OC2=CC(O)=CC=C12,,CYP1A2;CYP2C19;CYP2D6,0.93,N-Dealkylation
NNK,CN(CCCC(=O)C1=CC=CN=C1)N=O,,,O=NN(CO)CCCC(=O)C1=CC=CN=C1,,CYP1A1; CYP1A2; CYP1B1; CYP2A6; CYP2B6; CYP2D6; CYP2E1,0.92,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
DEET,CCN(CC)C(=O)C1=CC=CC(C)=C1,,"N,N-diethyl-m-hydroxymethylbenzamide",CCN(CC)C(=O)C1=CC=CC(CO)=C1,,CYP1A2; CYP2B6; CYP2D6; CYP2E1,0.87,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
DEET,CCN(CC)C(=O)C1=CC=CC(C)=C1,,,CCN(CCO)C(=O)C1=CC=CC(C)=C1,,CYP2A6; CYP2C19; CYP3A4; CYP3A5,0.88,Hydroxylation of terminal methyl
"dibenzo(a,h)anthracene",C1=CC=C2C(=C1)C=CC1=CC3=C(C=CC4=CC=CC=C43)C=C12,,"dibenzo(a,h)anthracene 1,2-epoxide",C1=CC2OC2C2=C1C=CC1=CC3=C(C=CC4=CC=CC=C43)C=C21,,CYP1A1; CYP1A2,0.08,ARENE_EPOXIDATION
"dibenzo(a,h)anthracene",C1=CC=C2C(=C1)C=CC1=CC3=C(C=CC4=CC=CC=C43)C=C12,,"dibenzo(a,h)anthracene 3,4-epoxide",C1=CC2=CC=C3C=C4C5=C(C=CC4=CC3=C2CC1)C1OC1C=C5,,CYP1A2 (major); CYP2B6 (minor); CYP2C9 (major),0.08,ARENE_EPOXIDATION
O-isopropyl acetaminophen,CC(O)=NC1=CC=C(OC(C)C)C=C1,,Acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,CYP1A2,0.73,O-deethylation
O-isopropyl acetaminophen,CC(O)=NC1=CC=C(OC(C)C)C=C1,,,COC1=CC=C(N=CO)C=C1,,CYP1A2,0.7,C-DEALYLATION
p-Methoxyacetanilide,COC1=CC=C(N=C(C)O)C=C1,,"p-Methoxyacetanilide, O-demethyl-",CC(O)=NC1=CC=C(O)C=C1,,CYP1A2,0.85,O-aryl dealkylation not adjacent to substituted carbon
MNAN,CCCCCN(C)N=O,,,CCCCCN(CO)N=O,,CYP2A6;CYP2E1,0.69,Aliphatic Hydroxylation
MNAN,CCCCCN(C)N=O,,,CC(O)CCCN(C)N=O,,CYP2A6;CYP2E1,0.72,Aliphatic Hydroxylation
NDPA,CCCN(CCC)N=O,,Alpha-OH NDPA,CCCN(N=O)C(O)CC,,CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2D6;CYP2E1;CYP3A4,0.47,Aliphatic Hydroxylation
NDPA,CCCN(CCC)N=O,,Dipropylimine,CCCNCCC,,CYP2E1;CYP3A4,0.37,Aliphatic Hydroxylation
NPYR,O=NN1CCCC1,,,O=NN1CCCC1O,,CYP2A6;CYP2E1,0.46,Aliphatic Hydroxylation
RP73401,COC1=CC=C(C(=O)N=C2C(Cl)=CNC=C2Cl)C=C1OC1CCCC1,,,COC1=CC=C(C(=O)N=C2C(Cl)=CNC=C2Cl)C=C1OC1CCC(O)C1,,CYP2B6,0.96,Aliphatic Hydroxylation
sulfinpyrazone_sulfide,O=C1C(CCSC2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,Sulfinpyrazone,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,CYP2C9;CYP3A4,0.93,S-Oxidation
sulfinpyrazone_sulfide,O=C1C(CCSC2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=C(O)C=C2)N1C1=CC=CC=C1,,CYP2C9;CYP3A4,0.89,Aromatic Hydroxylation
sulfinpyrazone_sulfide,O=C1C(CCSC2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,,O=C1C(CCS(=O)C2=CC=C(O)C=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,CYP2C9;CYP3A4,0.9,Aromatic Hydroxylation
Proguanil,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,,Cycloguanil,CC1(C)NC(=N)NC(=N)N1C1=CC=C(Cl)C=C1,,CYP1A2; CYP2C19; CYP2D6; CYP3A4; CYP2C9 (minor),0.51,Formation of cycloguanide
Proguanil,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,,4-Chlorophenylbiguanide,N=C(N)NC(=N)NC1=CC=C(Cl)C=C1,,CYP2C19,0.79,N-deisopropylation
4_nitro_phenol,O=[N+]([O-])C1=CC=C(O)C=C1,,4-nitrocatechol (4NC) ,O=[N+]([O-])C1=CC=C(O)C(O)=C1,,CYP2E1,0.66,Aromatic Hydroxylation
Furametpyr,CC1=NN(C)C(Cl)=C1C(O)=NC1=CC=CC2=C1C(C)OC2(C)C,,,CC1=C(C(O)=NC2=CC=CC3=C2C(C)OC3(C)C)C(Cl)=NN1,,CYP1A1;CYP1A2;CYP2C19;CYP3A4,0.91,N-Demethylation 
Bioresmethrin,CC(C)=CC1C(C(=O)OCC2=COC(CC3=CC=CC=C3)=C2)C1(C)C,,BFA,OCC1=COC(CC2=CC=CC=C2)=C1,,CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.46,Oxidation
TRANS-PERMETHRIN,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC2=CC=CC=C2)=C1,,(3-Phenoxyphenyl)methanol,OCC1=CC=CC(OC2=CC=CC=C2)=C1,,CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.36,Oxidation
LOSIGAMONE,COC1=CC(=O)OC1C(O)C1=CC=CC=C1Cl,,,COC1=CC(=O)OC1C(O)C1=CC=C(O)C=C1Cl,,CYP2A6,0.93,Aromatic Hydroxylation
LOSIGAMONE,COC1=CC(=O)OC1C(O)C1=CC=CC=C1Cl,,,COC1=CC(=O)OC1C(O)C1=CC(O)=CC=C1Cl,,CYP2A6,0.91,Aromatic Hydroxylation
Promethazine,CC(CN1C2=CC=CC=C2SC2=CC=CC=C21)N(C)C,,,CC(CN1C2=CC=CC=C2S(=O)C2=CC=CC=C21)N(C)C,,CYP2D6,0.83,S-Oxidation
Promethazine,CC(CN1C2=CC=CC=C2SC2=CC=CC=C21)N(C)C,,,CNC(C)CN1C2=CC=CC=C2SC2=CC=CC=C21,,CYP2D6,0.97,N-Demethylation
Verapamil,COC1=CC=C(CCN(C)CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,Norverapamil,COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,CYP2C8; CYP1A2; CYP3A4; CYP3A5,0.95,N-dealkylation of acyclic tertiary amine
Verapamil,COC1=CC=C(CCN(C)CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,D-617,CNCCCC(C#N)(C1=CC=C(OC)C(OC)=C1)C(C)C,,CYP2C8; CYP3A4; CYP1A2,0.88,N-dealkylation of acyclic tertiary amine
Verapamil,COC1=CC=C(CCN(C)CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,"2-(3,4-dimethoxyphenyl)acetaldehyde",COC1=CC=C(CC=O)C=C1OC,,CYP2C8; CYP3A4; CYP1A2,0.39,N-dealkylation of acyclic tertiary amine
METALAXYL,COCC(=O)N(C1=C(C)C=CC=C1C)C(C)C(=O)OC,,,COC(=O)C(C)N(C(=O)CO)C1=C(C)C=CC=C1C,,CYP2B6;CYP3A4,0.98,O-Demethylation
METALAXYL,COCC(=O)N(C1=C(C)C=CC=C1C)C(C)C(=O)OC,,,COCC(=O)N(C1=C(C)C=CC=C1C)C(C)C(=O)O,,CYP2B6;CYP3A4,0.95,O-Demethylation
METALAXYL,COCC(=O)N(C1=C(C)C=CC=C1C)C(C)C(=O)OC,,,COCC(=O)N(C1=C(C)C=CC(O)=C1C)C(C)C(=O)OC,,CYP3A4,0.85,Aromatic Hydroxylation
METALAXYL,COCC(=O)N(C1=C(C)C=CC=C1C)C(C)C(=O)OC,,,COCC(=O)N(C1=C(C)C=CC=C1CO)C(C)C(=O)OC,,CYP3A4,0.9,Aliphatic Hydroxylation
demethylmetalaxyl,COC(=O)C(C)N(C(=O)CO)C1=C(C)C=CC=C1C,,,CC1=CC=CC(C)=C1N(C(=O)CO)C(C)C(=O)O,,CYP2B6;CYP3A4,0.91,O-Demethylation
Deltamethrin,CC1(C)C(C=C(Br)Br)C1C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2)=C1,,4'-OH-deltamethrin,CC1(C)C(C=C(Br)Br)C1C(=O)OC(C#N)C1=CC=CC(OC2=CC=C(O)C=C2)=C1,,CYP2C8; CYP2C19; CYP3A4; CYP3A5,0.99,p-Hydroxylation of monosubstituted benzene
(1S)-trans-Cyfluthrin,CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=C(F)C(OC2=CC=CC=C2)=C1,,,CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=C(F)C(OC2=CC=C(O)C=C2)=C1,,CYP1A1;CYP1A2;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.99,Aromatic Hydroxylation
Bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CCC2(C)C,,6-hydroxy-bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)C(O)CC2(C)C,,CYP3A;CYP2C9;CYP2C19,0.8,Aliphatic Hydroxylation
Bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CCC2(C)C,,7-hydroxy-bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CC(O)C2(C)C,,CYP3A;CYP2C9;CYP2C19,0.79,Aliphatic Hydroxylation
Bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CCC2(C)C,,7-oxo-bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)C(=O)CC2(C)C,,CYP3A;CYP2C9;CYP2C19,0.81,Aliphatic Hydroxylation
Bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CCC2(C)C,,7-oxo-bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CC(=O)C2(C)C,,CYP3A;CYP2C9;CYP2C19,0.81,Aliphatic Hydroxylation
Dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3=O)C1=CNC2=CC=CC=C12,,Reduced dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=CC=C12,,CYP2D6;CYP3A4,0.87,Hydrogenation;Reduction
Halothane ,FC(F)(F)C(Cl)Br,,Trifluoroacetyl chloride,O=C(Cl)C(F)(F)F,,CYP2E1; CYP2A6,0.38,Oxidation of halotrifluoroethane
Halothane ,FC(F)(F)C(Cl)Br,,chlorotrifluoroethane,FC(F)(F)CCl,,CYP2A6; CYP3A4,0.55,Reduction of halotrifluoroethane
delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21,,11-OH-delata-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,,CYP2C9; CYP2C19; CYP3A4,0.97,Hydroxlation of methyl carbon adjacent to an aliphatic ring
delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21,,7-OH-delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1C(O)CC(C)=CC21,,CYP3A4,0.92,Hydroxylation of alicyclic secondary carbon
delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21,,7alpha-OH-delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1C(O)CC(C)=CC21,,CYP3A4,0.92,Hydroxylation of alicyclic secondary carbon
delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21,,8-OH-delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(C)=CC21,,CYP3A4,0.91,Hydroxylation of alicyclic secondary carbon
delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21,,8alpha-OH-delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(C)=CC21,,CYP3A4,0.91,Hydroxylation of alicyclic secondary carbon
S-Bioallethrin,C=CCC1=C(C)C(OC(=O)C2C(C=C(C)C)C2(C)C)CC1=O,,,C=CCC1=C(C)C(OC(=O)C2C(C=C(C)CO)C2(C)C)CC1=O,,CYP2C9;CYP2C19;CYP3A4,0.99,Aliphatic Hydroxylation
Rupatadine,CC1=CN=CC(CN2CCC(=C3C4=CC=C(Cl)C=C4CCC4=CC=CN=C34)CC2)=C1,,,ClC1=CC=C2C(=C3CCNCC3)C3=NC=CC=C3CCC2=C1,,CYP3A4,0.9,N-Dealkylation
RL-3142,CN(C)C1=CC=C(C=CC(=O)C2=CC=C(N3C=CN=C3)C=C2)C=C1,,,CNC1=CC=C(C=CC(=O)C2=CC=C(N3C=CN=C3)C=C2)C=C1,,CYP3A,0.96,N-Dementhylation
zafirlukast,COC1=CC(C(O)=NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=CC=C(N=C(O)OC3CCCC3)C=C12,,cyclopentyl NÃ¢â‚¬Â[1Ã¢â‚¬Â(hydroxymethyl)Ã¢â‚¬Â3Ã¢â‚¬Â({2Ã¢â‚¬ÂmethoxyÃ¢â‚¬Â4Ã¢â‚¬Â[(2Ã¢â‚¬Âmethylbenzenesulfonyl)carbamoyl]phenyl}methyl)indolÃ¢â‚¬Â5Ã¢â‚¬Âyl]carbamate,COC1=CC(C(O)=NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(CO)C2=CC=C(N=C(O)OC3CCCC3)C=C12,,CYP2C9; CYP3A4,0.98,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
zafirlukast,COC1=CC(C(O)=NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=CC=C(N=C(O)OC3CCCC3)C=C12,,3Ã¢â‚¬Âhydroxycyclopentyl NÃ¢â‚¬Â[3Ã¢â‚¬Â({2Ã¢â‚¬ÂmethoxyÃ¢â‚¬Â4Ã¢â‚¬Â[(2Ã¢â‚¬Âmethylbenzenesulfonyl)carbamoyl]phenyl}methyl)Ã¢â‚¬Â1Ã¢â‚¬ÂmethylindolÃ¢â‚¬Â5Ã¢â‚¬Âyl]carbamate,COC1=CC(C(O)=NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=CC=C(N=C(O)OC3CCC(O)C3)C=C12,,CYP2C9; CYP3A4,0.98,Hydroxylation of alicyclic secondary carbon
zaleplon,CCN(C(C)=O)C1=CC=CC(C2=CC=NC3=C(C#N)C=NN23)=C1,,Dementhylazed-zaleplon,CC(O)=NC1=CC=CC(C2=CC=NC3=C(C#N)C=NN23)=C1,,CYP3A4,0.85,N-Dementhylation
zatosetron,CN1C2CCC1CC(N=C(O)C1=CC(Cl)=CC3=C1OC(C)(C)C3)C2,,,CC1(C)CC2=CC(Cl)=CC(C(O)=NC3CC4CCC(C3)N4)=C2O1,,CYP3A4,0.97,N-Dementhylation
zatosetron,CN1C2CCC1CC(N=C(O)C1=CC(Cl)=CC3=C1OC(C)(C)C3)C2,,,CC1(C)CC2=CC(Cl)=CC(C(O)=NC3CC4CCC(C3)[N+]4(C)[O-])=C2O1,,CYP3A4,0.94,N-Oxidation
zatosetron,CN1C2CCC1CC(N=C(O)C1=CC(Cl)=CC3=C1OC(C)(C)C3)C2,,,CN1C2CCC1CC(N=C(O)C1=CC(Cl)=CC3=C1OC(C)(C)C3O)C2,,CYP3A4,0.91,Aliphatic Hydroxylation
zinc02949712,CCCCOC1=CC=C2C(C(F)(F)F)=CC(=O)OC2=C1,,HFC(7-hydroxy-4-trifluoromethylcoumarin),O=C1C=C(C(F)(F)F)C2=CC=C(O)C=C2O1,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.88,O-Demethylation
zinc15020070,COC1=CC=C2C(=C1)OC1=CC(O)=CC=C1C21OC(=O)C2=CC=CC=C21,,,O=C1OC2(C3=CC=C(O)C=C3OC3=CC(O)=CC=C32)C2=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2C19,0.97,O-Demethylation
zinc188,CC(CN(C)C)CN1C2=CC=CC=C2SC2=CC=C(C#N)C=C21,,S-oxide cyamemazine,CC(CN(C)C)CN1C2=CC=CC=C2S(=O)C2=CC=C(C#N)C=C21,,CYP1A2;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.86,S-Oxidation
zinc188,CC(CN(C)C)CN1C2=CC=CC=C2SC2=CC=C(C#N)C=C21,,N-demethyl-cyamemazine,CNCC(C)CN1C2=CC=CC=C2SC2=CC=C(C#N)C=C21,,CYP1A2;CYP2B6;CYP2C8;CYP2C19;CYP3A4,0.98,N-demethylations
zinc21985223,CN(C)C1=CC=C(C2CC3(C)C(CCC3(O)C=CCO)C3CCC4=CC(=O)CCC4=C23)C=C1,,,CNC1=CC=C(C2CC3(C)C(CCC3(O)C=CCO)C3CCC4=CC(=O)CCC4=C23)C=C1,,CYP3A4,0.98,N-demethylations
zinc33952402,CC1=CC=C(C(=O)C(C)N2CCCC2)C=C1,,HO-MPPP,CC(C(=O)C1=CC=C(CO)C=C1)N1CCCC1,,CYP2C19;CYP2D6,0.93,Aliphatic Hydroxylation
zinc33952517,CC(C(=O)C1=CC=C2OCOC2=C1)N1CCCC1,,di-HO-MDPPP,CC(C(=O)C1=CC=C(O)C(O)=C1)N1CCCC1,,CYP2C19;CYP2D6,0.81,O-Demethylation
zinc36377943,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,,6beta - HYDROXYBUDESONIDE,CCCC(O)OC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,,CYP3A4,0.73,O-dealkylation
zinc40442723,O=C1C=C2CN(C(C(=O)C3CC3)C3=CC=CC=C3F)CCC2S1,,,O=CC=C1CN(C(C(=O)C2CC2)C2=CC=CC=C2F)CCC1S,,CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.88,Unknown reaction
zinc4556587,CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(OC)=CC=C1N4,,12-hydroxyibogamine,CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4,,CYP2C19;CYP2D6;CYP3A4,0.98,O-DEMETHYLATION
zinc8660420,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2C3=O)O1,,,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(O)C=C4C2C3=O)O1,,CYP3A4;CYP2C19,0.99,O-DEMETHYLATION
zinc8660420,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2C3=O)O1,,,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2(O)C3=O)O1,,CYP3A4;CYP2C19,0.87,Aliphatic Hydroxylation
zinc8660420,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2C3=O)O1,,,C=C(CO)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2(O)C3=O)O1,,CYP3A4,0.86,Aliphatic Hydroxylation
zinc8660420,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2C3=O)O1,,,COC1=CC2=C(C=C1OC)C1(O)C(=O)C3=CC=C4OC(C5(C)CO5)CC4=C3OC1CO2,,CYP3A4,0.81,Epoxidation
zinc968306,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,,,CC(CC1=CC=CC=C1)NCC1=CC=CC=C1,,CYP2B6;CYP2C8;CYP3A4,0.83,N-Demethylation
ziprasidone,OC1=NC2=CC(Cl)=C(CCN3CCN(C4=NSC5=CC=CC=C45)CC3)C=C2C1,,,O=S1N=C(N2CCN(CCC3=CC4=C(C=C3Cl)N=C(O)C4)CC2)C2=CC=CC=C21,,CYP3A4,0.55,S-Oxidation
ziprasidone,OC1=NC2=CC(Cl)=C(CCN3CCN(C4=NSC5=CC=CC=C45)CC3)C=C2C1,,,C1=CC=C2C(N3CCNCC3)=NSC2=C1,,CYP3A4,0.55,N-dealkylation
ziprasidone,OC1=NC2=CC(Cl)=C(CCN3CCN(C4=NSC5=CC=CC=C45)CC3)C=C2C1,,,CCC1=CC2=C(C=C1Cl)N=C(O)C2,,CYP3A4,0.54,N-dealkylation
zolpidem,CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C)C=CC3=N2)C=C1,,methoxyzolpidem,CC1=CN2C(CC(=O)N(C)C)=C(C3=CC=C(CO)C=C3)N=C2C=C1O,,CYP3A4(major); CYP1A2 (minor); CYP2D6 (minor); CYP2C9 (minor); CYP2C19 (minor),0.92,Hydroxylation of  carbon next to amide
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,Norzotepine,CNCCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,CYP1A1; CYP1A2; CYP3A4; CYP3A5; CYP2B6; CYP2C19,0.99,N-dealkylation of acyclic tertiary amine
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,Zotepine N-oxide,C[N+](C)([O-])CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,CYP3A4,0.96,N-oxdation of aliphatic tertiary amine
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,2-OH-zotepine,CN(C)CCOC1=CC2=CC(O)=CC=C2SC2=CC=C(Cl)C=C12,,CYP1A2,0.9,Aromatic hydroxylation of fused benzene ring
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,3-OH-zotepine,CN(C)CCOC1=CC2=CC=C(O)C=C2SC2=CC=C(Cl)C=C12,,CYP1A1; CYP1A2; CYP3A4; CYP2D6; CYP2C19,0.92,Aromatic hydroxylation of fused benzene ring
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,Zotepine -oxide,CN(C)CCOC1=CC2=CC=CC=C2S(=O)C2=CC=C(Cl)C=C12,,CYP1A1; CYP1A2; CYP2B6; CYP3A4; CYP3A5,0.86,S-oxidation of diarylthioether to sulfoxide
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,"Benzo[a]pyrene-7,8-epoxide",C1=CC2OC2C2=CC3=CC=C4C=CC=C5C=CC(=C12)C3=C45,,CYP1A1; CYP1A2; CYP1B1,0.09,ARENE_EPOXIDATION
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,3-Hydroxybenzo[a]pyrene,C1=C2C=CC3=C4C=CC=CC4=CC4=CC=C(C2=C43)C2OC12,,CYP3A4; CYP2C8; CYP2C9;CYP2C19; CYP1A1; CYP1B1,0.08,ARENE_EPOXIDATION
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,9-Hydroxybenzo[a]pyrene,C1=CC2OC2C2=C1C=C1C=CC3=CC=CC4=CC=C2C1=C34,,CYP1A1; CYP1B1,0.08,ARENE_EPOXIDATION
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,1-Hydroxybenzo[a]pyrene,C1=C2C=CC3=CC4=CC=CC=C4C4=CC=C(C2=C34)C2OC12,,CYP1A1,0.08,ARENE_EPOXIDATION
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,"Benzo[a]pyrene-4,5-epoxide",C1=CC=C2C(=C1)C=C1C3=C2C=CC2=CC=CC(=C23)C2OC12,,CYP1A1; CYP1B1,0.13,ARENE_EPOXIDATION
ethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=CC=C4C3CCC21C,,,C#CC1(O)CCC2C3CCC4=CC(O)=C(O)C=C4C3CCC21C,,CYP1A2;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.96,Aliphatic Hydroxylation
ethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=CC=C4C3CCC21C,,,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4O)C3CCC21C,,CYP3A4;,0.87,Aliphatic Hydroxylation
1_2-dibromoethane,BrCCBr,,2-bromoacetaldehyde ,O=CCBr,,CYP2A6;CYP2B6;CYP2E1,0.43,Oxidation
2_2_4_4_5_5-hexachlorobiphenyl,ClC1=CC(Cl)=C(C2=CC(Cl)=C(Cl)C=C2Cl)C=C1Cl,,,OC1=C(Cl)C(Cl)=CC(C2=CC(Cl)=C(Cl)C=C2Cl)=C1Cl,,CYP2B6,0.63,Aromatic Hydroxylation
Nelfinavir,CC1=C(O)C=CC=C1C(O)=NC(CSC1=CC=CC=C1)C(O)CN1CC2CCCCC2CC1C(O)=NC(C)(C)C,,Nelfinavir hydroxyl-t- butylamide,CC1=C(O)C=CC=C1C(O)=NC(CSC1=CC=CC=C1)C(O)CN1CC2CCCCC2CC1C(O)=NC(C)(C)CO,,CYP2C19,0.99,Hydroxylation of terminal methyl
Nelfinavir,CC1=C(O)C=CC=C1C(O)=NC(CSC1=CC=CC=C1)C(O)CN1CC2CCCCC2CC1C(O)=NC(C)(C)C,,"3,4-Dihydroxynelfinavir",CC1=C(C(O)=NC(CSC2=CC=CC=C2)C(O)CN2CC3CCCCC3CC2C(O)=NC(C)(C)C)C=CC(O)=C1O,,CYP3A4,0.97,Hydroxylation of benzene on carbon orhto to a strongly electron donating group
Trichloroethane,CC(Cl)(Cl)Cl,,Trichloroethanol,OCC(Cl)(Cl)Cl,,CYP2E1,0.58,Aliphatic Hydroxylation
Duloxetine,CNCCC(OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,,,CNCCC(OC1=CC=C(O)C2=CC=CC=C12)C1=CC=CS1,,CYP1A2;CYP2D6,0.97,Aromatic Hydroxylation
Duloxetine,CNCCC(OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,,,CNCCC(OC1=CC=CC2=CC(O)=CC=C12)C1=CC=CS1,,CYP1A2;CYP2D6,0.98,Aromatic Hydroxylation
Duloxetine,CNCCC(OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,,,CNCCC(OC1=CC=CC2=C(O)C=CC=C12)C1=CC=CS1,,CYP1A2;CYP2D6,0.96,Aromatic Hydroxylation
leflunomide,CC1=C(C(=O)NC2=CC=C(C(F)(F)F)C=C2)C=NO1,,,CC(O)=C(C=N)C(=O)NC1=CC=C(C(F)(F)F)C=C1,,CYP1A2;CYP2C9;CYP3A4,0.32,N-O bond cleavage
paraxanthine,CN1C(O)=NC2=C(C1=O)N(C)C=N2,,,CN1C(O)=NC2=C(C1=O)N(C)C(O)=N2,,CYP1A2;CYP2A6,0.95,Aliphatic Hydroxylation
paraxanthine,CN1C(O)=NC2=C(C1=O)N(C)C=N2,,,CN1C(O)=NC2=C(N=CN2)C1=O,,CYP1A2,0.88,N-dementhylation
"N,N-Dimethylaniline",CN(C)C1=CC=CC=C1,,,CNC1=CC=CC=C1,,CYP1A2;CYP2B1;CYP4B1,0.77,N-dementhylation
Estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,2-hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,CYP1A1;CYP1A2;CYP3A4;CYP3A5,0.96,Aromatic Hydroxylation
Estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,,CC12CCC3C4=CC=C(O)C(O)=C4CCC3C1CCC2O,,CYP1B1,0.85,Aromatic Hydroxylation
alosetron,CC1=C(CN2CCC3=C(C2=O)C2=CC=CC=C2N3C)NC=N1,,,CC1=C(CN2CCC3=C(C2=O)C2=CC=CC(O)=C2N3C)NC=N1,,CYP1A2,0.91,Aromatic Hydroxylation
alosetron,CC1=C(CN2CCC3=C(C2=O)C2=CC=CC=C2N3C)NC=N1,,,CC1=C(CN2CCC3=C(C2=O)C2=CC=CC(O)=C2N3C)NC(O)=N1,,CYP1A2,0.89,Aromatic Hydroxylation
Phenobarbital,CCC1(C2=CC=CC=C2)C(O)=NC(=O)N=C1O,,p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(O)=NC(=O)N=C1O,,CYP2C9; CYP2C19; CYP2E1,0.95,p-Hydroxylation of monosubstituted benzene
Paroxetine,FC1=CC=C(C2CCNCC2COC2=CC=C3OCOC3=C2)C=C1,,,OC1=CC=C(OCC2CNCCC2C2=CC=C(F)C=C2)C=C1O,,CYP2D6,0.91,O-Demethylenation
Glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCCC2)C=C1,,2-trans-hydroxycyclohexyl glyburide ,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCCC2O)C=C1,,CYP3A4; CYP2C9; CYP2C19,0.92,Hydroxylation of alicyclic secondary carbon
Glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCCC2)C=C1,,4-cis-hydroxycyclohexyl glyburide ,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCC(O)CC2)C=C1,,CYP3A4; CYP2C9; CYP2C19,0.97,Hydroxylation of alicyclic secondary carbon
Glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCCC2)C=C1,,4-trans-hydroxycyclohexyl glyburide ,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCC(O)CC2)C=C1,,CYP3A4; CYP2C9; CYP2C19,0.97,Hydroxylation of alicyclic secondary carbon
Glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCCC2)C=C1,,3-trans-Hydroxycyclohexyl glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCC(O)C2)C=C1,,CYP3A4; CYP2C9; CYP2C19,0.94,Hydroxylation of alicyclic secondary carbon
Glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCCC2)C=C1,,3-cis-Hydroxycyclohexyl glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCC(O)C2)C=C1,,CYP3A4; CYP2C9; CYP2C19,0.94,Hydroxylation of alicyclic secondary carbon
(-)-bisoprolol,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,,"(-)-bisoprolol, O-deisopropyl",CC(C)NCC(O)COC1=CC=C(COCCO)C=C1,,CYP2D6; CYP3A4,0.94,O-deisopropylation
(r)-fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,3-(methylamino)-1-phenylpropan-1-one,CNCCC(=O)C1=CC=CC=C1,,CYP2D6,0.27,O-dealkylation
S-Mephenytoin,CCC1(C2=CC=CC=C2)N=C(O)N(C)C1=O,,4Ã¢â‚¬Â²-Hydroxymephenytoin,CCC1(C2=CC=C(O)C=C2)N=C(O)N(C)C1=O,,CYP2D6;  CYP2C19;  CYP1A2;  CYP2C18;  CYP3A4,0.96,p-Hydroxylation of monosubstituted benzene
S-Mephenytoin,CCC1(C2=CC=CC=C2)N=C(O)N(C)C1=O,,Nirvanol,CCC1(C2=CC=CC=C2)N=C(O)N=C1O,,CYP2C19; CYP2C18; CYP2D6; CYP1A2; CYP3A4; CYP2B6,0.42,N-dealkylation of dicarboximide
(S)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(S)-(-)-Mexiletine, p-hydroxyl",CC1=CC(O)=CC(C)=C1OCC(C)N,,CYP1A2 (minor); CYP2D6 (major),0.85,HYDROXYLATION_OF_AROMATIC_CARBON
(S)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(S)-(-)-Mexiletine, m-hydroxyl",CC1=CC=C(O)C(C)=C1OCC(C)N,,CYP1A2 (minor); CYP2D6 (major),0.78,HYDROXYLATION_OF_AROMATIC_CARBON
(S)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(S)-(-)-Mexiletine, 2-OH-hydroxymethyl",CC1=CC=CC(CO)=C1OCC(C)N,,CYP1A2 (minor); CYP2D6 (major),0.77,Hydroxylation of non-terminal aliphatic carbon adjacent to aromatic ring
(S)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(S)-(-)-Mexiletine, N-hydroxy",CC1=CC=CC(C)=C1OCC(C)NO,,CYP1A2 (major); CYP2B6; CYP2E1,0.91,N-hydroxylation of primary or secondary aliphatic amine
(S)-mianserin,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,"(S)-mianserin, N-Desmethyl",C1=CC=C2C(=C1)CC1=CC=CC=C1N1CCNCC21,,CYP1A2; CYP2B6; CYP3A4,0.96,N-dealkylation of alicyclic tertiary amine
(S)-mianserin,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,"(S)-mianserin, 8-hydroxy",CN1CCN2C3=CC(O)=CC=C3CC3=CC=CC=C3C2C1,,CYP1A2; CYP2D6; CYP3A4,0.93,Aromatic hydroxylation of fused benzene ring
(S)-mianserin,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,"(S)-mianserin, N-oxide",C[N+]1([O-])CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,CYP1A2,0.91,N-oxidation of alicyclic tertiary amine
(s)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2S)-1-(3-chlorophenyl)-2-[(1-hydroxy-2-methylpropan-2-yl)amino]propan-1-one,CC(NC(C)(C)CO)C(=O)C1=CC=CC(Cl)=C1,,CYP2B6; CYP3A4,0.92,Hydroxylation of terminal methyl
(s)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2S)-2-(tert-butylamino)-1-(3-chlorophenyl)-3-hydroxypropan-1-one,CC(C)(C)NC(CO)C(=O)C1=CC=CC(Cl)=C1,,CYP2C19,0.86,Hydroxylation of terminal methyl
(s)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2S)-2-(tert-butylamino)-1-(3-chloro-4-hydroxyphenyl)propan-1-one,CC(NC(C)(C)C)C(=O)C1=CC=C(O)C(Cl)=C1,,CYP2B6;CYP2C19; CYP2E1,0.82,Hydroxylation of aromatic carbon ortho to halide group
(s)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2S)-2-(tert-butylamino)-1-(3-chloro-5-hydroxyphenyl)propan-1-one,CC(NC(C)(C)C)C(=O)C1=CC(O)=CC(Cl)=C1,,CYP2B6;CYP2C19; CYP2E1,0.78,Hydroxylation of aromatic carbon meta to halide group
"1,4-dichlorobenzene",ClC1=CC=C(Cl)C=C1,,"2,5-dichlorophenol",OC1=CC(Cl)=CC=C1Cl,,CYP2E1 (major),0.38,Hydroxylation of aromatic carbon ortho to halide group
P-Hydroxynefazodone,CCC1=NN(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,"1Ã¢â‚¬Â(3Ã¢â‚¬ÂchloroÃ¢â‚¬Â4Ã¢â‚¬ÂoxocyclohexaÃ¢â‚¬Â2,5Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âylidene)Ã¢â‚¬Â4Ã¢â‚¬Â{3Ã¢â‚¬Â[3Ã¢â‚¬ÂethylÃ¢â‚¬Â5Ã¢â‚¬ÂoxoÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â1Ã¢â‚¬Âyl]propyl}Ã¢â‚¬Â1lambda5Ã¢â‚¬ÂpiperazinÃ¢â‚¬Â1Ã¢â‚¬Âylium",CCC1=NN(CCCN2CCN(C3=CC(=[Cl+])C(=O)C=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.71,_2_ELECTRON_OXIDATION_OF_P_AMINOPHENOLS_TO_QUINONE_IMINES_PATTERN1
"1Ã¢â‚¬Â{3Ã¢â‚¬Â[4Ã¢â‚¬Â(3Ã¢â‚¬ÂchloroÃ¢â‚¬Â4Ã¢â‚¬Âhydroxyphenyl)piperazinÃ¢â‚¬Â1Ã¢â‚¬Âyl]propyl}Ã¢â‚¬Â3Ã¢â‚¬ÂethylÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â5Ã¢â‚¬Âone",CCC1=NN(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,"1Ã¢â‚¬Â{3Ã¢â‚¬Â[4Ã¢â‚¬Â(3Ã¢â‚¬ÂchloroÃ¢â‚¬Â1Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â4Ã¢â‚¬ÂoxocyclohexaÃ¢â‚¬Â2,5Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âyl)piperazinÃ¢â‚¬Â1Ã¢â‚¬Âyl]propyl}Ã¢â‚¬Â3Ã¢â‚¬ÂethylÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â5Ã¢â‚¬Âone",CCC1=NN(CCCN2CCN(C3(O)C=CC(=O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.69,Oxidation of 4-substituted phenol
"1Ã¢â‚¬Â{3Ã¢â‚¬Â[4Ã¢â‚¬Â(3Ã¢â‚¬ÂchloroÃ¢â‚¬Â4Ã¢â‚¬Âhydroxyphenyl)piperazinÃ¢â‚¬Â1Ã¢â‚¬Âyl]propyl}Ã¢â‚¬Â3Ã¢â‚¬ÂethylÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â5Ã¢â‚¬Âone",CCC1=NN(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,"1Ã¢â‚¬Â[3Ã¢â‚¬Â(4Ã¢â‚¬Â{3Ã¢â‚¬ÂchloroÃ¢â‚¬Â4Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â7Ã¢â‚¬Âoxabicyclo[4.1.0]heptaÃ¢â‚¬Â2,4Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âyl}piperazinÃ¢â‚¬Â1Ã¢â‚¬Âyl)propyl]Ã¢â‚¬Â3Ã¢â‚¬ÂethylÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â5Ã¢â‚¬Âone",CCC1=NN(CCCN2CCN(C34C=C(Cl)C(O)=CC3O4)CC2)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.62,EPOXIDATION
1-aminopyrene,NC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,N-hydroxy-1-aminopyrene,ONC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,CYP1A1; CYP1A2; CYP3A4,0.75,N-hydroxylation of primary arylamine
17alpha-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=CC(O)=CC=C4C3CCC21C,,2beta-OH-17beta-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=CC(O)=C(O)C=C4C3CCC21C,,CYP2C9; CYP3A4; CYP2C19; CYP1A2,0.97,Aromatic hydroxylation of fused benzene ring
17alpha-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=CC(O)=CC=C4C3CCC21C,,4beta-OH-17beta-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=C(C=CC(O)=C4O)C3CCC21C,,CYP2C9; CYP3A4,0.88,Aromatic hydroxylation of fused benzene ring
17alpha-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=CC(O)=CC=C4C3CCC21C,,6beta-OH-17beta-Ethinylestradiol,C#CC1(O)CCC2C3(C)CC(O)C4=CC(O)=CC=C4C3CCC21C,,CYP2C9; CYP3A4,0.83,Hydroxylation of alicyclic secondary carbon
17alpha-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=CC(O)=CC=C4C3CCC21C,,6alpha-OH-17beta-Ethinylestradiol,C#CC1(O)CCC2C3(C)CC(O)C4=CC(O)=CC=C4C3CCC21C,,CYP2C9; CYP3A4,0.83,Hydroxylation of alicyclic secondary carbon
"2,6-Xylidine",CC1=CC=CC(C)=C1N,,"N-(2,6-dimethylphenyl)hydroxylamine",CC1=CC=CC(C)=C1NO,,CYP2A6; CYP2E1,0.71,N-hydroxylation of primary arylamine
3-aminobenzanthrone,NC1C=CC2=C3C(=CC=CC31)C(=O)C1=CC=CC=C21,,N-hydroxy-3-aminobenzanthrone,O=C1C2=CC=CC3C2=C(C=CC3NO)C2=CC=CC=C12,,CYP1A1; CYP1A2; CYP1B1; CYP2A6; CYP2B6; ,0.96,N-hydroxylation of primary arylamine
3-Hydroxylidocaine,CCN(CC)CC(O)=NC1=C(C)C=CC(O)=C1C,,3-Hydroxymonoethyl glycinexylidide,CCNCC(O)=NC1=C(C)C=CC(O)=C1C,,CYP1A2; CYP2D6; CYP3A4,0.95,N-dealkylation of acyclic tertiary amine
4'-HPPH,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,,"3Ã¢â‚¬â„¢,4Ã¢â‚¬â„¢- diHPPH",OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C(O)=C2)C(O)=N1,,CYP2C9; CYP2C19,0.87,Hydroxylation of benzene on carbon orhto to a strongly electron donating group
"4,4'-Dichlorobiphenyl",ClC1=CC=C(C2=CC=C(Cl)C=C2)C=C1,,"4,4Ã¢â‚¬Â²-Dichloro-3-biphenylol",OC1=CC(C2=CC=C(Cl)C=C2)=CC=C1Cl,,CYP1A2,0.55,Hydroxylation of aromatic carbon ortho to halide group
"(R)-mianserin, 8-hydroxy",CN1CCN2C3=CC(O)=CC=C3CC3=CC=CC=C3C2C1,,"(R)-mianserin, 8-OH-N-desmethyl",OC1=CC=C2CC3=CC=CC=C3C3CNCCN3C2=C1,,CYP2D6; CYP1A2; CYP3A4,0.97,N-dealkylation of alicyclic tertiary amine
Acetachlor,CCOCN(C(=O)CCl)C1=C(C)C=CC=C1CC,,,CCC1=CC=CC(C)=C1N=C(O)CCl,,CYP2B6; CYP3A4,0.3,N-dealkoxylation of N-aryl-N-chloroacetamide
Acetachlor,CCOCN(C(=O)CCl)C1=C(C)C=CC=C1CC,,,CCOCNC1=C(C)C=CC=C1CC,,CYP2B6; CYP3A4,0.51,N-demethoxymethylation
Bromazepam,OC1=NC2=CC=C(Br)C=C2C(C2=CC=CC=N2)=NC1,,,OC1=NC2=CC=C(Br)C=C2C(C2=CC=CC=N2)=NC1O,,CYP1A2; CYP2D6,0.89,"3-Hydroxylation of 5-aryl-1,4-benzodiazepine"
6-Aminochrysene,NC1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,N-Hydroxychrysene,ONC1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,CYP1B1; CYP1A2; CYP1A1; CYP2A6; CYP2B6,0.75,N-hydroxylation of primary arylamine
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,"Aminoflavone, N4'-Hydroxy",CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,CYP1A2; CYP1A1; CYP2C9; CYP2C19,0.98,N-hydroxylation of primary arylamine
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,,CC1=C(F)C(NO)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,CYP1A2; CYP2C9; CYP2C19,0.94,N-hydroxylation of primary arylamine
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,"Aminoflavone, C3-hydroxy",CC1=C(F)C(N)=C2C(=O)C(O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,CYP1A2,0.88,Hydroxylation of carbon alpha to conjugated carbonyl
"Aminoflavone, N4'-Hydroxyl",CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,"Aminoflavone, N4', N5-dihydroxy",CC1=C(F)C(NO)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,CYP1A2; CYP2C9; CYP2C19,0.95,N-hydroxylation of primary arylamine
Aprindine,CCN(CC)CCCN(C1=CC=CC=C1)C1CC2=CC=CC=C2C1,,"N-[3-(N,NDiethylamino)propyl]-N-phenyl-2-aminoindan-5-ol",CCN(CC)CCCN(C1=CC=CC=C1)C1CC2=CC=C(O)C=C2C1,,CYP2D6,0.87,Aromatic hydroxylation of fused benzene ring
Aprindine,CCN(CC)CCCN(C1=CC=CC=C1)C1CC2=CC=CC=C2C1,,p-Hydroxyphenylaprindine,CCN(CC)CCCN(C1=CC=C(O)C=C1)C1CC2=CC=CC=C2C1,,CYP2D6,0.93,Hydroxylation of benzene on carbon para to a strongly electron donating group
Aprindine,CCN(CC)CCCN(C1=CC=CC=C1)C1CC2=CC=CC=C2C1,,Desethylaprindine,CCNCCCN(C1=CC=CC=C1)C1CC2=CC=CC=C2C1,,CYP2D6,0.97,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES
Butachlor,CCCCOCN(C(=O)CCl)C1=C(CC)C=CC=C1CC,,,CCC1=CC=CC(CC)=C1N=C(O)CCl,,CYP2B6; CYP3A4,0.3,N-dealkoxylation of N-aryl-N-chloroacetamide
Butachlor,CCCCOCN(C(=O)CCl)C1=C(CC)C=CC=C1CC,,,CCC1=CC=CC(CC)=C1N=C(O)CCl,,CYP2B6; CYP3A4,0.3,N-demethoxymethylation
(+)-Camphor,CC12CCC(CC1=O)C2(C)C,,5-exo-hydroxycamphor,CC12CCC(CC1=O)C2(C)CO,,CYP2D6,0.74,Hydroxlation of methyl carbon adjacent to an aliphatic ring
Carbosulfan,CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2,,carbofuran,CN=C(O)OC1=CC=CC2=C1OC(C)(C)C2,,CYP1A1; CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C19; CYP3A4,0.6,NS-cleavage
Carbosulfan,CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2,,dibutyl(sulfanyl)amine,CCCCN(S)CCCC,,CYP1A1; CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C19; CYP3A4,0.07,NS-cleavage
Carbosulfan,CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2,,,CCCCN(CCCC)S(=O)N(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2,,CYP1A1; CYP2B6; CYP2C19; CYP3A4,0.9,Oxidation of S adjacent to an aliphatic nitrogen
Chlorpyrifos-oxon,CCOP(=O)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,"3,5,6-Trichloro-2-pyridinol",OC1=NC(Cl)=C(Cl)C=C1Cl,,CYP2C19; CYP2B6; CYP3A4,0.46,Dearylation of organphosphosulfur compound
Chlorpyrifos-oxon,CCOP(=O)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,Diethyl phosphate,CCOP(=O)(O)OCC,,CYP2C19; CYP2B6; CYP3A4,0.1,Dearylation of organphosphosulfur compound
Citalopram,CN(C)CCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,Citalopram N-oxide,C[N+](C)([O-])CCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,CYP2D6,0.96,N-oxdation of aliphatic tertiary amine
Citalopram,CN(C)CCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,N-Desmethylcitalopram,CNCCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,CYP2D6; CYP2C19; CYP3A4,0.99,N-dealkylation of acyclic tertiary amine
D-617,CNCCCC(C#N)(C1=CC=C(OC)C(OC)=C1)C(C)C,,D-620,COC1=CC=C(C(C#N)(CCCN)C(C)C)C=C1OC,,CYP3A4; CYP3A5,0.98,N-dealkylation of acyclic secondary amine
Dimethoate,CN=C(O)CSP(=S)(OC)OC,,Omethoate,CN=C(O)CSP(=O)(OC)OC,,CYP1A1; CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP3A4,0.49,Desulfuration of organophosphorodithioate
DEET,CCN(CC)C(=O)C1=CC=CC(C)=C1,,N-ethyl-m-toluamide,CCN=C(O)C1=CC=CC(C)=C1,,CYP2C19; CYP3A4,0.19,N-dealkylation of tertiary carboxamide
Diazoxon,CCOP(=O)(OCC)OC1=CC(C)=NC(C(C)C)=N1,,Pyrimidinol,CC1=CC(O)=NC(C(C)C)=N1,,CYP2C19,0.48,C-DE-ESTERIFICATION
Diazoxon,CCOP(=O)(OCC)OC1=CC(C)=NC(C(C)C)=N1,,Diethy phosphate,CCOP(=O)(O)OCC,,CYP2C19,0.11,Dearylation of organphosphosulfur compound
Disulfoton,CCOP(=S)(OCC)SCCSCC,,Disulfoton sulfoxide,CCOP(=S)(OCC)SCCS(=O)CC,,CYP1A2; CYP2B6; CYP2C9; CYP2C18; CYP2C19; CYP2D6; CYP3A4,0.85,S-oxidation of dialkylthioether to sulfoxide
Diuron,CN(C)C(O)=NC1=CC=C(Cl)C(Cl)=C1,,N-demethyldiuron,CN=C(O)NC1=CC=C(Cl)C(Cl)=C1,,CYP1A1; CYP1A2; CYP2C19; CYP3A4,0.43,N-dealkylation of urea
donepezil,COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,"2Ã¢â‚¬Â[(1Ã¢â‚¬ÂbenzylpiperidinÃ¢â‚¬Â4Ã¢â‚¬Âyl)methyl]Ã¢â‚¬Â5Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â6Ã¢â‚¬ÂmethoxyÃ¢â‚¬Â2,3Ã¢â‚¬ÂdihydroindenÃ¢â‚¬Â1Ã¢â‚¬Âone",COC1=CC2=C(C=C1O)CC(CC1CCN(CC3=CC=CC=C3)CC1)C2=O,,CYP3A4; CYP2C9; CYP2D6,0.99,O-aryl dealkylation adjacent to substituted carbon
donepezil,COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,"5,6Ã¢â‚¬ÂdimethoxyÃ¢â‚¬Â2Ã¢â‚¬Â(piperidinÃ¢â‚¬Â4Ã¢â‚¬Âylmethyl)Ã¢â‚¬Â2,3Ã¢â‚¬ÂdihydroindenÃ¢â‚¬Â1Ã¢â‚¬Âone",COC1=CC2=C(C=C1OC)C(=O)C(CC1CCNCC1)C2,,CYP3A4; CYP2C9,0.89,N-dealkylation of alicyclic tertiary amine
donepezil,COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,"2Ã¢â‚¬Â[(1Ã¢â‚¬ÂbenzylpiperidinÃ¢â‚¬Â4Ã¢â‚¬Âyl)methyl]Ã¢â‚¬Â6Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â5Ã¢â‚¬ÂmethoxyÃ¢â‚¬Â2,3Ã¢â‚¬ÂdihydroindenÃ¢â‚¬Â1Ã¢â‚¬Âone",COC1=CC2=C(C=C1O)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,CYP3A4; CYP2C9,0.99,O-aryl dealkylation adjacent to substituted carbon
Encainide,COC1=CC=C(C(=O)NC2=CC=CC=C2CCC2CCCCN2C)C=C1,,N-demethylencainide,COC1=CC=C(C(=O)NC2=CC=CC=C2CCC2CCCCN2)C=C1,,CYP2D6,0.95,N-dealkylation of alicyclic tertiary amine
Encainide,COC1=CC=C(C(=O)NC2=CC=CC=C2CCC2CCCCN2C)C=C1,,O-demethylencainide,CN1CCCCC1CCC1=CC=CC=C1NC(=O)C1=CC=C(O)C=C1,,CYP2D6,0.96,O-aryl demethylation
Esfenvalerate,CC(C)C(C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2)=C1)C1=CC=C(Cl)C=C1,,2'-OH-esfenvalerate,CC(C)C(C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2O)=C1)C1=CC=C(Cl)C=C1,,CYP2C8; CYP2C9; CYP2C19; CYP3A4; CYP3A5,0.94,o-Hydroxylation of monosubstituted benzene
Esfenvalerate,CC(C)C(C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2)=C1)C1=CC=C(Cl)C=C1,,4'-OH-esfenvalerate,CC(C)C(C(=O)OC(C#N)C1=CC=CC(OC2=CC=C(O)C=C2)=C1)C1=CC=C(Cl)C=C1,,CYP2C8; CYP2C9; CYP2C19; CYP3A4; CYP3A5,0.99,p-Hydroxylation of monosubstituted benzene
N-Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,N-Didesmethylclomipramine,NCCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,CYP2C19; CYP3A4; CYP1A2,0.99,N-dealkylation of acyclic secondary amine
N-Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,8-OH-N-desmethylclomipramine,CNCCCN1C2=CC(Cl)=CC=C2CCC2=C(O)C=CC=C21,,CYP2D6,0.81,Aromatic hydroxylation of fused benzene ring
N-demethylencainide,COC1=CC=C(C(=O)NC2=CC=CC=C2CCC2CCCCN2)C=C1,,"N,O-didemethylencainide",O=C(NC1=CC=CC=C1CCC1CCCCN1)C1=CC=C(O)C=C1,,CYP2D6,0.96,O-aryl demethylation
O-demethylencainide,CN1CCCCC1CCC1=CC=CC=C1NC(=O)C1=CC=C(O)C=C1,,"N,O-didemethylencainide",O=C(NC1=CC=CC=C1CCC1CCCCN1)C1=CC=C(O)C=C1,,CYP2D6,0.95,N-dealkylation of alicyclic tertiary amine
Endosulfan-alpha,O=S1OCC2C(CO1)C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl,,Endosulfan sulfate,O=S1(=O)OCC2C(CO1)C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl,,CYP2C9; CYP2C19; CYP3A4; CYP3A5; CYP3A7,0.98,S-oxidation of organosulfurous compounds
Fenthion,COP(=S)(OC)OC1=CC=C(SC)C(C)=C1,,Fenthion oxon,COP(=O)(OC)OC1=CC=C(SC)C(C)=C1,,CYP1A2; CYP2B6; CYP2C9; CYP2C19; CYP3A4; CYP3A5,0.71,Desulfuration of organophosphothioates
Flecainide,OC(=NCC1CCCCN1)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F,,"2-hydroxy-N-[(piperidin-2-yl)methyl]-5-(2,2,2-trifluoroethoxy)benzamide",OC(=NCC1CCCCN1)C1=CC(OCC(F)(F)F)=CC=C1O,,CYP2D6,0.91,O-aryl dealkylation adjacent to substituted carbon
lansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,,,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=C(O)C=C2N1,,CYP2C9;CYP2C19;CYP3A4,0.94,Aromatic Hydroxylation
Gavestinel,O=C(O)C1=C(C=CC(O)=NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,,p-OH-gavestinel,O=C(C=CC1=C(C(=O)O)NC2=CC(Cl)=CC(Cl)=C12)NC1=CC=C(O)C=C1,,CYP2C9,0.8,Hydroxylation of benzene on carbon para to an electron donating group
Gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCCC3C2)C=C1,,7-OH-gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CC(O)CC3C2)C=C1,,CYP2C9,0.9,Hydroxylation of alicyclic secondary carbon
Gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCCC3C2)C=C1,,Methylhydroxygliclazide,O=S(=O)(NC(O)=NN1CC2CCCC2C1)C1=CC=C(CO)C=C1,,CYP2C9; CYP2C19,0.95,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
Gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCCC3C2)C=C1,,6-OH-gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCC(O)C3C2)C=C1,,CYP2C9,0.82,Hydroxylation of alicyclic secondary carbon
Glimepiride,CCC1=C(C)CN(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCC(C)CC3)C=C2)C1=O,,Cyclohexylhydroymethylglimepiride,CCC1=C(C)CN(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCC(CO)CC3)C=C2)C1=O,,CYP2C9,0.98,Hydroxylation of terminal methyl
Glipizide,CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCCCC3)C=C2)C=N1,,4-trans-OH-glipizide,CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCC(O)CC3)C=C2)C=N1,,CYP2C9,0.96,Hydroxylation of alicyclic secondary carbon
Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,,Norhydromorphone,O=C1CCC2C3CC4=CC=C(O)C5=C4C2(CCN3)C1O5,,CYP3A4; CYP2C9; CYP2D6,0.98,N-dealkylation of mixed tertiary amine
Lansoprazole,CC1=CC(OCC(F)(F)F)=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=N1,,Hydroxylansoprazole,CC1=CC(OCC(F)(F)F)=C(C)C(CS(=O)C2=NC3=CC=CC(O)=C3N2)=N1,,CYP2C19; CYP2C9; CYP3A4,0.89,Aromatic hydroxylation of fused benzene ring
Lansoprazole,CC1=CC(OCC(F)(F)F)=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=N1,,Lansoprazole sulfone,CC1=CC(OCC(F)(F)F)=C(C)C(CS(=O)(=O)C2=NC3=CC=CC=C3N2)=N1,,CYP3A4,0.94,S-oxidation of sulfoxide to sulfone
Imidacloprid,O=[N+]([O-])NC1=NCCN1CC1=CC=C(Cl)N=C1,,,ON=NC1=NCCN1CC1=CC=C(Cl)N=C1,,CYP2B6; CYP2D6; CYP2E1; CYP3A4,0.65,Reduction of nitroimine
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,,Leukotoxin,CCCCCC=CCC1OC1CCCCCCCC(=O)O,,CYP2C9; CYP2C19,0.44,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,,Isoleukotoxin,CCCCCC1OC1CC=CCCCCCCCC(=O)O,,CYP2C9; CYP2C19,0.44,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
Lumiracoxib,CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)O)=C1,,Lumiracoxib metabolite 1,O=C(O)CC1=CC(CO)=CC=C1NC1=C(F)C=CC=C1Cl,,CYP2C9; CYP2C19,0.94,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
Lumiracoxib,CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)O)=C1,,Lumiracoxib metabolite 2,CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)O)=C1,,CYP2C9; CYP2C19,0.87,Hydroxylation of aromatic carbon meta to halide group
Mianserine,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,8-Hydroxymianserin,CN1CCN2C3=CC=C(O)C=C3CC3=CC=CC=C3C2C1,,"CYP2D6 (major; (major, RÃ¢â€°Ë†S)); CYP2B6 (R>S); CYP3A4  (S>R) ",0.93,Aromatic hydroxylation of fused benzene ring
Mianserine,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,Desmethylmianserin,C1=CC=C2C(=C1)CC1=CC=CC=C1N1CCNCC21,,CYP2B6 (R>S); CYP3A4 (R>S); CYP2C19 (R>S); CYP1A2 (RÃ¢â€°Ë†S),0.96,N-dealkylation of alicyclic tertiary amine
Mianserine,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,Mianserin N-oxide,C[N+]1([O-])CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,CYP3A4 (RÃ¢â€°Ë†S); CYP1A2 (S>R),0.91,N-oxidation of alicyclic tertiary amine
Mirtazapine,CN1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1,,Mirtazapine N-oxide,C[N+]1([O-])CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1,,CYP1A2; CYP2D6; CYP3A4,0.93,N-oxidation of alicyclic tertiary amine
Mirtazapine,CN1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1,,N-Desmethylmirtazapine,C1=CC=C2C(=C1)CC1=CC=CN=C1N1CCNCC21,,CYP1A2; CYP2D6; CYP3A4,0.97,N-dealkylation of mixed tertiary amine
Mirtazapine,CN1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1,,8-OH-mirtazapine,CN1CCN2C3=NC(O)=CC=C3CC3=CC=CC=C3C2C1,,CYP1A2; CYP2D6; CYP3A4,0.94,HYDROXYLATION_OF_HETEROAROMATIC_CARBON
(-)-Menthol,CC1CCC(C(C)C)C(O)C1,,"p-Menthane-3,-8-diol",CC1CCC(C(C)(C)O)C(O)C1,,CYP2A6,0.73,Hydroxylation of alkyl methine
Mestranol,C#CC1(O)CCC2C3CCC4=CC(OC)=CC=C4C3CCC21C,,Ethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=CC=C4C3CCC21C,,CYP2C9,0.94,O-aryl dealkylation not adjacent to substituted carbon
Mono-OH-methoxychlor,COC1=CC=C(C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl)C=C1,,Catechol-methoxychlor,COC1=CC=C(C(C2=CC=C(O)C(O)=C2)C(Cl)(Cl)Cl)C=C1,,CYP2B6; CYP3A4; CYP3A5,0.78,o-Hydroxylation of phenol
Mono-OH-methoxychlor,COC1=CC=C(C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl)C=C1,,Bis-OH-methoxychlor,OC1=CC=C(C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl)C=C1,,CYP1A2; CYP2C8; CYP2C19; CYP2D6,0.89,O-aryl dealkylation not adjacent to substituted carbon
Monodemethylated mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(NC)C=C3)CC21C,,Didemethylated mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(N)C=C3)CC21C,,CYP3A4,0.99,N-dealkylation of secondary arylalkylamine
Bis-OH-methoxychlor,OC1=CC=C(C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl)C=C1,,Tris-OH-methoxychlor,OC1=CC=C(C(C2=CC=C(O)C(O)=C2)C(Cl)(Cl)Cl)C=C1,,CYP3A4,0.76,o-Hydroxylation of phenol
methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,,"2ethylidene-1,5-dimethyl-3,3-diphenylpyrolidine",CCC1C(C)N(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2D6; CYP3A4 (major); CYP2B6; CYP2C8; CYP2C19,0.49,N-dealkylation of acyclic tertiary amine
Monoethylglycinexylidide,CCNCC(O)=NC1=C(C)C=CC=C1C,,3-Hydroxymonoethyl glycinexylidide,CCNCC(O)=NC1=C(C)C=CC(O)=C1C,,CYP1A2; CYP2D6; CYP3A4,0.71,HYDROXYLATION_OF_AROMATIC_CARBON
Monoethylglycinexylidide,CCNCC(O)=NC1=C(C)C=CC=C1C,,Glycinexylidide,CC1=CC=CC(C)=C1N=C(O)CN,,CYP1A2; CYP3A4,0.9,N-dealkylation of acyclic secondary amine
N-Desmethyltamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,,N-Desdimethyltamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN)C=C1)C1=CC=CC=C1,,CYP3A4; CYP3A5,0.98,N-dealkylation of acyclic secondary amine
N-Desmethyltamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,,alpha-OH-N-desmethyltamoxifen,CNCCOC1=CC=C(C(=C(C2=CC=CC=C2)C(C)O)C2=CC=CC=C2)C=C1,,CYP3A4; CYP3A5,0.85,Hydroxylation of penultimate aliphatic secondary carbon
"N-methyl-3,4methylenedioxyamphetamine ",CNC(C)CC1=CC=C2OCOC2=C1,,"N-Methyl-3,4dihydroxyamphetamine ",CNC(C)CC1=CC=C(O)C(O)=C1,,CYP2D6; CYP1A2 ,0.69,Methylenedioxy ring opening
1-Naphtaldehyde,O=CC1=CC=CC2=CC=CC=C12,,1-Naphthoic acid,O=C(O)C1=CC=CC2=CC=CC=C12,,CYP3A4,0.7,Aldehyde oxidation
Nateglinide,CC(C)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)O)CC1,,2Ã¢â‚¬Â{[4Ã¢â‚¬Â(1Ã¢â‚¬ÂhydroxypropanÃ¢â‚¬Â2Ã¢â‚¬Âyl)cyclohexyl]formamido}Ã¢â‚¬Â3Ã¢â‚¬Âphenylpropanoic acid,CC(CO)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)O)CC1,,CYP2C9; CYP3A4,0.99,Hydroxylation of terminal methyl
Nateglinide,CC(C)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)O)CC1,,2Ã¢â‚¬Â{[4Ã¢â‚¬Â(2Ã¢â‚¬ÂhydroxypropanÃ¢â‚¬Â2Ã¢â‚¬Âyl)cyclohexyl]formamido}Ã¢â‚¬Â3Ã¢â‚¬Âphenylpropanoic acid,CC(C)(O)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)O)CC1,,CYP2C9; CYP3A4,0.95,Hydroxylation of penultimate aliphatic tertiary carbon
Nicardipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC2=CC=CC=C2)C1C1=CC=CC([N+](=O)[O-])=C1,,De-benzylated nicardipine,CNCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC([N+](=O)[O-])=C1,,CYP2C8; CYP3A4,0.95,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES
Nicardipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC2=CC=CC=C2)C1C1=CC=CC([N+](=O)[O-])=C1,,Dehydronicardipine,COC(=O)C1=C(C)N=C(C)C(C(=O)OCCN(C)CC2=CC=CC=C2)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP1A1; CYP1A2; CYP2C8; CYP2D6; CYP2E1; CYP3A4; CYP3A5,0.38,"Dehydrogenation of 4-aryl substituted 1,4-dihydropyridine"
Nordoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,,2-Hydroxynordoxepin,CNCCC=C1C2=CC(O)=CC=C2COC2=CC=CC=C12,,CYP2D6,0.93,Aromatic hydroxylation of fused benzene ring
Norverapamil,COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,D-620,COC1=CC=C(C(C#N)(CCCN)C(C)C)C=C1OC,,CYP2C8; CYP3A4; CYP2D6,0.9,N-dealkylation of acyclic secondary amine
Norverapamil,COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,"2-(3,4-dimethoxyphenyl)acetaldehyde",COC1=CC=C(CC=O)C=C1OC,,CYP2C8; CYP3A4; CYP2D6,0.41,N-dealkylation of acyclic secondary amine
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,6-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(O)=CC=C1N2C,,CYP3A4; CYP2D6; CYP1A2,0.95,Aromatic hydroxylation of fused benzene ring
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,7-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(O)C=C1N2C,,CYP1A2; CYP2D6; CYP3A4,0.96,Aromatic hydroxylation of fused benzene ring
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,8-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(O)=C1N2C,,CYP1A2; CYP2D6; CYP3A4,0.91,Aromatic hydroxylation of fused benzene ring
Phorate,CCOP(=S)(OCC)SCSCC,,Phorate sulfoxide,CCOP(=S)(OCC)SCS(=O)CC,,CYP1A2; CYP3A4; CYP2B6; CYP2C9; CYP2C18; CYP2C19; CYP2D6,0.78,S-oxidation of dialkylthioether to sulfoxide
Pioglitazone,CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,"2Ã¢â‚¬Â[6Ã¢â‚¬Â(2Ã¢â‚¬Â{4Ã¢â‚¬Â[(2,4Ã¢â‚¬ÂdioxoÃ¢â‚¬Â1,3Ã¢â‚¬ÂthiazolidinÃ¢â‚¬Â5Ã¢â‚¬Âyl)methyl]phenoxy}ethyl)pyridinÃ¢â‚¬Â3Ã¢â‚¬Âyl]acetic acid",O=C(O)CC1=CC=C(CCOC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,CYP2C8; CYP3A4,0.93,OXIDATION_OF_PRIM_ALCOHOL_TO_CARBOXYLIC_ACID
Pioglitazone,CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,"5Ã¢â‚¬Â[(4Ã¢â‚¬Â{2Ã¢â‚¬Â[5Ã¢â‚¬Â(1Ã¢â‚¬Âhydroxyethyl)pyridinÃ¢â‚¬Â2Ã¢â‚¬Âyl]ethoxy}phenyl)methyl]Ã¢â‚¬Â1,3Ã¢â‚¬ÂthiazolidineÃ¢â‚¬Â2,4Ã¢â‚¬Âdione",CC(O)C1=CC=C(CCOC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,CYP2C8; CYP3A4,0.93,Hydroxylation of non-terminal aliphatic carbon adjacent to aromatic ring
Pioglitazone,CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,"5Ã¢â‚¬Â({4Ã¢â‚¬Â[2Ã¢â‚¬Â(5Ã¢â‚¬ÂethylpyridinÃ¢â‚¬Â2Ã¢â‚¬Âyl)Ã¢â‚¬Â2Ã¢â‚¬Âhydroxyethoxy]phenyl}methyl)Ã¢â‚¬Â1,3Ã¢â‚¬ÂthiazolidineÃ¢â‚¬Â2,4Ã¢â‚¬Âdione",CCC1=CC=C(C(O)COC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,CYP2C8; CYP3A4,0.89,HYDROXYLATION_OF_ALIPHATIC_SECONDARY_CARBON
17ÃŽÂ²-OH-progesterone,CC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,,17Beta-21-dihydroxyprogesterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C1CCC2(O)C(=O)CO,,CYP2D4; CYP2D6,0.95,Alpha hydroxylation of carbonyl group
Propafenone ,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,5-Hydroxypropafenone,CCCNCC(O)COC1=CC=C(O)C=C1C(=O)CCC1=CC=CC=C1,,CYP2D6,0.9,Hydroxylation of benzene on carbon para to an electron donating group
Propafenone ,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,N-Despropylpropafenone,NCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,CYP1A2; CYP3A4,0.94,N-dealkylation of acyclic secondary amine
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,para-hydroxyrosiglitazone ,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=C(O)C=N1,,CYP2C8,0.94,HYDROXYLATION_OF_HETEROAROMATIC_CARBON
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,N-Desmethylrosiglitazone ,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,,CYP2C8,0.92,N-dealkylation of mixed tertiary amine
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,ortho-hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=CC=C1O,,CYP2C8,0.89,HYDROXYLATION_OF_HETEROAROMATIC_CARBON
Rosuvastatin,CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC(O)CC(O)CC(=O)O,,Rosuvastatin 5 S-lactone,CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC1=CC(O)=CC(=O)O1,,CYP2C9,0.77,ESTERIFICATION
Simazine,CCN=C1N=C(Cl)NC(=NCC)N1,,N-Desethylsimazine,CCN=C1NC(Cl)=NC(=N)N1,,CYP1A1; CYP1A2; CYP2A6; CYP2C19; CYP2D6,0.97,N-dealkylation of secondary arylalkylamine
Styrene,C=CC1=CC=CC=C1,,"Styrene 7,8-oxide",C1=CC=C(C2CO2)C=C1,,CYP2E1,0.23,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE
Pyributicarb,COC1=CC=CC(N(C)C(=S)OC2=CC=CC(C(C)(C)C)=C2)=N1,,Pyributicarb metabolite 1,CN(C(=S)OC1=CC=CC(C(C)(C)C)=C1)C1=CC=CC(O)=N1,,CYP2C19,0.94,O-aryl demethylation
Sulprofos,CCCSP(=S)(OCC)OC1=CC=C(SC)C=C1,,Sulprofos sulfoxide,CCCSP(=S)(OCC)OC1=CC=C(S(C)=O)C=C1,,CYP1A1; CYP1A2; CYP3A4; CYP2C9; CYP2C18; CYP2C19; CYP2D6,0.9,S-oxidation of dialkylthioether to sulfoxide
Tamoxifen N-oxide,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[O-])C=C1)C1=CC=CC=C1,,alpha-OH-tamoxifen N-oxide,CC(O)C(=C(C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[O-])C=C1)C1=CC=CC=C1,,CYP3A4; CYP3A5,0.87,Hydroxylation of penultimate aliphatic secondary carbon
Tegafur,O=C1N=C(O)C(F)=CN1C1CCCO1,,5-Fluorouracil,OC1=NC=C(F)C(O)=N1,,CYP2A6; CYP1A2; CYP2C8,0.21,N-dealkylation of mixed tertiary amine
Thioridazine,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3C)C2=C1,,Thioridazine 2-sulfoxide ,CN1CCCCC1CCN1C2=CC=CC=C2SC2=CC=C(S(C)=O)C=C21,,CYP2D6; CYP3A4,0.92,S-oxidation of alkylarylthioether to sulfoxide
Thioridazine,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3C)C2=C1,,N-desmethylthioridazine ,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3)C2=C1,,CYP1A2; CYP3A4,0.96,N-dealkylation of mixed tertiary amine
Thioridazine,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3C)C2=C1,,Thioridazine 5-sulfoxide,CSC1=CC=C2C(=C1)N(CCC1CCCCN1C)C1=CC=CC=C1S2=O,,CYP1A2; CYP3A4,0.87,S-oxidation of diarylthioether to sulfoxide
Thymol,CC1=CC=C(C(C)C)C(O)=C1,,"p-Cymene-2,3-diol",CC1=CC=C(C(C)C)C(O)=C1O,,CYP1A2; CYP2A6; CYP2D6,0.8,o-Hydroxylation of phenol
Thymol,CC1=CC=C(C(C)C)C(O)=C1,,Thymoquinol,CC1=CC(O)=C(C(C)C)C=C1O,,CYP1A2; CYP2A6; CYP2D6,0.88,p-Hydroxylation of phenol
Thymol,CC1=CC=C(C(C)C)C(O)=C1,,p-Cymen-8-en-3-ol,C=C(C)C1=CC=C(C)C=C1O,,CYP1A2; CYP2A6; CYP2D6,0.62,Terminal desaturation
Tizanidine,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,,"2Ã¢â‚¬Â[(5Ã¢â‚¬ÂchloroÃ¢â‚¬Â2,1,3Ã¢â‚¬ÂbenzothiadiazolÃ¢â‚¬Â4Ã¢â‚¬Âyl)amino]Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬ÂimidazolÃ¢â‚¬Â4Ã¢â‚¬Âol",OC1CN=C(NC2=C(Cl)C=CC3=NSN=C23)N1,,CYP1A2,0.93,Hydroxylation of heteroalicyclic secondary carbon
Trichloroethylene,ClC=C(Cl)Cl,,Chloral hydrate,OC(O)C(Cl)(Cl)Cl,,CYP2E1; CYP1A2; CYP3A4,0.09,EPOXIDATION
TSU-68,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=CC=CC=C23)N1,,TSU-68 metabolite 1,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=CC=C(O)C=C23)N1,,CYP1A2; CYP1A1; CYP2C8,0.94,Aromatic hydroxylation of fused benzene ring
TSU-68,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=CC=CC=C23)N1,,TSU-68 metabolite 2,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=C(O)C=CC=C23)N1,,CYP1A1; CYP1A2; CYP2C8,0.9,Aromatic hydroxylation of fused benzene ring
TSU-68,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=CC=CC=C23)N1,,TSU-68 metabolite 3,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=CC(O)=CC=C23)N1,,CYP1A1; CYP1A2; CYP2C8,0.94,Aromatic hydroxylation of fused benzene ring
YM-64227,CCC1=CC=C2C(C3CCCCC3)=NC(=O)N(CC)C2=N1,,"M-2 (1,3-cis)",CCC1=CC=C2C(C3CCCC(O)C3)=NC(=O)N(CC)C2=N1,,CYP1A2,0.95,Hydroxylation of alicyclic secondary carbon
YM-64227,CCC1=CC=C2C(C3CCCCC3)=NC(=O)N(CC)C2=N1,,"M-3 (1,3-trans)",CCC1=CC=C2C(C3CCCC(O)C3)=NC(=O)N(CC)C2=N1,,CYP1A2,0.95,Hydroxylation of alicyclic secondary carbon
Zaltoprofen,CC(C(=O)O)C1=CC=C2SC3=CC=CC=C3C(=O)CC2=C1,,10-OH-zaltoprofen,CC(C(=O)O)C1=CC=C2SC3=CC=CC=C3C(O)CC2=C1,,CYP2C9,0.68,REDUCTION_OF_KETONES_TO_ALCOHOL
Zaltoprofen,CC(C(=O)O)C1=CC=C2SC3=CC=CC=C3C(=O)CC2=C1,,Zaltoprofen S-oxide,CC(C(=O)O)C1=CC=C2C(=C1)CC(=O)C1=CC=CC=C1S2=O,,CYP2C9,0.83,S-oxidation of dialkylthioether to sulfoxide
Zoplicone,CN1CCN(C(=O)OC2C3=NC=CN=C3C(=O)N2C2=CC=C(Cl)C=N2)CC1,,"4Ã¢â‚¬Â({[6Ã¢â‚¬Â(5Ã¢â‚¬ÂchloropyridinÃ¢â‚¬Â2Ã¢â‚¬Âyl)Ã¢â‚¬Â7Ã¢â‚¬ÂoxoÃ¢â‚¬Â5H,6H,7HÃ¢â‚¬Âpyrrolo[3,4Ã¢â‚¬Âb]pyrazinÃ¢â‚¬Â5Ã¢â‚¬Âyl]oxy}carbonyl)Ã¢â‚¬Â1Ã¢â‚¬ÂmethylpiperazinÃ¢â‚¬Â1Ã¢â‚¬ÂiumÃ¢â‚¬Â1Ã¢â‚¬Âolate",C[N+]1([O-])CCN(C(=O)OC2C3=NC=CN=C3C(=O)N2C2=CC=C(Cl)C=N2)CC1,,CYP3A4,0.98,N_HYDROXYLATION_OF_ALICYCLIC_TERTIARY_AMINE
4-VINYLCYCLOHEXENE,C=CC1CC=CCC1,,"VCH-7,8-epoxide",C1=CCC(C2CO2)CC1,,CYP2B6; CYP2E1,0.28,ALKENE_EPXODATION
4-VINYLCYCLOHEXENE,C=CC1CC=CCC1,,"VCH-1,2-epoxide",C=CC1CCC2OC2C1,,CYP2B6; CYP2E1,0.22,ALKENE_EPXODATION
"VCH-1,2-epoxide",C1=CCC(C2CO2)CC1,,VCH-diepoxide,C1CC2OC2CC1C1CO1,,CYP2B6; CYP2E1,0.39,ALKENE_EPXODATION
"VCH-7,8-epoxide",C=CC1CCC2OC2C1,,VCH-diepoxide,C1CC2OC2CC1C1CO1,,CYP2B6; CYP2E1,0.51,ALKENE_EPXODATION
Medroxyprogesterone Acetate (M4),CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)C(O)CC4(C)C3CCC21C,,M-1,CC(=O)OC1(C(C)=O)CCC2C3CC(C)(O)C4=CC(=O)C(O)CC4(C)C3CCC21C,,CYP3A4;,0.89,Aliphatic Hydroxylation
Methoxymorpholinyldoxorubicin,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3OC3CC(N4CCOC(OC)C4)C(O)C(C)O3)C(O)=C1C2=O,,PNU-159682,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3OC3CC4C(OC5COC(OC)CN54)C(C)O3)C(O)=C1C2=O,,CYP3A,0.95,Dehydroxylation 
Perospirone,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(C2=NSC3=CC=CC=C23)CC1,,,O=C1C2=C(CCCC2)C(=O)N1CCCCN1CCN(C2=NSC3=CC=CC=C23)CC1,,CYP3A4,0.73,Dehydrogenation
Perospirone,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(C2=NSC3=CC=CC=C23)CC1,,,O=C1C2CCC(O)CC2C(=O)N1CCCCN1CCN(C2=NSC3=CC=CC=C23)CC1,,CYP1A1;CYP2C8;CYP2D6,0.93,Aliphatic Hydroxylation
Perospirone,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(C2=NSC3=CC=CC=C23)CC1,,,O=C1C2CCCCC2(O)C(=O)N1CCCCN1CCN(C2=NSC3=CC=CC=C23)CC1,,CYP1A1;CYP2C8;CYP3A4,0.82,Aliphatic Hydroxylation
Perospirone,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(C2=NSC3=CC=CC=C23)CC1,,,C1=CC=C2C(N3CCNCC3)=NSC2=C1,,CYP1A1;CYP2C8;CYP3A4,0.68,N-Dealkylatiion
Perospirone,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(C2=NSC3=CC=CC=C23)CC1,,,O=C1C2CCCCC2C(=O)N1CCCCO,,CYP1A1;CYP2C8;CYP3A4,0.39,N-Dealkylatiion
Azimilide,CN1CCN(CCCCN2C(=O)CN(N=CC3=CC=C(C4=CC=C(Cl)C=C4)O3)C2=O)CC1,,,C[N+]1([O-])CCN(CCCCN2C(=O)CN(N=CC3=CC=C(C4=CC=C(Cl)C=C4)O3)C2=O)CC1,,CYP3A4;CYP3A5,0.98,N-Oxidation
Disopyramide,CC(C)N(CCC(C(=N)O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C,,N-Desisopropyldisopyramide,CC(C)NCCC(C(=N)O)(C1=CC=CC=C1)C1=CC=CC=N1,,CYP,0.97,N-Dealkylatiion
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+](=O)[O-])=C1,,,COCCOC(=O)C1=C(C)N=C(C)C(C(=O)OC(C)C)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP3A4,0.35,Dehydrogenation
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+](=O)[O-])=C1,,,CC1=NC(C)=C(C(=O)OC(C)C)C(C2=CC=CC([N+](=O)[O-])=C2)=C1C(=O)OCCO,,CYP3A4,0.34,O-Dementhylation
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+](=O)[O-])=C1,,,CC1=C(C(=O)O)C(C2=CC=CC([N+](=O)[O-])=C2)C(C(=O)OC(C)C)=C(C)N1,,CYP3A4,0.98,O-dealkylation
nisoldipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1C1=CC=CC=C1[N+](=O)[O-],,,COC(=O)C1=C(C)N=C(C)C(C(=O)OCC(C)C)=C1C1=CC=CC=C1[N+](=O)[O-],,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.38,Dehydrogenation
nisoldipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1C1=CC=CC=C1[N+](=O)[O-],,,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(O)C(C)C)C1C1=CC=CC=C1[N+](=O)[O-],,CYP1A2;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.96,Aliphatic Hydroxylation
OXODIPINE,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC2=C1OCO2,,OXODIPINE(m1),CCOC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=CC=CC2=C1OCO2,,CYP3A,0.38,Dehydrogenation
Tasosartan,CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C4=CC=CC=C4C4=NNN=N4)C=C3)C2=N1,,enoltasosartanÃ¢â‚¬â€°,CC1=NC(C)=C2C(=N1)N(CC1=CC=C(C3=CC=CC=C3C3=NNN=N3)C=C1)C(=O)CC2O,,CYP3A4,0.92,Aromatic Hydroxylation
HEXACHLOROBENZENE,ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl,,Pentachlorophenol,OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl,,CYP3A4,0.46,Aliphatic Hydroxylation
(-)-Epigallocatechin gallate,O=C(OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1)C1=CC(O)=C(O)C(O)=C1,,"(-)-Epigallocatechin gallate, 3p-OH-glucuronide",O=C(OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1)C1=CC(O)=C(O)C(O)=C1,,UGT1A9,0.72,Aromatic -OH glucuronidation
(-)-Epigallocatechin gallate,O=C(OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1)C1=CC(O)=C(O)C(O)=C1,,"(-)-Epigallocatechin gallate, 4p-OH-glucuronide",O=C(OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1)C1=CC(O)=C(O)C(O)=C1,,UGT1A9,0.73,Aromatic -OH glucuronidation
(-)-Epigallocatechin,OC1=CC(O)=C2CC(O)C(C3=CC(O)=C(O)C(O)=C3)OC2=C1,,"(-)-Epigallocatechin, 3p-OH-glucuronide",O=C(O)C1OC(OC2=CC(C3OC4=CC(O)=CC(O)=C4CC3O)=CC(O)=C2O)C(O)C(O)C1O,,UGT1A9,0.63,Aromatic -OH glucuronidation
2-Hydroxychalcone,O=C(C=CC1=CC=CC=C1O)C1=CC=CC=C1,,"2-Hydroxychalcone, 2-OH glucuronide",O=C(C=CC1=CC=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC=C1,,UGT1A9,0.33,Aromatic -OH glucuronidation
4-Hydroxychalcone,O=C(C=CC1=CC=C(O)C=C1)C1=CC=CC=C1,,"4-Hydroxychalcone, 4-OH-glucuronide",O=C(C=CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1=CC=CC=C1,,UGT1A9,0.32,Aromatic -OH glucuronidation
2p-Hydroxychalcone,O=C(C=CC1=CC=CC=C1)C1=CC=CC=C1O,,"2p-Hydroxychalcone, 2p-OH-glucuronide",O=C(C=CC1=CC=CC=C1)C1=CC=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.35,Aromatic -OH glucuronidation
4p-Hydroxychalcone,O=C(C=CC1=CC=CC=C1)C1=CC=C(O)C=C1,,"4p-Hydroxychalcone, 4p-OH-glucuronide",O=C(C=CC1=CC=CC=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.32,Aromatic -OH glucuronidation
Phloretin,O=C(CCC1=CC=C(O)C=C1)C1=C(O)C=C(O)C=C1O,,"Phloretin, 2p-OH-glucuronide",O=CC1OC(OC2=CC(O)=CC(O)=C2C(=O)CCC2=CC=C(O)C=C2)C(O)C(O)C1O,,UGT1A9,0.38,Aromatic -OH glucuronidation
Phloretin,O=C(CCC1=CC=C(O)C=C1)C1=C(O)C=C(O)C=C1O,,"Phloretin, 4p-OH-glucuronide",O=C(CCC1=CC=C(O)C=C1)C1=C(O)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1O,,UGT1A9,0.39,Aromatic -OH glucuronidation
7-Hydroxychromone,O=C1C=COC2=CC(O)=CC=C12,,"7-Hydroxychromone, 7-OH-glucuronide",O=C(O)C1OC(OC2=CC=C3C(=O)C=COC3=C2)C(O)C(O)C1O,,UGT1A9,0.38,Aromatic -OH glucuronidation
4-Methylumbelliferone,CC1=CC(=O)OC2=CC(O)=CC=C12,,4-Methylumbelliferone O-glucuronide,CC1=CC(=O)OC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C12,,UGT1A9,0.46,Aromatic -OH glucuronidation
4-Hydroxy-6-methylcoumarin,CC1=CC=C2OC(=O)C=C(O)C2=C1,,"6-methylcoumarin, 4-O-glucuronide",CC1=CC=C2OC(=O)C=C(OC3OC(C(=O)O)C(O)C(O)C3O)C2=C1,,UGT1A9,0.44,Aromatic -OH glucuronidation
6-Hydroxy-7-methoxyl-4-phenylcoumarin,COC1=CC2=C(C=C1O)C(C1=CC=CC=C1)=CC(=O)O2,,"7-methoxyl-4-phenylcoumarin, 6-O-glucuronide",COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)C(C1=CC=CC=C1)=CC(=O)O2,,UGT1A9,0.6,Aromatic -OH glucuronidation
8-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=CC(O)=C2OC1=O,,Warfarin 8-O-glucuronide,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C2OC1=O,,UGT1A9,0.74,Aromatic -OH glucuronidation
7-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=C(O)C=C2OC1=O,,Warfarin 7-O-glucuronide,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2OC1=O,,UGT1A9,0.73,Aromatic -OH glucuronidation
6-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC(O)=CC=C2OC1=O,,Warfarin 6-O-glucuronide,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C2OC1=O,,UGT1A9,0.75,Aromatic -OH glucuronidation
Scopoletin,COC1=CC2=C(C=C1O)OC(=O)C=C2,,Scopoletin OH-glucuronide,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)OC(=O)C=C2,,UGT1A9,0.44,Aromatic -OH glucuronidation
Curcumin,COC1=CC(C=CC(=O)CC(=O)C=CC2=CC=C(O)C(OC)=C2)=CC=C1O,,Curcumin 4-O-glucuronide,COC1=CC(C=CC(=O)CC(=O)C=CC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(OC)=C2)=CC=C1O,,UGT1A9,0.38,Aromatic -OH glucuronidation
Demethoxycurcumin,COC1=CC(C=CC(=O)CC(=O)C=CC2=CC=C(O)C=C2)=CC=C1O,,Demethoxycurcumin O-glucuronide,COC1=CC(C=CC(=O)CC(=O)C=CC2=CC=C(O)C=C2)=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.38,Aromatic -OH glucuronidation
Bisdemethoxycurcumin,O=C(C=CC1=CC=C(O)C=C1)CC(=O)C=CC1=CC=C(O)C=C1,,"Bisdemethoxycurcumin, 4-O-glucuronide",O=C(C=CC1=CC=C(O)C=C1)CC(=O)C=CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.29,Aromatic -OH glucuronidation
Emodin,CC1=CC(O)=C2C(=O)C3=C(O)C=C(O)C=C3C(=O)C2=C1,,Emodin 3-OH-glucuronide,CC1=CC(O)=C2C(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3C(=O)C2=C1,,UGT1A9,0.55,Aromatic -OH glucuronidation
Endoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,,Endoxifen O-glucuronide,CCC(=C(C1=CC=C(OCCNC)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1=CC=CC=C1,,UGT1A9,0.51,Aromatic -OH glucuronidation
Endoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,,Endoxifen O-sulfate,CCC(=C(C1=CC=C(OCCNC)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,,SULT,0.84,4-OH sulfonation of phenolic compound
Enterolactone,O=C1OCC(CC2=CC=CC(O)=C2)C1CC1=CC=CC(O)=C1,,Enterolactone O-glucuronide,O=C1OCC(CC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C2)C1CC1=CC=CC(O)=C1,,UGT1A9,0.46,Aromatic -OH glucuronidation
1-Naphthol,OC1=CC=CC2=CC=CC=C12,,1-Naphthyl glucuronide,O=C(O)C1OC(OC2=CC=CC3=CC=CC=C23)C(O)C(O)C1O,,UGT1A9,0.14,Aromatic -OH glucuronidation
Raloxifene,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C=C2)SC2=CC(O)=CC=C12,,Raloxifene 6-O-glucuronide,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C=C2)SC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C12,,UGT1A9,0.78,Aromatic -OH glucuronidation
Tyrphostin B42,N#CC(=CC1=CC=C(O)C(O)=C1)C(O)=NCC1=CC=CC=C1,,"Tyrphostin B42, 3-O-glucuronide",N#CC(=CC1=CC=C(O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1)C(O)=NCC1=CC=CC=C1,,UGT1A9,0.45,Aromatic -OH glucuronidation
Tyrphostin B42,N#CC(=CC1=CC=C(O)C(O)=C1)C(O)=NCC1=CC=CC=C1,,"Tyrphostin B42, 4-O-glucuronide",N#CC(=CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1)C(O)=NCC1=CC=CC=C1,,UGT1A9,0.46,Aromatic -OH glucuronidation
7-Hydroxyflavanone,O=C1CC(C2=CC=CC=C2)OC2=CC(O)=CC=C12,,Flavanone 7-O-glucuronide,O=C1CC(C2=CC=CC=C2)OC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C12,,UGT1A9,0.63,Aromatic -OH glucuronidation
4p-Hydroxy-3-methoxyflavanone,COC1C(=O)C2=CC=CC=C2OC1C1=CC=C(O)C=C1,,3-methoxyflavanone 4p-O-glucuronide,COC1C(=O)C2=CC=CC=C2OC1C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.74,Aromatic -OH glucuronidation
Hesperetin,COC1=CC=C(C2CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,Hesperetin 7-O-glucuronide,COC1=CC=C(C2CC(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1O,,UGT1A9,0.68,Aromatic -OH glucuronidation
Hesperetin,COC1=CC=C(C2CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,Hesperetin 3p-O-glucuronide,COC1=CC=C(C2CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.65,Aromatic -OH glucuronidation
Narigenin,O=C1CC(C2=CC=C(O)C=C2)OC2=CC(O)=CC(O)=C12,,Narigenin 7-O-glucuronide,O=C1CC(C2=CC=C(O)C=C2)OC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC(O)=C12,,UGT1A9,0.64,Aromatic -OH glucuronidation
2p-Hydroxyflavone,O=C1C=C(C2=CC=CC=C2O)OC2=CC=CC=C12,,Flavone 2p-O-glucuronide,O=C(O)C1OC(OC2=CC=CC=C2C2=CC(=O)C3=CC=CC=C3O2)C(O)C(O)C1O,,UGT1A9,0.54,Aromatic -OH glucuronidation
"3,4p-Dimethoxy-5,7,3p-trihydroxyflavone",COC1=CC=C(C2=C(OC)C(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,"3,4p-Dimethoxy-5,3p-dihydroxyflavone, 7-O-glucuronide",COC1=CC=C(C2=C(OC)C(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1O,,UGT1A9,0.74,Aromatic -OH glucuronidation
"3p-Benzyloxy-5,7-dihydroxy-3,4p-dimethoxyflavone",COC1=CC=C(C2=C(OC)C(=O)C3=C(O)C=C(O)C=C3O2)C=C1OCC1=CC=CC=C1,,"3p-Benzyloxy-5-hydroxy-3,4p-dimethoxyflavone, 7-O-glucuronide",COC1=CC=C(C2=C(OC)C(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1OCC1=CC=CC=C1,,UGT1A9,0.77,Aromatic -OH glucuronidation
3p-Hydroxyflavone,O=C1C=C(C2=CC=CC(O)=C2)OC2=CC=CC=C12,,Flavone 3p-O-glucuronide,O=C(O)C1OC(OC2=CC=CC(C3=CC(=O)C4=CC=CC=C4O3)=C2)C(O)C(O)C1O,,UGT1A9,0.54,Aromatic -OH glucuronidation
4p-Hydroxyflavone,O=C1C=C(C2=CC=C(O)C=C2)OC2=CC=CC=C12,,Flavone 4p-O-glucuronide,O=C(O)C1OC(OC2=CC=C(C3=CC(=O)C4=CC=CC=C4O3)C=C2)C(O)C(O)C1O,,UGT1A9,0.53,Aromatic -OH glucuronidation
"5,7-Dihydroxy-3p,4p,5p-trimethoxyflavone",COC1=CC(C2=CC(=O)C3=C(O)C=C(O)C=C3O2)=CC(OC)=C1OC,,"5-Hydroxy-3p,4p,5p-trimethoxyflavone, 7-O-glucuronide",COC1=CC(C2=CC(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)=CC(OC)=C1OC,,UGT1A9,0.67,Aromatic -OH glucuronidation
"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",CN1C(=N)NC2=NC=C(C3=CC=CC=C3)C=C21,,"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, N2-glucuronide",CN1C(NC2OC(C(=O)O)C(O)C(O)C2O)=NC2=NC=C(C3=CC=CC=C3)C=C21,,UGT1A1; UGT1A3; UGT1A4),0.46,Glucuronidation of primary aromatic amine
N2-OH-PhIP,CN1C(NO)=NC2=NC=C(C3=CC=CC=C3)C=C21,,N2-OH-PhIP-N3-glucuronide,C[N+]1=C(NO)N(C2OC(C(=O)O)C(O)C(O)C2O)C2=NC=C(C3=CC=CC=C3)C=C21,,UGT,0.5,N-Glucuronidation
N2-OH-PhIP,CN1C(NO)=NC2=NC=C(C3=CC=CC=C3)C=C21,,N2-OH-PhIP-N2-glucuronide,CN1C(NOC2OC(C(=O)O)C(O)C(O)C2O)=NC2=NC=C(C3=CC=CC=C3)C=C21,,UGT,0.65,Hydroxylamine O-glucuronidation
4'-OH-PhIP,CN1C(=N)NC2=NC=C(C3=CC=C(O)C=C3)C=C21,,PhIP 4'-O-glucuronide,CN1C(=N)NC2=NC=C(C3=CC=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3)C=C21,,UGT,0.63,Aromatic -OH glucuronidation
2-hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,Estradiol 2-O-glucuronide,CC12CCC3C4=CC(OC5OC(C(=O)O)C(O)C(O)C5O)=C(O)C=C4CCC3C1CCC2O,,UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A10,0.54,Aromatic -OH glucuronidation
2-hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,2-O-methoxyestradiol,COC1=CC2=C(C=C1O)CCC1C2CCC2(C)C(O)CCC12,,S-COMT,0.92,O-methylation
2-hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,3-O-methoxyestradiol,COC1=CC2=C(C=C1O)C1CCC3(C)C(O)CCC3C1CC2,,S-COMT,0.92,O-methylation
2-hydroxyestrone,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2=O,,2-O-methoxyestrone,COC1=CC2=C(C=C1O)CCC1C2CCC2(C)C(=O)CCC12,,S-COMT,0.92,O-methylation
2-hydroxyestrone,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2=O,,3-O-methoxyestrone,COC1=CC2=C(C=C1O)C1CCC3(C)C(=O)CCC3C1CC2,,S-COMT,0.92,O-methylation
2-hydroxyestrone,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2=O,,Estrone 2-O-glucuronide,CC12CCC3C4=CC(OC5OC(C(=O)O)C(O)C(O)C5O)=C(O)C=C4CCC3C1CCC2=O,,UGT1A1; UGT1A7; UGT1A8; UGT1A10,0.54,Aromatic -OH glucuronidation
17-beta-estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,17-beta-Estradiol glucuronide,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A10,0.61,17-OH glucuronidation of sterol
4-hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,Tamoxifen 4-O-glucuronide,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1=CC=CC=C1,,UGT1A1; UGT1A4; UGT1A6; UGT1A7; UGT1A8; UGT1A9; UGT1A10; UGT2B15; UGT2B17; UGT2B7,0.51,Aromatic -OH glucuronidation
tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,Tamoxifen N-glucuronide,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)C2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1=CC=CC=C1,,UGT1A4,0.48,N-glucuronidation of tertiary aliphatic amine
NÃ¢â‚¬â„¢-nitrosoanabasine,O=NN1CCCCC1C1=CC=CN=C1,,"NÃ¢â‚¬â„¢-nitrosoanabasine, N-glucuronide",O=NN1CCCCC1C1=CC=C[N+](C2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT2B10,0.47,N-Glucuronidation
Np-nitrosonornicotine,O=NN1CCCC1C1=CC=CN=C1,,"Np-nitrosonornicotine, N-glucuronide",O=NN1CCCC1C1=CC=C[N+](C2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT2B10,0.45,N-Glucuronidation
Nicotine,CN1CCCC1C1=CC=CN=C1,,Nicotine N-glucuronide,CN1CCCC1C1=CC=C[N+](C2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT1A4; UGT1A9,0.38,N-Glucuronidation
3-Phenoxybenozoic acid,O=C(O)C1=CC=CC(OC2=CC=CC=C2)=C1,,3-Phenoxybenzoic acid glucuronide,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC(OC2=CC=CC=C2)=C1,,UGT,0.31,O-glucuronidation of aromatic acid
3-Phenoxybenozoic acid,O=C(O)C1=CC=CC(OC2=CC=CC=C2)=C1,,3-Phenoxybenzoylglycine,O=C(O)CN=C(O)C1=CC=CC(OC2=CC=CC=C2)=C1,,GLYAT (EC 2.3.1.13),0.49,Glycination of aromatic acid
Dopamine,NCCC1=CC=C(O)C(O)=C1,,dopamine 3-O-sulfate,NCCC1=CC=C(O)C(OS(=O)(=O)O)=C1,,SULT,0.5,3-OH sulfonation of phenolic compound
Dopamine,NCCC1=CC=C(O)C(O)=C1,,Dopamine 4- D-Glucuronide,NCCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1,,UGT,0.22,Aromatic -OH glucuronidation
Gavestinel,O=C(O)C1=C(C=CC(O)=NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,,gavestinel 4-O-acyl glucuronide,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=C(C=CC(O)=NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,,UGT,0.73,O-glucuronidation of aromatic acid
p-OH-gavestinel,O=C(C=CC1=C(C(=O)O)NC2=CC(Cl)=CC(Cl)=C12)NC1=CC=C(O)C=C1,,gavestinel 4-sulfate,O=C(C=CC1=C(C(=O)O)NC2=CC(Cl)=CC(Cl)=C12)NC1=CC=C(OS(=O)(=O)O)C=C1,,SULT,0.95,4-OH sulfonation of phenolic compound
3-hydroxyguanfacine,N=C(N)N=C(O)CC1=C(Cl)C(O)=CC(O)=C1Cl,,3-hydroxyguanfacine glucuronide,N=C(N)N=C(O)CC1=C(Cl)C(O)=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1Cl,,UGT,0.45,Aromatic -OH glucuronidation
3-Hydroxymorphinan,OC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,,3-OH-morphinan -glucuronide,O=C(O)C1OC(OC2=CC=C3CC4NCCC5(CCCCC45)C3=C2)C(O)C(O)C1O,,UGT,0.65,Aromatic -OH glucuronidation
3-Hydroxymorphinan,OC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,,3-Hydroxymorphinan sulfate,O=S(=O)(O)OC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,,SULT,0.87,Aromatic -OH glucuronidation
12-Hydroxynevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1O,,12-Hydroxynevirapine O-glucuronide,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.84,Alkyl-OH glucuronidation
2-Hydroxynevirapine,CC1=CC(O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,2-Hydroxynevirapine glucuronide,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,UGT,0.82,Aromatic -OH glucuronidation
thymol,CC1=CC=C(C(C)C)C(O)=C1,,thymol O-glucuronide,CC1=CC=C(C(C)C)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.23,Aromatic -OH glucuronidation
thymol,CC1=CC=C(C(C)C)C(O)=C1,,thymol sulfate,CC1=CC=C(C(C)C)C(OS(=O)(=O)O)=C1,,SULT,0.49,3-OH sulfonation of phenolic compound
Catechol,OC1=CC=CC=C1O,,catechol sulfate,O=S(=O)(O)OC1=CC=CC=C1O,,SULT,0.27,O-sulfonation
Catechol,OC1=CC=CC=C1O,,,O=C(O)C1OC(OC2=CC=CC=C2O)C(O)C(O)C1O,,UGT,0.08,Aromatic -OH glucuronidation
3-OH-7-ethoxycourmarin,CCOC1=CC2=C(C=CC(=O)O2)C=C1O,,3-OH-7-ethoxycourmarin O-glucuronide,CCOC1=CC2=C(C=CC(=O)O2)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.48,Aromatic -OH glucuronidation
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,Aminoflavone N-glucuronide (MX),CC1=C(F)C(NC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,UGT,0.72,Glucuronidation of primary aromatic amine
Aminoflavone MIII,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,Aminoflavone MIII O-glucuronide,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(NOC4OC(C(=O)O)C(O)C(O)C4O)C(F)=C3)OC2=C1F,,UGT,0.78,Glucuronidation of primary aromatic amine
Aminoflavone M-IV,CC1=C(F)C(N)=C2C(=O)C(O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,Aminoflavone M-IV O-sulfate,CC1=C(F)C(N)=C2C(=O)C(OS(=O)(=O)O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,SULT,0.89,O-sulfonation
8-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(O)=C1N2C,,ondansetron 8-O-glucuronide,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C1N2C,,UGT,0.81,Aromatic -OH glucuronidation
8-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(O)=C1N2C,,ondansetron 8-O-sulfate,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(OS(=O)(=O)O)=C1N2C,,SULT,0.93,O-sulfonation
7-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(O)C=C1N2C,,ondansetron 7-O-glucuronide,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C1N2C,,UGT,0.81,Aromatic -OH glucuronidation
7-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(O)C=C1N2C,,ondansetron 7-O-sulfate,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(OS(=O)(=O)O)C=C1N2C,,SULT,0.95,O-sulfonation
6-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(O)=CC=C1N2C,,ondansetron 6-O-glucuronide,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C1N2C,,UGT,0.82,Aromatic -OH glucuronidation
6-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(O)=CC=C1N2C,,ondansetron 6-O-sulfate,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(OS(=O)(=O)O)=CC=C1N2C,,SULT,0.96,O-sulfonation
linoleyl alcohol,CCCCCC=CCC=CCCCCCCCCO,,linoleyl O-glucuronide,CCCCCC=CCC=CCCCCCCCCOC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.12,Alkyl-OH glucuronidation
Bilirubin,C=CC1=C(C)C(O)=NC1=CC1=C(C)C(CCC(=O)O)=C(CC2=C(CCC(=O)O)C(C)=C(C=C3N=C(O)C(C=C)=C3C)N2)N1,,"6-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",C=CC1=C(C)C(O)=NC1=CC1=C(C)C(CCC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C(CC2=C(CCC(=O)O)C(C)=C(C=C3N=C(O)C(C=C)=C3C)N2)N1,,UGT,0.84,O-glucuronidation of aliphatic acid
Bilirubin,C=CC1=C(C)C(O)=NC1=CC1=C(C)C(CCC(=O)O)=C(CC2=C(CCC(=O)O)C(C)=C(C=C3N=C(O)C(C=C)=C3C)N2)N1,,"(2S,3S,4S,5R,6S)Ã¢â‚¬Â6Ã¢â‚¬Â{[3Ã¢â‚¬Â(2Ã¢â‚¬Â{[3Ã¢â‚¬Â(2Ã¢â‚¬Âcarboxyethyl)Ã¢â‚¬Â5Ã¢â‚¬Â{[(2Z)Ã¢â‚¬Â4Ã¢â‚¬ÂethenylÃ¢â‚¬Â3Ã¢â‚¬ÂmethylÃ¢â‚¬Â5Ã¢â‚¬ÂoxoÃ¢â‚¬Â1HÃ¢â‚¬ÂpyrrolÃ¢â‚¬Â2Ã¢â‚¬Âylidene]methyl}Ã¢â‚¬Â4Ã¢â‚¬ÂmethylÃ¢â‚¬Â1HÃ¢â‚¬ÂpyrrolÃ¢â‚¬Â2Ã¢â‚¬Âyl]methyl}Ã¢â‚¬Â5Ã¢â‚¬Â{[(2Z)Ã¢â‚¬Â3Ã¢â‚¬ÂethenylÃ¢â‚¬Â4Ã¢â‚¬ÂmethylÃ¢â‚¬Â5Ã¢â‚¬ÂoxoÃ¢â‚¬Â1HÃ¢â‚¬ÂpyrrolÃ¢â‚¬Â2Ã¢â‚¬Âylidene]methyl}Ã¢â‚¬Â4Ã¢â‚¬ÂmethylÃ¢â‚¬Â1HÃ¢â‚¬ÂpyrrolÃ¢â‚¬Â3Ã¢â‚¬Âyl)propanoyl]oxy}Ã¢â‚¬Â3,4,5Ã¢â‚¬ÂtrihydroxyoxaneÃ¢â‚¬Â2Ã¢â‚¬Âcarboxylic acid",C=CC1=C(C)C(O)=NC1=CC1=C(C)C(CCC(=O)O)=C(CC2=C(CCC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C(C)=C(C=C3N=C(O)C(C=C)=C3C)N2)N1,,UGT,0.84,O-glucuronidation of aliphatic acid
hyocholic acid,CC(CCC(=O)O)C1CCC2C3C(O)C(O)C4CC(O)CCC4(C)C3CCC12C,,hyocholic acid 24-O-glucuronide,CC(CCC(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1CCC2C3C(O)C(O)C4CC(O)CCC4(C)C3CCC12C,,UGT,0.36,Bile acid C24 acyl glucuronidation
hyocholic acid,CC(CCC(=O)O)C1CCC2C3C(O)C(O)C4CC(O)CCC4(C)C3CCC12C,,hyocholic acid 6-O-glucuronide,CC(CCC(=O)O)C1CCC2C3C(O)C(OC4OC(C(=O)O)C(O)C(O)C4O)C4CC(O)CCC4(C)C3CCC12C,,UGT,0.38,6-OH glucuronidation of sterol
Resveratrol,OC1=CC=C(C=CC2=CC(O)=CC(O)=C2)C=C1,,Resveratrol 3-O-glucuronide,O=C(O)C1OC(OC2=CC(O)=CC(C=CC3=CC=C(O)C=C3)=C2)C(O)C(O)C1O,,UGT1A9,0.24,Aromatic -OH glucuronidation
Entacapone,CCN(CC)C(=O)C(C#N)=CC1=CC(O)=C(O)C([N+](=O)[O-])=C1,,,CCN(CC)C(=O)C(C#N)=CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C(O)C([N+](=O)[O-])=C1,,UGT1A9,0.59,Aromatic -OH glucuronidation
Ezetimibe,O=C1C(CCC(O)C2=CC=C(F)C=C2)C(C2=CC=C(O)C=C2)N1C1=CC=C(F)C=C1,,,O=C(O)C1OC(OC2=CC=C(C3C(CCC(O)C4=CC=C(F)C=C4)C(=O)N3C3=CC=C(F)C=C3)C=C2)C(O)C(O)C1O,,UGT1A9,0.75,Aromatic -OH glucuronidation
Mycophenolic Acid,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1CC=C(C)CCC(=O)O,,,COC1=C(C)C2=C(C(=O)OC2)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1CC=C(C)CCC(=O)O,,UGT1A9,0.65,Aromatic -OH glucuronidation
1-(1-pyrenyl)ethanol,CC(O)C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,,CC(OS(=O)(=O)O)C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,SULT1A1; SULT1E1,0.62,Sulfation of secondary alcohol
1-hydroxymethylpyrene,OCC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,,O=S(=O)(O)OCC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,"SULT1A1; SULT1B1, SULT2A1",0.64,Sulfation of primary alcohol
1-methoxy-3-indolylmethyl-alcohol,CON1C=C(CO)C2=CC=CC=C21,,,CON1C=C(COS(=O)(=O)O)C2=CC=CC=C21,,SULT1A1,0.81,Sulfation of primary alcohol
"2,4-dinitrobenzylalcohol",O=[N+]([O-])C1=CC=C(CO)C([N+](=O)[O-])=C1,,,O=[N+]([O-])C1=CC=C(COS(=O)(=O)O)C([N+](=O)[O-])=C1,,SULT1A1,0.78,Sulfation of primary alcohol
2-aminobenzylalcohol,NC1=CC=CC=C1CO,,,NC1=CC=CC=C1COS(=O)(=O)O,,SULT1A1,0.55,Sulfation of primary alcohol
"2-hydroxylamino-3-methyl-9H-pyrido[2,3-b]indole",CC1=CC2=C(N=C1NO)NC1=CC=CC=C12,,,CC1=CC2=C(N=C1NOS(=O)(=O)O)NC1=CC=CC=C12,,SULT1A1,0.85,Hydroxylamine O-sulfonation
2-hydroxylamino-5-phenylpyridine,ONC1=CC=C(C2=CC=CC=C2)C=N1,,,O=S(=O)(O)ONC1=CC=C(C2=CC=CC=C2)C=N1,,SULT1A1,0.73,Hydroxylamine O-sulfonation
5-hydroxymethylfurfural,O=CC1=CC=C(CO)O1,,,O=CC1=CC=C(COS(=O)(=O)O)O1,,SULT1A1,0.57,Sulfation of primary alcohol
"7-hydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene",OC1CCCC2=C1C=C1C=CC3=CC=CC4=CC=C2C1=C34,,,O=S(=O)(O)OC1CCCC2=C1C=C1C=CC3=CC=CC4=CC=C2C1=C34,,SULT1A1,0.68,Sulfation of secondary alcohol
N-acetyl-N-hydroxy-3-aminobenzanthrone,CC(=O)N(O)C1C=CC2=C3C(=CC=CC31)C(=O)C1=CC=CC=C21,,,CC(=O)N(OS(=O)(=O)O)C1C=CC2=C3C(=CC=CC31)C(=O)C1=CC=CC=C21,,SULT1A1,0.94,O-sulfonation
N-acetyl-N-hydroxy-3-aminobenzanthrone,CC(=O)N(O)C1C=CC2=C3C(=CC=CC31)C(=O)C1=CC=CC=C21,,,CC(=O)ON(C(C)=O)C1C=CC2=C3C(=CC=CC31)C(=O)C1=CC=CC=C21,,NAT1; NAT2,0.95,O-acetylation
6-hydroxymethylanthanthrene,OCC1=C2C=CC=C3C=CC4=CC5=CC=CC6=CC=C1C(=C65)C4=C32,,,O=S(=O)(O)OCC1=C2C=CC=C3C=CC4=CC5=CC=CC6=CC=C1C(=C65)C4=C32,,SULT1C3,0.64,Sulfation of primary alcohol
N-hydroxy-aminophenylnorharman,ONC1=CC=C(N2C3=CC=CC=C3C3=CC=NC=C32)C=C1,,,CC(=O)ONC1=CC=C(N2C3=CC=CC=C3C3=CC=NC=C32)C=C1,,NAT1; NAT2,0.92,O-acetylation of N-hydroxylarylamine
N-hydroxy-aminophenylharman,CC1=NC=CC2=C1N(C1=CC=C(NO)C=C1)C1=CC=CC=C21,,,CC(=O)ONC1=CC=C(N2C3=CC=CC=C3C3=CC=NC(C)=C32)C=C1,,NAT1; NAT2,0.94,O-acetylation of N-hydroxylarylamine
N-hydroxy-benzidine,NC1=CC=C(C2=CC=C(NO)C=C2)C=C1,,N-hydroxy-benzidine O-acetyl,CC(=O)ONC1=CC=C(C2=CC=C(N)C=C2)C=C1,,NAT1,0.69,O-acetylation of N-hydroxylarylamine
N-hydroxy-2-aminofluorene,ONC1=CC=C2C(=C1)CC1=CC=CC=C12,,"N-hydroxy-2-aminofluorene, O-acetyl",CC(=O)ONC1=CC=C2C(=C1)CC1=CC=CC=C12,,NAT1,0.87,O-acetylation of N-hydroxylarylamine
"N-[4-(2,4-dichlorophenoxy)phenyl]hydroxylamine",ONC1=CC=C(OC2=CC=C(Cl)C=C2Cl)C=C1,,"N-[4-(2,4-dichlorophenoxy)phenyl]hydroxylamine O-acetyl",CC(=O)ONC1=CC=C(OC2=CC=C(Cl)C=C2Cl)C=C1,,NAT1,0.82,O-acetylation of N-hydroxylarylamine
N‐(2‐methoxyphenyl)hydroxylamine,COC1=CC=CC=C1NO,,"NÃ¢â‚¬Â(2Ã¢â‚¬Âmethoxyphenyl)hydroxylamine, O-acetyl",COC1=CC=CC=C1NOC(C)=O,,NAT1,0.65,O-acetylation of N-hydroxylarylamine
isoniazid,NNC(=O)C1=CC=NC=C1,,isoniazid N-acetyl,CC(O)=NNC(=O)C1=CC=NC=C1,,NAT2,0.67,N-acetylation of Hydrazine derivative
hydralazine,NN=C1NN=CC2=CC=CC=C12,,hydralazine N-acetyl,CC(O)=NNC1=NN=CC2=CC=CC=C12,,NAT,0.29,N-acetylation of Hydrazine derivative
mesalazine,NC1=CC=C(O)C(C(=O)O)=C1,,"mesalazine, N-acetyl",CC(O)=NC1=CC=C(O)C(C(=O)O)=C1,,NAT,0.71,N-acetylation of arylamine
Sulfapyridine,NC1=CC=C(S(=O)(=O)NC2=CC=CC=N2)C=C1,,"Sulfapyridine, N-acetyl",CC(O)=NC1=CC=C(S(=O)(=O)NC2=CC=CC=N2)C=C1,,NAT,0.85,N-acetylation of arylamine
4-aminobenzoate,NC1=CC=C(C(=O)[O-])C=C1,,4-acetylaminobenzoate,CC([O-])=NC1=CC=C(C(=O)O)C=C1,,NAT,0.63,N-acetylation of arylamine
4-amino-3-methylbenzoic acid,CC1=CC(C(=O)O)=CC=C1N,,,CC(O)=NC1=CC=C(C(=O)O)C=C1C,,NAT1; NAT2,0.65,N-acetylation of arylamine
"2,3-dimethylaniline",CC1=CC=CC(N)=C1C,," 2,3Ã¢â‚¬Âdimethylacetanilide",CC(O)=NC1=CC=CC(C)=C1C,,NAT1; NAT2,0.47,N-acetylation of arylamine
"2,4-dimethylaniline",CC1=CC=C(N)C(C)=C1,," 2,4Ã¢â‚¬Âdimethylacetanilide",CC(O)=NC1=CC=C(C)C=C1C,,NAT1; NAT2,0.48,N-acetylation of arylamine
"2,5-dimethylaniline",CC1=CC=C(C)C(N)=C1,," 2,5Ã¢â‚¬Âdimethylacetanilide",CC(O)=NC1=CC(C)=CC=C1C,,NAT1; NAT2,0.46,N-acetylation of arylamine
2-(4-aminobenzamido)pyridine,NC1=CC=C(C(=O)NC2=CC=CC=N2)C=C1,,4Ã¢â‚¬ÂacetamidoÃ¢â‚¬ÂNÃ¢â‚¬Â(pyridinÃ¢â‚¬Â2Ã¢â‚¬Âyl)benzamide,CC(O)=NC1=CC=C(C(=O)NC2=CC=CC=N2)C=C1,,GST,0.84,N-acetylation of arylamine
(+)-2-bromo-3-(4-nitrophenyl)propanoic acid,O=C(O)C(Br)CC1=CC=C([N+](=O)[O-])C=C1,,2-(glutathion-S-yl)-3-(4-nitrophenyl)propanoic acid,NC(CCC(O)=NC(CSC(CC1=CC=C([N+](=O)[O-])C=C1)C(=O)O)C(O)=NCC(=O)O)C(=O)O,,GST,0.33,GSH-conjugation of organohalide
"1,3,5-trinitrobenzene",O=[N+]([O-])C1=CC([N+](=O)[O-])=CC([N+](=O)[O-])=C1,,"S-(2,4,6-trinitrocyclohexa-2,5-dien-1-yl)glutathione",NC(CCC(O)=NC(CSC1C([N+](=O)[O-])=CC([N+](=O)[O-])C=C1[N+](=O)[O-])C(O)=NCC(=O)O)C(=O)O,,GSTA1,0.07,GSH-conjugation of benzene substituted with an electron donating group
"1-chloro-2,3-dinitrobenzene",O=[N+]([O-])C1=CC=CC(Cl)=C1[N+](=O)[O-],,"S-(2,3-dinitrophenyl)glutathione",NC(CCC(O)=NC(CSC1=CC=CC([N+](=O)[O-])=C1[N+](=O)[O-])C(O)=NCC(=O)O)C(=O)O,,GST,0.26,GSH-conjugation
"1-chloro-2,4-dinitrobenzene",O=[N+]([O-])C1=CC=C(Cl)C([N+](=O)[O-])=C1,,"S-(2,4-dinitrophenyl)glutathione",NC(CCC(O)=NC(CSC1=CC=C([N+](=O)[O-])C=C1[N+](=O)[O-])C(O)=NCC(=O)O)C(=O)O,,GST,0.24,GSH-conjugation
"1-Chloro-2,4-dinitrobenzene",O=[N+]([O-])C1=CC=C(Cl)C([N+](=O)[O-])=C1,,,NC(CCC(O)=NC(CSC1(Cl)C=CC([N+](=O)[O-])C=C1[N+](=O)[O-])C(O)=NCC(=O)O)C(=O)O,,GST,0.12,GSH-conjugation
Brodifacoum,O=C1OC2=CC=CC=C2C(O)=C1C1CC(C2=CC=C(C3=CC=C(Br)C=C3)C=C2)CC2=CC=CC=C21,,Brodifacoum O-glucuronide,O=C(O)C1OC(OC2=C(C3CC(C4=CC=C(C5=CC=C(Br)C=C5)C=C4)CC4=CC=CC=C43)C(=O)OC3=CC=CC=C23)C(O)C(O)C1O,,UGT,0.77,Aromatic -OH glucuronidation
Nornalmefene,C=C1CCC2(O)C3CC4=CC=C(O)C5=C4C2(CCN3)C1O5,,Nornalmefene O-glucuronide,C=C1CCC2(O)C3CC4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C5=C4C2(CCN3)C1O5,,UGT,0.9,Aromatic -OH glucuronidation
Prechrysophanol,CC1=CC(O)=C2C(O)=C3CC(O)CCC3=CC2=C1,,Prechrysophanol O-glucuronide,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C2C(O)=C3CC(O)CCC3=CC2=C1,,UGT,0.51,Aromatic -OH glucuronidation
Lumiracoxib,CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)O)=C1,,Lumiracoxib O-glucuronide,CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.57,O-glucuronidation of aliphatic acid
4-Hydroxy-alpha-thujone,CC(C)C12CC(=O)C(C)(O)C1C2,,"alpha-thujone, 4-O-glucuronide",CC(C)C12CC1C(C)(O)C(=O)C2OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.43,Alkyl-OH glucuronidation
Scutellarein,O=C1C=C(C2=CC=C(O)C=C2)OC2=CC(O)=C(O)C(O)=C12,,Scutellarein 7-O-glucuronide,O=C(O)C1OC(OC2=CC3=C(C(O)=C2O)C(=O)C=C(C2=CC=C(O)C=C2)O3)C(O)C(O)C1O,,UGT,0.61,Alkyl-OH glucuronidation
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,,Desogestrel 17-O-glucuronide,C#CC1(OC2OC(C(=O)O)C(O)C(O)C2O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,,UGT,0.49,O-glucuronidation
3-Iodobenzoic acid,O=C(O)C1=CC=CC(I)=C1,,3-Iodobenzoyl glyucuronide,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC(I)=C1,,UGT,0.23,O-glucuronidation of aromatic acid
4-Iodobenzoic acid,O=C(O)C1=CC=C(I)C=C1,,4-Iodobenzoyl glyucuronide,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C(I)C=C1,,UGT,0.2,O-glucuronidation of aromatic acid
Oxoprenolol,C=CCOC1=CC=CC=C1OCC(O)CNC(C)C,,Oxprenolol glucuronide,C=CCOC1=CC=CC=C1OCC(CNC(C)C)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.37,Alkyl-OH glucuronidation
Zomepirac,CC1=C(C(=O)C2=CC=C(Cl)C=C2)N(C)C(CC(=O)O)=C1,,Zomepirac O-glucuronide,CC1=C(C(=O)C2=CC=C(Cl)C=C2)N(C)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.72,O-glucuronidation of aliphatic acid
Clioquinol,OC1=C(I)C=C(Cl)C2=CC=CN=C12,,Clioquinol O-glucuronide,O=C(O)C1OC(OC2=C(I)C=C(Cl)C3=CC=CN=C23)C(O)C(O)C1O,,UGT,0.48,Aromatic -OH glucuronidation
Quinotolast,O=C1C(C(O)=NC2=NNN=N2)=CC(OC2=CC=CC=C2)=C2C=CC=CN12,,Quinotolast N-glucuronide,O=C(N=C1N=NN(OC2OC(C(=O)O)C(O)C(O)C2O)N1)C1=CC(OC2=CC=CC=C2)=C2C=CC=CN2C1=O,,UGT,0.53,N-glucuronidation
RG12525,C1=CC=C(C2=NNN=N2)C(COC2=CC=C(OCC3=CC=C4C=CC=CC4=N3)C=C2)=C1,,RG12525 N2-glucuronide,O=C(O)C1OC(N2N=NC(C3=CC=CC=C3COC3=CC=C(OCC4=CC=C5C=CC=CC5=[NH+]4)C=C3)=N2)C(O)C(O)C1O,,UGT1A1; UGT2B7,0.54,N-glucuronidation of azole
JNJ-10198409,COC1=CC2=C(C=C1OC)C1=C(C2)C(=NC2=CC=CC(F)=C2)NN1,,JNJ-10198409 N-glucuronide B,COC1=CC2=C(C=C1OC)C1=C(C2)C(=NC2=CC=CC(F)=C2)NN1C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.67,N-glucuronidation of azole
JNJ-10198409,COC1=CC2=C(C=C1OC)C1=C(C2)C(=NC2=CC=CC(F)=C2)NN1,,JNJ-10198409 N-glucuronide C,COC1=CC2=C(C=C1OC)C1=C(C2)C(=[NH+]C2=CC=CC(F)=C2)N(C2OC(C(=O)O)C(O)C([OH2+])C2O)[N-]1,,UGT,0.67,N-glucuronidation of azole
JNJ-10198409,COC1=CC2=C(C=C1OC)C1=C(C2)C(=NC2=CC=CC(F)=C2)NN1,,JNJ-10198409 N-glucuronide C,COC1=CC2=C(C=C1OC)C1=C(C2)C(N(C2=CC=CC(F)=C2)C2OC(C(=O)O)C(O)C(O)C2O)=NN1,,UGT1A4; UGT1A9,0.62,N-glucuronidation of azole
Midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,Midazolam N-glucuronide,CC1=[N+](C2OC(C(=O)O)C(O)C(O)C2O)C=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,UGT1A4,0.7,N-glucuronidation of azole
Afloqualone,CC1=CC=CC=C1N1C(CF)=NC2=CC=C(N)C=C2C1=O,,Afloqualone N-glucuronide,CC1=CC=CC=C1N1C(CF)=NC2=CC=C(NC3OC(C(=O)O)C(O)C(O)C3O)C=C2C1=O,,UGT1A4,0.73,Glucuronidation of primary aromatic amine
N-Acetylbenzidine,CC(O)=NC1=CC=C(C2=CC=C(N)C=C2)C=C1,,"N-Acetylbenzidine, N-glucuronide",CC(O)=NC1=CC=C(C2=CC=C(NC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,,UGT1A1; UGT1A4; UGT1A9,0.25,Glucuronidation of primary aromatic amine
retigabine,CCOC(O)=NC1=CC=C(NCC2=CC=C(F)C=C2)C=C1N,,retigabine N2-glucuronide,CCOC(O)=NC1=CC=C(NCC2=CC=C(F)C=C2)C=C1NC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A1; UGT1A9,0.41,Glucuronidation of primary aromatic amine
Desmethylclozapine,ClC1=CC=C2NC3=CC=CC=C3C(N3CCNCC3)=NC2=C1,,Desmethylclozapine N-glucuronide,O=C(O)C1OC(N2CCN(C3=NC4=CC(Cl)=CC=C4NC4=CC=CC=C34)CC2)C(O)C(O)C1O,,UGT1A3,0.68,N-glucuronidation
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C21,,Desipramine N-glucuronide,CN(CCCN1C2=CC=CC=C2CCC2=CC=CC=C21)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.51,N-glucuronidation
Promethazine,CC(CN1C2=CC=CC=C2SC2=CC=CC=C21)N(C)C,,Promethazine N-glucuronide,CC(CN1C2=CC=CC=C2SC2=CC=CC=C21)[N+](C)(C)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.52,N-glucuronidation of tertiary aliphatic amine
Loxepine,CN1CCN(C2=NC3=CC=CC=C3OC3=CC=C(Cl)C=C23)CC1,,Loxepine N-glucuronide,C[N+]1(C2OC(C(=O)O)C(O)C(O)C2O)CCN(C2=NC3=CC=CC=C3OC3=CC=C(Cl)C=C23)CC1,,UGT1A3,0.69,N-glucuronidation of tertiary aliphatic amine
Clozapine,CN1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,,Clozapine N-glucuronide,C[N+]1(C2OC(C(=O)O)C(O)C(O)C2O)CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,,UGT1A3,0.67,N-glucuronidation of tertiary aliphatic amine
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,,Ketotifen N-glucuronide,C[N+]1(C2OC(C(=O)O)C(O)C(O)C2O)CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,,UGT1A3,0.73,N-glucuronidation of tertiary aliphatic amine
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21,,Chlorpromazine N-glucuronide,C[N+](C)(CCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.57,N-glucuronidation of tertiary aliphatic amine
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,,Doxepin N-glucuronide,C[N+](C)(CCC=C1C2=CC=CC=C2COC2=CC=CC=C12)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.61,N-glucuronidation of tertiary aliphatic amine
Tripelennamine,CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1,,Tripelennamine N-glucuronide,C[N+](C)(CCN(CC1=CC=CC=C1)C1=CC=CC=N1)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.45,N-glucuronidation of tertiary aliphatic amine
Cyproheptadine,CN1CCC(=C2C3=CC=CC=C3C=CC3=CC=CC=C23)CC1,,Cyproheptadine N-glucuronide,C[N+]1(C2OC(C(=O)O)C(O)C(O)C2O)CCC(=C2C3=CC=CC=C3C=CC3=CC=CC=C23)CC1,,UGT1A3,0.51,N-glucuronidation of tertiary aliphatic amine
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,,Imipramine N-glucuronide,C[N+](C)(CCCN1C2=CC=CC=C2CCC2=CC=CC=C21)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.51,N-glucuronidation of tertiary aliphatic amine
Nirvanol,CCC1(C2=CC=CC=C2)N=C(O)N=C1O,,Nirvanol N-glucuronide,CCC1(C2=CC=CC=C2)N=C(O)N(C2OC(C(=O)O)C(O)C(O)C2O)C1=O,,UGT,0.38,N-glucuronidation
Isonicotinoylhydrazine,NNC(=O)C1=CC=NC=C1,,,O=C(NNC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=NC=C1,,UGT,0.21,O-glucuronidation
Ketobemidone,CCC(=O)C1(C2=CC=CC(O)=C2)CCN(C)CC1,,Ketobemidone O-glucuronide,CCC(=O)C1(C2=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C2)CCN(C)CC1,,UGT,0.49,Aromatic -OH glucuronidation
Ketobemidone,CCC(=O)C1(C2=CC=CC(O)=C2)CCN(C)CC1,,Ketobemidone sulfate,CCC(=O)C1(C2=CC=CC(OS(=O)(=O)O)=C2)CCN(C)CC1,,SULT,0.81,3-OH sulfonation of phenolic compound
chlorofluoroacetic acid,O=C(O)C(F)Cl,,chloroacetyl-S-glutathione,NC(CCC(O)=NC(CSC(Cl)C(=O)O)C(O)=NCC(=O)O)C(=O)O,,GST,0.05,GSH-conjugation of organohalide
4-nitrobenzyl chloride,O=[N+]([O-])C1=CC=C(CCl)C=C1,,S-(4-Nitrobenzyl)glutathione,NC(CCC(O)=NC(CSCC1=CC=C([N+](=O)[O-])C=C1)C(O)=NCC(=O)O)C(=O)O,,GST,0.24,GSH-conjugation of organohalide
4-nitrobenzyl chloride,O=[N+]([O-])C1=CC=C(CCl)C=C1,,4-nitrobenzyl-glutathione,NC(CCC(O)=NC(CSCC1=CC=C([N+](=O)[O-])C=C1)C(O)=NCC(=O)O)C(=O)O,,GST,0.24,GSH-conjugation
4-nitrobenzyl chloride,O=[N+]([O-])C1=CC=C(CCl)C=C1,,"S-(2,4-dinitrophenyl)glutathione",NC(CCC(O)=NC(CSC1=CC=C([N+](=O)[O-])C=C1[N+](=O)[O-])C(O)=NCC(=O)O)C(=O)O,,GST,0.16,GSH-conjugation
monochlorobimane,CC1=C(C)N2C(CCl)=C(C)C(=O)N2C1=O,,Bimane-glutathione,CC1=C(C)N2C(CSCC(N=C(O)CCC(N)C(=O)O)C(=O)CNC(=O)O)=C(C)C(=O)N2C1=O,,GST,0.56,GSH-conjugation of organohalide
aminochrome,O=C1C=C2CCNC2=CC1=O,,,NC(CCC(O)=NC(CSC1=C(O)C(O)=CC2=C1NCC2)C(O)=NCC(=O)O)C(=O)O,,GST,0.18,GSH-conjugation
Prunetin,COC1=CC(O)=C2C(=O)C(C3=CC=C(O)C=C3)=COC2=C1,,,COC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)C(C3=CC=C(O)C=C3)=COC2=C1,,UGT1A9,0.61,O-glucuronidation
Triiodothyronine,NC(CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(=O)O,,,NC(CC1=CC(I)=C(OC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(I)=C2)C(I)=C1)C(=O)O,,UGT,0.48,Aromatic -OH glucuronidation
"3-Hydroxy-2p,3p-dimethoxyflavone",COC1=CC=CC(C2=C(O)C(=O)C3=CC=CC=C3O2)=C1OC,,,COC1=CC=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=CC=C3O2)=C1OC,,UGT1A9,0.67,O-glucuronidation
Irbesartan M8,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2N=N[N+](C3C(O)C(O)C(O)C(C(=O)O)C3O)=N2)C=C1,,UGT,0.63,O-glucuronidation
Resokaempferol,O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C(C3=C(O)C(=O)C4=CC=C(O)C=C4O3)C=C2)C(O)C(O)C1O,,UGT1A9,0.64,Aromatic -OH glucuronidation
7-Hydroxy-beta-thujone,CC1C(=O)CC2(C(C)(C)O)CC12,,,CC1C(=O)CC2(C(C)(C)OC3OC(C(=O)O)C(O)C(O)C3O)CC12,,UGT,0.43,Alkyl-OH glucuronidation
4-Hydroxy-beta-thujone,CC(C)C12CC(=O)C(C)(O)C1C2,,,CC(C)C12CC(=O)C(C)(OC3OC(C(=O)O)C(O)C(O)C3O)C1C2,,UGT,0.45,Alkyl-OH glucuronidation
2-iodobenzyl bromide,BrCC1=CC=CC=C1I,,,NC(CCC(O)=NC(CSC1=CC=CC=C1CBr)C(O)=NCC(=O)O)C(=O)O,,GST,0.12,GSH-conjugation
Hexafluoroisopropanol,OC(C(F)(F)F)C(F)(F)F,,,O=C(O)C1OC(OC(C(F)(F)F)C(F)(F)F)C(O)C(O)C1O,,UGT,0.1,Alkyl-OH glucuronidation
"2,4-diene-VPA",C=CC=C(CCC)C(=O)O,,,C=CC=C(CCC)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.19,O-glucuronidation of aliphatic acid
"3,7-Dihydroxyfavone",O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C(O)=C(C4=CC=CC=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.62,Aromatic -OH glucuronidation
"3,7-Dihydroxyfavone",O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3)OC3=CC(O)=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.57,Aromatic -OH glucuronidation
Indole-3-acetic-acid,O=C(O)CC1=CNC2=CC=CC=C12,,,O=C(CC1=CNC2=CC=CC=C12)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.47,O-glucuronidation of aliphatic acid
Paeonol,COC1=CC=C(C(C)=O)C(O)=C1,,,COC1=CC=C(C(C)=O)C(OS(=O)(=O)O)=C1,,SULT,0.56,Aromatic -OH glucuronidation
8-Hydroxy-7-methoxyisoflavone,COC1=CC(O)=C2OC=C(C3=CC=CC=C3)C(=O)C2=C1,,,COC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C2OC=C(C3=CC=CC=C3)C(=O)C2=C1,,UGT1A9,0.6,O-glucuronidation
"8,14-diOH-efavirenz",OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2(O)CC2)(C(F)(F)F)O1,,,O=C(O)C1OC(OC2(C#CC3(C(F)(F)F)OC(O)=NC4=C(O)C=C(Cl)C=C43)CC2)C(O)C(O)C1O,,UGT,0.83,O-glucuronidation
"4p-hydroxy-2,3p,4-trichlorobiphenyl",OC1=CC=C(C2=CC=C(Cl)C=C2Cl)C=C1Cl,,,O=S(=O)(O)OC1=CC=C(C2=CC=C(Cl)C=C2Cl)C=C1Cl,,SULT,0.66,4-OH sulfonation of phenolic compound
Hydroxyoxid acid,CC1(C)C2CCC3(C)C(C2)C(C(=O)O)CCC13O,,,CC1(C)C2CCC3(C)C(C2)C(C(=O)O)CCC13OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.38,Alkyl-OH glucuronidation
N-Desmethyl-4-OH- atomoxetine,CC1=CC(O)=CC=C1OC(CCN)C1=CC=CC=C1,,,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1OC(CCN)C1=CC=CC=C1,,UGT,0.47,Aromatic -OH glucuronidation
cis-6-(2-acetylvinylthio)purine,CC(=O)C=CSC1=NC=NC2=C1N=CN2,,,CC([O-])=CC(SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)SC1=NC=NC2=C1N=CN2,,GST,0.4,GSH-conjugation
N-Desmethyl p-hydroxyrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCN=C3C=CC(O)=CN3)C=C2)S1,,,O=C1N=C(O)C(CC2=CC=C(OCCN=C3C=CC(OS(=O)(=O)O)=CN3)C=C2)S1,,SULT,0.85,O-sulfonation
Tizoxanide,O=[N+]([O-])C1=CN=C(N=C(O)C2=CC=CC=C2O)S1,,,O=C(O)C1OC(OC2=CC=CC=C2C(O)=NC2=NC=C([N+](=O)[O-])S2)C(O)C(O)C1O,,UGT,0.55,Aromatic -OH glucuronidation
epicatechin metabo5,O=C1CCC(CC2=CC=CC(O)=C2)O1,,,O=C1CCC(CC2=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C2)O1,,UGT,0.41,Aromatic -OH glucuronidation
carvone metabo6,C=C(C)C1CC=C(C)C(=O)C1O,,,C=C(C)C1CC=C(C)C(=O)C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.46,Alkyl-OH glucuronidation
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,,UGT,0.67,17-OH glucuronidation of sterol
"N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",CN1C(NO)=NC2=NC=C(C3=CC=CC=C3)C=C21,,,CN1C(NOC2OC(C(=O)O)C(O)C(O)C2O)=NC2=NC=C(C3=CC=CC=C3)C=C21,,"UGT1A1, 1A3, 1A6",0.65,Hydroxylamine O-glucuronidation
"N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",CN1C(NO)=NC2=NC=C(C3=CC=CC=C3)C=C21,,,CN1C(NOS(=O)(=O)O)=NC2=NC=C(C3=CC=CC=C3)C=C21,,SULT1A1,0.91,Hydroxylamine O-sulfonation
Carboxy celecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O)C=C2)C=C1,,,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,,UGT,0.74,O-glucuronidation of aromatic acid
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,,COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC=C1N2)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.6,Alkyl-OH glucuronidation
6-gingerol,CCCCCC(O)CC(=O)CCC1=CC=C(OC)C(O)=C1,,,CCCCCC(O)CC(=O)CCC1=CC=C(OC)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.38,Aromatic -OH glucuronidation
6-gingerol,CCCCCC(O)CC(=O)CCC1=CC=C(OC)C(O)=C1,,,CCCCCC(O)CC(=O)CCC1=CC=C(OC)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.38,3-OH-glucuronidation of a phenolic compound
6-gingerol,CCCCCC(O)CC(=O)CCC1=CC=C(OC)C(O)=C1,,,CCCCCC(CC(=O)CCC1=CC=C(OC)C(O)=C1)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.47,O-glucuronidation
O-Desmethylnaproxen,CC(C(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,,CC(C(=O)O)C1=CC=C2C=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=CC2=C1,,UGT,0.34,Aromatic -OH glucuronidation
O-Desmethylnaproxen,CC(C(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C2C=C(O)C=CC2=C1,,UGT,0.35,O-glucuronidation of aliphatic acid
O-Desmethylnaproxen,CC(C(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,,CC(C(=O)O)C1=CC=C2C=C(OS(=O)(=O)O)C=CC2=C1,,SULT1A1; SULT1B1; SULT1E1,0.74,O-sulfonation
O-Desmethylnaproxen,CC(C(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,,CC(C(=O)OS(=O)(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,SULT1A1; SULT1B1; SULT1E1,0.67,O-sulfonation
4-hydroxycyclopenta[def]chrysene,OC1C2=CC=CC3=CC=C4C5=CC=CC=C5C=C1C4=C23,,,O=S(=O)(O)OC1C2=CC=CC3=CC=C4C5=CC=CC=C5C=C1C4=C23,,SULT1E1,0.69,Sulfation of secondary alcohol
Rhamnetin,COC1=CC(O)=C2C(=O)C(O)=C(C3=CC=C(O)C(O)=C3)OC2=C1,,,COC1=CC(O)=C2C(=O)C(OC3OC(C(=O)O)C(O)C(O)C3O)=C(C3=CC=C(O)C(O)=C3)OC2=C1,,UGT1A9,0.66,Aromatic -OH glucuronidation
4-Fluorophenol,OC1=CC=C(F)C=C1,,,O=C(O)C1OC(OC2=CC=C(F)C=C2)C(O)C(O)C1O,,UGT1A9,0.11,Aromatic -OH glucuronidation
"7,3p-Dihydroxyflavone",O=C1C=C(C2=CC=CC(O)=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C=C(C4=CC=CC(O)=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.57,Aromatic -OH glucuronidation
Methyl-4-hydroxybenzoate,CCOC(=O)C1=CC=C(O)C=C1,,,CCOC(=O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.26,Aromatic -OH glucuronidation
13-hydroxyoctadecadienoic acid,CCCCCC(O)C=CC=CCCCCCCCC(=O)O,,,CCCCCC(C=CC=CCCCCCCCC(=O)O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.21,Alkyl-OH glucuronidation
13-hydroxyoctadecadienoic acid,CCCCCC(O)C=CC=CCCCCCCCC(=O)O,,,CCCCCC(O)C=CC=CCCCCCCCC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.21,O-glucuronidation of aliphatic acid
Dihydrodaidzein,O=C1C2=CC=C(O)C=C2OCC1C1=CC=C(O)C=C1,,,O=C1C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2OCC1C1=CC=C(O)C=C1,,UGT1A9,0.63,Aromatic -OH glucuronidation
Aminoflavone M-VI,CC1=C(F)C(NO)=C2C(=O)C(O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,,CC1=C(F)C(NO)=C2C(=O)C(OC3OC(C(=O)O)C(O)C(O)C3O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,UGT,0.79,Aromatic -OH glucuronidation
Etodolac,CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,,,CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.82,O-glucuronidation of aliphatic acid
fenchone metabo3,CC1(C)C(=O)C2(C)CC1CC2O,,,CC1(C)C(=O)C2(C)CC1CC2OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.42,Alkyl-OH glucuronidation
"3-Hydroxy-7,4p-dimethoxyflavone",COC1=CC=C(C2=C(O)C(=O)C3=CC=C(OC)C=C3O2)C=C1,,,COC1=CC=C(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=C(OC)C=C3O2)C=C1,,UGT1A9,0.61,O-glucuronidation
O-Desmethyl-2p-OH-Indomethacin phenethylamide,CC1=C(CC(O)=NCC(O)C2=CC=CC=C2)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,,CC1=C(CC(O)=NCC(OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C2)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,UGT,0.81,O-glucuronidation
5-Hydroxyflavone,O=C1C=C(C2=CC=CC=C2)OC2=CC=CC(O)=C12,,,O=C(O)C1OC(OC2=CC=CC3=C2C(=O)C=C(C2=CC=CC=C2)O3)C(O)C(O)C1O,,UGT1A9,0.55,Aromatic -OH glucuronidation
Oroxylin A,COC1=C(O)C=C2OC(C3=CC=CC=C3)=CC(=O)C2=C1O,,,COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2OC(C3=CC=CC=C3)=CC(=O)C2=C1O,,UGT1A9,0.63,Aromatic -OH glucuronidation
ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,,,C[N+]1(C2OC(C(=O)O)C(O)C(O)C2O)CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,,UGT,0.73,N-glucuronidation
7-ethyl-10-hydroxycamptothecin,CCC1=C2CN3C(=CC4=C(COC(=O)C4(O)CC)C3=O)C2=NC2=CC=C(O)C=C12,,,CCC1=C2CN3C(=CC4=C(COC(=O)C4(O)CC)C3=O)C2=NC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,,UGT1A9,0.93,Aromatic -OH glucuronidation
Fenretinide,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)NC1=CC=C(O)C=C1,,,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT,0.48,Aromatic -OH glucuronidation
Fenretinide,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)NC1=CC=C(O)C=C1,,,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT,0.48,4-OH sulfonation of phenolic compound
"3-Hydroxy-6-methyl-3p,4p-methylenedioxyflavone",CC1=CC=C2OC(C3=CC=C4OCOC4=C3)=C(O)C(=O)C2=C1,,,CC1=CC=C2OC(C3=CC=C4OCOC4=C3)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C2=C1,,UGT1A9,0.66,Aromatic -OH glucuronidation
Sinapinic acid,COC1=CC(C=CC(=O)O)=CC(OC)=C1O,,,COC1=CC(C=CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=CC(OC)=C1O,,UGT,0.4,O-glucuronidation
Licofelone M2,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C(O)=C3)=C(CC(=O)O)N2C1,,,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C(O)=C3)=C(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)N2C1,,UGT,0.8,O-glucuronidation of aliphatic acid
O-methoxycatechol,COOC1=CC=CC=C1O,,,COC1=CC=CC=C1OS(=O)(=O)O,,SULT,0.2,Aromatic -OH glucuronidation
phenethyl isothiocyanate,S=C=NCCC1=CC=CC=C1,,,NC(CCC(O)=NC(CSC([S])=NCCC1=CC=CC=C1)C(O)=NCC(=O)O)C(=O)O,,GST,0.17,GSH-conjugation
6-hydroxymethylbenzo[a]pyrene,OCC1=C2C=CC=CC2=C2C=CC3=CC=CC4=CC=C1C2=C43,,,O=S(=O)(O)OCC1=C2C=CC=CC2=C2C=CC3=CC=CC4=CC=C1C2=C43,,SULT1B1; SULT1C3,0.64,O-sulfonation
Lonidamine,O=C(O)C1=NN(CC2=CC=C(Cl)C=C2Cl)C2=CC=CC=C12,,,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=NN(CC2=CC=C(Cl)C=C2Cl)C2=CC=CC=C12,,UGT,0.67,O-glucuronidation
"2,2‐dichloro‐2‐fluoroethanol",OCC(F)(Cl)Cl,,,O=C(O)C1OC(OCC(F)(Cl)Cl)C(O)C(O)C1O,,UGT,0.06,O-glucuronidation
Geraniol,CC(C)=CCCC(C)=CCO,,,CC(C)=CCCC(C)=CCOS(=O)(=O)O,,GST,0.51,GSH-conjugation
Nateglinide,CC(C)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)O)CC1,,,CC(C)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)CC1,,UGT,0.49,O-glucuronidation
trans-isoeugenol,CC=CC1=CC=C(O)C(OC)=C1,,,CC=CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(OC)=C1,,UGT,0.29,O-glucuronidation
Clofibric acid,CC(C)(OC1=CC=C(Cl)C=C1)C(=O)O,,,CC(C)(OC1=CC=C(Cl)C=C1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.32,O-glucuronidation
N-Hydroxymexiletine,CC1=CC=CC(C)=C1OCC(C)NO,,,CC1=CC=CC(C)=C1OCC(C)NOC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.33,O-glucuronidation
4-hydroxymethyl ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(CO)=N1)C(=O)O,,,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(CO)=N1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.74,O-glucuronidation
4-Methoxyphenol,COC1=CC=C(O)C=C1,,,COC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.11,O-glucuronidation
"3,5-Dihydroxyflavone",O=C1C(O)=C(C2=CC=CC=C2)OC2=CC=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3)OC3=CC=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.6,O-glucuronidation
"2-amino-6- methyldipyrido[1,2-a:3p,2p-d]- imidazole (Glu-P-1)",CC1=CC=CN2C1=NC1=C2NC(=N)C=C1,,,CC(O)=NC1=CC=C2N=C3C(C)=CC=CN3C2=N1,,"NAT1,NAT2",0.64,N-acetylation
1-iodoethane,CCI,,ethylglutathione,CCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.01,GSH-conjugation
Dihydroferulic acid,COC1=CC(CCC(=O)O)=CC=C1O,,,COC1=CC(CCC(=O)O)=CC=C1OS(=O)(=O)O,,SULT,0.64,O-sulfonation
4-Propoxyphenol,CCCOC1=CC=C(O)C=C1,,,CCCOC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.17,Aromatic -OH glucuronidation
valproic acid,CCCC(CCC)C(=O)O,,,CCCC(CCC)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.13,O-glucuronidation of aliphatic acid
Eugenol,C=CCC1=CC=C(O)C(OC)=C1,,,C=CCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(OC)=C1,,UGT1A9,0.29,Aromatic -OH glucuronidation
3-ethylphenol,CCC1=CC=CC(O)=C1,,,CCC1=CC=CC(OS(=O)(=O)O)=C1,,SULT,0.47,3-OH sulfonation of phenolic compound
Wogonin,COC1=C(O)C=C(O)C2=C1OC(C1=CC=CC=C1)=CC2=O,,,COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C(O)C2=C1OC(C1=CC=CC=C1)=CC2=O,,UGT1A9,0.67,O-glucuronidation
"3,3p,4p-Trihydroxyflavone",O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation
fenchone metabo4,CC12CC(O)C(C1)C(C)(C)C2=O,,,CC12CC(OC3OC(C(=O)O)C(O)C(O)C3O)C(C1)C(C)(C)C2=O,,UGT,0.41,O-glucuronidation
Sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(O)=NC3=CC=C(Cl)C(C(F)(F)F)=C3)C=C2)=CC=N1,,,CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)C3OC(C(=O)O)C(O)C(O)C3O)C=C2)=CC=N1,,UGT,0.51,O-glucuronidation
4-Hydroxyacetophenone,CC(=O)C1=CC=C(O)C=C1,,,CC(=O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.2,O-glucuronidation
Triclosan,OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl,,,O=C(O)C1OC(OC2=CC(Cl)=CC=C2OC2=CC=C(Cl)C=C2Cl)C(O)C(O)C1O,,UGT,0.32,O-glucuronidation
Triclosan,OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl,,,O=S(=O)(O)OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl,,SULT,0.62,Aromatic -OH glucuronidation
Combretastatin A4,COC1=CC=C(C=CC2=CC(OC)=C(OC)C(OC)=C2)C=C1O,,,COC1=CC=C(C=CC2=CC(OC)=C(OC)C(OC)=C2)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.34,O-glucuronidation
2-aminofluorene,NC1=CC=C2C(=C1)CC1=CC=CC=C12,,,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC=C12,,NAT,0.78,N-acetylation
Berberrubine,COC1=C(O)C=CC2=CC3=[N+](C=C12)CCC1=CC2=C(C=C13)OCO2,,,COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC2=CC3=[N+](C=C12)CCC1=CC2=C(C=C13)OCO2,,UGT,0.79,O-glucuronidation
7-Hydroxy-3-methylflavone,CC1=C(C2=CC=CC=C2)OC2=CC(O)=CC=C2C1=O,,,CC1=C(C2=CC=CC=C2)OC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C2C1=O,,UGT1A9,0.64,O-glucuronidation
4-aminoveratrole,COC1=CC=C(N)C=C1OC,,,COC1=CC=C(N=C(C)O)C=C1OC,,NAT,0.62,N-acetylation
phentolamine,CC1=CC=C(N(CC2=NCCN2)C2=CC=CC(O)=C2)C=C1,,,CC1=CC=C(N(CC2=NCCN2)C2=CC=CC(OS(=O)(=O)O)=C2)C=C1,,SULT1A3; SULT1A5,0.79,O-sulfonation
Resacetophenone,CC(=O)C1=CC=C(O)C=C1O,,,CC(=O)C1=CC=C(O)C=C1OS(=O)(=O)O,,SULT,0.52,O-sulfonation
Epinephrine,CNCC(O)C1=CC=C(O)C(O)=C1,,,CNCC(O)C1=CC=C(OS(=O)(=O)O)C(O)=C1,,SULT,0.66,O-sulfonation
Diallyl disulfide,C=CCSSCC=C,,,C=CCSSCC=CSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.06,GSH-conjugation
"10-hydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene",OC1CCCC2=CC3=CC=C4C=CC=C5C=CC(=C21)C3=C45,,,O=S(=O)(O)OC1CCCC2=CC3=CC=C4C=CC=C5C=CC(=C21)C3=C45,,SULT1E1,0.68,O-sulfonation
trovafloxacin,NC1C2CN(C3=NC4=C(C=C3F)C(=O)C(C(=O)O)=CN4C3=CC=C(F)C=C3F)CC12,,,NC1C2CN(C3=NC4=C(C=C3F)C(=O)C(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)=CN4C3=CC=C(F)C=C3F)CC12,,UGT,0.86,O-glucuronidation
2-hydroxymethylpyrene,OCC1=CC2=CC=C3C=CC=C4C=CC(=C1)C2=C34,,,O=S(=O)(O)OCC1=CC2=CC=C3C=CC=C4C=CC(=C1)C2=C34,,SULT2A1,0.61,O-sulfonation
alpha-methyl benzyl alcohol,CC(O)C1=CC=CC=C1,,,CC(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC=C1,,UGT,0.15,O-glucuronidation
Kaempferol,O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C(O)=C(C4=CC=C(O)C=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.66,O-glucuronidation
Kaempferol,O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.62,O-glucuronidation
2-ethylaniline,CCC1=CC=CC=C1N,,,CCC1=CC=CC=C1N=C(C)O,,NAT,0.47,N-acetylation
"N-hydroxy-2-amino-6-methyldipyrido[1,2-a:3p,2p-d]-imidazole",CC1=CC=CN2C1=NC1=CC=C(NO)N=C12,,,CC1=CC=CN2C1=NC1=CC=C(NOS(=O)(=O)O)N=C12,,SULT1A1,0.88,O-sulfonation
4-nonylphenol,CCCCCCCCCC1=CC=C(O)C=C1,,,CCCCCCCCCC1=CC=C(OS(=O)(=O)O)C=C1,,SULT1C1; SULT1C2,0.59,O-sulfonation
Tizanidine M6,OC1=CC(Cl)=C(NC2=NCCN2)C2=NSN=C12,,,O=C(O)C1OC(OC2=CC(Cl)=C(NC3=NCCN3)C3=NSN=C23)C(O)C(O)C1O,,UGT,0.67,O-glucuronidation
Tizanidine M6,OC1=CC(Cl)=C(NC2=NCCN2)C2=NSN=C12,,,O=S(=O)(O)OC1=CC(Cl)=C(NC2=NCCN2)C2=NSN=C12,,SULT,0.85,O-sulfonation
Dulcin,CCOC1=CC=C(NC(=N)O)C=C1,,,CCOC1=CC=C(NC(O)=NC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.26,O-glucuronidation
S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid,CC1=C(C2=CC=C(C(C)C(=O)O)C=C2)SC=C1,,,CC1=C(C2=CC=C(C(C)C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)SC=C1,,UGT,0.5,O-glucuronidation
S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid,CC1=C(C2=CC=C(C(C)C(=O)O)C=C2)SC=C1,,,CC1=C(C2=CC=C(C(C)C(=O)ONCCS(=O)(=O)O)C=C2)SC=C1,,TAU,0.76,Taurine conjugation of aliphatic acid
Jaceidin,COC1=CC(C2=C(OC)C(=O)C3=C(O)C(OC)=C(O)C=C3O2)=CC=C1O,,,COC1=CC(C2=C(OC)C(=O)C3=C(O)C(OC)=C(O)C=C3O2)=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.76,O-glucuronidation
menthol,CC1CCC(C(C)C)C(O)C1,,,CC1CCC(C(C)C)C(OC2OC(C(=O)O)C(O)C(O)C2O)C1,,UGT,0.19,O-glucuronidation
"5,6-O-DiDesmethyl Donepezil",O=C1C2=CC(O)=C(O)C=C2CC1CC1CCN(CC2=CC=CC=C2)CC1,,,O=C1C2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C(O)C=C2CC1CC1CCN(CC2=CC=CC=C2)CC1,,UGT,0.57,O-glucuronidation
"5,6-O-DiDesmethyl Donepezil",O=C1C2=CC(O)=C(O)C=C2CC1CC1CCN(CC2=CC=CC=C2)CC1,,,O=C1C2=CC(O)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2CC1CC1CCN(CC2=CC=CC=C2)CC1,,UGT,0.57,O-glucuronidation
"3,6,4p-Trihydroxyflavone",O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC=C(O)C=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C=C3)OC3=CC=C(O)C=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.57,O-glucuronidation
4p-Carboxylumiracoxib,CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)O)=C1,,,CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.62,O-glucuronidation
Norbuprenorphine,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1CC4=CC=C(O)C5=C4C3(CCN1)C2O5,,,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1CC4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C5=C4C3(CCN1)C2O5,,UGT,0.91,O-glucuronidation
O-Desmethylvenlafaxine,NCC(C1=CC=C(O)C=C1)C1(O)CCCCC1,,,NCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,,UGT,0.49,O-glucuronidation
"2,8-Dihydroxyquinoline",OC1=CC=C2C=CC=C(O)C2=N1,,,O=C(O)C1OC(OC2=CC=C3C=CC=C(O)C3=N2)C(O)C(O)C1O,,UGT,0.34,O-glucuronidation
Ketoprofen,CC(C(=O)O)C1=CC=CC(C(=O)C2=CC=CC=C2)=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC(C(=O)C2=CC=CC=C2)=C1,,UGT,0.43,O-glucuronidation
1-iodopropane,CCCI,,propyl-glutathione,CCCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.01,O-glucuronidation
7-hydroxy-12-methylbenz[a]anthracene,CC1=C2C=CC=CC2=C(O)C2=CC=C3C=CC=CC3=C12,,,CC1=C2C=CC=CC2=C(OS(=O)(=O)O)C2=CC=C3C=CC=CC3=C12,,SULT2A1,0.59,O-sulfonation
1-iodo-3-phenylpropane,ICCCC1=CC=CC=C1,,3-phenylpropyl-glutathione,NC(CCC(O)=NC(CSCCCC1=CC=CC=C1)C(O)=NCC(=O)O)C(=O)O,,GST,0.16,GSH-conjugation
4p-OH-aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,UGT,0.56,O-glucuronidation
4p-OH-aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,SULT,0.84,O-sulfonation
"4-Hydroxy-5-(3p,5p-dihydroxyphenyl)-valeric acid",O=C(O)CCC(O)CC1=CC(O)=CC(O)=C1,,,O=C(CCC(O)CC1=CC(O)=CC(O)=C1)OCOC1OC(C(O)O)C(O)C(O)C1O,,UGT,0.46,O-glucuronidation
1-iodobutane,CCCCI,,butyl-glutathione,CCCCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.02,GSH-conjugation
4-hydroxyatomoxetine,CNCCC(OC1=CC=C(O)C=C1C)C1=CC=CC=C1,,,CNCCC(OC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1C)C1=CC=CC=C1,,UGT,0.49,O-glucuronidation
7-Hydoxy-5-methylflavone,CC1=CC(O)=CC2=C1C(=O)C=C(C1=CC=CC=C1)O2,,,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC2=C1C(=O)C=C(C1=CC=CC=C1)O2,,UGT1A9,0.62,O-glucuronidation
"6,7,3p-Trihydroxflavone",O=C1C=C(C2=CC=CC(O)=C2)OC2=CC(O)=C(O)C=C12,,,O=C(O)C1OC(OC2=CC3=C(C=C2O)C(=O)C=C(C2=CC=CC(O)=C2)O3)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation
7-Hydroxy-alpha-thujone,CC1C(=O)CC2(C(C)(C)O)CC12,,,CC1C(=O)CC2(C(C)(C)OC3OC(C(=O)O)C(O)C(O)C3O)CC12,,UGT,0.43,O-glucuronidation
Pentaerythritol Dibromide,OCC(CO)(CBr)CBr,,,O=C(O)C1OC(OCC(CO)(CBr)CBr)C(O)C(O)C1O,,UGT,0.1,O-glucuronidation
"5-(3p,4p-Dihydroxyphenyl)-gamma-valerolactone-4p-O-methyl",COC1=CC=C(CC2CCC(=O)O2)C=C1O,,,COC1=CC=C(CC2CCC(=O)O2)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.45,O-glucuronidation
2-Methoxyestrone,COC1=CC2=C(C=C1O)CCC1C2CCC2(C)C(=O)CCC12,,,COC1=CC2=C(C=C1OC1OC(O)C(O)C(O)C1O)CCC1C2CCC2(C)C(=O)CCC12,,UGT,0.67,O-glucuronidation
Carveol,C=C(C)C1CC=C(C)C(O)C1,,,C=C(C)C1CC=C(C)C(OC2OC(C(=O)O)C(O)C(O)C2O)C1,,UGT,0.32,O-glucuronidation
7-Hydroxyflavone,O=C1C=C(C2=CC=CC=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C=C(C4=CC=CC=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.54,O-glucuronidation
Bisphenol A,CC(C)(C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,,,CC(C)(C1=CC=C(O)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.28,O-glucuronidation
25-Hydroxyvitamin D2,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)(C)O,,,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)(C)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.5,O-glucuronidation
Edaravone,CC1=NN(C2=CC=CC=C2)C(O)=C1,,,CC1=NN(C2=CC=CC=C2)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.4,O-glucuronidation
"6,7-Dihydroxyflavone",O=C1C=C(C2=CC=CC=C2)OC2=CC(O)=C(O)C=C12,,,O=C(O)C1OC(OC2=CC3=C(C=C2O)C(=O)C=C(C2=CC=CC=C2)O3)C(O)C(O)C1O,,UGT1A9,0.57,O-glucuronidation
Flurbiprofen,CC(C(=O)O)C1=CC=C(C2=CC=CC=C2)C(F)=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C(C2=CC=CC=C2)C(F)=C1,,"UGT2B7, UGT1A1, UGT1A3, UGT1A9, UGT2B4",0.46,O-glucuronidation
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCCCC1=[NH+]C(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2N=NN(C3OC(C(O)O)C(O)C(O)C3O)N2)C=C1,,"UGT1A1, UGT1A3, UGT1A10. UGT2B7, UGT2B17",0.58,O-glucuronidation
N-hydroxy-2-acetylamino-3-methyl-5-phenylpyridine,CC(=O)N(O)C1=NC=C(C2=CC=CC=C2)C=C1C,,,CC(=O)N(OC1OC(C(=O)O)C(O)C(O)C1O)C1=NC=C(C2=CC=CC=C2)C=C1C,,SULT1A1,0.54,O-sulfonation
5-OH-paeonol,COC1=CC(O)=C(C(C)=O)C=C1O,,,COC1=CC(OS(=O)(=O)O)=C(C(C)=O)C=C1O,,SULT,0.61,O-sulfonation
1-iodooctane,CCCCCCCCI,,octyl-glutathione,CCCCCCCCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.03,GSH-conjugation
4-phenoxyaniline,NC1=CC=C(OC2=CC=CC=C2)C=C1,,,CC(O)=NC1=CC=C(OC2=CC=CC=C2)C=C1,,NAT,0.59,N-acetylation
xanthurenic acid,O=C(O)C1=CC(O)=C2C=CC=C(O)C2=N1,,,O=C(O)C1=CC(O)=C2C=CC=C(OS(=O)(=O)O)C2=N1,,SULT,0.79,O-sulfonation
Acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,,CC(O)=NC1=CC=C(OS(=O)(=O)O)C=C1,,SULT,0.6,O-sulfonation
Acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,,CC(O)=NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT,0.22,O-glucuronidation
3-alpha-hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,,,C#CC1(O)CCC2C3CCC4=CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC4C3C(=C)CC21CC,,UGT,0.55,O-glucuronidation
3-alpha-hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,,,C#CC1(O)CCC2C3CCC4=CC(OS(=O)(=O)O)CCC4C3C(=C)CC21CC,,SULT,0.8,O-sulfonation
"B[a]P 7,8-epoxide",C1=CC2OC2C2=CC3=CC=C4C=CC=C5C=CC(=C12)C3=C45,,,NC(CCC(O)=NC(CSOC1C2=CC3=CC=C4C=CC=C5C=CC(=C2C=CC1O)C3=C45)C(O)=NCC(=O)O)C(=O)O,,GST,0.53,GSH-conjugation
4-Chlorophenol,OC1=CC=C(Cl)C=C1,,,O=C(O)C1OC(OC2=CC=C(Cl)C=C2)C(O)C(O)C1O,,UGT1A9,0.11,O-glucuronidation
Tyramine,NCCC1=CC=C(O)C=C1,,,NCCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT,0.17,O-glucuronidation
Minoxidil,N=C1N=C(N2CCCCC2)C=C(N)N1O,,,N=C1N=C(N2CCCCC2)C=C(N)N1OS(=O)(=O)O,,SULT,0.72,O-sulfonation
3p-Oxohexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(=O)CCC2)C1=O,,,CN1C(=O)N=C(O)C(C)(C2(SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)CCCC(=O)C2)C1=O,,GST,0.56,GSH-conjugation
Vitamin D2,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)C,,,C=C1CCC(OC2OC(C(=O)O)C(O)C(O)C2O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)C,,UGT,0.48,O-glucuronidation
5-O-Desmethyl Donepezil,COC1=CC2=C(C=C1O)CC(CC1CCN(CC3=CC=CC=C3)CC1)C2=O,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)CC(CC1CCN(CC3=CC=CC=C3)CC1)C2=O,,UGT,0.62,O-glucuronidation
6-Hydroxyflavone,O=C1C=C(C2=CC=CC=C2)OC2=CC=C(O)C=C12,,,O=C(O)C1OC(OC2=CC=C3OC(C4=CC=CC=C4)=CC(=O)C3=C2)C(O)C(O)C1O,,UGT1A9,0.55,O-glucuronidation
Dihydrocurcumin,COC1=CC(C=CC(=O)C=C(O)CCC2=CC=C(O)C(OC)=C2)=CC=C1O,,,COC1=CC(CCC(O)=CC(=O)C=CC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(OC)=C2)=CC=C1O,,UGT,0.48,O-glucuronidation
"4-OH-2,6-dimethylaniline",CC1=CC(O)=CC(C)=C1N,,,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC(C)=C1N,,UGT,0.23,O-glucuronidation
3-Hydroxy-6-methylflavone,CC1=CC=C2OC(C3=CC=CC=C3)=C(O)C(=O)C2=C1,,,CC1=CC=C2OC(C3=CC=CC=C3)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C2=C1,,UGT1A9,0.59,O-glucuronidation
1-iodoheptane,CCCCCCCI,,heptyl-glutathione,CCCCCCCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.03,GSH-conjugation
Tolcapone,CC1=CC=C(C(=O)C2=CC(O)=C(O)C([N+](=O)[O-])=C2)C=C1,,,CC1=CC=C(C(=O)C2=CC(O)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C([N+](=O)[O-])=C2)C=C1,,UGT1A9,0.51,O-glucuronidation
4-Nitrophenol,O=[N+]([O-])C1=CC=C(O)C=C1,,,O=C(O)C1OC(OC2=CC=C([N+](=O)[O-])C=C2)C(O)C(O)C1O,,UGT1A9,0.21,O-glucuronidation
3-Indole carboxylic acid,O=C(O)C1=CNC2=CC=CC=C12,,,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CNC2=CC=CC=C12,,UGT,0.43,O-glucuronidation
Fisetin,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.61,O-glucuronidation
Ornidazole,CC1=NC=C([N+](=O)[O-])N1CC(O)CCl,,,CC1=NC=C([N+](=O)[O-])N1CC(CCl)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.58,O-glucuronidation
"3-Hydroxy-6,4p-dimethoxyflavone",COC1=CC=C(C2=C(O)C(=O)C3=CC(OC)=CC=C3O2)C=C1,,,COC1=CC=C(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC(OC)=CC=C3O2)C=C1,,UGT1A9,0.6,O-glucuronidation
3p-Amino-3p-deoxythimidine,CC1=CN(C2CC(N)C(CO)O2)C(=O)N=C1O,,,CC1=CN(C2CC(N)C(COC3C(O)C(O)OC(C(=O)O)C3O)O2)C(=O)N=C1O,,UGT,0.77,O-glucuronidation
4-Ethylphenol,CCC1=CC=C(O)C=C1,,,CCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.15,O-glucuronidation
"3,3p-Dihydroxyflavone",O=C1C(O)=C(C2=CC=CC(O)=C2)OC2=CC=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC(O)=C3)OC3=CC=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.57,O-glucuronidation
MaxiPost,COC1=CC=C(Cl)C=C1C1(F)C(O)=NC2=CC(C(F)(F)F)=CC=C21,,,COC1=CC=C(Cl)C=C1C1(F)C(=O)N(C2OC(C(=O)O)C(O)C(O)C2O)C2=CC(C(F)(F)F)=CC=C21,,UGT2B7,0.6,O-glucuronidation
3-Methoxy-4-hydroxyphenylglycol,COC1=CC(C(O)CO)=CC=C1O,,,COC1=CC(C(O)CO)=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.37,O-glucuronidation
4p-OH-diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,UGT,0.51,O-glucuronidation
4p-OH-diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,SULT,0.82,O-sulfonation
Farnesol,CC(C)=CCCC(C)=CCCC(C)=CCO,,,CC(C)=CCCC(C)=CCCC(C)=CCOC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.14,O-glucuronidation
4-n-Butylphenol,CCCCC1=CC=C(O)C=C1,,,CCCCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.19,O-glucuronidation
Arbidol,CCOC(=O)C1=C(CSC2=CC=CC=C2)N(C)C2=CC(Br)=C(O)C(CN(C)C)=C12,,,CCOC(=O)C1=C(CSC2=CC=CC=C2)N(C)C2=CC(Br)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(CN(C)C)=C12,,UGT,0.83,Aromatic -OH glucuronidation
Lorazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2Cl)=NC1O,,,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N=C2O)C(O)C(O)C1O,,UGT,0.68,O-glucuronidation
fenchone metabo2,CC1(C)C(=O)C2(C)CCC1C2O,,,CC1(C)C(=O)C2(C)CCC1C2OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.43,O-glucuronidation
4-Phenylphenol,OC1=CC=C(C2=CC=CC=C2)C=C1,,,O=C(O)C1OC(OC2=CC=C(C3=CC=CC=C3)C=C2)C(O)C(O)C1O,,UGT1A9,0.16,O-glucuronidation
3p-OH-diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(O)=C1Cl,,,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1Cl,,UGT,0.52,O-glucuronidation
3p-OH-diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(O)=C1Cl,,,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(OS(=O)(=O)O)=C1Cl,,SULT,0.77,O-sulfonation
Irinotecan,CCC1=C2CN3C(=CC4=C(COC(=O)C4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(N4CCCCC4)CC3)C=C12,,,CCC1=C2CN3C(=CC4=C(COC(=O)C4(CC)OC4OC(C(=O)O)C(O)C(O)C4O)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(N4CCCCC4)CC3)C=C12,,UGT,0.94,O-glucuronidation
Syringetin,COC1=CC(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)=CC(OC)=C1O,,,COC1=CC(C2=C(O)C(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)=CC(OC)=C1O,,UGT1A9,0.72,O-glucuronidation
Syringetin,COC1=CC(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)=CC(OC)=C1O,,,COC1=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=C(O)C=C(O)C=C3O2)=CC(OC)=C1O,,UGT1A9,0.67,O-glucuronidation
6-Methoxyluteolin,COC1=C(O)C=C2OC(C3=CC=C(O)C(O)=C3)=CC(=O)C2=C1O,,,COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2OC(C3=CC=C(O)C(O)=C3)=CC(=O)C2=C1O,,UGT1A9,0.66,O-glucuronidation
Chrysin,O=C1C=C(C2=CC=CC=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C=C(C4=CC=CC=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.58,O-glucuronidation
Quinagolide,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2CC3=C(O)C=CC=C3CC21,,,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2CC3=C(C=CC=C3OC3OC(C(=O)O)C(O)C(O)C3O)CC21,,UGT,0.69,O-glucuronidation
"4,5-Dihydrodrospirenone",CC12CCC(O)CC1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,,,CC12CCC(S(=O)(=O)O)CC1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,,SULT,0.75,O-sulfonation
fenchone metabo1,CC12CCC(C1)C(C)(CO)C2=O,,,CC12CCC(C1)C(C)(COC1OC(C(=O)O)C(O)C(O)C1O)C2=O,,UGT,0.37,O-glucuronidation
"7,3p,4p-Trihydroxyflavone",O=C1C=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C=C(C4=CC=C(O)C(O)=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation
Daidzein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C(C4=CC=C(O)C=C4)=COC3=C2)C(O)C(O)C1O,,UGT1A9,0.55,O-glucuronidation
Lumiracoxib M23,CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)O)=C1,,Lumiracoxib M22,CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.62,O-glucuronidation
sulfamerazine,CC1=CC=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1,,,CC(O)=NC1=CC=C(S(=O)(=O)NC2=NC=CC(C)=N2)C=C1,,NAT,0.87,N-acetylation
Dihyroxy-1H-indole,OC1=CC2=C(C=C1O)NC=C2,,,O=C(O)C1OC(OC2=CC3=C(C=CN3)C=C2O)C(O)C(O)C1O,,UGT,0.31,O-glucuronidation
5-OH-diclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,O=C(O)CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,UGT,0.51,O-glucuronidation
5-OH-diclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,O=C(O)CC1=CC(OS(=O)(=O)O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,SULT,0.81,O-sulfonation
M23OH,CCCCC1=NC2=C(O)C=NN2C(N)=C1,,,CCCCC1=NC2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=NN2C(N)=C1,,UGT,0.64,O-glucuronidation
M23OH,CCCCC1=NC2=C(O)C=NN2C(N)=C1,,,CCCCC1=NC2=C(OS(=O)(=O)O)C=NN2C(N)=C1,,SULT,0.86,O-sulfonation
Fraxetin,COC1=CC2=C(OC(=O)C=C2)C(O)=C1O,,,COC1=CC2=C(OC(=O)C=C2)C(O)=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.5,O-glucuronidation
17-beta estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2O,,"UGT1A1, UGT1A3",0.55,O-glucuronidation
"3,2p-Dihydroxyflavone",O=C1C(O)=C(C2=CC=CC=C2O)OC2=CC=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3O)OC3=CC=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation
Dexmedetomidine,CC1=CC=CC(C(C)C2=CN=CN2)=C1C,,,CC1=CC=CC(C(C)C2=CN(C3OC(C(=O)O)C(O)C(O)C3O)C=[NH+]2)=C1C,,UGT2B20; UGT1A4,0.4,O-glucuronidation
Dexmedetomidine,CC1=CC=CC(C(C)C2=CN=CN2)=C1C,,,CC1=CC=CC(C(C)C2=CN=CN2C2OC(C(=O)O)C(O)C(O)C2O)=C1C,,UGT2B20; UGT1A4,0.37,O-glucuronidation
4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol,CN(CCCC(O)C1=CC=CN=C1)N=O,,,CN(CCCC(O)C1=CC=C[N+](C2OC(C(=O)O)C(O)C(O)C2O)=C1)N=O,,UGT,0.33,O-glucuronidation
Ethyl-4-hydroxybenzoate,CCOC(=O)C1=CC=C(O)C=C1,,,CCOC(=O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.26,O-glucuronidation
3-Hydroxy-5-methoxyflavone,COC1=CC=CC2=C1C(=O)C(O)=C(C1=CC=CC=C1)O2,,,COC1=CC=CC2=C1C(=O)C(OC1OC(C(=O)O)C(O)C(O)C1O)=C(C1=CC=CC=C1)O2,,UGT1A9,0.64,O-glucuronidation
3-Hydroxy-4p-methoxyflavone,COC1=CC=C(C2=C(O)C(=O)C3=CC=CC=C3O2)C=C1,,,COC1=CC=C(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=CC=C3O2)C=C1,,UGT1A9,0.58,O-glucuronidation
"Aflatoxin B1 exo 8,9-epoxide",COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C(O2)OC2OC21,,,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C(O2)OC(SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)C1O,,GST1A1; GST1A2; GSTM1; GSTM3; GSTP1,0.88,GSH-conjugation
Gypsogenin,CC1(C)CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C=O)C5CCC43C)C2C1,,,CC1(C)CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6O)C(C)(C=O)C5CCC43C)C2C1,,UGT,0.55,O-glucuronidation
p-Toluidine,CC1=CC=C(N)C=C1,,,CC(O)=NC1=CC=C(C)C=C1,,NAT,0.45,N-acetylation
Geraldol,COC1=CC(C2=C(O)C(=O)C3=CC=C(O)C=C3O2)=CC=C1O,,,COC1=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=C(O)C=C3O2)=CC=C1O,,UGT1A9,0.63,O-glucuronidation
3-Hydroxyflavone,O=C1C(O)=C(C2=CC=CC=C2)OC2=CC=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3)OC3=CC=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.55,O-glucuronidation
Myricetin,O=C1C(O)=C(C2=CC(O)=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC(O)=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.64,O-glucuronidation
4-Methylphenol,CC1=CC=C(O)C=C1,,,CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.11,O-glucuronidation
Biochanin A,COC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1O,,,COC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.6,O-glucuronidation
Datiscetin,O=C1C(O)=C(C2=CC=CC=C2O)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3O)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.64,O-glucuronidation
"3,7,3p-Trihydroxyflavone",O=C1C(O)=C(C2=CC=CC(O)=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC(O)=C3)OC3=CC(O)=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation
Limonen-10-ol,C=C(C)C1CC=C(CO)CC1,,,C=C(C)C1CC=C(COC2OC(C(=O)O)C(O)C(O)C2O)CC1,,UGT,0.27,O-glucuronidation
Nirvanol (N-demethylmephenytoin,CCC1(C2=CC=C(O)C=C2)N=C(O)N=C1O,,,CCC1(C2=CC=C(O)C=C2)N=C(O)N(C2OC(C(=O)O)C(O)C(O)C2O)C1=O,,UGT,0.41,O-glucuronidation
Galangin,O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C(O)=C(C4=CC=CC=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.65,O-glucuronidation
Galangin,O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.61,O-glucuronidation
7-Hydroxy-4p-methoxyflavone,COC1=CC=C(C2=CC(=O)C3=CC=C(O)C=C3O2)C=C1,,,COC1=CC=C(C2=CC(=O)C3=CC=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1,,UGT1A9,0.58,O-glucuronidation
3-Hydroxy-3p-methoxyflavone,COC1=CC=CC(C2=C(O)C(=O)C3=CC=CC=C3O2)=C1,,,COC1=CC=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=CC=C3O2)=C1,,UGT1A9,0.59,O-glucuronidation
1-iodomethane,CI,,methylglutathione,CSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.0,GSH-conjugation of organohalide
cis-Dibromochrysanthemic acid,CC1(C)C(C=C(Br)Br)C1C(=O)O,,,CC1(C)C(C=C(Br)Br)C1C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.36,O-glucuronidation
N-Acetyl-5-HT,CC(O)=NCCC1=CNC2=CC=C(O)C=C12,,,CC(O)=NCCC1=CNC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,,UGT,0.51,O-glucuronidation
N-Acetyl-5-HT,CC(O)=NCCC1=CNC2=CC=C(O)C=C12,,,CC(O)=NCCC1=CNC2=CC=C(OS(=O)(=O)O)C=C12,,SULT,0.82,O-sulfonation
4-Cyclopentylphenol,OC1=CC=C(C2CCCC2)C=C1,,,O=C(O)C1OC(OC2=CC=C(C3CCCC3)C=C2)C(O)C(O)C1O,,UGT1A9,0.25,O-glucuronidation
2-Methoxy-estradiol-17beta,COC1=CC2=C(C=C1O)CCC1C2CCC2(C)C(O)CCC12,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)CCC1C2CCC2(C)C(O)CCC12,,UGT,0.59,O-glucuronidation
4-Bromophenol,OC1=CC=C(Br)C=C1,,,O=C(O)C1OC(OC2=CC=C(Br)C=C2)C(O)C(O)C1O,,UGT1A9,0.11,O-glucuronidation
Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,,Hydromorphone 3-sulfate,CN1CCC23C4=C5C=CC(OS(=O)(=O)O)=C4OC2C(=O)CCC3C1C5,,SULT,0.94,O-sulfonation
Licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,,,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)N2C1,,UGT,0.78,O-glucuronidation
2-Hydroxymethyatomoxetine,CNCCC(OC1=CC=CC=C1CO)C1=CC=CC=C1,,,CNCCC(OC1=CC=CC=C1COC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC=C1,,UGT,0.49,O-glucuronidation
1-iodopentane,CCCCCI,,pentyl-glutathione,CCCCCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.02,GSH-conjugation
7-Hydroxy-6-methoxyisoflavone,COC1=CC2=C(C=C1O)OC=C(C1=CC=CC=C1)C2=O,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)OC=C(C1=CC=CC=C1)C2=O,,UGT1A9,0.6,O-glucuronidation
OT-7100 M5,CCCCC1=NC2=CC=NN2C(N)=C1,,,CCCCC1=NC2=CC=NN2C(NC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.51,O-glucuronidation
OT-7100 M5,CCCCC1=NC2=CC=NN2C(N)=C1,,,CCCCC1=NC2=CC=NN2C(NS(=O)(=O)O)=C1,,SULT,0.75,O-sulfonation
Erlotinib M18,C#CC1=CC=CC(NC2=NC=NC3=CC(OCCOC)=C(O)C=C23)=C1,,,C#CC1=CC=CC(NC2=NC=NC3=CC(OCCOC)=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C23)=C1,,UGT,0.66,O-glucuronidation
zaltoprofen,CC(C(=O)O)C1=CC=C2SC3=CC=CC=C3C(=O)CC2=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C2SC3=CC=CC=C3C(=O)CC2=C1,,UGT,0.59,O-glucuronidation
4p-OH-triamterene,N=C1NC2=NC(=N)C(C3=CC=C(O)C=C3)=NC2=C(N)N1,,,N=C1NC2=NC(=N)C(C3=CC=C(OS(=O)(=O)O)C=C3)=NC2=C(N)N1,,SULT,0.93,O-sulfonation
4-Ethoxyphenol,CCOC1=CC=C(O)C=C1,,,CCOC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.15,O-glucuronidation
4-Hydroxyduloxetine,CNCCC(OC1=CC=C(O)C2=CC=CC=C12)C1=CC=CS1,,,CNCCC(OC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C12)C1=CC=CS1,,UGT,0.57,O-glucuronidation
Pterostilbene,COC1=CC(C=CC2=CC=C(O)C=C2)=CC(OC)=C1,,,COC1=CC(C=CC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)=CC(OC)=C1,,UGT1A9,0.31,O-glucuronidation
6-OH-harmaline,CC1=NC=CC2=C1NC1=CC(O)=CC=C12,,,CC1=NC=CC2=C1NC1=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C12,,UGT,0.49,O-glucuronidation
6-OH-harmaline,CC1=NC=CC2=C1NC1=CC(O)=CC=C12,,,CC1=NC=CC2=C1NC1=CC(OS(=O)(=O)O)=CC=C12,,SULT,0.82,O-sulfonation
7-OH-efavirenz,OC1=NC2=CC(O)=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,,O=C(O)C1OC(OC2=CC3=C(C=C2Cl)C(C#CC2CC2)(C(F)(F)F)OC(O)=N3)C(O)C(O)C1O,,UGT,0.78,O-glucuronidation
6-O-Desmethyl Donepezil,COC1=CC2=C(C=C1O)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,UGT,0.61,O-glucuronidation
Morin,O=C1C(O)=C(C2=CC=C(O)C=C2O)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C=C3O)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.65,O-glucuronidation
6-OH-MXAA,CC1=C(CO)C=CC2=C1OC1=C(CC(=O)O)C=CC=C1C2=O,,,CC1=C(COC2OC(C(=O)O)C(O)C(O)C2O)C=CC2=C1OC1=C(CC(=O)O)C=CC=C1C2=O,,UGT,0.62,O-glucuronidation
Procainamide,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,,,CCN(CC)CCNC(=O)C1=CC=C(N=C(C)O)C=C1,,NAT,0.76,N-acetylation of arylamine
"3,4p-Dihydroxyfavone",O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C=C3)OC3=CC=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.56,O-glucuronidation
Neomenthol,CC1CCC(C(C)C)C(O)C1,,,CC1CCC(C(C)C)C(OC2OC(C(=O)O)C(O)C(O)C2O)C1,,UGT,0.19,Alkyl-OH glucuronidation
Glycitein,COC1=CC2=C(C=C1O)OC=C(C1=CC=C(O)C=C1)C2=O,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)OC=C(C1=CC=C(O)C=C1)C2=O,,UGT1A9,0.61,7-O-glucuronidation of isoflavone
N-Desmethyl o-hydroxyrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=NC=CC=C3O)C=C2)S1,,,O=C1N=C(O)C(CC2=CC=C(OCCNC3=NC=CC=C3OS(=O)(=O)O)C=C2)S1,,SULT,0.82,O-sulfonation
(11S)-11-hydroperoxylinoleic acid,CCCCCC=CC(C=CCCCCCCCC(=O)O)OO,,,CCCCCC=CC(C=CCCCCCCCC(=O)O)OOSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.25,GSH-conjugation
Naproxen,COC1=CC=C2C=C(C(C)C(=O)O)C=CC2=C1,,,COC1=CC=C2C=C(C(C)C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C=CC2=C1,,UGT,0.37,O-glucuronidation of aliphatic acid
Flavopiridol,CN1CCC(C2=C(O)C=C(O)C3=C2OC(C2=CC=CC=C2Cl)=CC3=O)C(O)C1,,,CN1CCC(C2=C3OC(C4=CC=CC=C4Cl)=CC(=O)C3=C(O)C=C2OC2OC(C(=O)O)C(O)C(O)C2O)C(O)C1,,UGT1A9,0.8,Aromatic -OH glucuronidation
5-OH-resacetophenone,CC(=O)C1=CC(O)=C(O)C=C1O,,,CC(=O)C1=CC(OS(=O)(=O)O)=C(O)C=C1O,,SULT,0.61,O-sulfonation
15-alpha-hydroxydesogestrel,C#CC1(O)CC(O)C2C3CCC4=CCCCC4C3C(=C)CC21CC,,,C#CC1(OC2OC(C(=O)O)C(O)C(O)C2O)CC(O)C2C3CCC4=CCCCC4C3C(=C)CC21CC,,UGT,0.54,O-glucuronidation
cyclic N-Acetylserotonin,CC(=O)N1CCC2=C1NC1=CC=C(O)C=C21,,,CC(=O)N1CCC2=C1NC1=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C21,,UGT,0.71,O-glucuronidation
7-Hydroxy-2p-methoxyflavone,COC1=CC=CC=C1C1=CC(=O)C2=CC=C(O)C=C2O1,,,COC1=CC=CC=C1C1=CC(=O)C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2O1,,UGT1A9,0.65,O-glucuronidation
8-OH efivarenz,OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,,O=C(O)C1OC(OC2=CC(Cl)=CC3=C2N=C(O)OC3(C#CC2CC2)C(F)(F)F)C(O)C(O)C1O,,UGT,0.78,O-glucuronidation
fenchone metabo5,CC12CCC(O)(C1)C(C)(C)C2=O,,,CC12CCC(OC3OC(C(=O)O)C(O)C(O)C3O)(C1)C(C)(C)C2=O,,UGT,0.44,O-glucuronidation
Genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C(C4=CC=C(O)C=C4)=COC3=C2)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation
Maackiain,OC1=CC=C2C(=C1)OCC1C3=CC4=C(C=C3OC21)OCO4,,,O=C(O)C1OC(OC2=CC=C3C(=C2)OCC2C4=CC5=C(C=C4OC32)OCO5)C(O)C(O)C1O,,UGT1A9,0.77,O-glucuronidation
Diosmetin,COC1=CC=C(C2=CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,,COC1=CC=C(C2=CC(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1O,,UGT1A9,0.64,Aromatic O-glucuronidation
"5-(3p,4p,5p-Trihydroxyphenyl)-gamma-valerolactone",O=C1CCC(CC2=CC(O)=C(O)C(O)=C2)O1,,,O=C1CCC(CC2=CC(O)=C(O)C(OC3OC(C(=O)O)C(O)C(O)C3O)=C2)O1,,UGT,0.42,O-glucuronidation
carvacrol,CC1=CC=C(C(C)C)C=C1O,,,CC1=CC=C(C(C)C)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.22,O-glucuronidation
carvacrol,CC1=CC=C(C(C)C)C=C1O,,,CC1=CC=C(C(C)C)C=C1OS(=O)(=O)O,,SULT,0.5,O-sulfonation
11-Hydroxyprogesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC12C,,,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3C(OC3OC(C(=O)O)C(O)C(O)C3O)CC12C,,UGT,0.55,O-glucuronidation
2-Hydroxydoxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=C(O)C=C12,,,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,,UGT,0.64,O-glucuronidation
N-Carbamoyllorcaserin,CC1CN(C(=O)O)CCC2=CC=C(Cl)C=C21,,,CC1CN(C(=O)OC2OC(C(=O)O)C(C)C(C)C2C)CCC2=CC=C(Cl)C=C21,,UGT,0.49,O-glucuronidation
Suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,,UGT,0.49,O-glucuronidation
Indomethacin,COC1=CC=C2C(=C1)C(CC(=O)O)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,COC1=CC=C2C(=C1)C(CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,UGT,0.8,O-glucuronidation
Norpatchoulenol,CC1(C)C2CCC3(C)C(C=CCC13O)C2,,,CC1(C)C2CCC3(C)C(C=CCC13OC1OC(C(=O)O)C(O)C(O)C1O)C2,,UGT,0.39,O-glucuronidation
5-OH-aceclofenac,O=C(O)COC(=O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,O=C(O)COC(=O)CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,UGT,0.56,O-glucuronidation
5-OH-aceclofenac,O=C(O)COC(=O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,O=C(O)COC(=O)CC1=CC(OS(=O)(=O)O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,SULT,0.84,O-sulfonation
3-Hydroxy-2p-methoxyflavone,COC1=CC=CC=C1C1=C(O)C(=O)C2=CC=CC=C2O1,,,COC1=CC=CC=C1C1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(=O)C2=CC=CC=C2O1,,UGT1A9,0.64,O-glucuronidation
Licofelone M4,CC1(C)CC2=C(C3=CC=C(O)C=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,,,CC1(C)CC2=C(C3=CC=C(O)C=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)N2C1,,UGT,0.78,O-glucuronidation
Chrysoeriol,COC1=CC(C2=CC(=O)C3=C(O)C=C(O)C=C3O2)=CC=C1O,,,COC1=CC(C2=CC(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)=CC=C1O,,UGT1A9,0.65,O-glucuronidation
Nitroso-dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N=O)C=C2)C=C1,,,NC1=CC=C(S(=O)(=O)C2=CC=C([NH+]([O-])SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)C=C2)C=C1,,GST,0.3,GSH-conjugation
S-MTPPA,CC1=C(C2=CC=C(C(C)(C)C(=O)O)C=C2)SC=C1,,,CC1=C(C2=CC=C(C(C)(C)C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)SC=C1,,UGT,0.51,O-glucuronidation
"8-OH-2,3,7-TriCDD",OC1=CC2=C(C=C1Cl)OC1=CC(Cl)=C(Cl)C=C1O2,,,O=C(O)C1OC(OC2=CC3=C(C=C2Cl)OC2=CC(Cl)=C(Cl)C=C2O3)C(O)C(O)C1O,,UGT,0.36,O-glucuronidation
Oxazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1O,,,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N=C2O)C(O)C(O)C1O,,UGT,0.64,O-glucuronidation
3p-OH-hexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(O)CCC2)C1=O,,,CN1C(=O)N=C(O)C(C)(C2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)CCC2)C1=O,,UGT,0.78,O-glucuronidation
p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(O)=NC(=O)N=C1O,,,CCC1(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(O)=NC(=O)N=C1O,,UGT (primary),0.61,O-glucuronidation
p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(O)=NC(=O)N=C1O,,,CCC1(C2=CC=C(OS(=O)(=O)O)C=C2)C(O)=NC(=O)N=C1O,,SULT,0.89,O-sulfonation
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,,,CC1=CC(NS(=O)(=O)C2=CC=C(NC3OC(C(=O)O)C(O)C(O)C3O)C=C2)=NO1,,UGT,0.5,O-glucuronidation
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,,,CC(O)=NC1=CC=C(S(=O)(=O)NC2=NOC(C)=C2)C=C1,,"NAT1, NAT2",0.88,N-acetylation of arylamine
4-n-Propylphenol,CCCC1=CC=C(O)C=C1,,,CCCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.17,O-glucuronidation
Butyl-4-hydroxybenzoate,CCCCOC(=O)C1=CC=C(O)C=C1,,,CCCCOC(=O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.3,O-glucuronidation
Quercetin,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.64,O-glucuronidation
Taurocholic acid,CC(CCC(O)=NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,,,CC(CCC(O)=NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(OS(=O)(=O)O)CCC4(C)C3CC(O)C12C,,SULT,0.78,O-sulfonation
Propranolol,CC(C)NCC(O)COC1=CC=CC2=CC=CC=C12,,,CC(C)NCC(COC1=CC=CC2=CC=CC=C12)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.37,O-glucuronidation
"3,7-Dihydroxy-3p,4p-dimethoxyflavone",COC1=CC=C(C2=C(O)C(=O)C3=CC=C(O)C=C3O2)C=C1OC,,,COC1=CC=C(C2=C(O)C(=O)C3=CC=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1OC,,UGT1A9,0.69,O-glucuronidation
"3,7-Dihydroxy-3p,4p-dimethoxyflavone",COC1=CC=C(C2=C(O)C(=O)C3=CC=C(O)C=C3O2)C=C1OC,,,COC1=CC=C(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=C(O)C=C3O2)C=C1OC,,UGT1A9,0.64,O-glucuronidation
Erlotinib M16,C#CC1=CC(NC2=NC=NC3=CC(OCCOC)=C(OCCOC)C=C23)=CC=C1O,,,C#CC1=CC(NC2=NC=NC3=CC(OCCOC)=C(OCCOC)C=C23)=CC=C1OS(=O)(=O)O,,SULT,0.88,O-sulfonation
Equol,OC1=CC=C(C2COC3=CC(O)=CC=C3C2)C=C1,,,O=C(O)C1OC(OC2=CC=C3CC(C4=CC=C(O)C=C4)COC3=C2)C(O)C(O)C1O,,UGT1A9,0.52,O-glucuronidation
4-Hydroxybenzophenone,O=C(C1=CC=CC=C1)C1=CC=C(O)C=C1,,,O=C(C1=CC=CC=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.25,O-glucuronidation
4p-Hydroxyfenoprofen,CC(C(=O)O)C1=CC=CC(OC2=CC=C(O)C=C2)=C1,,,CC(C(=O)O)C1=CC=CC(OC2=CC=C(OC3C(O)C(O)OC(C(=O)O)C3O)C=C2)=C1,,UGT,0.41,O-glucuronidation
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,,,NC(CCC(O)=NC(CSOC1CCOP(=O)(NCCCl)N1CCCl)C(O)=NCC(=O)O)C(=O)O,,GST,0.57,GSH-conjugation
"4p,5-diOH-diclofenac",O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,UGT,0.54,O-glucuronidation
"4p,5-diOH-diclofenac",O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,SULT,0.83,O-sulfonation
15-Hydroxypatchoulol,CC1(C)C2CCC3(C)C(C2)C(CO)CCC13O,,,CC1(C)C2CCC3(C)C(C2)C(COC2OC(C(=O)O)C(O)C(O)C2O)CCC13O,,UGT,0.3,O-glucuronidation
3-Methoxy-4-hydroxyphenylethyleneglycol,COC1=CC(C(O)CO)=CC=C1O,,,COC1=CC(C(O)CO)=CC=C1OS(=O)(=O)O,,SULT,0.67,4-OH sulfonation of phenolic compound
Seratrodast,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)C2=CC=CC=C2)=C(C)C1=O,,,CC1=C(C)C(=O)C(C(CCCCCC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C2)=C(C)C1=O,,UGT,0.65,O-glucuronidation
Isorhamnetin,COC1=CC(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)=CC=C1O,,,COC1=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=C(O)C=C(O)C=C3O2)=CC=C1O,,UGT1A9,0.66,O-glucuronidation
3-Hydroxy-7-methoxyflavone,COC1=CC=C2C(=O)C(O)=C(C3=CC=CC=C3)OC2=C1,,,COC1=CC=C2C(=O)C(OC3OC(C(=O)O)C(O)C(O)C3O)=C(C3=CC=CC=C3)OC2=C1,,UGT1A9,0.6,O-glucuronidation
Luteolin,O=C1C=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C=C(C4=CC=C(O)C(O)=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.62,O-glucuronidation
Luteolin,O=C1C=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(C3=CC(=O)C4=C(O)C=C(O)C=C4O3)=CC=C2O)C(O)C(O)C1O,,UGT1A9,0.61,O-glucuronidation
"7,2p-Dihydroxyflavone",O=C1C=C(C2=CC=CC=C2O)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C=C(C4=CC=CC=C4O)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.6,O-glucuronidation
4-Hydroxyphenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,,,O=C(O)C1OC(OC2=CC=C(C3(C4=CC=CC=C4)N=C(O)N=C3O)C=C2)C(O)C(O)C1O,,UGT,0.63,O-glucuronidation
Candesartan,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCOC1=NC2=CC=CC(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,UGT1A3,0.79,O-glucuronidation
Candesartan,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCOC1=[NH+]C2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN(C3OC(C(=O)O)C(O)C(O)C3O)N=N2)C=C1,,UGT1A3,0.75,O-glucuronidation
Phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,,O=C(O)C1OC(N2C(=O)C(C3=CC=CC=C3)(C3=CC=CC=C3)N=C2O)C(O)C(O)C1O,,UGT,0.37,O-glucuronidation
"benzo[a]pyrene-7,8-diol",OC1=CC=C2C(=C1O)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,,O=C(O)C1OC(OC2=C(O)C=CC3=C2C=C2C=CC4=CC=CC5=CC=C3C2=C45)C(O)C(O)C1O,,UGT1A1,0.18,O-glucuronidation
N-OH-mexiletine,CC1=CC=CC(C)=C1OCC(C)NO,,,CC1=CC=CC(C)=C1OCC(C)NOC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.33,O-glucuronidation
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CC=C(CO)N=C2)C=C1,,,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CC=C(COC3OC(C(=O)O)C(O)C(O)C3O)N=C2)C=C1,,UGT,0.68,O-glucuronidation
"N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CC1=CN=C2C=CC3=C(N=C(NO)N3C)C2=N1,,,CC1=CN=C2C=CC3=C(N=C(NOC4OC(C(=O)O)C(O)C(O)C4O)N3C)C2=N1,,UGT1A1,0.61,O-glucuronidation
(11R)-11-hydroperoxylinoleic acid,CCCCCC=CC(C=CCCCCCCCC(=O)O)OO,,,CCCCCC=CC(C=CCCCCCCCC(=O)O)OOSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.25,GSH-conjugatoon
Galantamine,COC1=CC=C2CN(C)CCC34C=CC(O)CC3OC1=C24,,,CN1CCC23C=CC(O)CC2OC2=C(OS(=O)(=O)O)C=CC(=C23)C1,,UGT,0.92,O-glucuronidation
4-Isopropylphenol,CC(C)C1=CC=C(O)C=C1,,,CC(C)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.17,O-glucuronidation
"3,6-Dihydroxyfavone",O=C1C(O)=C(C2=CC=CC=C2)OC2=CC=C(O)C=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3)OC3=CC=C(O)C=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.57,O-glucuronidation
4-Oxo-9-cis-retinoic acid,CC(C=CC1=C(C)CCC(=O)C1(C)C)=CC=CC(C)=CC(=O)O,,,CC(C=CC1=C(C)CCC(=O)C1(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.48,O-glucuronidation
Tetrahydrocurcumin,COC1=CC(CCC(=O)C=C(O)CCC2=CC=C(O)C(OC)=C2)=CC=C1O,,,COC1=CC(CCC(O)=CC(=O)CCC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(OC)=C2)=CC=C1O,,UGT,0.43,O-glucuronidation
7-Hydroxy-3p-methoxyflavone,COC1=C(C2=CC=CC=C2)OC2=CC(O)=CC=C2C1=O,,,COC1=C(C2=CC=CC=C2)OC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C2C1=O,,UGT1A9,0.68,O-glucuronidation
"3-Hydroxy-5,7-dimethoxyflavone",COC1=CC(OC)=C2C(=O)C(O)=C(C3=CC=CC=C3)OC2=C1,,,COC1=CC(OC)=C2C(=O)C(OC3OC(C(=O)O)C(O)C(O)C3O)=C(C3=CC=CC=C3)OC2=C1,,UGT1A9,0.65,O-glucuronidation
Psilocin,CN(C)CCC1=CNC2=CC=CC(O)=C12,,,CN(C)CCC1=CNC2=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C12,,UGT1A9,0.51,O-glucuronidation
Apigenin,O=C1C=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C=C(C4=CC=C(O)C=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation
4-sec-Butylphenol,CCC(C)C1=CC=C(O)C=C1,,,CCC(C)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.21,O-glucuronidation
Isoferulic Acid,COC1=CC=C(C=CC(=O)O)C=C1O,,,COC1=CC=C(C=CC(=O)O)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.31,O-glucuronidation
DMXAA,CC1=CC=C2C(=O)C3=CC=CC(CC(=O)O)=C3OC2=C1C,,,CC1=CC=C2C(=O)C3=CC=CC(CC(=O)OC4OC(C(=O)O)C(O)C(O)C4O)=C3OC2=C1C,,"UGT1A9, UGT2B7",0.59,O-glucuronidation
"3,7-Dihydroxy-3p,4p,5p-trimethoxyflavone",COC1=CC(C2=C(O)C(=O)C3=CC=C(O)C=C3O2)=CC(OC)=C1OC,,,COC1=CC(C2=C(O)C(=O)C3=CC=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)=CC(OC)=C1OC,,UGT1A9,0.7,O-glucuronidation
"3,7-Dihydroxy-3p,4p,5p-trimethoxyflavone",COC1=CC(C2=C(O)C(=O)C3=CC=C(O)C=C3O2)=CC(OC)=C1OC,,,COC1=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=C(O)C=C3O2)=CC(OC)=C1OC,,UGT1A9,0.65,O-glucuronidation
4-nitrophenethyl bromide,O=[N+]([O-])C1=CC=C(CCBr)C=C1,,4-nitrophenethyl-glutathione,NC(CCC(O)=NC(CSCCC1=CC=C([N+](=O)[O-])C=C1)C(O)=NCC(=O)O)C(=O)O,,GST,0.29,GSH-conjugation of organohalide
Erlotinib M14,C#CC1=CC=CC(NC2=NC=NC3=CC(OCCO)=C(OCCOC)C=C23)=C1,,,C#CC1=CC=CC(NC2=NC=NC3=CC(OCCOC4OC(C(=O)O)C(O)C(O)C4O)=C(OCCOC)C=C23)=C1,,UGT,0.74,O-glucuronidation
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,,,CC(O)=NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,,NAT2,0.72,N-acetylation of arylamine
Phenylephrine,CNCC(O)C1=CC=CC(O)=C1,,,CNCC(O)C1=CC=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.29,O-glucuronidation
"AFB1exo 8,9-epoxide",COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C(O)COC1O2,,,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C(O2)OC(SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)C1O,,"GSTA1/A2, GSTM1/M3, GSTP1",0.88,GSH-conjugatoon
4-tert-Butylphenol,CC(C)(C)C1=CC=C(O)C=C1,,,CC(C)(C)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.19,O-glucuronidation
Melatonin,COC1=CC=C2NC=C(CCN=C(C)O)C2=C1,,,COC1=CC=C2C(=C1)C(CCN=C(C)O)=CN2C1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.45,O-glucuronidation
Propyl-4-hydroxybenzoate,CCCOC(=O)C1=CC=C(O)C=C1,,,CCCOC(=O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.29,Aromatic -OH glucuronidation
rac-4-hydroxynonenal,CCCCCC(O)C=CC=O,,S-(4-hydroxy-1-oxononan-3-yl)glutathione,CCCCCC(O)C(CC=O)SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.09,"GSH-conjugation of apha,beta-unsaturated carbonyl"
Epicatechin,OC1=CC(O)=C2CC(O)C(C3=CC=C(O)C(O)=C3)OC2=C1,,"5-(3',4'-dihydroxyphenyl)-gamma-valerolactone",O=C1CCC(CC2=CC=C(O)C(O)=C2)O1,,Unspecified gut bacterial enzyme,0.33,Flavan-3-ol C-ring fission
Epicatechin,OC1=CC(O)=C2CC(O)C(C3=CC=C(O)C(O)=C3)OC2=C1,,Phloroglucinol,OC1=CC(O)=CC(O)=C1,,Unspecified gut bacterial enzyme,0.07,Flavan-3-ol C-ring fission
Daidzein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC=C12,,Dihydrodazein,O=C1C2=CC=C(O)C=C2OCC1C1=CC=C(O)C=C1,,Unspecified bacterial dehydroxylase,0.22,4'-Deydroxylation of substitued benzene
Dihydrodazein,O=C1C2=CC=C(O)C=C2OCC1C1=CC=C(O)C=C1,,Tetrahydrodaidzein,OC1=CC=C(C2COC3=CC(O)=CC=C3C2O)C=C1,,Unspecified gut bacterial enzyme,0.64,Dehydration of isoflavanone
Quercitrin,CC1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,L-Rhamnose,CC1OC(O)C(O)C(O)C1O,,EC 3.2.1.X,0.22,Glycoside hydrolysis
Quercitrin,CC1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,Quercetin,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,EC 3.2.1.X,0.68,Glycoside hydrolysis
Quercitrin,CC1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,alpha-L-Rhamnose,CC1OC(O)C(O)C(O)C1O,,EC 3.2.1.40,0.22,Rhamnohydrolysis of alpha-L-rhamnoside
Quercetin,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,Dihydroquercetin,O=C1C2=C(O)C=C(O)C=C2OC(C2=CC=C(O)C(O)=C2)C1O,,Unspecified gut bacterial enzyme,0.31,Flavonoid C-ring reduction
3-hydroxyphenylacetic acid,O=C(O)CC1=CC=CC(O)=C1,,2-Phenylacetic acid,O=C(O)CC1=CC=CC=C1,,Unspecified bacterial dehydroxylase,0.62,3'-Deydroxylation of substitued benzene
4-hydroxyphenylacetic acid,O=C(O)CC1=CC=C(O)C=C1,,2-Phenylacetic acid,O=C(O)CC1=CC=CC=C1,,Unspecified bacterial dehydroxylase,0.72,4'-Deydroxylation of substitued benzene
"3,4-dihydroxyphenylacetic acid",O=C(O)CC1=CC=C(O)C(O)=C1,,3-hydroxyphenylacetic acid,O=C(O)CC1=CC=CC(O)=C1,,Unspecified bacterial dehydroxylase,0.82,Dehydroxylation of catechol
"3,4-dihydroxyphenylacetic acid",O=C(O)CC1=CC=C(O)C(O)=C1,,4-hydroxyphenylacetic acid,O=C(O)CC1=CC=C(O)C=C1,,Unspecified bacterial dehydroxylase,0.7,Dehydroxylation of catechol
"3,4-dihydroxyphenylacetic acid",O=C(O)CC1=CC=C(O)C(O)=C1,,Protocatehuic acid,O=C(O)C1=CC=C(O)C(O)=C1,,Unspecified gut bacterial enzyme,0.39,Alpha-oxidation of carboxylic acid
"3,4-dihydroxyphenylpropionic acid",O=C(O)CCC1=CC=C(O)C(O)=C1,,3-(3-hydroxyphenyl)propanoic acid,O=C(O)CCC1=CC=CC(O)=C1,,Unspecified bacterial dehydroxylase,0.83,Dehydroxylation of catechol
"3,4-dihydroxyphenylpropionic acid",O=C(O)CCC1=CC=C(O)C(O)=C1,,4-hydroxy- 4-Hydroxyphenylpropionic acid,O=C(O)CCC1=CC=C(O)C=C1,,Unspecified bacterial dehydroxylase,0.73,Dehydroxylation of catechol
Cyanidin,OC1=CC(O)=C2C=C(O)C(C3=CC=C(O)C(O)=C3)=[O+]C2=C1,,"2,4,6-Trihydroxybenzaldehyde",O=CC1=C(O)C=C(O)C=C1O,,Unspecified gut bacterial enzyme,0.12,Anthocyanidin C-ring fission
Cyanidin,OC1=CC(O)=C2C=C(O)C(C3=CC=C(O)C(O)=C3)=[O+]C2=C1,,"3,4-Dihydroxyphenylacetic acid",O=C(O)CC1=CC=C(O)C(O)=C1,,Unspecified gut bacterial enzyme,0.14,Anthocyanidin C-ring fission
Genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,Dihydrogenistein,O=C1C2=C(O)C=C(O)C=C2OCC1C1=CC=C(O)C=C1,,Unspecified bacterial isoflavone reductase,0.24,Reduction of isoflavone to isoflavanone
Dihydrogenistein,O=C1C2=C(O)C=C(O)C=C2OCC1C1=CC=C(O)C=C1,,,C=C(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,Unspecified gut bacterial enzyme,0.47,Isoflavanone C-ring fission
,C=C(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,6'-Hydroxy-O-desmethylangolensin,CC(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,EC 1.6.99.1,0.62,"Reduction of alpha,beta unsaturated carbon-carbon double bond adjacent to an electron withdrawing group"
,C=C(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,4-hydroxyphenyl-2-propenoic acid,C=C(C(=O)O)C1=CC=C(O)C=C1,,Unspecified gut bacterial enzyme,0.37,Keto hydrolysis
,C=C(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,Phloroglucinol,OC1=CC(O)=CC(O)=C1,,Unspecified gut bacterial enzyme,0.11,Keto hydrolysis
Sudan I,OC1=CC=C2C=CC=CC2=C1N=NC1=CC=CC=C1,,1-Amino-2-naphthol,NC1=C(O)C=CC2=CC=CC=C12,,EC 1.7.1.6,0.64,Reduction of azobenzene
